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ABSTRACT 
The use of antimicrobials in poultry may lead to the emergence of resistant micro-organisms 
that could cause additional health risk to humans through food consumption. This study aims 
to investigate the relative health risks from Campy/obaeter and its antimicrobial resistance 
associated with chicken raised in organic and intensive rearing systems. Three groups of 
chicken were tested, pre-packaged intensively reared (PIC) and pre-packaged organically 
reared chickens (POC) both purchased from supermarkets and unwrapped intensively 
reared (BIC) chickens purchased from butcher' shops in London. Thirty chickens were 
randomly sampled for each group. 
Campy/obaeter was isolated using three culture methods and enumerated using most 
probable number method (MPN). A modified MPN was also developed for the study. 
Resistance rates to three antimicrobials were determined using an agar dilution method. 
Numbers and antimicrobial resistance rates of eampy/obaeter were used in consumer risk 
models to calculate health risks. 
The BICs harboured significantly highest numbers of Campy/obaeter (8.0~O.81!og10MPN/g), 
followed by the POCs and PICs. All isolates from all groups of chickens were resistant to 
erythromycin and nalidixic acid. All isolates from the POCs were susceptible to ciprofioxacin, 
whereas 8.7% of the PICs and 26.7% of the BICs harboured resistant isolates. 
The calculated risk of Campy/obaeter associated illness related to the consumption of 
chicken meals using the dose response relationship model was found to be the highest for 
the BICs group (33% probability). However, this is the worst case scenario. If elevated 
internal temperatures (63°C-72°C) are achieved for a sufficient length of time (1-5 minutes), 
this risk is reduced to <1 %. High resistance rates to antimicrobials may generate additional 
risk where levels of infection are high. 
Potential intervention options for the reduction of Campy/obaeter load in chickens and the 
control of antimicrobial resistance were considered. The most significant factors found were 
the initial number of organisms, personal hygiene practices and cooking procedures. 
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CHAPTER 1 
Introduction 
1.1 Background of study 
Foodborne disease exerts a significant toll on human health (WHO, 2002a). Food and 
waterborne diarrhoeal diseases are leading causes of illness and death in less developed 
countries, killing approximately 2.1 million people annually, most of whom are children. Up to 
one-third of the populations of developed countries are affected by foodborne illnesses each 
year. Diarrhoea is the most common symptom of food borne illness; however, other serious 
symptoms such as organ failure, neural disorder and death can occur. Surveillance and 
monitoring in a number of countries indicate that foodborne illnesses are on the increase 
around the world. In the UK, the total number of food poisoning notifications has grown 
steadily from under 10,000 per annum in the early 1980s to around 90,000 cases in 1998 
(WHO, 2001 and Adak et al., 2002). 
Although the burden of foodborne diseases is not well documented in many countries, 
estimation of costs of illness in terms of medical costs and productivity losses has been 
reported in several countries. These estimations involve the valuation of life and health 
(Buzby and Roberts,1997). As reported by ERS (2003), it was estimated that in the United 
States 55-70% of public health costs were attributable to foodborne diseases. In the UK 
Campylobacter infection is estimated to have cost the nation over £ 113 million in 2000 
(ACMSF,2004). 
Campylobacter infection has been a public health concern for decades. This is because: i) 
Campylobacter has been recognised as the most commonly reported case of acute 
gastroenteritis in Europe and North America (Barton, 2000; Threfall et aI, 2000 and Randall 
et aI, 2003), ii) the incidence rate of infection as well as total annual costs of illness have 
been steadily increasing, iii) debilitating long-term complications (i.e. Guillain-Berre 
syndrome) following the infection can occur and cause fatalities, particularly in children, in 
elderly people, and in immuno-compromised groups. 
In addition, concerns have been intensifying after the emergence of f1uoroquinolone 
resistance in Campylobacter species (mainly C.jejuni and C.colt) which has been reported 
from many countries (Endtz et al., 1991 and Engberg et al., 2001). Antimicrobial resistance 
in Campylobacter is evidently a result of the introduction of antimicrobial agents into animal 
production (Michael 2001). The uses of antimicrobials in poultry farming are for therapy, 
prophylaxis and growth promotion. These administrations have been thought to be the 
crucial factor influencing the development of resistance to antimicrobials. Due to the 
propensity of bacteria to share genes, resistant genes can be transferred between bacterial 
cells, both within species and across species (Collette et aI, 2001). Some of these bacteria 
pass to humans through food consumption (mostly of animal origin) and directly cause 
diseases and act as potential sources of antimicrobial resistance for human pathogens 
(David and Steven, 2000 and Moore et al., 2001). 
To date poultry consumption has been increasing considerably worldwide. This is a result of 
a shift in consumption patterns due to increasing food prices, greater total food supplies, 
higher incomes, new information on nutrition and food safety, changes in lifestyles, and 
technological advances in food production and marketing. So far, to satisfy global demands 
for poultry and achieve a high yield, most poultry farming for commercial production uses 
genetically and environmentally manipulated methods in order to accelerate growth. The 
intensive conditions in which these birds live lead to increased health problems in the flocks 
(such as bacterial infections). Therefore, antimicrobials are applied to eliminate or prevent 
the infection. Antimicrobials are also used as growth promoters, diverting nutrition by 
maintaining a more effective and absorptive gut lining (Aarestrup and Wegener,1999). 
Since poultry has been recognised not only as the main animal food product for humans, but 
also as a significant source of Campylobacter infection, the consumption of chicken is highly 
likely to be a primary route for illnesses related to Campylobacter infection. If this organism 
also carries antimicrobial resistant genes, it would amplify the health risk to consumers, 
particularly, to vulnerable groups. The extent of this health risk from Campylobacter (with 
and without antimicrobial resistance) is becoming a public health concern (Barton, 2000; and 
Engberg et al., 2001). As a result, several national public health agencies have developed 
and established control measures and surveillance programmes for Campylobacter 
infections (Flint, et al. 2005). 
The issues involved, however, are multifactorial and the working groups established are 
correspondingly diverse. Although the WHO has attempted to be a link between various 
agencies, controversies and disagreement continue due to lack of internationally accepted 
standards on a number of issues (e.g. antimicrobial use, surveillance programmes and 
control measures). Accordingly, strategies and intervention programmes for mitigation of 
Campylobacter have been developed and implemented independently by different groups or 
agencies and there is little co-ordination (Laisney et al., 1991; FAO, 1997; FSAI, 2001; Kist, 
2002; FSA, 2003a and 1FT, 2004). 
A number of interventions have focused on the reduction of the burden of Campylobacter 
infection carried from farm to table as part of the drive to provide consumers with safe food 
(Bryan and Doyle,1995 and Kist, 2002). T~e interventions have been developed and 
documented following use of microbial risk assessment as a significant scientific tool to 
assess health risks following the consumption of poultry harbouring Campylobacter 
(Christensen et al., 2001; WHO, 2002b and 2002c; and Nauta et aI, 2005b). However, other 
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works have attempted to control the use of antimicrobials on the farms without referring to 
the numbers or prevalence of Campylobacter. This estimation of health risks associated with 
antimicrobial resistant Campylobacter was based on totally different assumptions (Cox and 
Popken, 2004; Hurd et al., 2004 and Bartholomew et aI., 2005). The interventions for the 
control of antimicrobial resistance are however not based on the risk assessment. Most 
countries opt to adopt withdrawal of antimicrobial use on the farms despite a notable lack of 
sufficient data to support the association between antimicrobial use in food-producing 
animals and antimicrobial resistance in humans (Endtz et al., 1991 and Engberg et al., 2004). 
Furthermore, the mitigation of this problem becomes more complicated when it is considered 
in the context of organic rearing systems. The conflict is that organically reared chickens 
have been found to harbour high numbers of Campylobacter, however, it is thought to be 
less resistant to antimicrobials due to the rearing practices (EC, 2002 and UK-OEFRA, 2005). 
These practices involve prudent use of antimicrobials on the farms. It may be assumed that 
the risk of antimicrobial resistant Campylobacter following the consumption of organic 
chickens should be less than that of intensively reared chickens. 
However, there have been no recent studies that consider the comparative health risks from 
Campylobacter (with and without antimicrobial resistance) following the consumption of 
chicken raised in different rearing systems. Therefore, the assumption stated above may 
mislead consumers' perception of rearing practices on chicken farms. The perception is that 
organic chickens are safer or of better quality than standard (intensively reared) chickens. 
This perception influences their choice of purchase (Hammitt, 1990 and Kist, 2002). In 
parallel, organically farmed chickens are being increasingly introduced to the market on the 
presumption that they are safer and free from antimicrobial-resistant bacteria. This has 
resulted in a price increase despite a notable lack of evidence to support this assumption. 
1.2 Aims and objectives 
Rationale 
This study investigates antimicrobial resistance in Campylobacter. Campylobacter has been 
selected for the study because it is recognised as the commonest reported case of 
gastroenteritis. The consumption of poultry (significant source of Campylobacter) has been 
increasing around the world. In addition, the emergence of resistance to antimicrobials, 
particularly to drugs of choice used for treatment in campylobacteriosis is becoming a public 
health concern. As antimicrobials are not permitted to be used for non-therapeutic purpose, 
organic chickens are unlikely to frequently expose to antimicrobials. As a result, organic 
chickens may harbour micro-organisms including Campylobacter that are less resistant to 
antimicrobials than those found in intensive chickens. 
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Aims 
The aims of this study are:i) to investigate and compare the levels of campy/obacter with and 
without antimicrobial resistance isolated from chickens reared in different methods, ii) to 
consider Its implication in terms of risk to human health in the development of risk 
management options to health risk and iii) to explore intervention options. In order to 
address these, this study will endeavour to answer the following questions: 
1. What are the levels of Campy/obacter isolated from chickens at retail outlets in which 
originate from the two different rearing systems (intensive and organic)? 
2. What is the resistance rate to three antimicrobial agents of Campy/obacter isolated from 
chickens raised in these two different rearing systems? 
3. What are the important factors for health (i.e. the numbers of Campy/obacter or the levels 
of antimicrobial resistance) as far as consumers are concerned? 
4. To what extent does Campy/obacter (with and without antimicrobial-resistance) impose a 
risk to human health following the consumption of chickens? 
5. How useful is microbial risk assessment as a scientific tool for food risk management in 
this context? 
The specific objectives of the study are: 
1. To isolate and to enumerate numbers of Campy/obacter in intensively and organically 
reared chickens at retail outlets, namely, pre-packaged intensively reared chickens (PIC), 
pre-packaged organically reared chickens (POC) (both purchased from supermarkets), 
and unwrapped intensively reared chickens (BIC) purchased from butchers'shop. 
2. To test antimicrobial susceptibility in Campy/obacter isolated from the three types of 
chickens. 
3. To estimate the exposure of the population to Campy/obacter with and without 
antimicrobial-resistance following the consumption of these three types of chicken. 
4. To link the exposure (dose) to Campy/obacter with and without antimicrobial-resistance 
with a dose-response relationship model in order to estimate the probability of infection 
and probability of illness in humans. 
5. To integrate the results and then critically assess the comparative risk associated with 
the consumption of chickens raised in these two rearing systems. 
6. To evaluate the usefulness of quantitative microbial risk assessment models and 
whether they can be used as a scientific tool for decision making (risk management). 
7. To further explore potential intervention options currently used by a number of agencies 
and prioritise in the light of the data collected. Proposals for changes and improvement 
will be considered. 
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1.3 Conceptual framework 
The conceptual framework of the study is as follows: i) microbiological experiments (i.e. 
identification and enumeration of Campy/obacter and antimicrobial susceptibility to three 
antimicrobial agents), ii) estimation of health risk using quantitative microbial risk 
assessment (QMRA) at the consumer level and iii) consideration of risk management 
options for mitigating the relative risk from Campy/obacter (with and without antimicrobial 
resistance) following the consumption of positive- Campy/obacter chickens raised in different 
rearing systems. This framework is shown in Figure 1.1. 
Phase 1 
Literature reviews 
Phase 2 
Secondary 
data/information 
(model 
parameters. 
hygiene 
parameters) 
Phase 3 
Control measures 
currently used 
(literature reviews) 
Microbiological 
experiments 
-three groups of chickens 
-three antimicrobial agents 
Risk models from other 
studies 
, 
Development of 
modified risk model 
for estimating ABR-
Campy/obacter (from 
this study) 
-
Detection 
(isolation and 
identification) 
I Enumeration 
Antimicrobial 
susceptibility 
testing 
Estimate of health risk of 
Campy/obaeter with and 
without antimicrobial 
resistance (three 
antimicrobials) : 
, 
Consideration of Risk 
management options for 
"" -reduction of Campy/obaeter 
I---------------:-.. ~ load in chicken 
-reduction of antimicrobial 
resistant Campy/obaeter 
* ABR = antimicrobial resistance 
Figure 1.1 A conceptual framework of the study 
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1.4 Structure of the thesis 
The thesis has been divided into ten chapters. Chapters 1-4 cover the general introduction, 
aims, objectives, conceptual framework and literature reviews. The literature reviews the 
concept of food safety and provides a context to the study (Chapter 2). It then goes on to 
review the information and studies specific to Campy/obacter and antimicrobial resistance 
(Chapter 3). Chapter 4 reviews the rearing practices in poultry farming including organic 
farming. Chapters 5 and 6 deal with Campy/obacter isolation and enumeration and 
antimicrobial susceptibility testing. Chapters 7 and 8 describe simulation methods for the 
estimation of health risk from Campy/obacter. Chapter 9 considers the implications for 
previousely recommended risk management options based on the findings from Chapters 5-
8. Chapter 10 summarises the conclusions, suggestions and future prospects. 
1.5 Publication 
Soonthornchailku N, Garelick H, Jones H, Jacobs J, Ball 0, Choudhury M. 2006. 
Resistance to three antimicrobial agents of Campy/obacter isolated from organically-reared 
and intensively-reared chickens purchased from retail outlets. Int J Antimicrob Agents 27: 
125-130. 
1.6 Presentations 
1. Soonthornchailkul N. Antibiotic resistance in Campy/obacter isolated from chicken. 
Postgraduate summer conference "Bringing Research to Life" Institute of Social and Health 
Research. School of Health and Social Sciences. Middlesex University. June 20th 2003. 
2. Soonthornchailkul N. Incidence and antibiotic resistance level of Campy/obacter isolated 
from intensive and organic chicken. Postgraduate summer conference "Relevance of 
research in the real world" Institute of Social and Health Research. School of Health and 
Social Sciences. Middlesex University. June 18th 2004. 
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CHAPTER 2 
Microbiological Food Safety 
2.1 Food Safety 
This chapter reviews the literature related to microbiological food safety aiming to provide 
the context in which study of Campylobacter in chicken is carried out. The literature review 
related specifically to Campylobacter and antimicrobial resistance is presented in Chapter 3. 
2.1.1 Background 
With the growing global population, improved transportation and communication, the rapid 
globalisation of food production, processing, distribution and trade, food production has 
become more industrialised. As the supply chain has lengthened, people are becoming 
increasingly concerned about the potential for international incidents involving contaminated 
food and related health risks. The increase in consumers' concerns about health risks from 
food has been highlighted by well publicised food scares such as BSE and outbreaks and of 
food poisoning caused by E.coli, Listeria and Salmonella. This has led to regulartory actions 
over the past twenty years aim at improving the quality of food products and preventing 
foodborne hazards and illnesses. 
WHO asserts that ensuring food safety is an essential function to protect public health from 
foodborne hazards. Accordingly, food safety must be addressed along the entire food chain 
with measures based on sound scientific information at both national and international levels. 
In the last decade food safety has emerged as significant global issue with public health and 
international trade implications (Buzby and Roberts, 1999 and Satcher, 2000). These shifts 
have also been motivated by growing public demand for continuous improvement in food 
safety. As a result, food safety authorities all over the world have acknowledged that food 
safety must be tackled not only at the national level but also through closer linkages among 
food safety authorities at the international level. It is important to exchange routine 
information on food safety issues and to have rapid access to information in case of food 
hazard emergencies. 
There are a number of factors that have led both developing and industrialised countries to 
establish regulatory systems of food safety. These factors include: the emergence of 
food borne hazards and illnesses; the increasing knowledge and awareness of foodborne 
diseases; the development of advance technologies allowing more accurate detection 
methods for contaminants in foods; changes in lifestyle, particularly, in food consumption 
patterns (i.e. eating outside the home, buying ready-to-eat meal); the increasing numbers of 
compromised hosts ( such as AIDS patients. a great number of elderly people in population); 
expanded food production and international trade; increasing international travel. The 
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complex linkages between food, technology, pathogens and consumers make it unlikely that 
the marketplace will be ever entirely free from food hazards. Furthermore, while the cost of 
foodborne illness estimated by socio-economic methods is so hingh, so is the cost of control, 
so a compromise has to be turned. The costs of illness and premature death for a number of 
food borne illnesses have been used in regulatory cost-benefit and impact analyses in the 
US (Golan, 2003). Like all cost estimates, the estimations include assumptions about 
disease incidence, outcome severity, and the level of medical, productivity, and disutility 
costs. Changes to any of these assumptions could change the cost estimations and, as a 
result, change the way policymakers rank the risks, prioritise spending, and formulate food 
safety policies. A sound intervention will induce and further urge manufacturers, regulatory 
and public health agencies and allied organisations to develop partnerships to improve food 
safety management. 
2.1.2 International food safety standards 
The growth in world food trade, advance technology, transportation and the increasing 
mobility of populations are contributing factors to public concern related to food safety, in 
general and the increasing of emergence of food-borne diseases in particular. Consumers 
are more aware of food safety and health issues. As a result, consumers are demanding 
ever greater assurances about the safety and quality of foods they eat. Based on health 
considerations, the Sixteenth World Health Assembly approved the establishment of the joint 
Food and Agriculture Organisation of the United Nations (FAOIWHO) Food Standards 
Programme, with the Codex Alimentarius Commission (CAC) as its principal organ. Its 
headquater is based in Geneva as part pf the WHO strcture. The CAC has been involved in 
setting many international standards in food safety (WHO, 2002b) in order to promote food 
safety and quality and strengthen partnerships with all stakeholders. These include 
consumers and their representative organisations at the global and national level. The CAC 
relies on the opinions of scientific expert committees or consultations convened by FAO and 
WHO on specific issues. The CAC, FAO and WHO have strong interest in promoting 
national regulatory systems that are based on international principles and guidelines and 
address all components of the food chain. However, members may maintain or introduce 
measures which result in higher standards if there is scientific justification or as a 
consequence of decisions based on an appropriate risk assessment. In 1995, the members 
of the World Trade Organisation (WTO, 1995) have agreed on Sanitary and Phytosanitary 
Barriers (the SPS agreement), involving the introduction of international standards, 
guidelines and recommendations. This Agreement identifies procedures and criteria for the 
assessment of risk and the determination of appropriate levels of sanitary or phytosanitary 
protection based on practice in individual countries. 
The changes in the methods of food production have induced new risks and increased the 
risk of infectious agents being disseminated from the original pOint of production to 
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consumers. Further challenges arise from the new emergence and re-emergence of food-
borne pathogens. Consequently, there is an increased risk to human health as well as 
implications for international trade in food and ultimately food producers. The need for risk 
based scientific advice has been increasing (FAO, 2004). The CAC has introduced a food 
safety system and developed microbial risk analysis as a useful tool to inform actions and 
decisions aimed at improving food safety and made it equally available to both developing 
and developed countries (FAO, 2006) 
The EU integrated approach to food safety aims to assure a high level of food safety, animal 
health, animal welfare and plant health through coherent farm-to-table measures and 
adequate monitoring, while ensuring the effective functioning of the internal market. The 
European Food Safety Authority (EFSA) is the keystone in the provision of risk assessment 
and guidelines in the EU regarding food and feed safety. In close collaboration with national 
authorities and in open consultation with its stakeholders, EFSA provides independent 
scientific advice and clear communication on existing and emerging risks. EFSA also 
ensures that risk management is performed following science-based finding (EFSA, 2006). 
The Swiss Federal Office of Public Health (SFOPH) is the keystone for foodborne disease 
surveillance in Switzerland. The SFOPH collects information on foodborne infections and 
intoxications from regional health authorities. The Swiss Reporting System legally requires 
the federally registered laboratories to report identifications of all agents listed in the 
Regulation on Disease Notification of 1999 to the SFOPH. Therefore, only cases that are 
caused by the agents listed are reported. It is assumed that the numbers of reported cases 
of foodborne diseases represent a small fraction of their real number (WHO, 2003). 
2.1.3 The field of food safety 
Food safety associated with hazards in the food chain (Figure 2.1) can be classified into 
three categories. These are based on physical, chemical and biological hazards (Wag strom , 
2004). Each of these hazards needs to be considered separately when assessing food 
safety risks or when designing a food safety intervention programme. In addition, they must 
be considered in relation to the periods of time involved in the food chain and production line 
(Callaway et al., 2003 and Wagstrom, 2004). These periods are related to animal husbandry: 
~ Pre-harvest includes the time in an animal's life from birth (hatching) to loading onto 
transport to the processing plant. 
~ Peri-harvest accounts for the time after an animal leaves the farm up to the time that it 
reaches the processing plant. 
~ Post-harvest is the time from processing plant to consumer, including in-plant and 
distribution processes. 
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Figure 2.1 The food chain from production to consumption (adapted from Liu et al., 1999) 
2.2 Foodborne Disease 
Foodborne diseases including intoxication, infection and toxicoinfection (Figure 2.2), are 
illnesses caused by pathogens and their toxins entering the body through the consumption 
of contaminated food and drink, or through person-to-person contact (WHO, 2002a). Such 
contaminations usually arise from improper production, handling, preparation or storage of 
food. The pathogens and their toxins can damage or destroy host cells, or induce harmful 
host responses to their presence (1FT, 2002). 
When pathogenic micro-organisms are ingested, they colonised the intestine and sometimes 
invade the mucosa or other tissues. Illness can also be caused by adding pesticides or 
medicines to food, or by accidentally consuming naturally poisonous substances (e.g. 
poisonous mushrooms, reef fish). In addition, contact between food and pests, especially 
flies, rodents and cockroaches may cause further contamination of food. Some common 
gastroenteritis may be occasionally transmitted through the water vector (waterborne 
pathogens), or other routes, e.g. soil, work surfaces, public beaches, irrigation canals, ect . 
These include infections caused by Shigella, Hepatitis A, and Giardia lamblia and 
Cryptosporidium parvum. 
Foodborne diseases are one of the main causes of morbidity and mortality worldwide. It is 
possible to assume that every person is at risk of foodborne illness, in particular, young 
children less than 5 years in developing countries (WHO, 2002a). 
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Figure 2.2 A classification of the causes of foodborne disease (adapted from Buzby et 81.,1996) 
2.2.1 Clinical features 
Most foodborne diseases are characterised by symptoms limited to the gastrointestinal tract. 
After the ingestion of contaminated food or drink, microbes pass through the stomach into 
the intestine, attaching to the cells lining the intestinal walls and multiplying there. Some 
types of microbes stay in the intestine. Some produce a toxin that is absorbed into the 
bloodstream, and some can directly invade the deeper body tissues. The symptoms may 
appear immediately or may be delayed depending on the pathogenic agents involved (Table 
2.1 ). 
The incubation period (the delay between consumption of a contaminated food and 
appearance of the first symptoms) ranges from hours to days depending on the host, agent 
and infective dose, which varies according to the agent and the consumer's age and health 
status. 
Most cases of food borne illnesses are acute as they have a short incubation period and are 
self-limiting. Acute symptoms including diarrhoea, vomiting, or other gastrointestinal 
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manifestations such as dysentery and range from mild to severe and may even result in 
premature death. However, other pathophysiologic responses may occur independently or 
accompany acute-phase responses. Chronic sequelae which may impact on the remainder 
of a patient's life can occur following the acute phase, including ankylosing spondylitis, 
arthropathies, renal disease, cardiac and neurologic disorders, and nutritional and other 
malabsorptive disorders (Archer and Young, 1988; Foegeding, 1994; Bunning, 1994 and 
Bunning et al., 1997). For example, reactive arthritis and Guillain-Barre syndrome may follow 
campylobacteriosis (Mishu et al., 1993). 
There may be one or more symptoms involved. These may be nausea, vomiting, abdominal 
pain, diarrhoea, fever, headache and tiredness. However, some foodborne pathogens 
invade deeper tissues or produce toxins that are absorbed and cause systemic symptoms 
(e.g. fever, kidney failure, paralysis). Most cases without underlying illness fully recover 
without medical treatment or they may require only supportive care. However, some 
pathogens cause more severe symptoms and take longer time to subside, in particular, in 
vulnerable groups or immunocompromised hosts (i.e. young children, pregnant women, 
elderly people, and patients with immuno-suppressive administration). These complications 
can cause permanent health problems (e.g. Guillain-Barre syndrome) or even death 
(Bunning et al., 1997). 
Table 2.1 Major foodborne microbes by major presenting gastrointestinal symptoms 
(modified from CDC, 2001 ) 
Probable Microbes Incubation Period Probable food sources 
Staphylococcus aureus 1-6 hours Prepared food (eg, 
salads, dairy, meat} 
Bacillus cereus 1-6 hours Rice, meat 
Noroviruses (Norwalk-like 24-48 hours Shellfish, prepared food, 
viruses} salads, fruit sandwiches 
Clostridium eerfring,ens 8-16 hours Meat, ~oultry, gravy 
Enteric viruses 10-72 hours Faeces-contaminated 
food or water 
Enterotoxigenic 1-3 days Faeces- contaminated 
Escherichia coli food or water 
CY.,closeora caY.,etanensis 1-11 da~s Im~orted berries, basil 
Clostridium parvum 2-28 days Vegetables, fruit, water, 
un~asteurised milk 
Vibrio earahemolyticus 2-48 hours Raw shellfish 
Non-typhoidal Salmonella 1-3 days Eggs, poultry, meat, 
species unpasteurised milk or 
juice, fresh ~roduce 
Shigella species 1-3 days Faeces-contaminated 
food and water 
Shiga toxin-producing 1-8 days Ground beef, water 
Escherichia coli unpasteurised milk, 
juice, raw vegetables, 
Campylobacter species 2-5 days Poultry, water 
un~asteurised milk 
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2.2.2 Etiological agents 
Foodborne diseases can be caused by a variety of pathogenic agents including bacteria, 
viruses and parasites, toxins and prions. More than 250 different foodborne diseases have 
been described (CDC, 2001). Other diseases include poisonings caused by harmful toxins 
or chemicals that have contaminated the food, for example, poisonous mushrooms. The 
world Health Organisation (WHO, 2002a) indicated that the most virulent foodborne 
diseases and foodborne pathogens causing illness are Bovine spongiform encephalopathy 
(BSE), Campylobacter, Escherichia coli, Salmonella and Shigella. 
Pathogenic bacteria 
Bacterial infections are the most common cause of food poisoning. Bean and Griffin (1990) 
reported that 90% of confirmed foodborne illness cases and death reported to the Centers 
for Disease Control and Prevention (CDC) are attributed to bacteria. In the United Kingdom 
during 2000 the following pathogens were identified: Campylobacter jejuni 77.3%, 
Salmonella 20.9%, Escherichia coli 0157:H7 1.4%, with others accounting for less than 
0.1% . 
Many pathogens, including Salmonella, Escherichia coli 0157:H7, Campylobacter, and 
Yersinia enterocolitica, have reservoirs in healthy food animals, from which they spread to 
variety of foods. Whilst Campylobacter can colonise the intestinal tract of some poultry 
without any associated clinical consequences, people who consume undercooked chicken 
from contaminated chicken can get ill. 
Farm livestock colonised with foodborne pathogenic bacteria may spread the infection 
among the herd or flock through water or their manure. After processing at the 
slaughterhouse, the contaminated meat eventually passes through the food chain to 
consumers. In the past, the main challenge of foodborne disease prevention lay in 
interventions to prevent the contamination of human food with sewage or animal manure or 
in the prevention of spoilage. It is now recognised that this is not sufficient and that the 
challenge now is to prevent contamination of food throughout production to consumption as 
contamination may occur at any point in the food chain: on the farm, during slaughter and 
processing, at the point of sale, or in the home. Thus, the Economic Research Service (ERS) 
of the US Department of Agriculture (ERS, 2003) measures the costs of foodborne diseases 
caused by such contamination as well as evaluating the economic consequences of efforts 
to control contamination by industries and consumers. 
In addition, some bacteria, for example, clostridium botulinum, clostridium perfringens and 
staphylococcus aureus, excrete exotoxins during bacterial growth. These exotoxins can 
cause illness even when the microbes that produced them have been killed. Symptoms 
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typically appear after 1-6 hours depending on the amount of toxin ingested. Table 2.2 shows 
the common food vehicles for pathogenic bacteria causing illness to humans. 
Table 2.2 Common food vehicles for pathogens 
Pathogen Food sources 
Major: poultry. 
Campylobacter jejuni or coli Minor: milk, mushrooms, clams, hamburger, water, cheese, 
pork, shellfish, eggs, cake icing. 
Major: meat, meat stews, meat pies, and beef, turkey, and 
Clostridium perfringens chicken gravies. 
Minor: beans, seafood. 
Major: beef particularly ground beef. 
Escherichia coli 0157:H7 Minor: poultry, apple cider, raw milk, vegetables, cantaloupe, 
hot dogs, mayonnaise, salad bar items. 
Major: soft cheese, pate, ground meat. 
Listeria monocytogenes Minor: poultry, dairy products, hot dogs, potato salad, 
chicken, seafood, vegetables. 
Salmonella (non-typhoid) Major: poultry, meat, eggs, milk, and their products. 
Minor: vegetables, fruits, chocolate, peanuts, shellfish. 
Major: workers handling foods: meat (especially sliced meat) 
Staphylococcus aureus poultry, fish, canned mushrooms. 
Minor: dairy products, prepared salad dressing, ham, salami, 
bakery items, custards, cheese. 
Vibrio spp. Major: oysters. 
Minor: other seafood. 
Other pathogens 
Viruses 
Viral infections make up perhaps one third of cases of food poisoning in developed countries. 
They are usually of intermediate (1-3 days) incubation period and cause illnesses which are 
self-limited in otherwise healthy individuals. The symptoms are similar to the bacterial forms 
described above. The common viruses are norovirus (formerly Norwalk virus), rotavirus, 
hepatitis A and hepatitis E. 
Parasites 
Most foodborne parasite infections are Zoonoses including platyhelminthes, Taenia saginata, 
Taenia solium, Fasciola hepatica, tapeworm, nematode and protozoa. 
Natural toxins 
Several foods contain naturally occurring toxins such as aflatoxin, alkaloid, ciguatera toxin, 
mushroom toxin, phytohaemagglutinin, pyrrolizidine alkaloid, shellfish toxin, scombrotoxin 
and tetrodotoxin. 
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Prions 
Prions are a unique type of infectious agent which is an abnormally-structured form of a 
protein found in the brain. Prions are believed to be the etiological agent for some diseases, 
for example, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker disease 
(GSS), fatal familial insomnia (FFI), and kuru in humans, and SSE and scrapie in animals. 
2.2.3 Incidence 
Surveillance and monitoring systems in a number of countries indicate that foodborne 
diseases are increasing around the world (Sockett, 1993; Henson, 1996 and WHO, 1997). 
The Centre for Disease Control and Prevention (CDC) estimates that in the United States, 
approximately 76 million persons contract foodborne illnesses each year, resulting in 
325,000 hospitalizations and 5,000 deaths (ERS, 2003). In England and Wales (from 1996 
to 2000), an estimated 1,724,315 cases of indigenous foodborne disease occurred per year 
(3,400 cases for 100,000 inhabitants) resulting in 21,997 hospitalizations and 687 deaths 
(Adak et aI., 2005). There were 750,000 cases in France (1,210 cases per 100,000 
inhabitants). In Australia, notification rates for both campylobacteriosis and salmonellosis 
(common foodborne illnesses) have continued to increase annually. 
2.3 Microbial Risk Analysis 
2.3.1 Introduction 
Foodborne diseases caused by pathogenic micro-organisms occur when persons consume 
food(s) contaminated with bacteria, viruses or parasites. Changes in pathogens, food 
preparation, distribution, consumption, and population immunity have the potential to 
adversely affect human health and the epidemiology of foodborne diseases. This 
persistence of the disease burden from food poisoning to public health may lead to a 
constant threat and new problems emerging, resulting in a major impact on the food industry, 
government and consumers. Food production and processing, the distribution system and 
consumption can amplify or attenuate the trend and are a potential source of health hazards. 
Predicting the impact of a trend in one part of the food continuum requires an understanding 
of the whole system. As a full understanding of pathogen contamination, infection, and 
survival is difficult, a systematic approach to assess the impact of the pathogen on human 
health may improve the quality of public health decisions (WHO, 2002b). 
Quantitative risk analysis used in environmental toxicology is a possible approach for 
managing foodborne diseases. In an attempt to address this, risk analysis has been 
developed as one of the measures for food safety management. This includes improvement 
of the understanding of health consequences of foodborne hazards and their associated 
costs (Schlundt, 2000). However, each country has its own perception, concerns, 
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acceptance, policy and priorities. Buzby and Roberts (1999) pOinted out that consumer 
perceptions of food safety are influenced by a complex function of factors. These include 
baseline food safety and risk levels, information on food safety and food risks, public trust in 
the source of information, and experiences and backgrounds with food safety incidents. In 
addition, there may be basic differences in how people view and value the consequences of 
food borne illness. 
Post (2005) observed that conflicts over food safety standards have emerged as one of the 
most controversial international trade issues in recent years. By consideration of the uptake 
of the two standards across four very different regulatory environments, the United States, 
the European Union, Argentina, and the Dominican Republic, the major finding of Post (2005) 
is that the role of interest groups is of much less importance than theories of political 
economy. The World Trade Organization (WTO) has encouraged countries to adopt food 
safety standards facilitated by the Codex Alimentarius Commission (CAC) in order to 
remove non-tariff barriers to trade (WTO, 1995). As recommended by the Codex, Hazard 
Analysis and Critical Control Point (HACCP) is currently regarded as the most effective 
international standard for processing safe food worldwide (CFSAN, 1998; CAC, 2002a and 
1FT, 2004). 
For the World Health Organisation (WHO) and the Food and Agriculture Organisation of the 
United Nations (FAO), the prevention of foodborne and waterborne diseases remains a 
major task of these organisations. In this context effective prevention requires a well-
balanced set of management strategies. Hence, the CAC has played a central role in 
developing and standardising the risk analysis for the evaluation of the safety of food and 
water supplies at an international level. 
In addition, in 1993 the Uruguay Round of General Agreement on Tariffs and Trade (GATT) 
resolved the barriers to the international trade in food. In this agreement attention is 
particularly focused on public health, and health concerns take precedence over trade 
issues. The agreement requires that food safety measures taken by individual countries 
should: 
~ be applied only to the extent required to protect human health; 
~ be based on scientific principles; 
~ not be maintained without scientific evidence; 
~ be based on the assessment of the risk to health that is appropriate to the circumstance. 
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Based on the application of the SPS 1, the WTO refers to the term 'an appropriate level of 
protection' (ALOP)2 against risks to human life or health, or to animal and plant life (WTO, 
1995). The ALOP focuses on public health related to the disease burden associated with a 
particular hazard! food combination (WHO, 2002b). This statement indicates that a zero-risk 
approach is not suitable for a country with a significant trade in agricultural commodities. So 
far, this concept has been perceived by many WTO members as being about compromised 
and acceptable risk. Since the complete elimination of risks from food production and 
consumption is an impossible goal, the reduction of risk to as low as reasonably achievable 
(ALARA) would be an alternative approach for establishing risk management options (WHO, 
2000b). 
Microbial risk analysis is an analytical tool for estimating specific risks associated with the 
microbial contamination of food and food products and indicating how particular production-
to-consumption processes or practice contribute to the risks. It also provides risk decision-
makers with information which helps them to assess the effectiveness of different 
interventions from production to consumption (farm-to-fork) chain. 
A framework of risk analysis defined by the CAC comprises of: risk assessment; risk 
management and risk communication (Figure 2.3) 
+-+---. Management 
Policy based 
Figure 2.3 Risk analysis framework (adopted from CAG, 2002b) 
1 Sanitary and Phytosanitary Measures refer to any measure, procedure, requirement, or regulation, 
taken by governments to protect human, ~nimal, or. plant life or health.f.rom the ~sks arising fro.m the 
spread of pests, diseases, disease-causing organisms, or from additives, tOXinS, or contaminants 
found in food beverages, or feedstuffs. 
2 An appropri~te level of protection (ALOP) is ~ statement of the degree of public ~ealth protectio~ f~om 
a particular hazard or food that is to be achieved by the food safety systems Implemented within a 
country 
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2.3.2 Microbial risk assessment (MRA) 
This tool is an extension of the principles of chemical risk assessment to estimate the 
consequences and occurrence of exposures to pathogenic micro-organisms (Hathaway, 
2001; Brown and Sringer, 2002 and WHO, 2002b) (Figure 2.4). The performance of MRA 
will always be limited by the availability of data. In spite of this, risk assessments leading to 
management options are undertaken based on expert opinions and assumptions which can 
be validated. 
(a) Chemicals (b)Microbiological agents 
Food safety Food safety 
objectives objectives 
r , 
Food safety policy Quantitative risk 
analysis 
,Ir 
,Ir 
Appropriate level 
of protection 
(ALOP) 
Appropriate level 
of protection 
(ALOP) 
" 
Quantitative risk 
analysis 
'F Ir 
Incorporation in 
HACCP 
Incorporation in 
HACCP 
Figure 2.4 Generic framework of current food safety systems developed for chemicals and 
microbiological agents (adapted from Hathaway, 2001; Brown and Stringer, 2002 and 
WHO,2002b) 
The ad hoc Joint FAOIWHO Expert Meetings on Microbial Risk Assessment (JEMRA) have 
developed and conducted a series of risk assessments for food borne microbiological 
hazards at the international level (WHO, 2000). The JEMRA aims to provide a scientific 
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basis for the relevant risk management deliberations of the CAC, whose purpose is to 
develop food standards, guidelines and related texts aimed at protecting consumer health 
and ensuring fair food trade practices. 
Scope of microbial risk assessment 
The body of MRA is based on the critical reviews of the best available scientific evidence 
and consensus, and is derived by integrating information related to adverse health effects. 
The process defined by the CAC is a scientifically based process consisting of four 
components (Figure 2.5) (CAC, 2002b). 
, 
Hazard 
Characterisation 
Hazard 
Identification 
, 
Risk 
Characterisation 
Exposure 
Assessment 
Figure 2.5 Components of microbial risk assessment (adopted from CAC, 2002b) 
The definitions of these four components are: 
~ Hazard identification predominantly intends to identify micro-organisms or microbial 
toxins of concern in food or water. It must include as much information on the hazard of 
concern as possible. 
~ Hazard characterisation provides a description of the nature of adverse health effects 
that may result from ingestion of a micro-organism. It also focuses on how to quantitatively 
assess the relationship between the magnitude of food borne exposure and the likelihood of 
adverse health effects occurring. 
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~ Exposure assessment should provide an estimate, with the associated uncertainty, of 
the occurrence and level of the pathogen in a specified portion of food at the time of 
consumption, or in a specified volume of water using a production-to-consumption approach. 
Whilst a mean value may be used, more accurate estimates will include and estimate the 
distribution of exposures. This will typically include identification of the annual food and 
water consumption frequencies and weights or volumes for a given population or 
subpopulations, and should combine the information to estimate exposure to pathogens in a 
population through a certain food or water commodity. When data are available, the 
exposure assessment model should be developed. Finally, the likelihood and magnitude of 
exposure to the pathogen of concern following the consumption of the food of interests is 
quantified. 
~ Risk characterisation is performed by the consideration of the results of the hazard 
identification, hazard characterisation and exposure assessment. This is an integration of 
the three previous steps in order to obtain a risk estimate (i.e., an estimate of the likelihood 
and severity of the adverse health effects that would occur in a given population, with the 
associated uncertainties). 
Brown and Stringer (2002) indicated that with the definitions shown above, an MRA is still 
relatively new and emerging discipline. Although to date some groups of researchers from 
European countries and New Zealand (Lake, et al. 2003) have attempted to perform 
MRAlQMRA, it appears that few studies for formal MRA have been completed. Additionally, 
there are many problems related to the availability of relevant data (both quantitative and 
qualitative) or to issues of handling of variability and uncertainty. Furthermore, each step of 
MRA undertaken is based on an individual opinion and assumption of each working group 
and is influenced by the limited availability of trained personnel. Debates have continued 
over the methodology, for example, how best to model the inputs of the hazard to the supply 
chain and the resulting outputs with products, and how to express the output of risk 
assessment in a way that is both accurate and meaningful to food safety managers and 
consumers. 
Uncertainty and variability in the risk assessment process 
Health-risk assessment is a quantitative evaluation and integration of information and 
relevant scientific data on potential health hazards from exposure to various agents (e.g. 
chemical, biological agents). There are many factors which may be defined as variable or 
uncertain. The variability refers to real and identifiable differences, which are attributable to 
the diversity in biological sensitivity and to exposure parameters, between individuals within 
a population. These differences can be better understood, but are not reduced by further 
research. On the other hand, uncertainty refers to the lack of knowledge about specific 
factors, parameters or models. Although in some cases, this may be reduced through further 
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study or better information, it may not always be possible (USEPA, 1997 and Thompson, 
2002). 
There are three types of variability defined by US Environmental Protection Agency (1997), 
which are: 
~Spatial variability can occur at both macro-scale and micro-scale. For example, the level 
of contamination of bacteria in animal foods can significantly vary depending on the region 
or country or farm. 
~ Temporal variability refers to the variations that occur over time and may relate to a 
short-term or long-term situation, for example, seasonal variation. 
~ Inter-receptor variability can be related to two main factors: i) human characteristics (i.e. 
age, gender, body weight) and ii) human behaviours (i.e. consumption pattern, personal 
hygiene). 
The types of uncertainty are categorised as follows: 
~ Parameter uncertainty occurs from the estimation of values from limited data or 
incomplete information, for example, the errors from measurement, sampling. 
~ Modelling uncertainty arises from the use of inadequate or inappropriate models to 
perform the assessment and also from the deficiencies of the models in representing reality. 
~Completeness or scenario uncertainty relates to the inability of the analyst to evaluate 
all contributions to the risk model. This refers to the problem of assessing what may have 
been omitted in analysis. 
2.3.3 Food risk management 
Risk management is the process of weighing policy alternatives to accept, minimise or 
reduce risks associated with food. The goal of management is to protect public health by 
controlling such risks as effectively as possible through the selection and implementation of 
appropriate measures (FAO, 1997). 
Based on the SPS Agreement, food risk management must consider the measures that 
protect human, animal or plant life or health within its territory (CAC, 2002a). The SPS 
Agreement defines a certain level of protection for foodborne microbiological hazard which is 
to an Appropriate Level of Protection (ALOP). This level of protection is a reflection of a 
particular country's expressed public health goals for a microbiological hazard(s) associated 
with a food. It is deemed appropriate by the individual country. 
General principles of food risk management 
The implementation of risk management options should be based on principles and 
strategies that explain the approach taken to risk and safety. Generally, these require 
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balancing of the risk reduction against other factors such as costs and benefits and (even in 
same cases) public perception. The World Health Organization (WHO, 2000) proposed 
same general principles of food safety risk management so as to achieve the goal of food 
risk management, which are: 
~"Risk management should follow a structured approach including risk evaluation, risk 
management option assessment, implementation of management decisions and monitoring 
and review. However, it is not necessary for all of these elements to be included in risk 
management activities." 
~ "Protection of human health should be the primary consideration in risk management 
decisions. Decisions on acceptable levels of risk should be justified by human health 
considerations. Considerations of other factors (i.e. economics, benefits, technical feasibility 
and societal preferences) may be taken into account for some appropriate risk management 
contexts. These considerations should be prioritised and explicit." 
~"Risk management decisions and practices should be transparent. The identification and 
systematic documentation of all elements of a risk management process should be included 
so that the rationale is transparent to all interested parties." 
~"Determination of risk assessment policy should be included as a specific component of 
risk management. Risk assessment policy documents the guidelines for value judgements 
and policy choices which may need to be applied at specific decision points in the risk 
assessment process. This should be carried out in advance of risk assessment and in 
collaboration with risk assessors." 
~ "Risk management should ensure the scientific integrity of the risk assessment process by 
maintaining the functional separation of risk management and risk assessment. This would 
reduce any conflict of interests between risk assessment and risk management." 
~"Risk management decisions should take into account uncertainty in the output of the risk 
assessment. The estimates of risk should clearly express not only the variables, but also the 
uncertainties. The full implications of the range of uncertainty can be taken into account for 
the risk management decision. If the risk estimation involves high uncertainty, the risk 
management decision should be more conservative." 
~"Risk management should include clear and interactive communication with consumers 
and other interested parties concerning all aspects of process. Risk communication is 
essential for risk management to disseminate the information and opinion to public." 
~"Risk management should be a continuing process that takes into account all newly 
generated data in the evaluation and review of risk management decisions." 
Risk management framework 
The primary goal of the management of risks associated with the consumption of food 
contaminated with micro-organism is to protect public health by controlling such risks as 
effectively as possible through the selection and implementation of appropriate measures 
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(FAO, 1997). As recommended by the CAC (CAC, 2002a), risk management should be 
conceptualised following the framework illustrated in Figure 2.6. 
Monitoring & 
Review 
Evaluation 
Implementation 
Option 
assessment 
Figure 2.6 Risk management framework (adopted from WHO, 2000) 
The four elements of the framework are: 
~ Preliminary risk assessment activities include the establishment of a risk profile, 
facilitating consideration of the issue within a particular context and provide as much 
information as possible to guide further action (Thompson and Graham, 1996; FAO, 1997 
and WHO, 2000). As a result of this process, the risk manager may commit to carry out a 
risk assessment as an independent scientific process to inform decision-making. The 
evaluation of risk management options will require information on: 
- Identification of a food safety problem 
- Establishment of a risk profile 
- Ranking of the hazard for risk assessment and risk management 
- Establishment of risk assessment policy for conduct of risk assessment 
- Commissioning of risk assessment 
- Consideration of risk assessment result 
~ Evaluation of risk management options is the process of weighing available options for 
managing a food safety issue. It is based on the scientific information on risks and other 
factors and may include a decision on an appropriate level of consumer protection (8all and 
Goats, 1996 and CFSAN, 1998). An important goal is to optimise food control measures, 
which must be efficient, effective and practical, and technological feasibility at selected 
points throughout the food-chain. A cost-benefit analysis could be performed at this stage 
(Cox, 2002). This process will likely be considered by a risk manager in relation to: 
- Identification of available management options 
_ Selection of a preferable management option, including consideration of an appropriate 
safety standard dependent on the level of acceptable risk 
- Final management decision 
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~Implementation of risk management decision: This will usually involve regulatory food 
safety measures. Flexibility in the choice of individual measures applied by industry is a 
desirable element as long as the overall programme can be objectively shown to achieve the 
stated goals. Ongoing verification of the application of food safety measures is essential. 
~ Monitoring and review: This final step of risk management considers the assessment of 
effectiveness of measures taken and, if necessary, reviews risk management decisions and 
risk assessment. It needs the gathering and analysis of data in order to give an overview of 
food safety and consumer health. Monitoring of contaminants in food and foodborne disease 
surveillance should identify new food safety problems as they emerge. Where there is 
evidence that the goals are not being achieved, redesign of food safety measures is needed. 
The outcome, following the application of the framework, should provide the available risk 
management options in order that risk manager can make a decision on the intervention. In 
arriving at the decision, human health protection should be the primary consideration over 
other factors (e.g. economic costs, benefits, technical feasibility, risk perceptions, etc.). The 
measures must be effectively able to reduce the prevalence and numbers of pathogens in 
food, resulting in reducing health risk to humans. A variety of implementations can be 
selected and set up. However, in practice the factors involved are often complex and 
unpredictable. It may be necessary to consider which options are appropriate to a specific 
risk management question (Figure 2.7). Since food safety issues are usually multifactorial, 
generating unpredictable associations which may lead to unexpected and undesirable 
problems, flexible responses in risk management may be necessary. 
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Figure 2.7 The overall conceptual framework of risk management activities for managing 
foodborne risks to human health (adopted from WHO, 2002b) 
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Evaluation of risk management options 
In the assessment of risk management options, all relevant data, knowledge and information 
pertinent to decisions are often dispersed among various interested parties. Evaluation of 
risk management options must consider their inherent advantages and disadvantages 
together with their impact on risks. Relevant considerations include: 
- acceptability of the technology or the resulting food product by industry and consumers; 
- cost effectiveness; 
- technological feasibility; 
- expected level of compliance with control measures; 
- options for monitoring and review; 
- possibility of new risks arising from the options selected 
The main point of concern is that who judges an option to be optimal and according to what 
criteria. For example, steam surface pasteurisation of citrus fruit to remove pathogens may 
provide the same reduction in risks as washing by hand in an appropriate sanitising solution. 
For example, following a cost-benefit analysis, where labour costs are high, the former 
measure may be the most optimal. 
Implementation 
Although many food safety measures can be successfully implemented without asseSSing 
the risk, in this context (of a more complex issue) implementation of food safety controls 
should be based on the scientific basis of an MRA. Following the evaluation of risk 
management options, a wide range of food safety measures, including regulatory standards, 
guidelines and related issues, may be implemented, either alone or in combination. All 
parties interested in food safety may be involved in implementation. Implementation of risk 
management involves complex factors in which competing stakeholders including 
consumers with imcompatible views and values. Public perceptions should be therefore 
taken into account. The efficiency of implementation depends on the acceptability of the 
interventions to stakeholders. 
Implementation of possible risk management options would be varied according to the 
particular circumstances, for example: 
- Avoid risk by banning the foods, or limit sales of food that show a history of contamination 
or toxicity under certain condition. 
- Reducing exposure (e.g. not eating specific foods) 
- Educating consumers (e.g. labelling products, informing consumers of the risk) 
- Controlling initial levels of hazards (e.g. assessing the quality of ingredients by using 
microbiological criteria) 
_ Preventing an increase in the levels of hazards (e.g. contamination in the food chain) 
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- Reducing the level of hazards (e.g. disinfection, freezing, pasteurisation, irradiation) 
- Removing pathogens (e.g. washing, ultra-filtration) 
2.3.4 Risk communication 
Risk communication is currently recognised as involving an interactive discussion and 
exchange of information about risks associated with food borne hazards between interested 
parties, including government, agencies, corporations, media, scientist, organisations and 
individual citizens (HSE, 1998). A remarkable consideration of risk communication is that the 
target usually varies between from a variety of audiences. Different audiences are likely to 
have different interests, values, levels of intelligence, education and understanding. 
Communicators should recognise and overcome gaps in knowledge as well as obstacles 
inherent in the uncertainties of scientific risk assessment (Bennett, 1999). 
The goal of risk communication is to provide meaningful, relevant and accurate information 
in clear and understandable terms targeted to a specific audience. It may not resolve all 
differences between parties. However, it may lead to a better understanding of those 
differences (FAO, 1998). It may also be a guide to more widely understood and accepted 
risk management decisions (Edwards et a/., 2003). 
The expert consultation on risk communication of a joint FAOIWHO (FAO, 1998) proposed 
that the principles of risk communication must be based on follwing factors: 
- know the audience 
- involve the scientific experts 
- establish expertise in communication 
- be a credible source of information 
- share responsibility 
- differentiate between science and value judgement 
- assure transparency 
- put the risk in perspective 
2.4 Consumer perceptions on organically produced foods 
Consumer attitudes and perceptions are thought to be significant factors influencing 
consumer's food choice. The attitudes and perceptions are in fact influenced by geography, 
history, culture, religion, scientific development, fashion and the media (Williams and 
Hammitt, 2001). Food related health scares have driven consumer concerns, resulting in 
demands for safer food. Attitudes and perceptions towards foods related to risk have 
influenced agricultural policies and practices (Raab and Grobe, 2005). The main hazard of 
concern has often been pesticides. There are few studies referring to the concerns for other 
hazards, e.g. microbial pathogens. Recently, it was found that consumers tend to 
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underestim ate the proba bility of foodborne illness from common foodborne pathogens , i.e. 
Salmonella , Campylobacter (Zehnder et aI. , 2003 ). 
It was suggested that most consumers believe th eir perceived food safety risks are justified 
(Kraus , et aI. , 1992 and Graham et al., 1999). The most common bel ief of consumers about 
organ ic foods is that they are safer, hea lth ier and more nutritious, better for the environment 
and kinder to animals . However, organ ic foods are more expensive th an commercially grown 
products . In a global survey conducted on the internet across 38 countries , it was found that 
organic products are purchased mainly for perce ived hea lth reasons . Europeans seem to be 
conscious of other possible benefits of organic products (ACN ielsen , 2005). The results of 
this survey are presented in Figures 2.8 and 2.9 
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Figure 2.8 The main reasons for purchasing organic products across th e world 
(based on data from ACNielsen , 2005) 
120 ' 
'if. 100 1 
2 80 1 
c: 
'" 60 --0 
c: 
0 40 1 Q. 
If! 
20 J '" a::
0 
ASia Europe North Latin Gloval 
Pacif ic America A merica average 
o Other 
• lack of trust In 
claim 
o Expens ive 
• Not available 
Figure 2.9 The main reasons for not purchasing organic products across the world 
(based on data from ACN ielsen, 2005) 
The choice between organically and conventiona lly grown products invokes the role of risk 
perception in decision-maki ng for consum er. Alth ough eating qual ity becomes more 
important , the association between diet and hea lth are not well understood , part icularly for 
latent health consequences . Other factors (e.g. cost) may playa potent ial role influencing 
consumers ' food choice as th ese factors can be demonstrated with hard evidence. 
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CHAPTER 3 
Campylobacter and Antimicrobial Resistance 
3.1 Introduction 
The genus Campy/obaeter was first identified and named in 1963 by Sebald and Veron 
(Penner, 1988). The name was derived from the Greek word for a curved rod. Initially, this 
genus included two species (C. fetus and "C. bubu/us") , which had formally been referred to 
as Vibrio species. 
The habitats of Campy/obaeter species vary greatly. Some species appear to be obligated 
parasites narrowly restricted to one organ or site in the body, whilst others are ubiquitous 
and are widely distributed in nature (e.g., C.jejum). According to their inability to ferment or 
oxidise carbohydrate, some isolates would be excluded from this species if the isolates are 
differentiated following microbiological criteria using general biochemical tests available in 
the diagnostic laboratory. Therefore, the genetic constitution of the strain has been 
developed and introduced for the taxonomy of this genus for more than two decades 
(Penner, 1988) 
Following the recognition of the clinical and economic importance of Campy/obaeter, a range 
of techniques, including molecular techniques such as DNA-rRNA hybridization, 16S 
ribosomal RNA sequence analysis, and immuno-typing analysis, have been developed for 
their identification and characterisation. Campy/obaeter species and related taxa belong to 
the same phylogenetic group named rRNA superfamily VI. The rRNA superfamily VI 
currently comprises of five genera, which are Campy/obaeter, Aerobacter, Helieobaeter, 
Wolinella and F/exispira (Koneman et a/., 1997). 
At present, the genus contains 16 species and six subspecies of true Campy/obaeter 
(signified by the partial 16S rRNA sequences). Many species formerly referred to as 
Campy/obaeter spp. or Campy/obaeter-like organisms have been assigned to other genera, 
most of which are phylogenetically related. 
3.2 General characteristics of Campylobacter 
Member of the genus Campy/obaeter are non-sporeforming, oxidase-positive, gram-negative 
rods. Actively dividing cells (log-phase cells) are slender, curved or spiral shapes (or S-
shaped cells), 0.2 to 0.5 Jim wide and 0.5 to 8.0 Jim long. Some species are predominantly 
curved or straight rods. Located at one or both ends of the cell are one or more polar or 
amphitrichous flagella which are highly motile and darting in corkscrew-like fashion, spinning 
around their long axes and frequently reversing direction (Figure 3.1). This feature may be 
important in pathogenesis (Adams and Moss, 2000). 
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Figure 3.1 Illustration of Campylobacter spp. Bar =1 11m (taken from 
http ://www.bacteriamuseum.org/species/campylobacter.shtml) 
All Campylobacter species are unable to ferment or oxidize sugars and usually obtain 
energy from amino acid or from the tricarboxylic acid cycle (TCA). Typical biochemical 
reactions include the reduction of fumerate to succinate with indole production reactions . 
Most species are oxidase positive, however, only C.jejuni is hippurate positive. The catalase 
test is one of few useful tests for differentiating between species . Campylobacters are 
oxygen-sensitive microaerophiles and capnophilic, thus requring atmospheres containing 5-
10% oxygen and 3-5% carbon dioxide. The optimal temperature is 37° C, except for C. jejuni 
and C. coli. Their optimum growth is at 42°C. They do not grow below 25° C and have poor 
survival at room temperature. Because of these two conditions, their ability to multiply 
outside of the animal is severely restricted. Consequently, unlike other foodborne pathogens, 
they are not normally capable of multiplication in food during processing or storage at 
temperatures below 25°C (Park, 2002). Although many studies have explored the dormant 
phase of Campylobacter spp., these have focused mainly on C.jejuni and C. coli. These 
studies suggested that Campylobacter enter a dormant phase under stress conditions . This 
phase is affected by temperature, oxygenation, moisture, osmolality and microcosm water 
system (Jones et al., 1991; Lazaro et a/., 1999; Hald et a/., 2001 and Kam et a/., 2001). 
C.jejuni has also shown the ability to tolerate refrigeration and freeze-thawing. 
In general, Campylobacter species do not grow in conventional aerobic or anaerobic culture 
systems. Since they are sensitive to hydrogen peroxide and superoxide anions produced in 
media, lysed animal blood and ferrous sulfate are added to enrichment broths and selective 
agars in order to neutralise these toxic oxygen products and increase the aerotolerance of 
the organisms (ICMSF, 1996). 
Within the entire genus Campylobacter, C.jejuni and G.coli are the species most often 
encountered by medical laboratories responding to gastro-enteritis worldwide (Kothary and 
Babu, 2001). They jointly account for over 95% of the prevalence of infection in humans, 
with reported infective doses as low as 500 organ isms (Black et a/., 1988). Although 
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infections with C.upsaliensis, C./a,i, C. foetus and C.hyointestinalis may be recognised, they 
appear to be much less frequent. 
It is easy to distinguish C.jejuni and C.coli from other Campy/obaete, species by their high 
optimum growth temperature (42°C). C.jejuni has two subspecies; subspecies jejuni - the 
familiar cause of enterocolitis in man and subspecies doy/ei - a more fastidious and slower 
growing organism which does not grow at 43°C. Unlike C.jejuni, C.eo/i does not hydrolyse 
hippurate acid. C. upsa/iensis is seldom detected by conventional methods used for C.jejuni 
and as for C.eoli, primarily isolation for this organism usually requires the use of selective 
filtration, non-selective media and incubation at 37°C. In addition, it requires H2 or formate 
for the microaerophilic growth (Holt et a/., 1994). The differentiation of the most important 
species of Campy/obaete, is shown in Tables 3.1 and 3.2. 
Table 3.1 Differentiation of Campy/obaete, species related to human disease 
Biochemical test 
Organism Catalase Nitate H2S2 Urease Indoxyl Hippurate 
(triple sugar acetate hydrolysis 
iron) 
C.coli + + + 
C.concisus + + NA 
C.curvus + + + 
C.fetus subsp. fetus + + 
C.fetus subsp. + + 
venerealis 
C.gracilis + v 
C.helveticus + + 
C.hyoilei + + + NA 
C.hyointestinalis + + + 
subsp. hyointestinalis 
C.hyointestinalis + + + 
subsp. lawsonii 
C.jejuni subsp. jejuni + + + + 
C.jejuni subsp. doylei v + + 
C.lari + + 
C.mucosalis + + 
C.rectus + + + 
C.showae + + + + 
C. upsaliensis -(w) + + 
C.fecalis + + + 
+, strong reaction; v, 11 %-89% of strains are positive; w, weak reaction; NA, results not available 
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Table 3.2 The optimal temperature for growth of Campy/obacter species 
Organism Temperature (0C) 
25 37 42 
G.eoli + + 
C.coneisus + c 
C.curvus + + 
C.fetus subsp. fetus + + 
C.fetus subsp. venerealis + + 
C.graeilis NA + NA 
C.helvetieus + + 
C.hyoi/ei NA + + 
C.hyointestinalis subsp. 
v + + 
hyointestinalis 
C.hyointestinalis subsp. lawsonii + + 
C.jejuni subsp. jejuni + + 
C.jejuni subsp. doylei + w 
G.lari c + + 
C.mueosalis + + 
G.reetus + w 
C.showae + + 
C. upsaliensis + + 
C.feealis + + 
+, 90% or more of strains are positive; -, 90% or more of strains are negative;v, 11 %-89% of strains 
are positive. w, weak reaction; NA, results not available; c, contradictory reports in literature. 
3.2.1 Growth condition and survival characteristics 
The health risk associated with Campy/obacte, transmitted through the food chain relies on 
the growth condition and survival of the organism in a food commodity. Usually, 
Campy/obacte, does not readily grow in a food commodity unless there are the preferable 
conditions for growth. Despite this, during slaughtering and preparation of raw birds, a high 
percentage of poultry carcasses may become contaminated with the Campy/obacte,. In 
addition, Zhao et a/. (2001) found that rates of cross-contamination were significantly 
different for each of the store chains of various supermarkets although all of the chains sold 
the same products. Thereby, pre and post-processing treatments entailing a variety of 
conditions can affect the survival of Campy/obaete,. 
A number of studies have attempted to demonstrate the survival of Campy/obacte" 
especially, C. jejuni (Storz et a/., 1990; Pesci et a/., 1994; Wosten et a/., 1998 and Day et a/., 
2000). Black et a/., (1988) and Babakhani et a/. (1993) demonstrated that under the electron 
microscope organisms reside within epithelial cells lining the gut lumen as well as 
granulocytes and parenchymal cells located within the lamina propria. These provide the 
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fastidious, asaccharolytic, slow-growing organism an unoccupied niche where microbial 
competition is relaxed or nonexistent. Nowadays, the mechanism of how this organism is 
able to persist in the undesirable conditions and biological and environmental factors that 
affect pathogen occurrence and survival are still poorly understood (Day et a/., 2000). 
However, the survival rate of Campy/obacter is thought to be affected by sensitivity to 
atmospheric conditions, stress during transport, processing, storage, water activity and 
competitive organisms (Jones et a/., 1991). 
Temperature 
The temperature for optimal growth for Campy/obacter is 42°C (Table 3.3). In general, it 
appears that Campy/obacter is comparatively slow growing (Lake et. a/., 2003) and it does 
not grow under refrigeration conditions. This indicates that Campy/obacter does not multiply 
during slaughtering, post processing, transport and refrigeration. However, at low 
temperatures (i.e., in refrigerator or freezer) these organisms may be transformed to viable-
but non-culturable (VNC) cells which can survive for a prolonged period (Hazeleger et a/., 
1994). Lake et a/.(2003) have found that the survival of Campy/obacter in food kept under a 
condition of refrigeration is better than when kept at room temperature (up to 15 times at 2°C 
longer than at 20°C) due to oxygen concentration. 
Table 3.3. Growth characteristics of Campy/obacter (ICMSF, 1996) 
Condition Minimum Optimum Maximum 
Temperature(°C) 32 42-43 45 
pH 4.9 6.5-7.5 ca.9.0 
NaCI(%) 0.5 1.5 
Water activity(aw) ~0.987 0.997 
Atmosphere 5%02 +10%.C02 
Refrigeration does reduce viable numbers of these organisms on chicken or red meats, but 
the decrease is not predictable (Kinde et a/., 1983 and Koidis and Doyle, 1983). Under these 
conditions, Campy/obacter does not multiply and the numbers decrease depending on the 
length of storage. Campy/obaeter is sensitive to freezing with numbers declining faster at the 
initial reduction phase followed by a slower reduction during long-term storage. 
In addition, these bacteria can survive up to an hour on hands and moist surfaces at room 
temperature. Christensen et a/. (2001) summarised the effect of storage temperatures on the 
number of Campy/obaeter in chicken products as shown in Table 3.4. C.jejuni and C.coli are 
sensitive to heat and do not survive cooking or pasteurisation temperatures (D-value are 
0.21-2.25 minutes at 55-60°C; ICMFS, 1996). However, Bryan and Doyle (1995) indicated 
that if the cooking temperature is less than 74°C, e.g., microwave application, the organisms 
may survive. 
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Table 3.4 Effect of storage temperature on Campylobacter in chicken products (adopted 
from Christensen et al., 2001) 
Initial Total 
Chicken Storage Decrease Decrease Reference product temp.(oC) (log cfu/day) (log cfu/day) 
Carcass -20 
-0.1-1.4/21 
-0.5-2.3/84 Hanninen, 1981 
-20 
-0.5/36 -1.4/64 Oosterom et a/., 1983 
4 -0.6-1/4-7 Oosterom et al., 1983 
Drip -20 -0.1-1.1/21 -0.6-2.5/84 Hanninen, 1981 
Drumsticks -20 -1.4/7 -2.7/182 Yogasundram et al., 1989 
4 -0.7/7 
Breast skin -20 -2.4/3 Ca.-3.7/56 Lee et a/., 1998 
4 1.4/3 Lee et al., 1998 
Breast (meat) 2 
-5-6/24 Curtis et al., 1995 
10 
-5-6/13 Curtis et a/., 1995 
Q!!: 
Campylobacter is inactivated at pH below 5.0 and above 9.0. The optimum is 6.5 to 7.5. 
Bhaduri and Cottrell (2004) found that the pH in ground chicken and chicken skin were 5.96 
and 6.41. 
Atmosphere 
Campylobacter requires a micro-aerobic condition, with oxygen levels less than 5%. 
However, some isolates can adapte to aerobic conditions, e.g., C.jejuni. 
Water activity (awl 
Water activity (aw) is the ratio of the partial vapour pressure of water in equilibrium with the 
food. This is a physical property that has a direct implication on microbiological safety of 
food (Beuchat, 1981 and Fontana, 2000). Basically, water activity is controlled by drying, 
addition of salt (NaCI) or sugar and freezing (Fontana, 2000). The optimal growth conditions 
for Campylobacter is at awapproximately 0.997 (= 0.5% of NaCI). Campylobacter does not 
grow when the aw is less than 0.98 (salt concentration above 1.5%), thus Campylobacter is 
particularly sensitive to drying conditions. In food processing and packaging (plastic 
overwraps) methods are generally selected to retain water activity and temperature (water 
activity is dependent on temperature), thus controlling microbiological growth and the quality 
of the food product. 
3.2.2 The role of viable non-culturable stages (VNC) 
It is believed that Campylobacter can be resistant to four critical stresses, including 
temperature, oxidative stress, osmotic change and starvation. Although, Campylobacter 
species appear to lack many adaptive responses, some species, e. g. C.jejuni, can mount 
adaptive responses to both acidic and aerobic conditions. The organisms are thought to 
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transform themselves into a dormant phase, i.e ., viable-Non-Culturab le state (VNC). In thi s 
phase, they are capable of survival without replication in conventional media , whilst 
maintaining their metabol ic activity (Roll ins, 1986 and McKay, 1992). The VNC cells cannot 
be detected by standard culture methods . However, under re-enrichment cond itions they 
may revert to full viability . There is still a controversy over whether to cons ider the VNC 
stage as a degeneration form or a dormant phase. Manning et al. (2001) reviewed results of 
genotyping from several studies and proposed that the VNC stage may be a consequence of 
both natural competence and genomic re-arrangements of Campylobacter to overcome the 
undesirable conditions . This may be the missing explanation of how this organ ism maintains 
its diversity and ability to survive in a wide range of habitats . However, the mechanism of 
this instability is unknown. 
A number of studies have demonstrated the viability and VNC phase of C.jejuni during low 
temperature storage. Jones et al. (1991) and Solow et al. (2003) found that when suspended 
in microcosm system and incubated at 4°C , various strains of C.jejuni enter a VNC phase 
after 18-28 days . Lazaro et al. (1999) detected the changes in cell morphology of C. jejuni 
from spiral to coccoid from . C. jejuni cells at late lag phrase were spiral with the length of ca . 
1.4859 11m . After starvation for 7 months, the length of the cells decreased to ca. 1.2409 11m 
at 4°C (Figure 3.2B-E) and ca . 1.2925 11m at 20°C. 
A B 
Figure 3.2 Different morphologies of C.jejuni cells at late lag phase and after starvation 
for 7 months: A) Typical spiral cell at late lag phrase; B to E) Transformation 
of rod shape to coccoid shape after starvation for 7 months 
(taken from Lazaro et al., 1999) 
Tholozan et al. (1999) described that ability to enter a VNC stage depends on the strain as 
well. So far, a number of studies have indicated that a predominantly coccoid morphology, 
thought to be the beginn ing of a VNC phase, is associated with exposure to oxygen , change 
in temperature, and starvation . Hazeleger et al.(1998) found that at different storage 
temperatures , C.jejuni strains became non-culturable after about 1 week at 25°C , 3 weeks at 
120C 6 weeks at 4°C . Reezal et al. (1998) postulated that at lower temperature , in particular 
, 
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at 4°C, the osmolarlity of media has a synergistic effect on the change of morphology of C. 
jejuni from a rod shape to a coccoid shape 
The concurrence of culturability and infectivity of VNC was also further discussed by Jones 
et al. (1991) and Sutcliffe et al. (1991) . Although C.jejuni became a coccal form after 
exposure to water, their antigen remained detectable for several months after they were no 
longer culturable . In addition , after storing the cu lture for a minimum of 2 weeks , under the 
electron microscope most of coccoid forms also showed degenerative change but a small 
proportion did retain structural integrity and had the appearance associated with viability. 
After resuscitation of VNC under laboratory conditions, C.jejuni strains were found to multiply, 
but their infectivity weakened and terminated (Hald et al., 2001). 
3.3 Pathogenicity 
Currently, the real mechanism of how the virulence of Campylobacter affects the human 
body is not clear. Prevention and treatment of the infection essentially requires 
understanding of its nature, regulation and mechanism . Hence, several hypotheses have 
been proposed on what are the possible determinants of pathogenicity (Tauxe,1987; Black 
et al., 1988 and Blaser et al., 1997) . 
Two types of diarrhoea occurring in humans due to C.jejuni infection are: i) inflammatory 
diarrhoea with fever and slimy bloody faeces containing leukocytes and ii) non-inflammatory 
diarrhoea with watery faeces without blood cells . The indication is that the virulence of 
Campylobacter spp. (e.g. C.jejum) involves both host and pathogenic specific factors. By 
considering the pathophysiology of Campylobacter enteritis , four major virulence factors 
were presumptive including motility, adherence, invasion and tox in production (Walker et 
al. ,1986) . Wooldridge and Ketly (1997) also suggested that poss ible determinants of 
pathogenicity involved in the induction of campylobacteriosis , diarrhoea in particular, include 
chemotaxis, motility and flagella , which are required for attachment and colonisation of the 
gut epithelium . As soon as the colonisation occurs , other possible consequences would go 
toward iron acquisition , host cell invasion , toxin production, inflammation and active 
secretion and epithelial disruption with leakage of fluid. However, the mechanisms of host 
cell invasion remains poorly understood . Flagella mediated motility may be a major 
influencing factor on the change of cell membrane of host cells or the internal cytoskeletal 
structure (Wooldridge et al., 1997 and Hanel et al., 1998). It appears that different hosts 
react differently to invasion , with fluid secretion being dependent on the extent of the host 
response and degree of ep ithelial damage. 
Wassenaar (1997) summarised the four virulence properties of Campylobacter as fo llows : (i) 
Motility plays a crucial role in pathogenesis of C.jejuni. The flagella characteristic is thought 
to be the main factor for the attachment sites and penetration into the intestinal cells ; (ii) 
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Adherence of the organisms to the epithelial surface may be important for the colonisation 
and increase of the local concentration of secreted bacterial prod ucts. However, th e specific 
adhesions on the flagella or the body have not been identif ied ; (iii) Following adhesion and 
penetration, bacteria invade the host cells and multiply. Preven ted by the intracellular 
immune system, invasion levels are however normally low and (iv) Toxins have been 
considered as a crucial factor for pathogenesis . 
The function and role of toxins are not however fully elucidated . It was reported that C.jejuni 
and C.eo/i produce a number of different toxin activities . These include both enterotoxins 
(defined as secreted proteins able to bind to a cellular receptor, entering the cell and 
elevating cyclic AMP levels) and cytotoxins (defined as proteins that kill target cells) . Gilbert 
and Slavik (2004) suggested that whilst toxicity may be a primary determinant of C.jejuni 
pathogenicity, C.jejuni found in the food chain may not contribute to a toxicity level high 
enough to cause disease in humans . In an undesirable environment, C.jejuni rather 
produces the proteins enhancing its ability to survive and may play a role of cytotoxicity, 
many of which are similar to those found in some other bacteria . Only one of these toxins 
was genetically defined, cytolethal distending toxin (COT). Moreover, the role of this 
cytotoxin on foodborne illness has not been fully elucidated (Eyigor et a/., 1999) . 
3.4 Human campylobacteriosis 
3.4.1 Acute illness 
Campy/obaeter infection displays a broad range of clinical symptoms. These can be mild, 
self-limiting, non-inflammatory diarrhoea or severe inflammatory bloody and 
polymorphonuclear leukocytes with severe cramping and fever (Blaser et a/., 1979). It is 
hard to distinguish Campy/obaeter infection from gastro-enteritis caused by other enteric 
pathogens. In young children, under 5 years old and immunocompromised hosts (i.e. elderly 
people, HIV-positive patients), the illness may exhibit bacteraemia and relapsing or 
unremitting symptoms . 
The incubation period of Campy/obaeter infection may vary from one day to two weeks , 
typically 1-3 days . The main symptoms are malaise, fever, abdominal pain, abdom inal 
cramp and diarrhoea with or without blood . Commonly, the diarrhoea is self-l imiting and may 
persist for up to a week . However, Alios and Blaser (1995) showed that 20% of symptoms 
may last from one to three weeks and the organism may be found in faeces for up to 2-3 
weeks. 
The symptoms of Campy/obaeter infection may also vary in different populations . Th is may 
be due to the immune response and the exposure dose. In developed cou ntries , where 
infection is relatively rare , Its manifestations may be more severe , such as inflammatory 
diarrhoea containing blood and polymorphonuclear leukocytes with severe cramping and 
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fever (Blaser et al., 1979). Campylobacter infections are seasonal , peaking in late summer 
and autumn . Sporadic illness associated with food consumption or waterborne exposures 
has been reported . 
By comparison, campylobacteriosis appears to be endemic and non-seasonal in develop ing 
countries . The symptoms are typically watery, non-inflammatory, relatively mild diarrhoea . 
Infection rates are typically highest during the first two years of life and decline with age. 
There is also attenuation of the symptoms and reduction in convalescent phase of bacterial 
excretion with increasing age. Convalescent excretion occurred for 14.:!:.2 days in Thai 
children less than 1 year and for 8.:!:.2 days in children between 1-5 years (Taylor, 1992). 
3.4.2 Long term sequelae 
Symptoms of campylobacteriosis are usually self-limiting and are usually resolved within a 
period of 3-10 days. Nonetheless, late complications may occur in a person who is 
vulnerable, for example, elderly people. These include Guillain-Barre syndrome (an acute 
peripheral neuropathy), hemolytic uremic syndrome, pancreatitis and reactive arthritis. 
Among these complications, Guillain-Barre syndrome is the most serious . 
Guillain-Barre syndrome (GBS) is an acute, bilateral, ascending paralysis developing 
typically 1-3 weeks following the onset of diarrhoea . GBS is thought to be associated with C. 
jejuni infection. Several studies determined the prevalence of C.jejuni infection leading to 
GBS, ranging from 15%-66%. Specific C.jejuni serotypes, 0: 19 and 0 : 41, have been 
implicated in the development of GBS in certain setting (Kuroki et al., 1993; Mishu et aI, 
1993; Rees et aI, 1995; Lastovica et al., 1997 and Alios et al. , 1998). Post infection 
arthropathies may occur within two weeks following the onset of diarrhoea . The symptoms 
appear in more than one joint, commonly knees , ankles , wrists and lower back. 
In general, the mortality rate of campylobacteriosis is low and most cases of mortality occur 
among infants, elderly and immuno-supressive individuals (Tauxe, 1992; Altekruse et al. , 
1999). Philips (1995) reported that in England and Wales fewer than 10 deaths out of 
approximately 280,000 cases «0.0036%) have been reported from 1981 to 1991 . 
3.4.3 Epidemiology 
Although Campylobacter is a zoonotic organism , colon ising the gastrointest inal tract of warm 
blooded animals, its infection is recognised to date as the most common enteric pathogen 
caused human illness (Barton , 2000; Threfall et al., 2000 ; Randall et al., 2003 and Ridley 
and Newell, 2004) . The epidemiology of Campylobacter is still however poorly characterised . 
This is mainly due to the lack of routine microbiological characterisation. In add ition , the 
symptoms of the infection are self-limiting , and thus patients infected with these organisms 
may not be seen in General Practice. The true population burden must be therefore greater 
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than that given by national surveil lance programmes . Furthermore , surveillance does not 
exist in some regions or countries . 
Oberhelman et a/.(2000) and Coker, et a/.(2002 ) found that despite the lack of national 
surveillance programmes for campylobacteriosis in most developing countries , 
Campylobacter is the most frequently isolated bacteria from faeces of child ren, in particular, 
under 5 years old. Most estimates of the incidence in develop ing countries are from 
laboratory-based surveillance of pathogens responsible fo r diarrhoea . The incidence ranges 
from 5-20% (Oberhelman et a/., 2000). Based on case-control commun ity-based studies , the 
incidence was 40,000 to 60,000 per 100,000 for children aged less than 5 years and 
90/100,000 for the general population. Coker, et a/.(2002) summarised the isolation rate of 
Campylobacter in faeces which is shown in Table 3.5 
Table 3.5 Isolation rate of Campylobacter in faeces from diarrhoeal pat ients , age <5 years , 
in selected developing countries (taken from Coker, et al.2002) 
WHO region and country 
Africa 
- Algeria 
- Cameroon 
- Ethiopia 
- Nigeria 
- Tanzania 
- Zimbabwe 
Americas 
- Brazil 
- Guatemala 
Eastern Mediterranean 
- Egypt 
- Jordan 
Southeast Asia 
- Bangladesh 
- Thailand 
- Laos 
Isolation rate (%) 
17.7 
7.7 
13.8 
16.5 
18.0 
9.3 
9.9 
12.1 
9.0 
5.5 
17.4 
13.0 
12.1 
In developed countries , such as in Europe and the United States , ep idemiologica l data have 
indicated that the incidence of campylobacteriosis has increased stead ily. Some European 
and North America countries have established surveillance programmes, e.g., Euro-
surveillance, FoodNet (U .S.A), National Notifiable Diseases Summary program (NNDS, 
Canada) and Campylobacter Sentinel Surveillance Scheme (UK). These show that the 
incidence rate varies from country to country. For example, the Netherlands reported 36 per 
100000 between 1997 and 200 1 (Van Pelt et a/., 2003 ), with 54 .7-65 .8/100,000 in Denmark 
, 
(1997 -2003) and 30/1 00 ,000 in Sweden . In the United State , it is estimated to be 
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880/1 00 ,000 , nearly twice as high as th e rate of Sa lm one lla. In several countr ies it is still 
unclear whether th is observed rise could be attributed to a rea l increase in incidence, or to 
an improvement in diagnos is, or to both . Most reported cases of campylobacter ios is occur 
sporad ically , as sing le cases , or small family outbreaks, and are generally caused by 
Campylobacter jejuni. Th is may be because there is no internation al standard iso lat ion 
method for Campylobacter. It is diff icult to compare the iso lation rate between countries or 
regions . 
In the UK, Campylobacter are the most commonly reported cases of in fectious in testina l 
disease (110) and most cases are sporad ic . Ribe iro and Frost (2000) estim ated that 
Campylobacter causes 110 in 8.7 cases per 1000 person years compared with a rate for al l 
110 of 194 cases/1 000 person years . 
Adak et a/.(2002 ) reported that in 2000 there were 1,388 ,772 cases of indigenous foodborne 
disease (IFo) in England and Wales . Campylobacter was respons ible fo r 26 .85% of IFo 
cases . Of all cases of campylobacterios is, 47 .62% cases were seen in General Practice 
(GP) , 4 .7% cases requ ired hospital adm ission and 0.0002% were fatal. There has been a 
steady annual increase in the number of reported infections since surve illance began in 
1977 (Figure 3.3). Latest published data fo r 2004 for laboratory reports of faeca l iso lates of 
Campylobacter spp. in England and Wa les are shown in Figure 3.4. 
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Figure 3.4 Numbers of reported case of Campy/obacte, spp. by faecal isolates England & 
Wales, 1986-2004 (source: UK-HPA, 2004) 
Buzby and Roberts (1997) estimated that the economic burden due to Campy/obacte, 
infection in the United States was around US$ 4.3 billion per year. In the UK the average 
cost of a case of acute Campy/obacte, infection was estimated to be £315. Therefore, 
Campy/obacte, infections cost the nation over £113 million in 2000 (ACMSF, 2004). As 
reported by Gillespie et a/. (2002), the true incidence of campylobacteriosis is however 
thought to be much higher than that shown in the national report. There may be eight cases 
unrecognised for every laboratory-confirmed report by national surveillance. Following this 
assumption, the true annual estimate cost must be higher than £113 million. 
The study carried out by ACMSF (2004) found the highest age-specific incidence rate in 
children under the age of 5 years, with a secondary peak in young adults. In addition, this 
report also showed that the epidemiology of human Campy/obacte, infection shows a 
consistent seasonal pattern with the peak in the spring and late summer and a lower rate in 
the winter. 
3.5 Sources of Campylobaeter species 
3.5.1 Chicken as a major source of Campy/obaeter 
Although Campy/obacte, was identified as early as the 1970s, its isolation rate is thought to 
be underestimated worldwide. This is due to the fastidious nature of these bacteria, 
especially in food samples, which requires specific media and atmospheric conditions for 
detection. For the last two decades, following the rise in public concern about infections 
related to food consumption, several studies have been established to characterise the true 
reservoirs of these bacteria. Broiler chickens, milk, water and contact with pets and farm 
animals were identified as sources of infection (Table 3.6). A recent report of a joint 
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FAOlWorld Health Organisation (WHO, 2002c) indicated that there is linear relationship 
between flock prevalence and the probability of human campylobacteriosis. 
Table 3.6 Campy/obacter species and their host (adapted from Wesley, 1998) 
Species 
Campy/abaeter jejuni* 
Campy/abaeter eali* 
Campy/abaeter fetus 
Campy/abaeter eaneisus 
Campy/abaeter eurvus 
Campy/abaeter gracilis 
Campy/abaeter he/vetieus 
Campy/abaeter 
hyaintestinalis 
Campy/abaeter /ari 
Campy/abaeter mueasalis 
Campy/abaeter rectus 
Campy/abaeter shawae 
Campy/abaeter upsaliensis 
Host distribution 
Livestock 
Paultry, cattle, pigs and sheep 
Pigs, turkey and cattle 
Cattle and sheep 
NA 
NA 
NA 
Damestic pets 
Pigs, cattle and guinea pigs 
Birds, dogs 
Cattle, pigs 
NA 
NA 
Domestic pets 
Human 
enteritis 
Enteritis 
Enteritis 
Periodontal disease 
Periodontal disease 
Head, neck infection 
Enteritis 
Enteritis 
Enteritis 
Enteritis 
Periodontal disease 
Periodontal disease 
enteritis 
*Note C.jejuni is found mainly in poultry and C.eali is found in pig and turkey 
NA = not available 
The principal habitat of this foodborne pathogen is, in fact, the alimentary tract of warm-
blooded animal. Campy/obaeter is found in cattle, pigs, sheep, dogs and wild animals and 
birds. Water also plays an important part of the ecology of Campy/obaeter. Campy/obaeter 
may enter the environment, including drinking water, or be transmitted from host to host 
through the faecal-oral route. Campy/obaeter has been isolated from surface water, rivers 
and lakes at prevalences up to 50% (Bolton et a/., 1987; Carter et a/., 1987; Brennhoved et 
a/., 1992 and Arvanitidou et a/., 1995). In addition, 45% of sand samples from bathing 
beaches contained Campy/obaeter (Bolton et a/., 1999a). Campy/obaeters can also be found 
in dogs and cats. They are therefore considered as zoonoses, infectious agents transmitted 
to humans from animals. 
The prevalence of Campy/obaeter infection in retail chicken is evidently associated with 
campylobacteriosis in human. The UK recent survey report documented by the Food 
Standards Agency (2003b) showed that the overall frequency of Campy/obaeter 
contamination in retail chicken, UK-chicken, was 50%. However, when considering different 
parts of the UK, England, Wales, Scotland and Northern Ireland, higher isolation rates were 
found in Northern Ireland (77%) and Scotland (75%). The frequency of contamination of 
fresh chicken (56%) was higher than for frozen chicken (31 %). Whole chickens were more 
likely to be contaminated (57%) than portions (46%). Although control of Campy/obaeter 
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contamination in chicken was implemented throughout the whole production chain in the 
Netherlands, more than 30% of all retail chicken was found to be contaminated with this 
organism (Katsma et a/., 2005). 
3.5.2 Sources of colonisation in chicken 
A number of studies carried out in many countries agree on the importance of a variety 
routes of infection by Campy/obaeter in poultry production. These routes are contaminated 
water, vertical transmission from parent flocks, contaminated feed, carry-over from a 
previous flock, domestic and wild animals, contaminated transport (crates, vehicles), 
personnel at flock thinning, feed withdrawal and the external environment. 
Flock colonisation and prevalence 
Although very young chicks (one-day and seven-day old) were found negative to 
Campy/obacter, broiler chicks can be colonised by C.jejuni at 3-4 weeks of age (Berndtson 
et a/., 1992). Unlike Sa/monella spp., this late colonisation may be a result of early protection 
from maternal anti-Campy/obacter antibodies or the presence of bacterial flora antagonistic 
to Campy/obaeter (Pearson et a/., 1993 and Sahin et a/., 2001). In addition, several studies 
support the notion that Campy/obaeter is not transmitted vertically (from parents to chicks). 
C.jejuni, was also found not to contaminate the contents of uncracked eggs (Jones et 
a/., 1991; Jacobs-Reitsma et aI, 2001 ; and Saleha, 2004). 
In poultry, once Campy/obaeter colonises the mucous overlying the epithelial cells in the 
caeca and small intestine, with the doses as low as 40 cfu, it can rapidly reach high numbers 
in the caecal content as high as 107-109 cfu without apparent symptoms (Newell and 
Fearnley, 2003; and Stern and Robach, 2003). The potential for colonisation is at least 
1000-fold in most strains and up to 10,000-fold in some strains. Faecal shedding is therefore 
presumed to be an important factor in the spreading of organisms around the flocks or the 
environment. 
The proportion of positive-Campy/obaeter broiler flocks varies between countries and 
regions. In Europe, the prevalence ranges from 18% to >90%, with the northernmost parts 
having lower rate than southern European countries. In the United States, it appears that 
nearly 90% of flocks are colonised (Stern and Robach, 2003). Furthermore, there is a 
seasonal variation in the prevalence of flock colonisation. For example, the rate of infection 
in summer is higher than in winter. Variation in excretion rates has been also identified. 
Patrick et a/. (2004) suggested that limiting bird-to-bird contact or climate changes influences 
colonisation. Longitudinal studies in the UK have indicated that infection is unpredictable 
from the previous status of the flocks. The negative flocks often become positive and 
positive flock can occur even in newly constructed broiler houses (Gregory, et al. 1997). 
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Feed and litter 
Since dryness is unsuitable condition for growth, dry feed or feed additive and fresh litter are 
not potential sources of infection (Newell and Fearnley. 2003). 
Contaminated water 
Pearson et a/.(1996) demonstrated that Campy/obacter was isolated from water lines and 
reservoirs of broiler houses. This suggests that this organism can survive in water. Water 
contamination usually follows flock colonisation, suggesting that this is a consequence of the 
tracking up through the water lines of organisms excreted from the birds. In addition, viable 
non-culturable Campy/obacter may be responsible for the initial colonisation (ACMSF, 2004). 
In broiler houses, drinking water provided by the bell drinkers may also be a vehicle for 
horizontal transmission from a positive Campy/obaeter bird to others within the houses. A 
number of studies showed that Campy/abaeter can be part of biofilms found in the water 
systems of broiler houses (Stern et a/.,2002; Trachoo and Frank, 2002 and Joshua et 
a/.,2006). However, there has been considered debate as to the effect of water-related 
environmental stresses on the infectivity of Campy/abaeter. Fearnley et a/.(1998) suggested 
that the colonisation potential of culturable of C.jejuni for chicks is severely compromised by 
long- term exposure to water. The levels of chlorination in potable water would normally be 
considered lethal to C.jejuni. It appears that water-borne protozoa, for example, 
Tetrahymena pyriformis, may be likely to be reservoirs for C.jejuni in water system of broiler 
houses (Jacobs-Reitsma et a/., 2001). 
Domestic and wild animals 
As most warm-blooded animals are suitable reservoirs for Campy/abacter, wild animals are 
also presumed to be an indirect source of flock colonisation, resulting in contamination 
through the environment. Evidently, farms with mixed animal species may increase flock 
infection due to the movement of farm staff. This would transmit the bacteria from wild birds, 
cattle, sheep or pigs to chickens. Similarly, cats and dogs are also frequently 
Campy/abacter-positive. Houseflies have also found to be a source of C.jejuni (Shane et a/., 
1985). 
Contamination during transport at flock thinning 
It is suggested that during the thinning process, removing a cohort of birds approximately 5 
weeks of age for slaughter, using contaminated crates or vehicles, or gloves and clothing of 
workers, may introduce Campy/abacter to negative flocks (ACMSF, 2004). During catching, 
loading and transport to the processing plant, crate surfaces and lorry decks become 
contaminated with faeces. Due to budgetary constrains, transport crates are used repeatedly. 
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In addition, inadequate crate washing results in leaving the washer contaminated with 
Campy/obacter. 
Human passage and activities on farm 
Farm staff may carry Campy/obacter-positive faeces around the bird houses to the outside 
or from the external environment to the houses through boots, external clothes and 
equipment. The risk of having positive flocks is greater when staff have been tending other 
food animals prior to entering broiler houses. C.jejuni can be recovered from both standing 
water and soils. Hiett et a/.(2002} showed that the genotyping of isolates from, particularly, 
standing water recovered before the flock became positive had the same pattern as those 
subsequently recovered from the broiler flocks. 
3.6 Antimicrobial resistance in Campylobacter 
3.6.1 Antimicrobial action on micro-organism 
Antimicrobial agents used in the treatment of infectious disease are divided into two groups, 
which are: i} antibiotics, which are natural substances produced by certain groups of micro-
organisms, and ii} chemotherapeutic agents, which are chemically synthesized (McManus, 
1997). A hybrid substance is a semi-synthetic antibiotic produced by the microbe that is 
subsequently modified by the chemist to achieve desired properties. 
During infection, bacteria can grow and multiply repeatedly to increase numbers, damaging 
the host. Antimicrobial action of agents interferes with specific processes of the bacterial cell, 
which synthesize the essential bio-molecules for growth or division. Antimicrobial agents 
have various levels of effectiveness against micro-organisms which depends on the main 
mode of action on the targets in the microbial systems. These modes of action include 
effects on cell growth/division. These effects are expressed by the following mechanisms: 
inhibition of cell wall synthesis, inhibition of nucleic acid replication, inhibition of protein 
synthesis and inhibition of synthesis of essential metabolites (Neu et aI, 1996). 
Inhibition of bacterial cell wall synthesis 
Antimicrobial agents in this group distress the peptidoglycan layer of the cell wall of both 
gram positive and gram negative organisms. This layer is essential for the survival of 
bacteria in hypotonic environments. Without this layer, the bacterial cells can be destroyed 
or damaged, resulting in death. 
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Interference of the function of cytoplasmic membrane 
As the cytoplasmic membrane composing of lipid, protein and lipoprotein is a diffusion 
barrier for water, ions, nutrients and transport system, specific antimicrobial agents can 
cause disorganisation of the membrane, interfering with the function of the bacterial cell. 
Inhibition of nucleic acid synthesis 
Antimicrobial agents can inhibit nucleic acid synthesis at different levels. They can: i) inhibit 
nucleotide synthesis or interconversion, ii) impair the template function of DNA and iii) 
interfere with the polymerases involved in the replication and transcription of DNA (McManus, 
1997). 
Quinolones (such as nalidixic acid) interfere with the replication and transcription of DNA by 
binding to the cleavage DNA gyrase3 and topoisomerase I. This action causes a detrimental 
effect on the normal DNA replication process, resulting in death of bacterial cells. 
Fluoroquinolones is a new derivative group that can interact with DNA gyrase and process a 
broad spectrum of antimicrobial activity. This new group includes ciprofloxacin, norfloxacin 
and offloxacin. 
Inhibition of protein synthesis 
Macrolides (e.g. erythromycin), a large lactone ring compound, can bind the 50S ribosomal 
subunit and thus impair a peptidyltransferase reaction or translocation or both. These can 
inhibit protein synthesis. 
Inhibition of synthesis of essential metabolites 
Antimicrobial agents in this group interfere with metabolism of essential compounds, e.g. 
tetrahydrofolate, lipids. 
3.6.2 The development of antimicrobial resistance in pathogenic 
bacteria 
Recent data from European countries suggest that the emergence of antimicrobial 
resistance in Campy/obacter is related to antimicrobial use in animal. When an animal is 
administered with certain antimicrobials, a selective pressure is applied on the bacteria. 
Some of them have the ability to resist antimicrobials and to express resistance genes. The 
development of antimicrobial resistant food-borne pathogens would take place in the gut of 
animals and they may be transferred to other bacteria. Lyons et a/. (1980) and Marshall et a/. 
3 DNA gyrase is essential for relieving torsional strain during replication of circular chromosomes in 
bacteria. 
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(1990) stated that intestinal bacterial strains, carrying the resistance genes, are capable of 
natural transmission to humans. This may affect human health directly, particularly for 
people who are vulnerable. The United Kingdom set up a Joint Committee on the use of 
Antimicrobials in Animal Husbandry and Veterinary Medicine. As a result of the Committee's 
recommendations, the principle of using different antimicrobials for therapy or growth 
promotion became established in the EU. Recently, the World Health Organization set up ad 
hoc committees to investigate the potential impact on human health from the use of 
antimicrobials in food-producing animals (WHO, 2004). 
The development of antimicrobial resistance amongst pathogenic bacteria has emerged as a 
public concern. In particular, it is assumed to be associated with foodborne pathogens. 
Scientists initiated research on the association between the use and overuse of 
antimicrobials and the development of resistance. It was estimated that approximately 50% 
of antimicrobial agents released into the biosphere during the last 50 years are used in 
veterinary practice and agriculture (Mazel and Davies, 1999; Teuber, 2001 and KUmmerer, 
2003). Antimicrobial resistant bacteria have been found in farm animals where antimicrobials 
were heavily used (Smith et al., 2003). Follet (2000) proposed that almost half of total 
consumption of antimicrobials in the EU is by humans. Collectively, widespread emergence 
of genes expressing resistance to antimicrobials and selection of new resistant strains 
occurred only after the agents become widely used in humans and for animals. 
3.6.3 Antimicrobial use in poultry production 
The European Agency for the Evaluation of Medicinal Products (EMEA, 1999) concluded 
that due to the emergence of multiple antimicrobial resistances there was a need for the 
establishment of a Joint Committee on the use of Antimicrobials in Animal Husbandry and 
Veterinary Medicine. The committee stated that these hazards could largely be avoided and 
recommended that antimicrobials available without prescription in animal feed should be of 
economic value in livestock production. There should have been, however, little or no 
application as therapeutic agents in either man or animals and should not be able to impair 
the efficacy of prescribed therapeutic drugs through the development of resistant strains of 
the organism. 
Antimicrobial agents have been used in livestock and poultry since the early 1950s to treat 
infections and improve growth (increase rate of weight gain) and feed efficiency. The use of 
antimicrobials to treat and control disease (using a subtherapeutic concentration) in both 
farm animals and domestic pets has contributed to improvements in animal health and 
welfare and to the marked increase in productivity of livestock supplied for human 
consumption. In general, veterinary surgeons use antimicrobial products to treat one or a 
number of sick animals in a group resulting in a reduction of symptoms. During enzootic 
infection, healthy animals may also need to be protected from the spread of disease. 
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Although antimicrobials are only administered following prescription by veterinary surgeon, 
farmers believe that in order to increase the rate of weight gain and reduce the amount of 
feed per unit of gain, certain antimicrobials must be used for growth promotion as well. 
Antimicrobial administration in animals is carried out for three main objectives; therapy, 
prophylaxis and growth promotion. Farmers may treat individual sick animals with a high 
dose over a short period of time to overcome pathogens by adding antimicrobials into feed 
or drinking water. Prophylactic treatment, however, would involve moderate to high doses 
and similarly it is also delivered through feed and water. The three suggested explanations 
for how antimicrobials can improve growth in animals are: (i) control of subclinical disease; (ii) 
enhanced nutrient availability; and (iii) minimising activation of the immune response. As 
they may accelerate growth, antimicrobials tend to be given in feed at sub-therapeutic levels 
(below 200 g/ton of feed) over extended periods to entire herds and flocks. Although they 
are given at sub-therapeutic doses, they still exceed the minimal inhibitory concentration of 
any pathogen (Endtz et al., 1991 and Barton, 2000). Overall the largest quantities are used 
as a regular supplement for prophylaxis and growth promotion. In Europe a recent report 
has shown that production of 1 kilogram of animal meat may use approximately 100 
milligrams of antimicrobial (EMEA, 1999). 
Due to lack of education on the appropriate use of diagnostic services, relevant laboratory 
support and application of antimicrobial in animal husbandry, the use is apparently careless 
and uncontrolled (EMEA, 1999). In addition, antimicrobials used as growth promoters may 
be generally licensed solely as feed additives. However, there is currently little information 
showing the real situation of how antimicrobial to be used in poultry. Table 3.7 shows the 
major classes of antimicrobial agents approved for use as prophylaxis and growth promotion 
in poultry. 
Table 3.7 Major antimicrobial agent classes approved for non-therapeutic use in poultry 
(Based on Shea, 2004) 
Antimicrobial class Pro~h~laxis Growth ~romotion 
Aminoglycoside Yes No 
r.,-Lactam 
- penicillin Yes Yes 
- cephalosporin Yes No 
lonophore Yes Yes 
Lincosamide Yes Yes 
Macrolide Yes Yes 
Polypeptide Yes Yes 
Streptogram in Yes Yes 
Sulfonamide Yes Yes 
Tetracycline Yes Yes 
Bambermycins Yes Yes 
Carbadox Yes Yes 
Novobiocin Yes No 
S~ectinom~cin Yes No 
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In North America and Europe , it is estimate that approximately 50% (in tonnage) of all 
antimicrobial production is used in food-producing animals and poultry (FEDESA, 1998). In 
the UK, approximately tonnes of ant imicrobials were used for human therapy, tonnes for 
animal therapy and prophylaxis and tonnes for growth promoters . Stati stics on antimicrobial 
sales in the European Union and Switzerland for the year 1997 showed that about 52% were 
used in humans whereas therapeutic animal health antimicrobial use accounted fo r 33%, 
and growth promoters for 15% (Figure 3.5) . 
52% OHuman use 
33% O Animal (therapeutic) 
EJ Animal (growth promotion) 
Figure 3.5 Antimicrobial use in humans and animals in the EU in 1997 (10,500 tonnes of 
active ingredient at 100% purity) (taken from Follet, 2000) . 
Sales volumes of various antimicrobials showed in Tables 3.8 and 3.9. 
Table 3.8 Sales volumes of antimicrobial use as therapeutics and growth promoters in 
different EU member in 1997. (taken from FEDESA, 1998) 
Therapeutic group 
Penicillins 
Tetracyclines 
Macrolides 
Aminoglycosides 
Fluoroquinolones 
Trimethoprim/Sulphonamides 
Other therapeutics 
Estimated total 
(% of total) 
9 
66 
12 
4 
2 
5 
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Table 3.9 Sales volumes of antimicrobials in the EU and Switzerland in 1997: Therapeutic 
groups (tonnes of active ingredients) (Follet, 2000) 
country 
Austria 
Belgium+ Luxemburg 
Denmark 
Finland 
France 
Germany 
Greece 
Ireland 
Italy 
Netherlands 
Portugal 
Spain 
Sweden 
UK 
Sales of growth promoters 
(% EU market) 
1 
7 
5 
<1 
21 
16 
1 
2 
6 
14 
2 
12 
<1 
12 
Routes of drug administration 
Feed 
Sales of therapeutics 
(% EU market) 
<1 
4 
2 
<1 
14 
14 
3 
<1 
11 
9 
1 
18 
<1 
23 
Several diet formulas are typically fed to poultry from hatching to market. Pre-starter and 
starter diets are fed to broilers for up to 19 days after hatching. These diets may contain up 
to three drugs: (i) a prophylactic coccidiostat; (ii) a growth promoter antimicrobial and (iii) an 
organiC arsenical compound. 
One-day-of-age injection 
This route can be applied for drugs that must be approved for usage in poultry. It is for 
treatment of sick chickens or protection of chicks from injection-site abscesses after 
vaccination. In addition, mass incubation and hatching techniques create significant bio-
aerosols containing various genera of Enterobacteriaceae, One-day-of-age injections can be 
used to improve early viability. 
Water medication 
In general, sick birds are medicated through drinking-water systems. Either systemic or 
intestinal medication can be given by this route. To achieve and maintain therapeutic 
concentrations, the actual water used for each class of poultry is based on the age of birds, 
and the environmental temperature is controlled and monitored. 
3.6.4 Emerging antimicrobial resistance in Campy/obaeter 
Many would consider antimicrobial therapy to be unnecessary for campylobacteriosis 
because of the low mortality and self-limiting symptoms. However, treatment may be 
indicated for patients whose symptoms develop severely or who are immuno-compromised. 
In those cases, antimicrobials, at least, can reduce the severity and duration of illness. When 
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the antimicrobial treatment is indicated, the drugs of choice are either macrolides (e.g. 
erythromycin) or quinolone- fluoroquinolones (e.g. nalidixic acid, ciprofloxacin). 
Campy/obaeter is found to be resistant to a number of antimicrobial agents, e.g., penicillin, 
~-Iactams, glycopeptides, macrolide and fluoroquinolones (Taylor and Courvalin,1988 and 
Piddock, 2000). Although the increase in the resistance rate of Campy/obaeter to 
antimicrobials has been fully recognised for some antimicrobials used in humans and 
animals, the most alarming increase in resistance is for f1uoroquinolones. This is because 
fluoroquinolones are new, potent, broad-spectrum agents used for a wide range of gram-
negative and gram-positive infections as well as being considered as a drug-of-choice for 
patients whose symptoms are severe. It is also used in adults for therapy and prevention of 
traveller's diarrhoea (Aarestrup and Wegener, 1999). 
The increasing rate of antimicrobial resistant Campy/obaeter has been observed and 
reported, over the last four decades. Reports from several countries in Europe and North 
America have shown the rising prevalence of the resistance in humans. Not surprisingly, 
after introduction of enrofloxacin into animal husbandry in European countries, the increase 
in fluoroquinolone-resistant Campy/obacter was up by 35% (EMEA, 1999). In 1993, when 
enrofloxacin was first licensed for oral use in food producing animals in the UK, a small 
study expressed the maximum value of the minimal inhibitory concentration (MIC) of 
enrofloxacin for C.jejuni as 1 tlg/ml. Afterwards, the further studies carried out from 1994-
1995 showed that 7% of the isolates had a higher MIC, 4 tlg/ml (EMEA, 1999). Endtz et a/. 
(1991) presented a long term study of Campy/obaeter resistance to f1uoroquinolones. In the 
Netherlands, from 1982 to 1989, the incidence rate of ciprofloxacin resistance in 
Campy/obaeter isolated from chickens rose from 0% to 14%, and this increase was in 
parallel with an increase in humans from 0% to 11 %. 
MAFF (1998) has carried out an overview of antimicrobial resistance in Campy/obaeter. In 
the UK less than 1 % of Campy/obaeter was found to be resistant to erythromycin. Guant and 
Piddock (1996) indicated a steady increase in f1uoroquinolone resistant Campy/obaeter. 
Many studies in Spain showed the existence of multi-resistance among ampicillin (69%), 
erythromycin (1.5%), tetracyclin (43%) and ciprofloxacin (57%). However, in countries that 
strictly control antimicrobial use like Sweden and Finland, rates of resistance to erythromycin 
and ciprofloxacin among Campy/obaeter were low. Importantly, resistance to ciprofloxacin 
was not encountered among human isolates and infrequently among poultry isolates. It is 
noted that there is no internationally accepted breakpoint for characterising resistance in 
Campy/obaeter species. Therefore, it is difficult to compare the resistance rate between 
countries. 
51 
Macrolide resistance 
Some studies in the UK and Canada reported that few Campy/obacter strains from humans 
«30%) were resistant to erythromycin (Brunton et ai, 1978; Piddock et a/., 2000 and Moore 
et a/. 2001). Aarestrup and Wegener (1999) and Saenz, et a/. (2000) reported however that 
a higher frequency of erythromycin resistance (53-81 %) found in C.coli isolated from 
humans and pigs. it is also evident that C.coli shows a higher resistance to erythromycin 
than that found in C.jejuni. 
Fluoroguinolones resistance 
Several Campy/obacter species, including C.jejuni, C.coli, C.fetus subsp. fetus and 
C.hyointestinalis, are usually susceptible to quinolones and fluoroquinolones. In vitro, 
C.jejuni and C.coli are highly susceptible to ciprofloxacin, norfloxacin and ofloxacin 
(Goossens et a/., 1985). As the rate of resistance to fluoroquinolones in humans and poultry 
has been increasing in many countries, this has become a matter of public health concern 
worldwide. Since then it has been tracked down by a large group of researchers around the 
world. The resistance varies from country to country as well as from humans to animals. The 
details were presented in Tables 3.10 and 3.11. 
Table 3.10 Approval date for fluoroquinolones use in humans and food-producing animals 
(adopted from Anderson et ai, 2001) 
Country Human use (year and antimicrobial) 
Netherlands 1985, Norfloxacin 
1988, Ciprofloxacin 
1989, Pefloxacin 
1989,Ofloxacin 
Spain 
UK 
US 
1987, Ciprofloxacin 
1987, Ciprofloxacin 
1986, Norfloxacin 
1987, Ciprofloxacin 
1990, Ofloxacin 
1997, Sparfloxacin and Levofloxacin 
Animal use (year and antimicrobials) 
1980s, Flumequine 
1987, Enrofloxacin 
1990, Enrofloxacin 
1993, Enrofloxacin 
1995, Enrofloxacin and Sarafloxacin 
1998, Enrofloxacin (cattle) 
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Table 3.11 Resistance of C. jejuni and C. coli to quinolones and fluoroquinolones in human 
and poultry 
Country and year 
Resistance rate (%) 
Reference 
Human Poultry 
Autralia (1997) 34.1-34.9 EMEA( 2001) 
Belgium (1998) 44.2 Looveren et a/(2001) 
Canada (2001) 47 Gaudreau et a/.(2003) 
Denmark (2002) 5.2 Engberg et a/.(2004) 
- domestic 9.9 
- travelers 50 
Finland (1997) 35-37 Hakanen et a/.(2003) 
Germany (2001) 45.1 45.6 Luber, et a/.(2003) 
Italy (1993) 25.9 47-56 EMEA (2001) 
Japan (1991) 10.7 Engberg et a/.(2001); Takahasi et al 
(2005) 
Netherlands (1997) 29 14 Endtz et a/.(1991) 
Singapore Engberg et a/.(2001) 
Spain 88 98.7 Hakanen et a/.( 2003) 
Sweden (1993) 6.1-25.5 EMEA(2001 ) 
Thailand (1995) 84 Hoge et a/.(1998); Hakanen et a/.(2003) 
United Kingdom 11.7-16.2 10.8 Thwaites and Frost(1997) 
(1997) EMEA(2001) 
United States 10.8-23.9 35-41 EMEA(2001); Ge et a/.(2003) 
3.6.5 Mechanism of antimicrobial resistance in Campy/obaeter 
Antimicrobial resistance is a microbiological phenomenon, which mayor may not have 
clinical implications depending on pharmacokinetic and pharmacodynamic parameters as 
bacteria develop the resistance to specific antimicrobials. Following survival adaptation, 
bacteria will develop the potential to inhibit the action of specific antimicrobial agents through 
cellular mechanisms, for example, genetic mutation, gene transfer or a combination of both. 
The drug selection pressure depends in part on the concentrations of antimicrobials to which 
bacteria are exposed and whether a concentration is achieved that can actually assist in the 
selection for the proliferation of resistant organisms. A tremendous selection pressure has 
been exerted on bacterial eco-systems in humans and animals. Huovinen (1997) stated that 
development of bacterial resistance has been expected, rather than beingan unpredicted 
phenomenon. 
Resistance in bacterial populations mayor may not be reversible, depending on the 
antimicrobials used, the bacterial species, selection pressures and other factors. Most likely 
the adaptation process has a genetic basis. Bacteria store genetic information in genes on 
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the DNA of their single chromosome. However, they also keep genetic information on 
accessory pieces of DNA separate from the chromosome, plasm ids, or transposons. All 
resistance genes might either be a fixed part of the bacteria genome or transferable between 
bacteria. They may be occasionally transferred to the new host by bacteriophages (Neu et aI, 
1996). Thereby, the resistance can be achieved by horizontal acquisition of resistant genes 
(carried by plasm ids or transposons) by recombination of foreign DNA into the chromosome, 
or by mutations in different chromosomal loci (Martinez and Baquero, 2000). 
Resistance can be acquired through chromosomal mutation or acquisition of foreign DNA 
(plasm ids or transposons). Resistance can be an intrinsic property of the bacteria itself, such 
that every strain in the species is resistant. Bacteria can transfer chromosomal or plasmid 
DNA containing resistant genes to other bacteria by conjugation, transduction and 
transformation. 
Campy/obacter species are capable of transformation, i.e. facilitation of the uptake of naked 
DNA. This may become chromosomally integrated by site-specific recombination (Wang et 
a/., 1993; and Taylor and Chau 1997). Campy/obacter also presents the structure of integron-
like character which pOints to the transmission of antimicrobial resistance genes. 
Most recent studies of antimicrobial resistance in Campy/obacter species have been focused 
on C.jejuni and, to a lesser extent, C.coli. Both are intrinsically resistant to a number of 
antimicrobials, including bacitracin, novobiocin, rifampin, streptogramin B, trimethoprim, 
vancomycin and cephalothin (Taylor and Courvalin, 1988). C.jejuni and C.coli are usually 
susceptible to erythromycin and ciprofloxacin. Thereby, they are becoming drugs of choice 
for campylobacteriosis. As reported by Endtz et a/. (1991), however, several Campy/obacter 
(i.e.,C.jejuni, C.coli, C.fetus subsp. fetus) are inclined to be resistant to these drugs. Engberg 
et a/. (2001) reviewed and proposed mechanisms of fluoroquinolone and macrolide 
resistance, that are; 
Mechanism of macrolide resistance 
Erythromycin resistance in C.jejuni and C.co/i is chromosomally mediated and is due to 
alteration of the ribosome (Taylor, 1992). The resistance mechanism is not consistent with 
presence of rRNA methylase, or modification of the antimicrobial or efflux systems 
(extruding noxious agents through the cytoplasmic membrane). Sequencing of the 23S 
rRNA genes from erythromycin resistant Campy/obacter showed the mutation at the sites of 
23S rRNA (Figure 3.6). 
Mechanism of fluoroguinolone resistance 
Fluoroquinolone resistance in C.jejuni appears to be due most often to mutations in the 
genes encoding subunits of DNA gyrase (gyrA) and occasionally to topoisomerase IV (parC) 
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(Figure 3.7). A number of studies suggest that the mutations for quinolone resistance occur 
primarily in the quinolone resistance-determining region (QRDR) (Wang et al.,1993; Gaunt 
and Piddock, 1996; Taylor and Chau 1997 and Zirnstein et al.,1999). Fluoroquinolone acts 
on DNA gyrase and topoisomerase IV. Gyrase is involved in DNA replication, recombination 
and transcription. It is a tetramer composed of two A and two B subunits which are encoded 
by the gene gyrA and gyrB. Topoisomerase IV is encoded by the gene parC and parE. The 
parC plays a role in the partitioning of replicated chromosomes (Luttinger, 1995). In C.jejuni, 
the region 269-fragment of the gyrA gene encodes for a 41-amino-acid quinolone 
resistance-determining region (QDRD) develops mutation at amino acid position Thr-86, 
ACA (threonine). The amino acid Thr-86, ACA (threonine) is substituted to ATA (isoleucine), 
Asp-90 and Ala-70. Apart from the mutation of Thr-86-to-lie-gyr A, mutations may be 
encountered on other proteins, for example, the parC (topoisomerase IV) and parE. 
However, Cooper et al. (2002) found that the genomes of QRDR in C.jejuni and C.coli do not 
contain parC and parE. 
Resistance 
Macrolide 
Fluoroauinolone 
) 
) 
Mutation 
Domain V of 23 rRNA 
A2058-7 G 
A205~G 
gyrA --7 Thr- 86 (hiqher MIC) 
Thr- 90, Ala- 70 (lower MIC) 
highest MIC{ 
gyrA --7 Thr-86 
+ 
parC ) Arq-139 
Figure 3.6 Macrolide and fluoroquinolone resistance mechanisms found in Campylobacter 
(from Engberg et al., 2001) 
The resistance mechanisms of Campylobacter developed against the use of these 
antimicrobials are also summarised in Table 3.12. 
Table 3.12 Resistance mechanisms against macrolides and {fluoro)quinolones (modified 
from EMEA, 1999). 
Modification 
Bacterial cell 
Class of permeability Antimicrobial over-
antimicrobial Cellular target Decrease Increase inactivation Target production 
influx efflux 
Macrolides 50S RNA subunit + + + + -
(Floro )quinolones DNA gyrase + + - + -
Topoisomerase IV 
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3.6.6 Transmission of antimicrobial resistant Campy/obaeter from 
animals to humans 
Over decades the rate of antimicrobial resistance in Campy/obacter infection has been 
increasing sharply in many countries. In addition, much of the evidence relating to the 
potential for transfer of a resistance problem from animals to humans comes to a matter of 
epidemiology of Zoonoses. Studying the transmission of resistant strains from animals, 
especially poultry to humans has been difficult because the pathway of transmission is 
complex (Figure 3.7). However, several studies have attempted to compare not only 
serotypes but also genotypes of Campylobacter isolated from human samples and food 
samples. It was concluded that food-producing animals could be a substantial source of 
infection in humans (Orr et a/., 1995; On et al., 1998; Smith, et a/., 1999 and Owen et a/., 1999). 
Currently, there are no studies that demonstrate a direct causal links between the use of 
antimicrobial agents in animal husbandry and the rate of antimicrobial resistance in humans. 
However, three studies have shown an association between strain types of Campy/obacter 
in human infection and those found in retail chickens. Other studies have also proposed that 
the use of antimicrobial agents in poultry husbandry could be one of the factors influencing 
the development of resistance in Campy/obacter with the risk that this resistance may pass 
to humans via food (Endtz et a/., 1991; Sarah, 2002; Luber et a/., 2003; Randall et a/., 2003 
and Wagner et a/., 2003). 
A recent study (Humphrey et a/., 2005) has shown that ciprofloxacin-resistant 
Campy/obacter strains emerge during fluoroquinolone treatment in commercially reared 
chickens. Following the increased reporting of antimicrobial resistance in general and 
f1uoroquinolone resistance in particular in Campy/obacter worldwide, attempts have been 
made to better control their use in animal husbandry (Sanchez et al., 1994; Piddock et a/., 
2000; Tollefson, 2002 and Luber et a/., 2003). 
Moreover, multidrug resistance is also a problem. In particular, multidrug resistance to 
macrolides and fluoroquinolones must be considered highly undesirable because both of 
them are drugs-of-choice as well as being first and second-line drugs for treatment of 
campylobacteriosis. Gaudreau and Giltbert (1998); Saenz et a/.(2000) and Randall et a/. 
(2003) found cross-resistance between nalidixic acid,ciprofloxacin, erythromycin, tetracycline 
and ampicillin. 
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Figure 3.7 Mode of the distribution and transmission of antimicrobial susceptible or resistant 
gastro-intestinally pathogens between animals and humans (taken from 
Phillips et al., 2004) 
3.6.7 Definition of susceptibility and resistance to antimicrobials 
As defined by the British Society of Antimicrobial Chemotherapy (BSAC). antimicrobial 
susceptibility and resistance are relative terms and provide an interpretation of the clinical 
significance of concentrations of an antim icrobial agent. 
~Minimal inhibitory concentration (MIC) is defined as the lowest concentration of 
antimicrobial that inhibits the visible growth of a micro-organism after overnight incubation. 
~Break point is recommended as a measure for the point at which a MIC is sufficiently high 
to indicate resistance. 
~ Laboratory resistance is the level that is more than a 2-fold increase in the concentration 
of antimicrobial compared to a normal susceptible strain. 
~Clinical resistance is the ability of an organism to grow at clinically achievable 
concentrations of antimicrobial. 
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Water I 
CHAPTER 4 
Organic Chicken Farm ing 
4.1 I ntrod uction 
With a growing number of cons umers switching from red meat to poultry, the chicken and 
turkey industries have a boom ing business (Tab le 4.1). To ach ieve high prod uctivity at low 
cost, most poultry farmings use genetica lly and en vi ronm entally manipu lated methods to 
rear chickens . Factory farming methods , especially intens ive rearing systems, have been 
implemented in the poultry industry. In such sys tems the number of bird s typically increases 
(up to 40 ,000 birds) without expanding the rearing houses . Birds often have to spend the ir 
entire life indoors . The stocking rate for housed bro il er chickens is 32 Kg/m2 (EC , 2002). 
Ch ickens are bred to develop qu ickly so they reach slaughter weight at 42 days. Each 
ch icken is given less than half a square foot of space, barely be ing able to move. They may 
be crammed into a windowless build ing , with low levels of art ificial light (e.g. Figure 4.1) 
They are not provided with fresh litter and in a fast growing period they are unable to support 
their bodies. In these cond itions their legs and breasts are burnt by the man ure and are 
eventually infected with micro-organ isms. For example, millions of chickens in the UK die of 
heart disease before reach ing slaughter we ight at 6 weeks of age (e.g Figure 4.2). As a 
result , antimicrobials have been introduced into the system to keep th em alive and hea lthy. 
This also forces the ir rate of growth . Many of the antimicrobials used may eventually impact 
on human health . 
Figure 4.1 Intensively reared farming : inside the house (the example which may not be typica l 
for al l chicken farms) (Sou rce : http ://www.factoryfarming.com/gallery/broiler01.htm) 
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Table 4.1 Poultry meat consumption per capita in selected countries (Kg/capita) (Source: 
http://www.foodmarketexchange.com/datacenter/productlpoultryIchicken) 
Region and country 
Amount of consumption (Kg/capita) 
1996 1997 1998 1999 2000 
North America 
Canada 30.7 31.4 32.0 33.8 34.8 
Mexico 18.8 18.9 19.8 21.5 22.7 
United States 45.7 46.2 46.7 49.1 49.3 
South America 
Argentina 19.8 22.8 25.5 25.6 24.9 
Brazil 21.5 23.2 23.4 27.3 28.2 
Colombia 17.0 17.5 17.6 16.6 17.2 
Honduras 7.7 10.0 10.7 10.7 10.8 
Venezuela 17.2 17.3 16.6 15.7 16.1 
European Union 
France 24.8 24.7 25.1 24.4 24.9 
Germany 14.1 14.7 15.0 15.2 15.2 
Italy 19.2 19.5 19.5 19.1 18.7 
Netherlands 21.3 21.8 22.2 21.5 21.0 
Spain 26.0 24.2 24.3 26.7 26.4 
United Kingdom 26.0 25.9 27.7 28.1 28.4 
Eastern European 
Bulgaria 11.4 12.3 14.6 15.0 15.6 
Hungary 25.0 26.1 29.4 25.4 27.4 
Poland 11.1 12.7 14.0 14.2 14.3 
Russia 12.2 12.7 10.6 10.6 11.3 
Ukraine 5.3 5.0 4.9 5.8 5.8 
Middle East 
Kuwait 44.5 44.7 40.8 41.7 41.1 
Saudi Arabia 32.0 35.8 34.8 35.1 34.3 
United Arab Emirates 32.0 31.8 34.3 40.5 40.2 
Africa 
Egypt 6.0 7.0 7.6 8.9 8.5 
Republic of South 21.7 21.6 24.6 26.6 26.4 
Asia 
China (PRC) 8.2 8.8 9.0 9.3 9.6 
Hong Kong 50.3 52.5 59.0 57.0 57.4 
Indonesia 4.6 4.3 2.1 2.9 3.4 
Japan 14.4 14.0 13.8 13.7 13.8 
Malaysia 33.1 34.0 29.4 31.1 32.1 
Republic of Korea 10.8 10.8 9.5 11.0 11.3 
Taiwan 31.1 34.1 33.6 33.0 34.0 
Thailand 12.0 12.6 11.6 12 13 
Oceania 
Australia 27.0 28.3 30.5 31.4 32.4 
59 
Figure 4.2 The chicks at the age of 6 weeks 
(Source : http//www.factoryfarming .com/gallery/bro iler01.htm) 
In addition , lighting in the houses is bright so as to encourage maximum feeding and 
drinking . It may remain on for 23 .5 hours a day (e.g.Figure 4.3). Prolonged inactivity (rest) is 
deemd economically undesirable because birds do not eat and then put on we ight . 
Figure 4.3 Lighting in the rearing house of intensive chicken farm ing 
(So u rce : http ://www.advocatesforanimals .org .ukJresources/farmed/broilers .html) 
Note: All pictures presented in this chapter are taken from an an imal welfare resource. 
These represent typical rearing conditions . There are many worse although the re are a few 
better. 
Because of increasing degree of awareness of food safety and hea lth, as well as animal 
rights , public concerns have increased . Sustainabil ity is a further iss ue. Altern ative farm ing , 
for example , organic farming , has been re-establ ished . As reported by DEFRA, pou ltry meat 
sales account for 15% of the UK organic meat market (UK-DEFRA 2003). The number of 
organic poultry slaughtered in the UK expanded from an estim ated £1 .3 mil lion in 2000/2001 
to £ 2.1 million in 2001 /2002 . Farm gate val ue increased from £7.2 milli on to £10.5 million. 
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4.2 Organic chicken farming 
4.2.1 Definition 
According to the proposed Codex definition, organic farming is a form of agriculture that 
relies on ecosystem management and attempts to reduce or to eliminate external 
agricultural inputs, especially synthetic ones. It is a holistic production management system 
that promotes and enhances agro-ecosystem health, including biodiversity, biological cycles, 
and soil biological activity. Organic farming emphasises management practices, taking into 
account that regional conditions require locally adapted systems, using both traditional and 
scientific knowledge (UKROFS, 2000). 
The definition and criteria of what constitutes organic farming is regulated by government 
through law in a number of countries (e.g. Australia, Norway, Thailand, Taiwan and in the 
EU). Under such Regulation, each member state is required to establish a national 
competent authority to ensure adherence to the law, for example, the Department of 
Environment and Rural Affairs (DEFRA) in the UK. Organic farmers must be registered with 
a certification body which must be approved by the National Competent Authority and 
organic food must be produced from a certified farm only. The non-certified farm cannot 
label products as organically produced food. In Canada, voluntary certification is available, 
while legislation may be pending (IFOAM, 2005). 
There are ten approved certification schemes for organic producers in the UK, of which the 
five most important in terms of number of licensees are Soil Association (SA), Organic 
Farmers and Growers (OFG), Scottish Organic Producers Association (SOPA), (Biodynamic 
Agricultural Association (BDAA) and Organic Food Federation (OFF). 
4.2.2 General principles of organically produced poultry 
The recommendations propose that livestock production must contribute to the equilibrium of 
systems of agriculture, environment and ecology. It must be done by providing for the 
nutrient requirement for crops, through the soil's organic matter, and by utilising renewable 
natural resources. The number of livestock must be closely related to the area available in 
order to avoid problems of adverse effects, not only on the animal health but also on 
environmental quality. 
Lower stocking rates apply to organic farms. The rate is limited at 21 kg/m2 . Organic birds 
must be reared in open-range conditions and should have free access to open-air runs 
throughout the day. In addition, chickens have a minimum slaughter age of 81 days, allowing 
more balanced growth of muscle, bone and vital organs, and virtually doubling their life span 
compared to intensively farmed chickens (IFOAM, 2005). 
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The national organic livestock standards (the United Kingdom Register of Organic Food 
Standards( UKROFS) state that organic poultry must be reared in accordance with 
standards set for organic livestock and organic livestock products. These standards are 
described as follows: 
Origin of animals 
In the choice of breeds or strains, account must be taken of the capacity of animals to adapt 
to local conditions. All chicks for broiler production must be less than three days old at the 
time they leave the production unit where they are produced. 
Feed is intended to ensure quality of production rather than maximisation of production. It 
must meet the nutritional requirement of livestock at various stages of their development. 
However, forced feeding is forbidden. For poultry, the feed formula used in the fattening 
stage must contain at least 65% cereals. Feed stuff and certain products used in animal 
nutrition must not have been produced with the use of genetically modified organisms 
(GMOs) or products derived from GMOs. 
Disease prevention and veterinary treatment 
Disease prevention shall be based on the good animal-husbandry practices appropriated to 
the requirements of poultry, for instance, broiler chicken. Owing to the fact that if animal 
becomes sick or injured, it is necessary to use veterinary medicinal products, i.e., 
phytotherapeutic4 or homeopathic products. The use of either product shall comply with the 
therapeutic effect for combating illness or injury. In addition those products shall be used in 
preference to chemically synthesised allopathic 5 veterinary medicinal products or 
antimicrobials. 
The use of chemically synthesised allopathic veterinary medicinal products or antimicrobials 
for preventive treatments and for promoting growth or production is prohibited. Nonetheless 
if an identified disease risk occurs and the welfare of animals cannot maintain by 
management practices alone, it may be permitted. Vaccination is permitted in cases where 
there is a known disease risk. 
4 Phytotherapeutic product consists of complex mixtures of one or more active ingredients extracted 
from plants which are used in most countries for management of various diseases. 
5 Allopathic products usually include registered veterinary pharmaceutical or proprietary medicinal 
products (e.g. antimicrobial agents, painkillers). Some phytotherapeutic treatments could also be 
viewed as allopathic in their mode of actions. 
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Husbandry management practices, transport and identification of livestock products 
Poultry must be reared in open-range conditions and cannot be kept in cages. Their houses 
shall comply with their own grazing, air space, ventilation, feed, water and litter disposal 
needs. 
The size of a group reared together must depend upon the stage of their development and 
the behavioural needs of the species of concern. During transportation, live animals and 
birds must be handling with proper care and concern for their welfare, minimising stress and 
avoiding the likelihood of injury. 
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CHAPTER 5 
Detection and Enumeration 
5.1 Introduction 
Since Campy/abacter was firstly recognised in 1960s, significant detection including isolation 
and identification methods have been developed in order to understand growth 
characteristics, genetics, molecular biology and pathogenic mechanisms of this genus as 
well as host response (Karmali et a/., 1986; Walker et a/., 1986 and Penner, 1988). In 
addition, because of its clinical and economic implications, development of detection 
procedures, pathogenesis, epidemiology and molecular biology have rapidly progressed. 
Molecular techniques have first been used in clinical laboratories for both direct identification 
and confirmation (Sails et a/., 2001). 
5.1.1 Detection methods 
Although traditional detection methods currently used in most studies are not internationally 
accepted standard methods, there are some generally agreed procedures. These include 
pre-enrichment media (with or without blood supplement), selective agar supplemented with 
antimicrobials, growth conditions (optimal temperature and micro-aerobic atmosphere) and 
confirmation criteria (Corry et a/., 1995; Tran, 1998 and Baylis et a/., 2000). Since the first 
selective medium was successfully developed by Skirrow in 1977, methods for the detection 
of Campy/abacter have been developed to recover C.jejuni from faecal specimens where the 
organisms are present in relatively large numbers (Wesley et a/., 1983). These methods 
were based on traditional isolation techniques used for the isolation of pure cultures. 
However, like other foodborne pathogens, the isolation of Campy/abaeter from foods is often 
difficult because: i) this organism may be present in lower numbers than numbers of 
competitor organisms, ii) cells may also be sub-lethally injured by food processing, iii) 
Campy/abaeter requires specific growth conditions, e.g. micro-areobic eonditions(5-10% 
oxygen and 3-5% carbon dioxide), ferric iron and iv) Campy/abaeter is a slow growing 
bacterium that requires long periods for incubation (Baylis et a/., 2000 and Nogva et aI, 
2000). Thus, a number of studies attempted to improve the efficiency of recovery of 
Campy/abaeter from food (Wesley et a/., 1983; Fongsiri et a/., 1989; Baylis et a/., 2000 and 
Moore, 2001). 
As traditional culture techniques are time-consuming, labour intensive and less efficient 
methods for detection of Campy/abaeter in food samples, molecular methods (e.g. 
polymerase chain reaction (PCR) based assay, Fluorescence In Situ Hybridisation) have 
been comparatively developed. They presently are preferable to culture techniques due to 
improoved speed and accuracy. However, these methods require high performance 
equipment and unfeasibly high costs. Therefore the two groups of methods currently used 
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for the detection of Campy/obaeter in food samples are based on: i) traditional culture 
method involving enrichment and sub-culture on the selective media according to the growth 
conditions and ii) molecular based methods which, in contrast, detect the organism without 
enrichment and sub-culture and involve enzymatically replicating DNA. Both types have their 
advantages and disadvantages. 
5.1.1.1 A traditional culture technique 
A traditional culture method for the detection of Campy/obaeter requires enrichment media 
and appropriate growth conditions. 
Enrichment broths used in recent studies are summarised in Table 5.1 [ Bolton broth (BB), 
Exeter broth, Preston broth and Campy/obaeter Enrichment broth (CEB) supplemented with 
animal blood (horse or sheep)]. However, the broths are used either micro-aerobically or 
aerobically. Micro-aerobic incubation has been suggested for growing Campy/obaeter. Tran, 
1998 and Baylis et a/., 2000 indicated that Campy/obaeter can be recovered under aerobic 
condition with appropriate media (types of nutrient and supplements) and containing 
equipment (tightly fitting lid container with head space less than 1-2 em). These conditions 
can reduce the oxygen toxic derivatives. 
Following pre-enrichment, enriched sample is further sub-cultured onto selective agar and 
incubated micro-aerobically at 42°C. Campy/obaeter selective agars include nutrient based 
agar and supplements (antimicrobial agents and animal blood). A variety of Campy/obaeter 
selective agars have been used in a number of studies. They can be categorised as: i) 
blood-selective agar (e.g. Skirrow, Campy-Cefex, Butzler and modified Butzler, Preston and 
Exeter) and ii) blood-free selective agar with charcoal as an oxygen quencher (e.g. a 
modified Charcoal Cefoperazone Deoxycholate agar). However, some protocols may 
combine more than one formula in order to enhance growth rate of Campy/obaeter (Corry et 
a/.; 1995; Tran, 1998 and Baylis et a/., 2000. 
Baylis et a/. (2000) showed that Bolton broth and Campy/obaeter Enrichment broth were 
better than Preston broth, and Bolton broth offered the best balance between inhibition of 
competitor organisms and the growth of Campy/obaeter spp. In addition, a modified charcoal 
cefoperazone deoxycholate agar (mCCDA) recommended by a number of organisations is 
most compatible to growth requirements of Campy/obaeter species following pre-enrichment 
in Bolton, broth (Corry et a/., 1995; Donnison, 1998; FDA BAM, 1998; and UK HPA,2002). 
Pre- enrichment protocols currently used for resuscitation of Campy/obaeter in food samples 
are shown in Table 5.1. 
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Table 5.1 Current pre-enrichment protocol~_LJsed for resuscitation of Campy/obacter 
Protocol Formula 
Preston broth 
- original formula 
- modified formula 
Exeter 
Bolton broth 
Campy/obaeter Enrichment 
broth (CEB) 
Park and Sanders broth 
(j') 
(j') 
Nutrient broth (not includind yeast extract), 5% lysed 
horse blood and antimicrobials (polymixin B, 
rifampin, trimethoprim and cyclohexamide) 
Original formula with additional FBP mixture 
(including sodium pyruvate, sodium metabisulphite 
and ferrus sulphate) 
Modified Preston based formula, FBP mixture, 5% 
lysed horse blood and antimicrobials (polymixin B, 
rifampin, trimethoprim, amphotericin and 
cefoperazone) 
Peptone, yeast extract, alpha- ketoglutaric acid, 
sodium pyruvate, sodium metabisulphite, sodium 
carbonate, haemin, lysed horse blood (FDA BAM, 
1998) or lake horsed blood (Baylis, et aI, 2000), 
antimicrobials (trimethoprim, vancomycin, 
cefoperazone and cyclohexamide) 
Peptone, yeast extract, alpha- ketoglutaric acid, 
sodium pyruvate, sodium metabisulphite, sodium 
carbonate, haemin, lake horsed blood, 
antimicrobials (trimethoprim, vancomycin, 
cefoperazone and natamycin) 
Brucella broth, lysed horse blood, antimicrobials 
(trimethoprim, vancomycin, cefoperazone and 
cyclohexamide) 
Incubation condition Reference 
Micro-aerobic, 42°C Bolton and Robertson (1982) 
Aerobic, 37°C for 4hrs following 42°C Tran (1998) and Baylis et a/. (2000) 
for 48hrs 
Aerobic condition in container fitted with 
a screw cap with head space < 1 cm. 
37°C for 4hrs following 42°C for 24-
48hrs 
Micro-aerobic (FDA BAM, 1998) or 
aerobic condition in a container fitted 
with a screw cap with head space < 2 
cm (Tran, 1998 and Baylis eta/, 2000) 
Aerobic condition in a container fitted 
with a screw cap with head space < 2, 
37° C for 4hrs following 42°C for 20-44 
hrs 
Micro-aerobic condition, 32°C for 4 hrs, 
37°C for 4 hrs and 42°C for 40-42hrs 
Humphrey (1986) and Martin et a/., 
(2002) 
Tran (1998), FDA BAM (1998) and 
Baylis et al (2000) 
Baylis et al. (2000) 
Scotter et al.(1993) 
5.1.1.2 Molecular based methods 
Traditional detection methods have been used for the identification of Campy/obacter in a 
large number of studies. However, there is great variation in isolation frequencies and 
different predominant species in certain reservoirs such as animals. This is due to 
differences in sampling and isolation techniques and characterisation of Campy/obacter 
(J0rgensen et a/., 2002). Molecular based methods have been considered as superior tests 
for Campy/obacter identification and species differentiation. These methods were first used 
for genotyping of Campy/obacter in clinical specimens such as faeces. They were applied to 
identify pure culture isolated from samples using traditional culture methods. The initial 
objective of genotyping applied to faecal samples obtained from diarrhoeal patients is to 
differentiate certain species of Campy/obacter causing enteritis in humans. This information 
is significantly beneficial for epidemiological studies (Desai et a/., 2001). Advantages of 
molecular methods have led to further applications to directly detect Campy/obacter spp. in 
environmental samples such as water and foods (WegmOller et a/., 1993). To date, multiple 
molecular techniques have been combined in the application of the tests in order to 
maximise the performance characteristics of the tests, which include accuracy, precision, 
sensitivity and specificity, i.e. polymerase chain reaction/restriction enzyme analysis typing 
(PCR/REA), amplified fragment length polymorphism (AFLP), pulsed-field gel 
electrophoresis (PFGE) and random amplified polymorphic DNA and ribotyping (Wassenaar 
and Newell, 2000; Lehtola et a/., 2005 and Schmid et a/., 2005). 
Applications of molecular methods have been further used for the identification of resistant 
genes. Several studies have conducted these techniques to identify the antimicrobial 
resistant region on the gyrA gene of Campy/obacter that expresses evidence of mutation to 
certain antimicrobials, in particular, (fluoro )quinolones (Zirnstein et a/., 1999 and Fluit et a/., 
2001 ). 
Although these techniques have considerable advantages, they require intricate equipment, 
skilled staff and are of high consumable cost. Some methods involving the analysis of PCR 
product have not yet been validated for the use on different viability states of bacteria. 
Therefore these techniques are not applicable for routine work or in small scale laboratories. 
5.1.2 Confirmation methods 
As traditional culture methods are not species-specific methods, additional indicators are 
necessary for confirmation of Campy/obacter spp. Indicators including physical, traditional 
gram staining, motility, biochemical and genetic characteristics are needed. Specific tests for 
Campy/obacter used in this study are outlined below: 
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Selective media and growth condition 
Selective temperature (42°C) and gas atmospheres or micro-aerobic conditions are required 
to isolate thermotolerant Campy/obaeter. Table 5.2 expresses the optimal temperature for 
growth of Campy/abaeter species. Moreover, the agar, mCCDA with its supplement is 
selective not only by enhancing the growth of Campy/abaeter, but also by suppressing other 
competitive bacteria (Baylis et a/., 2000). As a result, any colonies that are able to grow on 
this selective media are most likely to be thermotolerant Campy/abaeter. 
Table 5.2 Relationship between temperature and growth for Campy/abaeter species 
Temperature (0C) 
Species 
C.coli 
C.concisus 
C.curvus 
C.fetus subsp. fetus 
C.fetus subsp. venerealis 
C.gracilis 
C.he/veticus 
C.hyoiJei 
C.hyointestinalis subsp. 
hyointestinalis 
C.hyointestinalis subsp. /awsonii 
C.jejuni subsp. jejuni 
C.jejuni subsp. doy/ei 
C./ari 
C.mucosalis 
C.rectus 
C.showae 
C. upsa/iensis 
C.fecalis 
25 
+ 
+ 
NA 
NA 
v 
c 
37 42 
+ + 
+ c 
+ + 
+ 
+ 
+ NA 
+ + 
+ + 
+ + 
+ + 
+ + 
+ w 
+ + 
+ + 
+ w 
+ + 
+ + 
+ + 
+, 90% or more of strains are positive; -, 90% or more of strains are negative; v, 11%-89% of strains 
are positive; w, weak reaction NA, results not available; c, contradictory reports in literature. 
General typical appearances displayed onto mCCDA 
Colonies of Campy/abaeter species are usually odourless and small ranging from pinpoint to 
2 mm in diameter. However, colonial morphology is variable and different in several species. 
C. jejuni and C. /ari show flat, glossy and effuse colonies on selective agar. They have a 
tendency to spread along the streak lines. Some colonies may resemble droplet fluid. On 
moist agar a thin and spreading film may be observed. C.ea/i has less effuse and often 
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convex shape colon ies and IS oversh iny. Figure 5.1 presents typ ical ch aracterist ics of 
Campy/obaeter spp. 
Motility 
Figure 5.1 Typical characteristics of Campy/obaeter displayed onto mCCDA 
(taken by Soonthornchaikul , 2004) 
On occasion , other thermophilic bacteria may break through and grow on this selective agar, 
in particular, Pseudomonas aeroginosa. It might be confused with Campy/obaeter species . 
However, this may be differentiated by the characteristic motility of Campy/obaeter wh ich 
has darting or corkscrew-like movement. 
Biochemical tests 
Additional biochemical tests are necessary for the differentiat ion Campy/obaeter species. 
Since the majority of Campy/obaeter species in chickens are C.jejuni and C.eo/i, the specific 
metabolic end-products of Campy/obaeter jejuni were selected for identification . These tests 
are catalase, oxidase and hippurate hydrolysis test respect ively . C.jejuni is capable of 
hydrolyzing hippurate but C.eali is not (Penner, 1988) . Table 5.3 presents biochemica l 
characteristics of Campy/abaeter spp., which may be used for th e initial differentiation 
amongst species (Engvall et a/., 2002). 
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Table 5.3 The biochemical characteristics of Campy/obaeter species 
Biochemical test 
Organism Catalase Nitate H2S2 Urease Indoxyl Hippurate 
(triple sugar acetate hydrolysis 
iron) 
C.coJi + + + 
C.coneisus + + NA 
C.CUlVUS + + + 
C.fetus subsp. fetus + + 
C.fetus subsp. + + 
venereaJis 
C.gracilis + v 
C.helveticus + + 
C.hyoiJei + + + NA 
C.hyointestinaJis + + + 
subsp. hyointestinalis 
C.hyointestinaJis + + + 
subsp. lawsonii 
C.jejuni subsp. jejuni + + + + 
C.jejuni subsp. doylei v + + 
C.lari + + 
C.mucosalis + + 
C.rectus + + + 
C.showae + + + + 
C. upsaJiensis -(w) + + 
C.fecaJis + + + 
+, strong reaction; W, weak reaction; NA, results not available 
Note: All Campylobacter species are oxidase postive 
Hippurate test 
C.jejuni is able to hydrolyse hippurate acid (N-benzoylglycine; CgHgN03). This reaction can 
be detected by a colour change following the reaction with the reagent colour, ninhydrin, 
demonstrated in Figure 5.2. 
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Hippuricase (from C.jejun i) 
1 H, O,. heat 
Lactic acid + glycine 
Ninhydrin 
Dark purple 
Figure 5.2 Hippurate test 
Fluorescence In Situ Hybridisation (FISH) 
Fluorescence In Situ Hybridisation (FISH) is a molecular cytogenetic method . It allows DNA 
or RNA sequences to be detected through the use of fluorescent labelled oligonucleotide 
probes complementary to the appropriate regions (e.g.16s rRNA).The bound fluorescen t 
probe can then be visualised using a fluorescent microscope. This method combines the 
precis ion of molecu lar genetics with visual information from microscopy (Amann et a/., 1995) . 
5.1.3 Enumeration method 
Since microbial risk analysis has been adopted for the development of food safety 
management in order to control Campylobacter in the food chain , the prevalence and 
numbers of Campylobacter are needed for the estimation of health risk . Several studies 
have attempted to enumerate Campylobacter species in poultry as a significant source of 
Campylobacter (Beuchat, 1985; Wang 2002 ; Donn ison , 2003 and EI-Sh ibiny et aI. , 2005 ). 
There are a number of methods ava ilable for enumeration of Campylobacter in food samples , 
including culture and non-culture methods. Various methods based on culture techniques 
have been used including direct plating (before enrichment) or the conventional Most 
Probable Number (c-MPN) . However, under the env ironmental stresses wh ich these 
bacteria are exposed to du ring food production and subsequent storage, Campylobacter 
may change to a viable-but-non-culturable (VNC) form . As such conventional culture 
methods would be less sensit ive in its detection . These methods are tedious and time-
consuming . Over the last decade, severa l stud ies have developed rapid methods to directly 
detect Campylobacter. These are based on polymerase chain reaction (PCR), DNA 
hybridization , enzyme immunoassays (EIAs) and Fluorescence In Situ Hybridisation (FISH ) 
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(On, 1996; Waage, 1999; Moreno et aI, 2000 and Waller et aI, 2000). Although these non-
culturing approaches are fast and specific, they require intricate operations which may not 
be available in general laboratories. Microbiologists see advantages and disadvantages of 
these methods. Selection of appropriate methods must be considered on the basis for the 
recovery of Campy/obacte" performances of the tests (e.g. sensitivity, specificity, false 
positive and false negative), confirmation rates and practical aspects (availability, readability 
and friendliness). Comparison of advantages and disadvantages of two different based 
methods are presented in Table 5.4. 
Table 5.4 Comparison of enumeration methods used for Campy/obacte, in food samples 
Methods 
Culture-based method 
(i.e. MPN, DP) 
Non-culturing based 
method (e.g. 
Hybridisation) 
Advantages 
-less complicated procedures 
-do not require skilled operator 
-can be performed in 
laboratory 
-detect viable cell only 
-fast 
-high sensitivity and specificity 
Disadvantages 
-time consuming 
-less sensitive for non-viable 
any cells 
-require a large number of 
materials 
- high cost 
-require skilled operator 
-may produce other hazards, 
e.g. radio-isotopes 
-cannot distinguish between 
viable and dead cells 
In this study, the selected methods used for determination of positive Campy/obacte, 
chicken samples were i) direct plating, ii) MPN and iii) traditional culture isolation. In addition, 
the numbers of Campy/obacte, isolated from chickens were calculated using the MPN 
technique. 
5.1.3.1 The direct plating method 
A number of studies reported the success of using direct plating (before enrichment) to 
determine the numbers of Campy/obacte, in faecal samples from humans or animals. These 
types of sample usually contain very high numbers of viable Campy/obacte, (Stern and 
Robach, 2003; and Oyarzabal et a/., 2005). Most food samples however harbour low 
numbers of Campy/obacte, and the organisms may be partially damaged during food 
processing and subsequent storage. Enumeration of Campy/obacte, in food samples prior to 
recovery damaged cells appears unsuitable and less sensitive to obtain the cells (FDA BAM, 
1998). 
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5.1.3.2 The most probable number (MPN) method 
A most probable number (MPN) method is particularly efficient for enumeration of low 
concentrations of bacteria, especially in milk and water, and for those foods whose 
particulate matter may interfere with accurate colony counts (FAD BAM 1998). The 
assumption of the MPN is that bacteria in tested samples are distributed randomly and not 
clustered together. The growth medium and conditions of incubation are chosen so that 
every inoculum containing at least one viable organism will produce detectable growth. It is 
therefore sensitive only for viable organisms. 
The principle of an MPN technique is that the detection of organism at each dilution of the 
sample from first dilution to such a degree that inocula will sometimes but not always contain 
viable organisms. The numbers of inocula producing growth at each dilution will imply an 
estimate of the original, undiluted concentration of bacteria in the sample (FDA BAM, 1998). 
Finally, the estimate of MPN level of Campy/obacter can be calculated from the MPN index 
based upon the application of probability to the numbers of observed positive growth 
responses after incubation (Mageau, 1998 and FDA, 2001). The most probable number of 
bacteria is therefore scored from the MPN table. 
A conventional MPN has been used for enumeration of Campy/obacter in several types of 
samples including faeces, coacal content, water and food (Stern and Robach, 2003). This 
technique is simple and sensitive especially for samples harbouring low concentrations of 
bacteria as it includes a pre-enrichment stage. However, it requires two media, a number of 
test tubes, confirmation criteria and time. 
5.2 Materials and Methods 
In this chapter detection and enumeration of Campy/abacter were carried out with three 
groups of chickens, PIGs, POGs and BIGs (see section 5.2.1). All samples were processed 
for isolation and identification (see section 5.2.1 to 5.2.5). The numbers of Campy/abacter 
were enumerated (see section 5.2.4) and the framework of experiment regimes in this 
chapter is presented in Figure 5.3. 
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Traditional culture (TC) : 
Incubation (micro-aerobic 
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42°C x 24h) 
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(10-1 to lO-n) 
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Micro-aerobically incubated 42uC x 48h 
Confirmation 
Growth conditions 
Typical appearances 
Biochemical tests 
Microscopic Characteristics 
I 
Fluorescence In Situ Hybridisation (perform ing on ly on the BICs) 
Figure 5.3 A framework of experiment regimes (detection and en um eration) 
5.2.1 Sampling Regime 
Type and number of samples 
The samples in this study were whole carcasses of fresh broiler ch ickens . A broiler ch icken 
is a bird in wh ich the tip of the sternum is flexible (not ossified ) and it is ra ised specifica lly for 
meat. A fresh chicken carcass is defined as ch icken meat not st iffened by th e cooling 
process , which is to be kept at a temperature not below -2°C and not higher than 4°C at any 
time (UK-DEFRA 2004b) . The whole carcass includes the whole body of the bird . Remova l 
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of the heart, liver, lungs, gizzard, crop, kidneys and legs at the tarsus or the head are 
optional. However, carcasses sampled in this study were without giblets. 
Three groups of fresh whole chickens were selected. These were; 91) a pre-packaged 
intensively reared chicken (PIC), (2) a pre-packaged organically reared chicken (POC), 
grown in accordance with the standards certified by the UKROF (the definition and 
conditions of these are found in chapter 4, and (3) an unwrapped intensively reared chicken 
(BIC). All raw chickens purchased from supermarkets (PICs and POCs) were pre-packaged 
whilst the raw chicken purchased from local butchers' shops (BICs) were unwrapped. Both 
PIC and POC group were labelled as reared and processed in accordance with the EEC 
Poultry Meat Marketing Standards Regulations 1999 (UK-DEFRA 2004a). In contrast, no 
labeling or information was available on the origin and processing of the BIC group. 
30 fresh pre-packaged intensively reared chickens (PICs) and 30 fresh pre-packaged 
organically reared chickens (POCs) were randomly purchased from supermarkets. 30 fresh 
unwrapped intensively reared chickens (BICs) were purchased from butcher's shops. The 
chickens purchased from butcher's shops (no label) were assumed to be the intensively 
reared chicken based on the price, which is cheaper than that of an organic or a free-range 
chicken. Since there is no evidence to assure that the unwrapped organic chickens sold at 
retail shops comply to the UKROFS criteria, unwrapped organic chickens were not included 
in this study. 
Sampling programme 
Selection of chicken outlets 
In order to reduce farm-specific effects and to sample as representatively as possible, the 
PIC and POC groups were randomly purchased from five separate major supermarkets 
chains. These chains represent over 70% of total UK retailer's volume sales, which are 
TESCO (30%), Sainsbury (21 %), Safeway or Morrison (12% or 7%), Marks & Spencer and 
Waitrose (1 %) (Oligopoly Watch, 2003). Although, Marks & Spencer and Waitrose share a 
small volume, these shops regularly supply organic chicken. Tesco, Sainsbury and Safeway 
provide organic chicken occasionally in selected branches. Ten separate butcher's shops 
were selected for the BIC purchase. A" supermarkets and butcher's shops were located in 
North East London, the London Borough of Haringey, Barnet and Enfield (Figure 5.4). 
In order to reduce possible temporal variation effects, timing of purchases from all 
supermarkets and butcher's shops was undertaken using 40 separate randomly allocated 
purchasing days (Appendix 2). In each purchase the name of supermarket or of butcher's 
shops, type of chicken and numbers of whole chickens were randomly drawn with no prior 
knowledge of their Campylobacter status. 
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Figure 5.4 London borough map showing locati on of Enfield, Barnet and 
Haringey. 
Transport and storage of sample 
Each pre-packaged chicken was kept in a separate plastic bag . And al l of th em were 
transported and exposed to condit ions that reflect the cond it ion that may be experienced by 
the average consumer. On arrival at the lab, each chicken 's type, sou rce , weigh t, expiry date 
and price was recorded . Each chicken was then given a code on it as '11 ' (to 30) or '0 1 (to 
30)' or ' B1 (to 30) '. The letter 'I ' represents the PIC group, the letter 0 represents the POC 
group and the letter 8 represents the BIC group. The number reflects the order of purchase 
for each chicken . Following the coding all chickens were stored in the fridge (50 -1O°C) until 
the next day when they were processed for Campylobacter iso lation. 
5.2.2 Media components 
Enrichment broth 
Campylobacter requires specific nutrient to recove r the ce ll prior to be sub-cu ltured (Skirrow, 
1974). The media must contain peptones as a nutrient source, laked horse blood for growth 
and antibiotics to prevent other competitive bacteria. Based on the recommendat ion of th e 
U.S. Food and Drug Adm inistration (FDA BAM, 1998) and using method proposed by Baylis 
et al. (2000), th is study used Bo lton select ive enrichm ent broth (CM0983, Oxoid Ltd, Co., 
Basingstoke, Hants , UK) for Campylobacter isolation . The compositions of Bolton broth are 
shown in Append ix 1-1. 
In order to quench toxic oxygen, e.g. hydrogen peroxide, which may form on the med ia 
exposure to light, 5% laked horse blood (SR0048, Oxoid Ltd , Co., Bas ingstoke, Hants , UK) 
was added to the broth . 
76 
A vial of Bolton broth selective supplement (SR0183 Oxoid Ltd , Co ., Bas ing stoke, Hants , 
UK), which cons ists of three antibiot ics, was added to 500 ml of broth to suppress the growth 
of other micro-organisms which may complete with Campylobacter. The components of 
selective supplement are presented in Append ix 1-2. 
Campv/obaeter blood-free selective agar and the selective supplement 
The use of Campylobacter Blood-Free Selective Agar is specified by the UK Ministry of 
Agriculture , Fisheries and Food (MAFF) in a val idated method for isolation of Campylobacter 
from foods (MAFF, 1993) . A vial of mCCDA selective supplement (SR 0155: Oxoid Ltd , Co ., 
Basingstoke, Hants , UK) was added to the 500 ml medium for suppress ing other micro-
organisms. The composition of Modified Charcoal Cefoperazone Deoxycholate agar 
(mCCDA: CM0739 Oxoid Ltd, Co., Basingstoke, Hants, UK) and CCDA selective 
supplement are described Appendix1-3 . 
5.2.3 Sample preparation 
Three samples were taken from three different parts of each whole broiler carcass . These 
were: a) meat and skin , b) a whole tail and c) internal cavity (Figure 5.5). 
Internal cavity 
Meat and skin -------'7) A whole tail 
Figure 5.5 Three sampling parts of a chicken carcass 
A total of 100 g of meat and skin were cut from the neck, the breast and both thighs , and put 
into a sterile bag . These were cut into very sma ll pieces and mixed thoroughly. 25 g was put 
into a stomacher bag containing 100 ml of Bolton broth . The sample was homogenised in a 
stomacher at a frequency of 230 rpm for 2 minutes . The homogenate solution was then 
poured into a 300-ml glass bottle with a screwcap. 125 ml Bolton broth was added . The fina l 
dilution of homogen ised sample was 10-1 . 
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The whole tail of each broiler was cut off and then weighed, and put into a sterilised plastic 
bag containing 100 ml of Bolton broth. It was homogenised by a stomacher for 2 minutes 
and poured into a 300-ml glass bottle with screwcap. The final volume was determined 
based on the original weight of the tail making a dilution to 10-1. 
The liquid in the internal cavity was swabbed with 10 moistened specified 100 cm2 (Duffy et 
a/., 2001) and pre-weighed, sterile cotton swabs. After liquid collection, all swabs were 
weighed again in order to obtain the approximate volume of liquid. Then the swabs were put 
into a 100-ml glass bottle with screwcap containing the appropriate volume giving the final 
dilution equal to 10-1 dilution. The sample was mixed thoroughly by using vortex (Vortex 
Genie2) for 2 minutes. 
5.2.4 Enumeration 
Two significant approaches long used for bacterial enumeration are the conventional most 
probable number (MPN) and direct plating (DP) method. Each method has advantage and 
disadvantage for enumeration of Campy/abaeter. Both methods are used in this study. 
However, a conventional MPN (c-MPN) requires a large quantity of materials (for enrichment, 
sub-culture and confirmation), incubator space and time consuming, the new modified MPN 
(m-MPN) was then developed for replacement of a c-MPN in order to reduce some of these 
disadvantages (i.e. material use and incubator space). 
5.2.4.1 MPN and Direct plating methods 
The conventional MPN 
A conventional MPN was performed by using a 5-tube set for three consecutive volumes, 10, 
1 and 0.1 ml (Oblinger and Koburger, 1975). The homogenate samples (see section 5.2.3) 
were diluted by 10-fold serial dilutions. Aliquots of 10 ml of each dilution were transferred 
into a test tube containing 10 ml of Bolton broth one by one for 5 test tubes. Similarly, 
aliquots of 1 and 0.1 ml were also transferred into other set of 5 test tubes containing 5 ml of 
Bolton broth. All tubes were incubated micro-aerobically at 37° C for 24 hours and 48°C for 
24 hours. The micro-aerobic atmosphere was generated by using commercial gas-
generating kits (BBL ™ GasPack TM) in an airtight container. Presumptive positive results 
were identified from the change in media turbidity. 30 JlI aliquots of presumptive positive 
samples were streaked onto a mCCDA and micro-aerobically incubated at 42°C for 48 hours. 
Presumptive colonies of Campy/abaeter were identified by the specific appearance of colony 
on the agar. These were then inspected under a light microscope for motility and gram 
staining and were tested for hippurate hydrolysis. 
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The modified MPN (m-MPN) 
A modified MPN (m-MPN) was developed based on the principle of a c-MPN. The 
modifications were carried out on three aspects: i) a 48-well plate was used instead of sets 
of 5 tubes for the volumes of 1 ml and 0.1 ml and ii) the new volumes of 10 ml and 1 ml 
volume were used for the first sample dilution and iii) for each subsequent sample dilution 
these volumes were represent 0.1 ml of the appropriate previous volume (e.g. volume of 
original 1 and 0.1 ml of the original concentration (10.1) are considered equivalent to 10 ml 
and 1 ml of the concentration of 10.2 . The m-MPN is then interpreted through the use of the 
c-MPN table. Tests comparing the c-MPN and the m-MPN were carried out in parallel. The 
reliability of the m-MPN was statistically analysed before the m-MPN was used throughout 
the study. These are illustrated in Figure 5.6. 
Original sample --.~ll0 ml (10·') ~(10.'~ml (10·') 
10ml(10·2 ) 1 ml(10·2 ) 0.1 ml{10·2) 
~ 
1 ml (10.3 ) 
t 
¥ 
0.1 ml (10-3) 
0.1 ml (10·n) 
Figure 5.6 Algorithm of modified volumes of serial dilutions used in the m-MPN 
Aliquots of 10ml of the original homogenate samples (10.1 dilution) were processed in the 
same way in the c-MPN. Using the new modified volumes, 1 ml aliquots of 10.
1 
were 
transferred into a well plate for 5 wells, following with consecutive volumes, 0.1 ml aliquots 
10.1 to 10·n (PIC and POC 10.1-10.7 and BIC 10.1_10.12). These volumes were transferred into 
a well plate for 5 wells in each dilution (Figure 5.7a). To make the final volume of each well 
to 1.4 ml (maximum volume of each well is approximately 1.5 ml), Bolton broth was added 
into all wells. 
All 48-well plates were micro-aerobically incubated at 370C for 24 hours and then at 420C 
for 24 hours. The presumptive positive results were identified from the change of media 
turbidity like the conventional method stated above. Aliquots of each presumptive positive 
sample (30 Ill) were dropped onto a mCCDA (Figure 5.7b). They were micro-aerobically 
79 
incubated at 42°C for 48 hours . Pres umptive colon ies of Campylobacter were identified by 
the specific appearance of a colony on the agar. These were then inspected under the light 
microscope for motility and gram staining and were tested for the hippurate hydrolysis . 
The positive control organism was Campylobacter jejuni (NCTC 11322) . The negative 
control organisms were Escherichia coli (NCTC 10418), Pseudomonas aeroginosa (NCTC 
10662) and Staphylococcus aureus (NCTC 6571 ). The negat ive control sample was cod fi sh 
and the blank was the media (Bolton broth supplemented with lake horse blood and SR0 183) 
sterilised . These were processed in the same way as chicken samples. 
1 2 3 4 5 
1 ml 
~.~ 
• • 
0 .1 ml 
0 .1 ml 
• • • • • 
• • • • • 
• • • • • 
0.1 ml 
Blank 
a b 
Figure 5.7 The m-MPN method using 6 x 8 well plate 
The Direct plating method 
Aliquots of pre-enrichment homogenate (100 III ) were directl y dropped onto a mCCDA plate , 
and then streaked out on the surface of the agar in duplicate plate . All inoculated plates 
were micro-aerobically incubated at 42°C for 48 hours. 
5.2.4.2 Protocol of enumeration 
Prior to application of the new m-MPN method was tested in parallel with a conventional 
MPN in order to evaluate its reliability . The supplementary tests were then carried out for 20 
samples of chicken parts . The results were statistically compared . After supp lementary tests 
showed no significant difference between a c-MPN and m-MPN , the new modified tech nique 
was used for enumeration instead of a c-MPN throughout th is study. 
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The enumerations and iso lat ions of Campylobacter from three groups of chickens were 
carried out using the m-MPN and DP methods . A sche me of detection includ ing enumeration 
applied to three groups of ch ickens is presented in Figure 5.8. 
Conventiona l MPN· 
10 ml 
1ml 
0.1 ml 
Micro-aerobical~ incubate 
(37°C x 24h , 42 C x 24h) 
Reading (turbidity) 
Colony appearance 
· performing only in supplementary lest 
serial dilution 10·' -1 On 
Modified MPN (a) Direct plati ng (b) 
1 
Appearance on mCCDA 
Colony appearance on mCCDA 
Growth cond itions 
Confi rm ation Typica l appearances 
Motility 
Hippu rate test 
Figure 5.8 Scheme of Campylobacter enumeration methods 
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5.2.5 Isolation method 
The isolation and identification methods used in this study were based on the standard 
methods recommended by the US Food and Drug Authority (FDA BAM,1998) and the UK 
Health Protection Agency (UK HPA, 2002) which include enrichment, sub-culture and 
confirmation methods. 
Campy/obacter in food samples deteriorates with time. They therefore require an enrichment 
stage for optimal isolation and cultivation. Each sample was pre-enriched in Bolton broth 
(section 5.2.3), and stored in a glass bottle fitted with a screw cap leaving a head-space of 
less than 2 cm (Tran, 1998 and Baylis et a/., 2000). The inoculated broth was aerobically 
incubated at 37°C for 24 hours followed with 42°C for another 24 hours. After enrichment, 
30111 of the inoculated broth were streaked onto 2 duplicate plates of mCCDA. The plates 
were then incubated under a micro-aerobic condition, using a commercial gas-generating 
kits (BBL™ GasPack TM) in an airtight container (an aerobic gas jar), at 42°C for 48 hours. 
5.2.6 Identification methods 
Following cultivation on mCCDA (section 5.2.5), all plates were examined for the presence 
of typical and atypical colonies. The presumptive colonies (one or more typical colonies) 
were selected from each mCCDA plate for further confirmation using characteristics 
explained in section 5.1.2. 
Presumptive colonies were confirmed by: i) selective media and growth condition, ii) general 
typical appearances, iii) traditional gram staining, iv) cell morphology and motility, v) 
biochemical tests (including catalase test, oxidase test and hippurate test) and vi) FISH. The 
principles of confirmation methods for Campy/abaeter, mainly C.jejuni and C.ea/i are 
explained in section 5.1.2. 
Procedures of confirmation methods 
Motility 
Motility was determined by a wet mount method (Koneman et a/., 1997). A very small drop of 
suspect Campy/abaeter suspension was applied onto a slide and covered with a coverslip. 
The preparation was examined immediately, using light microscopy with the magnification 
1000. Campy/abacter species were highly motile slender rods with spiral morphology. 
Catalase test 
Suspect colonies were spread out on the slide. A drop of 3% hydrogen peroxide was 
dropped over the colonies. Positive result was detected by gas production by visual 
observation of bubble formation. 
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Oxidase test 
2 or 3 drops of 1 %NNNN-tetramethyl-p-phenylenedianine dihydrochloride were placed on 
the centre of filter paper (Whatman No.1) and left to allow for a few seconds for absorption. 
A loopful of presumptive colony was smeared onto the paper by using a plastic loop. The 
reaction of the enzyme with oxygen produces a dark purple colour in positive samples within 
5-10 seconds. 
Hippurate hydrolysis test 
A loopful or more of suspect colonies was inoculated into 0.4 ml of 1 % aqueous sodium 
hippurate and incubated in a water bath at 37°C for 4 hours. 0.2 ml of Ninhydrin solution was 
slowly added to form an overlay, taking care not to shake the tubes after Ninhydrin addition. 
The tubes were re-incubated at 37°C for 20 minutes. Hydrolysis of hippurate was indicated 
by a colour change to dark purple due to the release of glycine. A purple colour is a positive 
result for C.jejuni (Figure 5.2). No colour or a faint trace of purple is a negative result. 
It is interesting to observe that the number of loopfuls is important for the reaction. This 
appears to be dependent on the characteristic of colonies isolated from chicken sample. For 
example, if the colonies are thick, creamy and loose, a loopful would be sufficient for the 
reaction. In contrast, more than a loopful would be required if the colonies showed thin, flat 
and sticky characteristics. 
This study performed the FISH method by using a partial 16S rRNA gene sequence (DNA 
probe) as a probe to detect Campylabacter species (Amann et al., 1995, Christensen et al., 
1999 and Moreno et al., 2001). 
The probe type 
There were two probes are used in this study, EUB 338 and CAM 1. The former is a 
universal probe complementary to the domain bacteria, which are common and live almost 
anywhere. It was used as a positive control to select all bacteria in samples. The sequence 
of EUB 338 is 5'-FGCTGCCTCCCGTAGGAGT (prepared by Sigma Genosys, Cambridge, 
U.K.). 
The latter is complementary to a portion of the 16s rRNA gene conserved in the domain of 
Campy/abacter. The CAM 1 probe is specific for C.jejuni and C.coli. This probe is prepared 
and labelled by Sigma Genosys (Cambridge, U.K.) with 5(6)-carboxy-ftuorecein-N-
hydroxysuccinimide ester (FLUOS) and tetramethylrhodomine-5-isothyocyanate (TRITC), of 
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which the maximum absorbance is 555 nm and the maximum em iss ion 580 nm . The 
sequence of the oligonucleotide is 5'OCTGCCTCTCCCTCACTCT. 
Probe preparation 
The oligonucleotide , CAM 1 or EUB 338 was normalised in 1XTris-EDTA buffer (TE buffer; 
10mM TrisHCI and 0.1 mM EDTA) . To prepare a stock solution of 1 ~g/~ I , the probe was 
dissolved in TE buffer in proportion to the amount of mass (based on the preparation of the 
company) , which is 1: 1. This stock solution was maintained at -40°C until required . For a 
working solution (1 00 ng/~I), an aliquot of stock solution (1 ~ I ) was dissolved in 9 ~ I of 1X TE 
buffer. 
Procedure 
Fixation: aliquot of each homogenate sample (1 ml) (see section 5.2.3) was put into a 2-ml 
micro-centrifuged tube . The cells were harvested by centrifuging at 940-990 rpm for 5 
minutes and the supernatant discarded . The pellet was washed twice with 1 ml of 1x PBS. 
The cells were fixed in 1 ml of paraformaldehyde (4%) at 4°C for 10 - 20 minutes . 
Sample preparation : Following fixation , the cells were washed once again with 1 ml of 
1 xPBS and re-suspended it with 1 xPBS and ice-cold absolute ethanol at a 1: 1 ratio . A 5 ~d 
aliquot of fixed sample was applied onto a gelatine-coated well slide (Figure 5.9) , air-dried 
and dehydrated with serial concentrations of ethanol (50% , 80% , 98-100%) . 
Inlll 
Figure 5.9 A 1 O-well slide 
Hybridization: The cells were hybridized with the CAM1 and EUB 338 probes (volumes 
applied are presented in Table 5.5) . The cells were incubated to enable hybridisation at 46°C 
for 2 hr. 
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Table 5.5 Proport ion of CAM 1 and EU B 338 used fo r hybridization 
Volu me ( ~.tI) 
Numbers of probes 
CAM 1 EUB 338 HB* 
1 probe 100 
2 probes 50 50 
* Hybridization buffer (HB) was not combined with the probes in this study 
Washing : The remaining probes were washed out with a warm wash ing buffer (the buffe r 
was pre-heated at temperature 60°C in a water-bath) . The slide was then rinsed with sterile 
water. 
Mounting and visualisation: a slide was mounted (wet) with the antifade agent (1 ,4-
phenylene diamine: 1,4 phenylene diamine, 86% glycerol , 1 xPBS , sodium bicarbonate and 
sodium carbonate) and visualized using a fluorescence microscope at 1000 magnification 
(Olympus@ BX51 IBX52). 
The model illustrated in Figure 5.10 displays the flow chart of the general procedures of 
FISH. 
d~oo>7 
~ 
/ - ;-.1./ 
~ 
Fixation 
Sample preparation 
Hybridization 
Wash ing 
Mounting 
Visua lisation 
Figure 5.10 Flow chart of a FISH method (adopted from Moter and Gobel, 2000) 
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5.3 Data analysis and statistical approaches 
5.3.1 Data transformation 
From literature reviews, MPN values usually show skewed distribution pattern. The MPN 
values in this study were transformed to be logarithm It for the calculation. The transformed 
values become symmetric in shape at the natural log level (Limpert et a/., 2001, Bohannan 
and Hughes, 2003) and are therefore log-normally distributed. The lognormal distribution is 
the function of x given a mean (J..l) and a standard deviation (a); 
1 (I 2 2 I(x \ Jl, a) = e- nx-p) /2CJ 
x 0'.J 21r 
The geometric mean, standard deviation and variance were used as representive 
parameters for statistical analysis. These parameters are determined by the formulas as 
follows; 
Mean 
Variance 
= exp(u + a /2) [or using @ risk, v 4.5*, RiskLognormal2 (Il,a)), 
= [exp(a2) -1] exp(2,u + ( 2 ) 
Standard deviation = ~[exp(a2) -1]exp(2,u + ( 2 ) 
* @ Risk (Risk analysis and simulation add-in for Microsoft Excel release 4.5, Palisade 
Corporation, Newfield, NY, USA) 
5.3.2 Statistical approach 
Comparison of two MPN methods 
To ascertain whether the difference between the two methods of MPN, conventional MPN 
and modified MPN, is significantly different, the data were analysed statistically using the 
Mann-Whitney. 
Comparison of the levels of MPN between three groups of chicken 
Under conditions explained in section 5.2.1, all samples are considered to be randomly 
selected and independent. The differences of the levels of MPN of Campy/obacter isolated 
from samples obtained from three groups of chicken were examined using the Analysis of 
Variance (ANOVA) test (using Minitab release 14). Prior to ANOVA approach, the equality of 
variance of the data was tested. Multiple comparisons were performed after ANOVA in order 
to determine where a difference in the samples' means exists. The means of all samples 
were compared by Tukey's Honestly Significant Difference (HSD) Test. 
All statistical analyses were performed using Minitab, release 14,2005. 
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Comparison of the isolation rate 
The difference in isolation rates between two groups was analysed using a 2 proportions test, 
computing a confidence interval and testing the hypothesis test using Fisher's exact test. A 
chi-square test was performed to compute the difference of isolation rates of 
Campylobacfer-positive chicken between three groups of chicken, PIC, POC and BIC. 
5.3.3 Estimating sensitivity and specificity of detection method 
with an imperfect gold standard 
The qualitative measurement of detection for micro-organisms in a sample is expressed by a 
positive or a negative reading. As there are several detection methods usually used for 
identifying the status of tested samples, index tests must be evaluated by comparison with a 
perfect gold standard, which assesses the real status of sample with certainty (Joseph et al., 
1995). The performance of such a test is usually expressed by its sensitivity and specificity. 
Sensitivity and specificity of index tests can be estimated using the 2 X 2 table under a 
binomial sampling model. Ideally, if a gold standard exists, the observed performance is the 
true performance. There is no bias from measurement error, where parameters a, b, c and d 
are equal to zero. Table 5.6 demonstrates the performance of an index test when a perfect 
gold standard is available. 
Table 5.6 Observed status of index test when a perfect gold standard is known (parameters 
a, b, c and d are bias due to measurement error) 
True status 
Positive Negative 
Index test Reference test (R) Reference test 
(I) Positive False Sub- False Negative Sub- Total 
negative total positive total 
Positive X11-a a (=0) X11 C (=0) X12-C X21 
Negative X21-b b (=0) X21 d (=0) X22-d X22 
Total nR++(a+b) a+b nR+ c+d nR.-(c+d) nR- N 
Where: xwa is that truth = +, reference = +, index = +; a is that truth = +, reference = -, index = + 
X12-C is that truth = -, reference = -, index = +; c is that truth = -, reference = +, index = + 
X21-b is that truth = +, reference = +, index = -; b is that truth = +, reference = -, index =-
X22-d is that truth = -, reference = -, index = -; d is that truth = -, reference = +, index =-
Sensitivity = XI 1/ n R+ 
Specificity = x22 / nR-
[5-1 ] 
[5-2] 
[5-3] 
[5-4] 
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However, it has been recognised that a perfect gold standard may be unavailable, 
particularly for index tests used in diagnosis of microbiological infection. This is due to 
measurement error or possible high costs, (Joseph et a/., 1995 and Hadgu, 1999). More 
frequently available but imperfect reference tests are used as a gold standard. 
Misclassification by imperfect gold standard may introduce bias and result in error of 
sensitivity, specificity and predictive prevalence (Hadgu, 1999). These errors can be 
resolved using two different approaches: i) improving an imperfect gold standard (i.e. using 
technologic advanced methods, using more than one reference test) and ii) applying 
mathematical and statistical resolutions (Joseph, 1995; Hadgu, 1999 and Dendukuri et a/., 
2004). 
The three culture methods for detecting Campy/abaeter used in this study were the m-MPN, 
the TC and the DP. Limitations of these methods have been recognised as Campy/abaeter 
in food samples may change to the viable-non-culturable form (VNC) that cannot be 
detected by conventional culture methods. Although most recent studies used direct plating 
to enumerate as well as to detect Campy/abaeter (Mead et a/., 1995; Stern et a/.1995; 
Bashors et a/., 2004 and Keener et a/. 2004), most samples were obtained from live birds 
rather than food samples (carcasses). Campy/abaeter can grow and multiply easily in the gut 
of live birds. Thus, it is easier to detect Campy/abaeter from caecal content without 
enrichment as the bacteria are likely to be in good condition for growth. Chen and Stern 
(2001) postulated that the good colonisers were isolated from caeca or caecal droppings, 
whereas most poor colonisers were found from broiler wash. The test performances (i.e. 
sensitivity, specificity, false positive and false negative) of these methods are uncertain for 
food samples. Relative comparison for the performances of an index test requires a gold 
standard (Joseph et a/., 1995). However, none of the methods used here (the TC, m-MPN 
and DP) can be a gold standard. The performances of these three methods may include 
uncertainties resulting from using an imperfect test as a gold standard. Evaluation of test 
performances is therefore necessary. 
In this study, evaluation of test performances was cansidered following two criteria: i) within 
pre-enrichment methods (the TC and the m-MPN) and ii) between enrichment (the m-MPN) 
and before enrichment methods (the DP). For the former, sensitivity, specificity, false 
positive and false negative of the TC and the m-MPN were calculated twice with different 
gold standards by switching between the TC or the m-MPN as a gold standard. Similarly, for 
the latter, performances were evaluated using either the m-MPN or the DP as a gold 
standard for each other. 
As neither of them can be a gold standard, errors occur. This may result in decrease or 
increase of the performances, affecting the true prevalence. Although recently, several 
stUdies suggested that molecular methods show higher performances than conventional 
culture methods (Wassenaar and Newell, 2000), these methods are expensive and also 
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detect both viable and non-viable cells. Threfore, whilst the molecular based methods 
overestimate the prevalence, the culture based methods underestimate the prevalence. The 
application of mathematics is therefore considered as an alternative approach in revising the 
bias from measurement error. It has been suggested that this problem can be resolved using 
mathematical functions, e.g. Bayesian estimation, discrepant analysis (Joseph, 1995; Hadgu, 
1999 and Dendukuri et al., 2004). The performances of parameters have to be revised 
following new assumption as presented in Table 5.7. The parameters a, b, c and dare 
biased due to measurement errors. 
Table 5.7 Assumption of observed status of index test when using an imperfect gold 
standard: parameter Xij as in table 5.6 and parameter a, b, c and d as measurement error 
True status of sample 
Positive Negative 
Reference test Reference test 
Index test Total 
Positive False Sub- False Negative Sub-
negative total positive total 
Positive X11-a a X11 c X12-C X12 nl+ 
Negative x21-b b X21 d x22-d X22 nl_ 
Total nR++(a+b) a+b nR+ c+d nR_-(c+d) nR_ N 
As the reference test is thought to be imperfect, the new cross-classification of events can 
be further developed as demonstrated in Table 5.8. 
Table 5.8 Observed status of index test when using an imperfect gold standard 
Imperfect reference 
Positive Negative 
Index test True status True status Total 
Positive False Sub-total of False Negative SUb-total of 
pos. observed pos. neg. observed neg. 
Positive X11-a c x11-a+c a X12-C x12+a-c nl+ 
Negative X21-b d x21-b+d b X22+b-d x22+b-d nl_ 
Total nR.-(a+b) c+d n R.-( a+b )+( c+d) a+b nR-(c+d) nR.-(c+d)+ (a+b) N 
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Following Table 5.8, the new observed data can be re-arranged and presented in Table 5.9. 
Table 5.9 New observed status of index test after adjustment 
Index test 
Imperfect reference 
-------------------- Total 
Positive Negative 
Positive 
Negative x21-b+d 
Total nR_-(c+d)+ a+b N 
Therefore, new sensitivity, specificity, false positive and false negative of index performance 
can now be re-expressed as follows: 
Sensitivity = XII - (a + c)/{nR+ - (a + b) + (c + d)} 
Specificity = x 22 + (b - d)/{nR_ - (c + d) + (a + b)} 
Falsepos =XI2 +(a-c)/nJ+ 
jaiseNeg = X2I + (b - d)/ nJ-
[5-5] 
[5-6] 
[5-7] 
[5-8] 
When comparing with the relative performance of index test (using a perfect gold standard), 
the new expressions as presented in equations 5-5 to 5-8 can be developed to show the 
errors of measurement due to the use of an imperfect reference as a gold standard (Table 
5.10). 
Table 5.10 Comparison of performance expressions between using a perfect gold standard 
and an imperfect gold standard 
Performance 
A perfect gold standard An imperfect gold standard 
parameters 
Sensitivity X11/nR+ x11-(a+c )/{nR+-(a+b )+( c+d)} 
Specificity X22/nR- x22+(b-d)/{nR_( c+d)+( a+b)} 
False positive X12/nl+ X12+(a-c)/nl+ 
False negative X21/nl- x21+(b-d)/nl_ 
Tables 5.7 to 5.10 present the eight parameters that cannot be determined through 
measurement. These parameters are taken as uncertainties, affecting the true status of 
performance characteristics of an index test. This problem arises from misclassification. 
Joseph et al.(1995) proposed a solution to improve the performances of the index test using 
Bayesian estimation. The principle is that: 1) prior distributions of unknown parameters are 
firstly constructed over all unknown values, 2) The likelihood functions of missing information 
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are analysed using latent class analysis (LCA) (Kaldor and Clayton, 1985; Tanner and Wong, 
1987; Water and Irwig, 1988; and Joseph et al., 1995). It is therefore likely that the posterior 
distributions are a proportional product of prior distributions time likelihood functions using 
Bayes theorem. 
Posterior distribution oc prior distributions x likelihood functions 
A prior distribution over all model parameters can be drawn from previous data, expert 
opinions or a combination of both. Joseph et al.(1995 and 2000) also demonstrated 
likelihood functions when using two diagnostic tests. These functions were derived from 
prevalence of positive results ( 1t ), sensitivity of test 1 (Sl) and test 2 (S2) and specificity (C
1 
and C2). These likelihood contributors are illustrated in Table 5.11 
Table 5.11 Possible likelihood contributors of observed and latent data for two detection 
tests (adopted from Joseph, et al., 1995). 
Product Truth test 1 result Test 2 result Likelihood 
Y1 + + + 
Y2 + + 
Y3 + + 
Y4 + 
U - Y1 + + 
V - Y2 + 
W-Y3 + 
X - Y4 
1t denotes prevalence of positive sample in population 
S1 denotes sensitivity of index test 1 using index test 2 as reference standard 
S2 denotes sensitivity of index test 2 using index test 1 as reference standard 
C1 denotes specificity of index test 1 using index test 2 as reference standard 
C2 denotes specificity of index test 2 using index test 1 as reference standard 
Information presented in Table 5.11 can be re-written by 2 x 2 table as shown in Table 5.12 . 
Table 5.12 Observed and latent data for the case of two detection methods when using 
imperfect reference as a gold standard. 
True status 
Positive Negative 
Test 2 Test 1 Test 1 Total 
+ SUb-total + Sub-total 
+ Y1 Y3 Y1+Y3 U-Y1 W-Y3 (u- Y1 )+( W-Y3) a 
Y2 Y4 Y2+Y4 v-Y2 z-Y4 (V-Y2)+( Z-Y4) b 
Total Y1+Y2 Y3+Y4 (Y1 +Y3)+( Y2+Y4) (u+v)- (w+z)- (u+v+w+z)- N 
(Y1+Y2) ( Y3+Y4) (Y1+ Y2+Y3+Y4) 
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The new cross-classification can now be re-expressed as the real situation of using two 
diagnostic methods for calculating performance status. Table 5.13 shows the observed 
parameters following the new classification. 
Table 5.13 Observed data of two detection methods in the absence of a gold standard 
following table (adapted from Joseph et a/., 1995) 
Test 1 Test 2 (Reference) Total (Index test) Positive Negative 
Positive Y1+( U-Y1) = u Y3+( W-Y3) = w u+w 
Negative Y2+( V-Y2) = v Y4+( X-Y4) = Z v+z 
U+V W+Z N 
Parameters u, v, wand z are the actual values determined and these values include 
uncertainties due to measurement error. These parameters can be re-adjusted using Bayes' 
theorem to estimate the posterior distribution of performance characteristics. Given 
assumption propsed by Joseph et a/. (1995) (shown in Tables 5.11-5.13), the joint posterior 
distribution is proportional to the product of the likelihood function and the prior distribution. If 
(alt , Blt), (as,Bs) and (ac,BC) represent the prior beta distribution of the parameters for 1t, S 
and C, respectively, the joint posterior distribution formulated by Joseph et a/. (1995) is given 
by 
The joint posterior distribution (equation 5-9) can be constructed using the Gibbs sampler 
which is iterative with Markov-chain Monte Carlo (MCMC) technique (Appendix 3-2). This 
technique was carried out using Winbugs software (release 1.4). (Winbugs software is 
available at http://www.mrc-bsu.cam.ac.uklbugs/winbugs/contents.shtml.) 
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5.4 Results 
5.4.1. Comparison of MPN levels estimated by two methods 
A change in turbidity of the media and colony formation on the mCCDA were used to 
describe a presumptive positive or negative result in the MPN test (Figure 5.11 ) 
Turbidity 
Colonv formation 
Figure 5.11 Characteristics indicating the positive results for enumeration of 
Campy/obaeter 
These presumptive results were analysed using the Mann-Whitney test. Although levels of 
MPN determined from the change of turbidity in the c-MPN method were lower than those 
expressed by the colony formation, this difference was not significant. Results from the m-
MPN method in contrast showed a significant difference between the values interpreted by 
the two indicators at p<0.001 . When comparing the two methods using the turbid ity 
characteristics , the values estimated from the c-MPN were sign ificantly higher than those 
from the m-MPN (p= 0.002). However, there was no significant difference between the two 
methods when using colony formation as the indicator (p>0.05) . Table 5.14 shows the 
results of this section . 
Table 5.14 Campy/obacter levels determined by the c-MPN and the m-MPN method . 
Campylobacter level (log 10MPN/g) : 
Method Turbidity Colony appearance 
Mean:tSE* 95%CI** Mean:tSE 95%CI 
Conventional MPN (c-MPN) 3 . 87~1 . 34 1.24 , 6.5 4.23~1.44 1.40,7.06 
Modified MPN (m-MPN) 1 . 18~0 . 36 0.47 ,1.88 4.68+1.54 1.67, 7.69 
P-value 0.002 NS 
* Geometric mean and geometric SE , ** 95% confidence interval of the mean 
NS = No significant difference 
P-value 
NS 
< 0.001 
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5.4.2 Determination of test performances for three detection 
methods in the absence of a gold standard 
5.4.2.1 Pre-adjustment performances of three detection methods 
Tables 5.15 and 5.16 show the performance characteristics of three detection methods 
using different gold standards. When considering the difference between with and without 
enrichment methods for detecting Campy/obacter, using the TC method as a gold standard , 
the m-MPN method showed higher sensitivity (91.8%) than that found for the DP (54.4%). 
However, it also gave a higher rate of false positive (26.2%). Although the DP was more 
specific than the m-MPN (66.7%), it contained very high rate of false negative (85.7%). 
When using the m-MPN as a gold standard, the TC was found to have a lower sensitivity, 
but higher specificity than those shown in the m-MPN. 
Table 5.15 Performance of index test when using different reference tests as a gold 
standard: a) m-MPN, b) traditional culture and c) direct plating 
Index Gold standard: m-MPN Performance Percentage 
test G+ G- characteristics (%) 
1+ 112 10 Sensitivity 71.8 
TC n = 180 Specificity 58.3 
I - 44 14 False positive 8.2 
False negative 75.9 
Gold standard: TC Performance Percentage 
G+ G- characteristics (%) 
1+ 112 44 Sensitivity 91.8 
m-MPN n = 180 Specificity 24.1 
I - 10 14 False positive 26.2 
False negative 46.7 
Gold standard: m-MPN Performance Percentage 
G+ G- characteristics (%) 
1+ 43 3 Sensitivity 54.4 
DP n = 88 Specificity 66.7 
I - 36 6 False positive 6.5 
False negative 85.7 
Gold standard: DP Performance Percentage 
G+ G- characteristics (%) 
1+ 43 36 Sensitivity 93.5 
n = 88 Specificity 14.3 m-MPN 
I - 3 6 False positive 45.6 
False negative 33.3 
G+ = a gold standard shows positive results; G- = a gold standard shows negative results 
1+ = an index test shows positive results; 1- = an index test shows negative results 
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Table 5.16 Summary of comparison of performance characteristics of three index tests 
using different reference tests as a gold standard 
Gold standard Performance parameters 
Predictive Sensitivity Specificity False False 
prevalence (%) (%) (%) positive(%) negative(%) 
Traditional culture: 62.2 91.8 24.1 28.2 41.7 
m-MPN 
m-MPN: Traditional 62.2 71.8 58.3 6.5 75.9 
culture 
m-MPN : Direct 48.9 54.4 66.7 6.5 85.7 
plating 
Direct plating : m- 48.9 93.5 14.28 45.6 33.3 
MPN 
5.4.2.2 Post-adjustment performances of the three detection methods 
using Bayesian estimation 
Using an imperfect gold standard, previous values of the performances of the index tests 
were thought to include uncertainties occurring from measurement errors. Therefore, 
Bayesian estimation was applied to determine the joint posterior distribution following the 
studies of Joseph, et al. (1995 and 2001). As there is currently no previous information on 
the performance characteristics of these three methods, the prior distribution cannot be 
performed. Therefore, the true joint distribution (equation 5-9) cannot be calculated due to 
no information of beta-coefficient represented with ex, p. However, in order to demonstrate 
the approach to resolve the evaluation of performance characteristics of detection methods 
for Campylobacter in the absence of a gold standard, the beta prior densities (espressed 
with Beta coefficient ex, P) were adapted from the study of Joseph et al., (1995), which 
performed the beta prior densities for the test parameters in the diagnosis of Strongyloides 
infection. Following this (Table 5.17), the prior coefficients selected were based on the fact 
that the TC and the m-MPN are performed after the samples were enriched. Under these 
conditions, Campylobacter cells are thought to be recovered from stressed environment 
during food processing. Thus, these cells are easier to detect (Moore, 2001). In contrast, the 
DP was performed without enrichment. Therefore, it is assumed that the TC and the m-MPN 
have high sensitivity and the DP has high specificity. The coefficients of the beta prior 
densities used for the demonstration are shown in Table 5.18 
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Table 5.17 Coefficient of the beta prior densities for the test parameters in the diagnosis of 
Strongyloides infection (taken from Joseph et al., 1995) 
Stool examination Serology 
Test parameters Range (%) Beta coefficients Beta coefficients 
a ~ Range (%) ~ a 
Sensitivity 5-45 4.44 13.31 65-95 21.96 5.49 
Specificity 90-100 71.25 3.75 35-100 4.1 1.76 
Table 5.18 Ranges and coefficients of the beta prior densities of three detection methods for 
Campylobacter (adapted from Joseph et al., 1995) 
TC m-MPN DP 
Performance 
parameters Range a Range a ~ Range a 
(%) (%) (%) 
Sensitivity 35-100 4.1 1.76 65-95 21.96 5.49 5-45 4.4 13.31 
Specificity 5-45 4.4 13.31 5-45 4.4 13.31 65-95 21.96 5.49 
Comparison of posterior performance parameters of three methods for the 
combination of the two tests 
Assuming the prior distributions in Table 5.18 are correct, the posterior values confirmed the 
highest sensitivity, but lowest specificity of the m-MPN method. The TC does not 
demonstrate a good performance for both sensitivity and specificity. However, it is still higher 
than the DP. Although the DP showed very low sensitivity, it is very specific to negative 
samples. Table 5.19 shows the posterior sensitivity and specificity when using the two tests. 
Figure 5.12 shows the densities of posterior distribution of sensitivity and specificity as 
calculated through simulation using Winbug software released 1.4.1. The densities of both 
sensitivity and specificity from the m-MPN method are found to be highly skewed, whereas 
the densities from the TC are symmetrical. 
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Table 5.19 Posterior median and 95% confidence interval (CI) for the combination of the two 
tests: TC and m-MPN; m-MPN and DP 
Test 
TC vs m-MPN 
Sensitivity 
Specificity 
-m-MPN:Sensitivity 
Specificity 
-m-MPN : Sensitivity 
Specificity 
-DP: Sensitivity 
Specificity 
Median 
0.61 
0.30 
0.81 
0.24 
Sensitivity 
Stc sample: 19500 
6.0 
95%CI 
0.33-0.90 
0.11-0.47 
0.64-0.92 
0.08-0.46 
0.0 0.25 0.5 0.75 1.0 
6.0 
4.0 
2.0 
Smpn sample: 19500 
O.OL.,.-__ r-_--r" __ ~---r-
0.2 0.4 0.6 0.8 
Sdp sample: 19500 
4.0 
2.0 
O.O'L.-_-T"""_....,--.,--,.--r 
-0.2 0.0 0.2 0.4 0.6 
Posterior values 
TC vs DP m-MPN vs DP 
Median 95%CI Median 
NA NA 
NA NA 
0.93 
0.10 
0.24 
0.81 
Specificity 
Ctc sample: 19500 
6.0 
4.0 /\ 
2.0 ~ "-
O'°L-r-_~_~_~_~_r 
-0.2 0.0 0.2 0.4 0.6 
Cmpn sample: 19500 
6.0 
4.0 ~ 
2.0 -./ "---
0.0 L-r-----.--...,...----r--r 
0.0 0.2 0.4 0.6 
Cdp sample: 19500 
95%CI 
0.73-0.98 
0.02-0.48 
0.08-0.47 
0.64-0.93 
6.0 
4.0 
2.0 ~~ 
0.0 L,....--~---.----,---..,-I T I 
0.2 0.4 0.6 0.8 
Figure 5.12 Posterior distributions of sensitivity and specificity of three detection 
methods (tc = traditional method, mpn = modified MPN, dp = direct plating, S 
=sensitivity and C = specificity) 
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5.4.3 Isolation rates of Campylobacter isolated from three groups 
of chicken 
Rates of isolation from whole carcasses 
Table 5.20 shows the isolation rate of Campy/obaeter. The isolation rates of positive-
Campy/obaeter carcasses determined by the m-MPN method demonstrated a significantly 
higher rate than those determined by the TC and the DP in all groups of chicken (p=0.03 
within the PICs, p<0.001 within the POCs and p= 0.007 within the BICs). The differences of 
the isolation rate between the different groups range from 7 to 13%. 
The isolation rates found in the BIC group showed the highest values whether it was 
determined by the TC (93%) or the m-MPN (100%) or the DP (90%). The rates found in the 
PIC group, in contrast, showed the lowest values (80% for the TC, 90% for the m-MPN and 
77.8% for the DP). The isolation rates between these three groups are significantly different 
at p= 0.04, except for that determined by the m-MPN. In addition, when using the FISH 
method for identification of Campy/obaeter in the BIC group, which was performed before 
the samples were enriched, both the m-MPN and the FISH were capable of detecting the 
organism at the same rate (100%).The image of Campy/obaeter cell hybridised with the 
CAM 1 probe visualised under the fluorescence microscope is shown in Figure 5.13 
Table 5.20 Isolation rate (per carcass) of Campy/obaeter obtained from three types of 
chickens 
Isolation ratel carcass (%) 
Detection procedure 
Type of chicken 
TC m-MPN DP * FISH 
* PIC 80.00 90.00 77.78 
POC 83.33 96.67 77.78 * 
BIC 93 100 90 100 
P-value 0.04 NS 0.04 NA 
* Fluorescence In Situ Hybridization (FISH) performing on the BICs only 
** Significant difference between Te, m-MPN and DP, FISH was not included 
NA =not applicable, NS = no significant difference 
** P-value 
0.03 
<0.001 
0.007 
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a b 
Figure 5.13 The image of Campy/obacter cel l hybridised w ith the CAM 1 probe and 
visualised by fluorescence microscope (x 1000): a) C.jejuni NCTC 11322 
(reference strain ) and b) Campy/obacter iso lates fro m th e BIC 
Rate per part of chicken 
Using the TC method , the rate of isolation of Campy/o bacter obtained from meat or cavi ty or 
tail part of the BIC group showed a sign ificantly higher level (-93%) than those found in th e 
PIC and the POC samples (p=0.04 ) (Table 5.21) . 
However, when indicating by the m-MPN , only th e outcomes from cavity samples showed 
significant difference (p=0.002) whereas the PIC-cavity samp les showed th e lowest level at 
70%. Although the rates found in meat and tail samp les differ between these three groups , 
they were no statistically significant differences . 
When using the DP method for all groups , the iso lation rates from different parts of the 
ch icken were found to be sign ifican tl y different (p = 0.002), w ith th e lowest value in cavity 
samples (22% for the PICs , 33% fo r the POCs and 46% for the BICs). 
The rates estimated using the direct plating provided th e signifi cant lowest value compared 
to the other two methods. These sign ifica nt fin dings were simi larly noted in all three groups 
of the chicken . The m-MPN gives th e highest rate of detection in all cases . 
In relation to the four detection methods used for th e BIC group, the m-MPN and the FISH 
gave the highest rate (100%) of detection, fol lowing by the TC (93%) . The direct plating 
method contributed the lowest ra te of isola tion (46 - 80%). 
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Table 5.21 Isolation rate (per part) of Campy/abaeter obtained from three types of chickens 
determined by the TC, the m-MPN, the DP and the FISH methods 
Isolation rate! part of chicken (%) 
Type of TC mMPN Direct plating FISH* chicken 
Meat Cavity Tail Meat Cavity Tail Meat Cavity Tail Meat Cavity Tail 
PIC1 86.67 60.00 70.00 83.33 70.00 83.33 55.56 22.22 44.44 * * * 
POC2 76.67 73.33 76.67 90.00 90.00 90.00 77.78 33.33 72.22 * * * 
SIC3 93.33 92.86 93.33 100 100 100 80.00 46.43 80.00 100 100 100 
P-value 0.04 0.04 0.04 NS 0.002 NS 0.002 0.002 0.002 NA NA NA 
1significant at p<O.001 for the rates on meat or cavity or tail determined by TC, m-MPN and DP sample 
within PICs 
2 significant at p=O.03 for the rates on meat or cavity or tail determined by TC, m-MPN and DP sample 
within POCs 
3 significant at p<O.001 for the rates on meat or cavity or tail determined by TC, m-MPN and DP sample 
within BICs 
*NA = not applicable, NS = no significant difference 
Prevalence of positive-hippurate Campv/obaeter 
The proportion of positive-hippurate Campy/abaeter slightly varied from part to part or group 
of chicken (Table 5.22). 65- 83 %, 63-82 % and 70-73 % of isolates from the three parts of 
the PICs, the POCs and the BICs, respectively, that were pasitive for the hippurate 
hydrolysis test. The frequencies found in meat and tail samples of all groups of chickens 
were not significantly different, whilst those occurring in cavity samples indicated a 
significant difference at p= 0.01. Within the same group of chicken, the cavity samples of the 
PIC group exhibited the highest frequency of positive hippurate (83%) and was significantly 
different (p=0.013) between the three parts. In contrast, the cavity samples of the POC 
group displayed the lowest positive-hippurate Campy/abaeter (64%) (p=0.016) compared to 
the other two parts. The levels of positive results for hippurate test of the three parts of the 
BIC group did not demonstrate a significant difference. 
Table 5.22 The outcomes of hippurate hydrolysis test of Campy/abaeter isolated from three 
parts of chickens 
Rate of positive-hippurate test (%) 
Type of chicken p-value 
Meat Cavity Tail 
PIC 65.39 83.33 76.19 0.013 
POC 73.91 63.64 82.61 0.016 
BIC 73.33 73.33 70.00 NS 
p-value NS 0.01 NS 
NS = no significant difference 
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Level of Campvlobacter in three groups of chicken 
The levels of Campylobacter isolated from three groups of ch icken in this top ic were taken 
into account as the pooled samples and samples from ind ividual parts (meat or cavity or tail) . 
The data were all normally distributed after logarithm transformation (Figures 5.14: a, band 
c) 
35 
~ ~ 30 
>. 
u 25 c:: 
Ol 
:::l 
c-
20 
Ol 
.... 15 .... 
Ol 
> 10 
·z 
ru 
Ol 5 
0::: 
0 
35 
~ ~ 30 
>. 25 u 
c:: 
Ol 20 :::l 
c-
Ol 15 .... .... 
Ol 
> 10 :;:; 
ru 
Qj 5 
0::: 
0 
~ 
~ ~ 
>. 
u 
c:: 
Ol 
:::l 
c-
Ol 
.... 
.... 
Ol 
> 
:;:; 
ru 
Ol 
0::: 
a 
0·2 2 1-4 41 -6 61 -8 81-10 10 1-12 
Campy/obaeter level (InMPN/g) 
b 
0-2 2.1-4 4.1-6 6.1-8 8.1-10 10.1-12 12.1-14 
Campy/obaeter level (InMPN/g) 
70 c 
60 
50 
40 
30 
20 
10 
0 
<7 7.0-11.0 12.0-16.017.0-19.0 
Campy/obaeter level (InMPN/g) 
Figure 5.14 Distribution of the levels of Campylobacter per carcass in the three 
types of chickens : a) PIC , b) POC and c) BIC 
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Table 5.23 shows results calculated as pooled samples accumulating values from three 
parts of the chicken . Sign ificantly higher levels were fo und in the BICs, with th e lowest levels 
in the P ICs at p< 0.001 with multiple statistic differences between three means (using HSD test) . 
Although the level was sl ightly different between the PICs and th e POCs , it still remained 
statistically different. These findings are highlighted in Figure 5.15. 
Table 5.23 Levels of Campylobacter isolated from three types of ch ickens (per carcass ) 
Level of Campy/obaeter (log 1oMPN/g) 
Type of chicken 
Mean.:!:SE 95% (CI)* 
PIC 3 . 73~0 . 59 2.98, 4.48 
POC 4.44~0 . 64 3.70 , 5.22 
BIC 8.1 0~0 . 81 6.57 , 9.23 
P-va/ue <0 .001 
* 95%Confidence interval of the mean 
9 
.... 8 Q) 
-
(.,) 7 (1) 
.Q~ 6 ~ Cl 
~-Q.z 5 E a.. 
(1) :2: 4 l) Cl 
0 3 '0- :::=.. 
0 
a:; 2 
> 1 Q) 
..J 
0 
PIC mc BIC 
Type of chicken 
Figure 5.15 Level of Campylobacter per carcass comparing PIC , POC 
and BIC 
A high significant difference (p<0.001) was also noted for the levels estimated from 
individual parts, meat or cavity or tail samples (Table 5.24 and Figure 5.1 6). Regard ing th e 
difference within the group , representing by meat, cavity and tail , no sign ificant difference 
was found for the PICs. In contrast , in the POCs and the BICs, the highest level was noted 
from the samples obtained from tail and followed by meat and cavity samples. These 
findings also showed a significant difference at p= 0.003 for the POCs and at p<0.001 for th e 
BIC group . 
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Table 5.24 Levels of Campylobacter isolated from three types of ch ickens grouping at the 
level per individual part of chicken 
Level of Campylobacter (log 10 MPN/g) 
Type of chicken Type of sample 
. Mean + SE 95%CI P-value 
PIC Meat8 3.72.± 0 .64 2 .53,5.02 
Cavity 3.64 .± 0 .72 2.23, 5.04 NS 
Tailc 3.63.± 0 .62 2.43,4.84 
POC Meat8 4.00 .± 0 .60 2.82, 5.18 
} 0.003 Cavitl 3.63.± 0 .62 2.42 , 4 .85 
Tailc 4 .80 + 0 .68 3.46,6.14 
BIC Meat8 7.28 + 0.88 5.54 , 9 .00 
Cavity 6 .35.± 0.89 4.61, 8.09 <0.001 
Tailc 7.49 + 0 .90 5.74 , 9 .24 
* 95%Confidence interval of the mean 
a Significant at p-value <0.001 for MPN levels of meat samples between PIC, pac and BIC group 
b Significant at p-value <0.001 for MPN levels of cavity samples between PIC, pac and BIC group 
C Significant at p-value <0.001 for MPN levels of tail samples between PIC, pac and BIC group 
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Figure 5.16 Level of Campylobacter per part of chicken (meat or cavity or tail) 
and between PIC , POC and BIC 
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5.5 Discussion 
5.5.1 Reliability of the new modified MPN 
To date, there is no internationally accepted standard method for the enumeration of 
Campy/obacter in food samples. This is because of its fastidious requirements for growth. 
Both conventional methods (i.e. MPN, direct plate count) and molecular-based methods (e.g. 
PCR/REA, PFGE) have their advantages and disadvantages. Consequently, the results of 
the enumerations of Campy/obacter carried out over decades are difficult to compare as 
there were major differences in the methodologies used (i.e. type of media, concentrations, 
sampling regime, and type of samples). These differences are presented in Table 5.25 
Table 5.25 Campy/obacter prevalence in chicken (post processing) in selected countries 
Country 
Belgium 
Denmark 
Finland 
Ireland 
New Zealands 
Sweden 
UK 
USA 
Type of sample 
carcass 
breast 
skin 
carcass 
carcass 
a carcass wash 
carcass 
carcass 
chicken portion 
pre-packaged 
broiler (grocery) 
Method 
convention 
isolation 
no information 
no information 
no information 
conventional 
isolation 
no information 
conventional 
isolation 
conventional 
isolation 
Prevalence (%) Reference 
28.5 Uyttendaele et al., 
21.7 1999 
23.5 
37.7 EC (2003) 
10.6 EC (2003) 
58 EC (2003) 
63 Bongkot, 1997 
9.3 EC (2003) 
83.3 Kramer et al. , 2000 
98 Stern and Line, 1992 
Since the environments during the slaughter and processing as well as storage at retail 
points are unfavourable for the growth of Campy/obacter (affecting the viability of the cells) 
(Beuchart, 1985; Chaveerach et a/., 2003; Stern et aI, 2003 and Vashin and Stoyanchev, 
2004), the enumeration prior to enrichment of these organisms may be less efficient in 
determining actual levels. It is evident that the direct plating method is performed before the 
homogenate is enriched. In contrast, the principle of the conventional MPN is that the 
enumeration occurs alongside the enrichment. Several studies have used these methods to 
enumerate Campy/obacter in chickens as presented in Table 5.26. 
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Table 5.26 Overview of the enumeration studies of Campy/obacter in chicken 
Type of sample Level Unit Method Reference 
Caecal content (Farm) 6-10 log10 cfu/g Direct plating Beery et al.(1988), 
Stern et al. (1988) 
Caecal content (Farm) 6.83 log10 cfu/g Direct plating Stern et al. (1995) 
Caecal content (Farm) 6.4 log10 cfu/g Direct plating Mead et al. (1995) 
Feathers 5.4 log10 cfu/g Direct plating Berrang et aI, 1999 
Skin 3.8 
Caeca 7.3 
Parts of chicken 2-3 log10 cfu/g Direct plating Berrang et aI, 2001 
Crate wash water >4 log10 MPN/ml MPN Siader et al. (2002) 
Carcass rinse + neck 9 log10 cfu/g Direct plating Bull et al., (2003) 
skin (slaughterhouse) 8 
-at entrance 7-8 
-post bleed 6-7 
-post defeathering 5-7 
-post evisceration 5 
-post chill 
-post packaging 
Faeces 3-6 log10 cfu/g Direct plating Stern and Robach 
Carcass rinse 3-5 (2003) 
Feather 8 log10 cfu/g Direct plating Keener et al.(2004) 
Carcass wash 4.75 log10 cfu/g Direct plating Bashors et al. (2004) 
Packaging (retail) 4.64 log10 cfu/g Direct plating Keener et al. (2004) 
Caecal content (Farm) 4.95- log10 cfu/g Direct plating Nauta et al. (2005b) 
6.00 
Caecal content (Farm) log10 cfu/g Direct plating EI-Shibiny et al.(2005) 
-organic chicken 4.5-
-free range chicken 9.7 
6.7-
9.2 
Caecal content (Farm) 7.15- log10 cfu/g Direct plating Nauta et al. (2005b) 
9.20 
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The convent ional MPN , using a set of test tubes (either 3 or 5 tubes), is laborious and 
consumes time, space and materials . For this reason , the convent iona l MPN (c-MPN) was 
modified by using a 48-well plate instead of a set of test tubes . As there was no sign ificant 
difference in the results of the enumeration between the c-MPN and the m-MPN (sect ion 
5.4 .1) , this modified method is comparable to the conventional MPN . Nevertheless , because 
of interference from lake horse blood added in the broth (Figure 5.17a), the turb idity 
occurring in the wells is not easy to be noticed by the naked eye, except for samples 
harbouring high concentrations of organisms (Figure 5.17b). 
a b 
Figure 5.17 Samples in Bolton broth after enrichmen t: a) samp le harbouring a low 
concentration of organisms and b) sample harbouring a high concentrat ion of 
organisms 
The presumptive positive result of the m-MPN must be ind icated by the colony formation 
onto the mCCDA. However, the c-MPN , interpreting by the turbidity is comparable to that 
determined by colony formation . Thus , the results of c-MPN may be directly readable from 
the change of the turbidity . It is interesting to further cons ider whether the turbidity can be 
detected by the naked eyes in a sample harbouring low concentrat ion of organisms . If not, 
there is still a need to use colony formation on the agar and confirm ation methods as a 
positive indicator. Comparing between turbidity and colony formation , it is suggested that 
colony formation is a more precise indicator for positive samples . The whole processes 
using both methods needed at least five days to gain sufficiently precise detection . Th is is 
one of the disadvantages of the MPN method . Nonetheless, the new modified method (m-
MPN) can reduce the use of materials , specifical ly, the media. 
Although the enumeration of Campylobacter by both the c-MPN and the m-MPN is 
performed under enrichment cond itions or the enrichment processes do not change the 
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status of the original samples (positive or negative). Enrichment is used for recovering 
Campy/obaeter in the samples. If the original sample is negative, after enrichment, it still 
remains negative. In addition, by the assumption of MPN determination, the sample showing 
a positive tube/well represents that there is at least one colony of organism in the original 
tested sample (Swaroop, 1951; Oblinger and Koburger, 1975 and US-FDAlCFSAN, 2001). It 
is therefore suggested that enrichment-enumeration method does not increase the levels of 
MPN in the tested samples. 
5.5.2 Comparison of test performances for the three detection 
methods in the absence of a gold standard 
Two groups of conventional culture methods have been used for detecting Campy/obacter in 
a number of studies (Beuchat, 1985, Wang, 2002 and Stern and Robach, 2003). These are: 
i) with enrichment method (i.e. Traditional culture (TC) and MPN methods) and ii) without 
enrichment method (i.e. direct plating method, DP). 
None of these three tests in the current study gave perfect performance status. For example, 
the m-MPN showed high sensitivity but low specificity. Amongst these tests, the TC and the 
m-MPN were performed with the enrichment stage. With the enrichment stage, 
Campy/obacter is in better condition than that in the sample without enrichment. Therefore, 
the TC and the m-MPN have high sensitivity. 
As only the viable Campy/obacter can cause infection, the three methods used in this study 
are appropriate to provide the association between the prevalence of positive chicken at 
retail point and the consequence to human health. However, the performance characteristics 
of the tests are important for determining the true prevalence. Amongst these three methods, 
each of them shows advantages and disadvantages regarding sensitivity and specificity. The 
bias due to measurement error can be resolved using the application of Bayesian estimation. 
The demonstration of using Bayesian application to adjust the performance of these tests 
supports that the m-MPN and the TC have high sensitivity but low specificity. This suggests 
that detection of Campy/obacter in chicken samples should be performed using at least two 
methods. 
5.5.3 Isolation rates and levels of Campylobacter in three groups 
of chicken 
The varying results in isolation rates highlight the importance of considering the type and 
condition of the samples in relation to the selection of enumeration and detection methods. 
The direct plating did not perform well in terms of both isolation and detection for 
Campy/obaeter in chicken carcasses, suggesting that the direct plating is less sensitive for 
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the detection of Campylobacter in food samples. The findings from the individual parts of 
chicken clearly indicate that the DP provided the significant lowest rate of detection. in 
particular. of cavity sample in three groups (22-46%). Serrang et al.(2001) also reported 
significant difference in the levels of Campylobacter from different chicken parts (e.g. breast. 
thighs and drumsticks) with and without skin. 
These differences in isolation rate between different parts of the same chicken may be a 
result of variation in: i) levels of Campylobacter colonising in the gut prior to slaughter 
process. ii) rates of cross-contamination and iii) pathways of cross-contamination. The 
results clearly indicate that the SIC group showed higher rate of not only colonisation but 
also cross-contamination. This is supported by the different results found between pre-
packaged and unwrapped chicken. Since the SIC group were all unwrapped. the carcasses 
must be openly exposed to each other. This increases the chance of a negative-
Campylobacter chicken being contaminated with a positive one. This cross-contamination 
after slaughter processes plays a significant role of spreading and consequent increased 
positive-Campylobacter chickens exposure to consumers. The similar isolation rates in three 
parts of chicken in the SIC group indicate that SIC-chickens unwrapped and of unknown 
origin. exhibited high colonisation and cross-contamination. However. further studies are 
needed in order to evaluate whether the significant cross-contamination takes place pre- or 
post slaughtering. 
Recent studies reported variable prevalence of Campylobacter in chicken (Stern et al .• 1988; 
Mead et al .• 1995 and Serrang et al. 1999). These differences indicate considerable variation 
in isolation method. source of sample. type of sample (whole or part of chicken. fresh or 
frozen. with or without giblets). sampling methods or country as well as actual variation in 
prevalence of Campylobacter. It was proposed by Jones et al. (1991) that the faecal 
isolation rate of Campylobacter in normal flock can range from 0 to 100%. During the 
slaughter process. faecal content from birds can easily be spread to the surface of chicken 
carcasses or equipment (Izat et al .• 1988; Khalafalla. 1990 and van de Giessen et al .• 1992). 
The follicles of the chicken skin create the micro-aerophilic environment. which is a 
preferable habitat of Campylobacter spp. This is coupled with the cold humid processing 
environment. promoting the survival of these organisms on carcasses (Cloak et al .• 2001 
and Solow et al., 2003). It is plausible that the slaughter process is the major factor in the 
spreading of the organisms from positive to negative carcasses. 
The levels of Campylobacter in each group of chicken support the assumption of 
colonisation and cross-contamination. Very high concentrations were found in the SIC group 
(6-7 10g1QMPN/g of sample) compared with the PIC and the POC groups. The differences 
between these groups of chicken are found to be highly significant (p<O.001). with the 
significant lowest in the PIC group (3.72~0.59 10g1QMPN/g). 
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Several studies showed the concentration of Campy/obacter in the caecal content of live 
birds on the farms. The concentrations range from 6 log10 cfu/g to 9 log10 cfu/g. However, 
most of them, except for one study of EI-Shibiny et a/ (2005), did not describe the specific 
type of chicken rearing (i.e. intensive or organic method). EI-Shibiny et al. (2005) showed a 
very high concentration of Campylobaeter obtained from the caecal content of both organic 
and free range chicken (5-10 log10 cfu/g). As caecal content is thought to be main source of 
Campylobaeter, the transport crates were then prone to be contaminated with 
Campylobaeter through the shedding from birds. Siader et al. (2002) and Hansson et a/ 
(2005) presented that most transport crates were contaminated with Campy/obaeter (85%) 
and the levels were higher than 104 MPN/ml. 
Other studies investigated the concentration of Campy/obaeter during slaughter processes 
(Mead et ai, 1995; Bull et a/., 2003; Stern and Robach, 2003 and Bashors et a/.2004). The 
concentrations varied in different steps of the processing. However, they were still high 
being between 5 10glO cfu/g to 9 log10 cfu/g throughout the processes. Presumably, by the 
end of the slaughter process the negative-Campy/obaeter chicken would become positive. A 
number of studies indicated that during slaughter and processing, Campy/obaeter may be 
transmitted through the skin of the birds as the feather follicles were thought to be the entry 
for Campylabaeter into the subcutaneous layer (Berndtson et aI, 1992; and Berrang and 
Dickens, 2000). This assumption was supported by the study of Uyttendaele et al. (1999), 
which showed that skinless parts of chicken were less likely to be contaminated with 
Campy/abaeter. 
The results from the BIC group indicate that cross-contamination may be responsible for the 
high level of Campy/abacter. It is possible that at high levels Campy/abaeter may have high 
probability of spreading to be contaminated to other carcasses. This is supported by results 
obtained from the individual parts of the chicken. Significantly lower levels were found in 
cavity samples. The results from the POC groups indicating significant higher levels than 
found in the PIC group supports the assumption that organic chickens allowed to be outside 
most of the day tend to be exposed to Campy/obaeter from the environment (UK-DEFRA, 
2005). By the time of processing in a slaughterhouse, the carcass harbouring high numbers 
of organisms can be a high contributor to other carcasses. 
Considering information collected from other studies related to the concentration and the 
prevalence of Campy/abaeter in chicken from farms to points of sale, it is unlikely to find the 
negative-Campy/abaeter chicken at the time of purchase of consumers. However, there is a 
big gap of the isolation rates per carcass at the point of sale amongst several studies, 
ranging from less than 10% to 98% (Table 5.25). This may be due to lack of internationally 
accepted methodology using from country to country. In addition, the imperative point is that 
most studies were not conducted consecutively from farm to slaughterhouse and to retail 
outlet. It is therefore difficult to analyse, compare and conclude the critical point of the real 
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situation of Campylobaeter in the food chain. As a result, managing further reductions in 
Campylobaeter contamination in poultry in many countries cannot be efficiently achieved. An 
achievement in the reduction of Campylobaeter contamination could depend upon stringent 
controls of infection and contamination from farm to consumption. 
Finally, specified by the hippurate hydrolysis test, C. jejuni was the most commonly isolated 
species from all groups of chicken in this study (approximately 70-80%). However, further 
confirmation of Campylobaeter requires more specific indicators, e.g. genotyping. Solow et 
al., 2003 have highlighted such confirmation difficulty in suggesting that the incidence of 
C.eoli may be underestimated because C.eoli is more sensitive than C.jejuni to 
antimicrobials used in the selective media. 
5.6 Summary 
This chapter describes the development of methods for enumeration of Campylobacter in 
food samples. Three methods were compared: i} traditional culture (TC), ii} modified MPN 
(m-MPN) and iii} direct plating (DP). The findings show that: 
1. The levels of Campylobaeter in chicken samplesdetermined by the new modified 
MPN (4.68±1.54 log1OMPN/g)* were found to be comparable to that by the 
conventional MPN (4.23±1.44Iog10MPN/g). 
2. All three methods exhibit imperfect performances in detection of Campylobaeter 
carried in chicken samples (section 5.4.2.1). The efficiency of detection can be 
improved using the combination of at least two methods such as the MPN and the 
direct plating. 
3. Based on three detection methods, isolation rates of Campylobaeter per carcass 
were 78-90% for the PICs, 78-97% for the POCs and 90-100% for the BICs. 
4. Comparison of the three detection methods shows that direct plating had the lowest 
rate of detection for Campylobaeter (77-90%). The TC and the m-MPN had a 
detection rate of 80-100%. 
5. When comparing samples from three parts of the chicken, the samples obtained 
from the cavity gave the lowest prevalence for Campylobaeter, particularly when 
using the DP (60-90% for the TC, 70-100% for the m-MPN and 22-46% for the DP). 
6. The BIC group was found to harbour high levels of Campylobaeter (8.10±0.81 
log1OMPN/g), followed by the POC (4.44±0.64 log1OMPN/g) and the PIC (3.73±0.59 
log1OMPN/g). 
7. The levels of MPN found in the three different parts of chickens indicate that 
contamination with Campylobaeter in chickens can occur during pre- and post 
slaughtering processes (Tables 5.21 and 5.24). 
*Note: log1ON±SE 
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CHAPTER 6 
Antimicrobial Susceptibility Testing 
6.1 Introduction 
Antimicrobial susceptibility testing (In-vitro) is used for predicting the success or failure of 
antimicrobial therapy, in which micro-organisms are divided into treatable and non-treatable 
group on the basis of the breakpOint. The susceptibility of micro-organisms to antimicrobial 
can be determined in a quantitative or qualitative way. Quantitative methods will result in the 
data that can be related to the actual concentrations of antimicrobial agents inhibiting the 
visible growth of micro-organisms, e.g., the minimal inhibitory concentration (MIC). 
Qualitative methods categorise micro-organisms as susceptible, intermediate or resistant. 
However, the breakpoint (see 6.1.2) may differ between different susceptibility testing 
methods or may be set at different levels to reflect differences in the pharmacokinetics or 
pharmacodynamics of an antimicrobial in different animal species or ages. 
6.1.1 Susceptibility testing methods 
Several methods have been used for both a quantitative or qualitative analysis of 
antimicrobial susceptibility. These include agar/broth dilution method, agar diffusion method, 
Epsilon test (E-test) and molecular methods. However, molecular methods are not routinely 
used in laboratory. 
Agar/broth dilution method 
Different dilutions methods designed to determine the MIC are widely used the comparative 
testing of antimicrobial agents, in particular, new agents. These methods are reliable than 
other methods such as disc diffusion method (EUCAST, 2000). Procedures for the 
standardisation of dilution methods are described by a number of organisations, including 
the BSAC, the US NCClS. 
These methods are applied to determine the lowest concentration of an antimicrobial that 
inhibits visible in vitro growth of micro-organisms (MIC). The MIC is considered as a gold 
standard for determining the susceptibility of organisms to antimicrobial agents. Thus, 
dilution methods are internationally accepted as the reference standard when other methods 
are tested. A disadvantage of the dilution methods is that they can be costly and time 
consuming. Due to lack of the internationally accepted breakpoints, the interpretative criteria 
for the MIC must be agreed before the tests are performed in order to provide a meaningful 
comparison of resistance rates (Kahlmeter et al., 2003). 
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Agar diffusion method (Kirby-Bauer diffusion method) 
Agar or disc diffus ion susceptibil ity testing is amongst the most widely adopted altern ative 
approaches . Disc diffusion method is based on an approximation of the effect of 
antimicrobial on bacterial growth on solid medium . The principle of th is testing is based on 
the inoculation of the surface of an agar plate with a suspens ion of test organism foll owed by 
application of a paper disc containing a defined quantity of antim icrobial agent (BSAC, 2002). 
The interaction of the antimicrobial agent diffusing through the med ium with the organism on 
the surface of the agar plate results in inh ibition of bacterial growth for a variable distance 
around the paper disc, expressing by the zone diameter (Figure 6.1). A zone of growth 
inhibition around the antimicrobial disc will occur if the organism is susceptible to the 
antibiotic. Standardized regression curves have been developed that correlate inh ibition 
zone size to the minimal inhibitory concentration of the antimicrob ial . However, even though 
it is the most common test for antimicrobial effectiveness , not all bacteria can be tested 
using disc diffusion . 
The concentration of the antibiotic at different distances from the disc will depend on its 
original concentration on the disc and its diffusion rate through the agar. There is a 
relationship between the diameter of the zone of inhibition of bacterial growth around the 
disc and the MIC of the test organism for the particular antim icrob ial agent. The antimicrobia l 
content of the paper disc is a key determinant of the diameter of the zone of inh ibition of 
growth. The relationship between MIC (as determ ined under defined cond itions ) and the 
diameter of the zone of inhibition is complex and affected by many variables . In general 
terms, the lower the MIC for a particular antimicrobial agent , the larger the diameter of the 
zone of inhibition of growth (Cormican et al., 2005) . 
Figure 6.1 Disc Diffus ion Test 
(Source: http ://www.poultry.baytril. com/119/SusceptibilityTesting .htm) 
Epsilon test (E-test) 
The Epsilon test com bines th e principles of dilution method wi th agar diffusion method . This 
gradient diffusion meth od uses commercial strips instead of disc and allows determining the 
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MIC values . In this test fixed concentration of antimicrob ial agents , representing the cut-off 
points of susceptibility or resistance , are incorporated with into agar or broth dilution method . 
Figure 6.2 shows an elliptical zone of inhib ition resul ts. 
The Epsil on Test 
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Figure 6.2 An elliptical zone of inhibition from the Eps ilon test 
(Source: http://www.poultrv.baytril.co m/11 9/Suscepti bi lityTesting .htm) 
Molecular methods 
These methods are mainly based on the polymerase chain react ion and DNA-DNA 
hybridisation method . These molecular methods are usually used for identification of 
bacterial strains , e.g. Campylobacter jejuni. They can be applied to a lesser exten t to directly 
detect resistance gene in clinical samples as well. However, the procedures involve complex 
processes, in particular, in gram-negative bacteria wh ich have the diversity of resistance 
mechanisms. Molecular methods are then not routinely used in clin ical laboratories (Fluit et 
al., 2001). 
6.1.2 Breakpoint consideration 
The setting of breakpoints to a certain antimicrobial agent resulti ng from th e MIC values or 
zone of inhibition diameters is a contentious subject and has been the focus of much debate 
among microbiologists , regulators and industry. There are many aspects to the 
determination of breakpoint interpretive criteria. These include microbiolog ical (the pattern of 
distribution of MIC measurements for a group of isolates of th e same species ), 
pharmacological (achievable blood and tissue levels of th e antimicrobial agent) . an imal 
models and cl inical trial (Kahlmeter et al., 2003). The issue is furth er compl icated by 
differences in the interaction between an antimicrobial agent and different species or groups 
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of bacteria. Therefore, a single antimicrobial agent (e.g. ampicillin) may have different 
breakpoint interpretive criteria. 
The European Committee for Antimicrobial Susceptibility Testing (EUCAST) defines 
separate breakpOints for epidemiological cut-off values and clinical breakpoint. The 
epidemiological cut-off values are used for the detection of bacteria with resistance 
mechanisms and the monitoring of resistance development. The clinical breakpoint is used 
for guidance of therapy (Kahlmeter et al., 2003). 
Clinical breakpOints are defined based on three criteria, which are: i) "A micro-organism is 
defined as clinically susceptible (S) by a level of antimicrobial activity associated with a high 
likelihood of therapeutic success, or by applying the appropriate breakpoint in a defined 
phenotypic test system", ii) "A micro-organism is defined as clinically intermediate (I) by a 
level of antimicrobial activity associated with indeterminate therapeutic effect, or by applying 
the appropriate breakpoints in a defined phenotypic test system" and iii) "A micro-organism 
is defined as clinically resistant (R) by a level of antimicrobial activity associated with a high 
likelihood of therapeutic failure, or by applying the appropriate breakpOint in a defined 
phenotypic test system". 
These breakpoints may be altered with legitimate changes in circumstances. Clinical 
breakpoints are presented as S~x mg/l; I>x, ~y mg/l; R>y mg/L. 
Microbiological resistance and epidemiological cut-off values are defined based on the basis 
of the following: i) "A micro-organism is defined as wild type (WT) for a species by the 
absence of acquired and mutational resistance mechanisms to the drug in question, or by 
applying the appropriate cut-off value in a defined phenotypic test system" and ii) "A micro-
organism is defined as microbiological resistance - Non-Wild Type (NWT) (NWT) for a 
species by the presence of an acquired or mutational resistance mechanism to the drug in 
question, or by applying the appropriate cut-off value in a defined phenotypic test system". 
In addition, this cut-off value will not be altered by changing circumstances as well as wild 
type micro-organisms mayor may not respond clinically to antimicrobial treatment. The wild 
type is presented as WT ~z mg/l and non-wild type as NWT >z mg/l (z values is obtained 
from reference database of EUCAST) 
It is becoming clear that there are no standard methods for antimicrobial susceptibility 
testing for Campylobacter spp. However, the approved method described by the National 
Committee for Clinical laboratory Standards (NCClS, 2001), an agar dilution method, has 
been widely used to measure the susceptibility. This method will provide the quantitative 
values in interpreting the rate of resistance. In addition, it is also internationally accepted as 
a reference method for the comparative testing. 
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For this reason, the in vitro agar dilution method to determine the susceptibility of 
Campy/obacter to three antimicrobials was selected for this study. 
6.2 An agar dilution method 
6.2.1 Principle 
The determination of the minimal inhibitory concentration (MIC) of antimicrobials was 
performed by using twofold serial dilutions of the antimicrobial agent in the agar growth 
medium. The results were interpreted by the identification of the lowest concentration (MIC) 
of an antimicrobial agent that inhibits visible growth of Campy/obacter isolates on the agar 
(NCClS, 2001). 
6.2.2 Materials and methods 
Sample and Isolate 
The details of the sampling regime (30 fresh PICs, 30 fresh POCs and 30 fresh BICs), 
isolation and identification were described in Chapter 5, section 5.21. All isolates from all 
positive-Campy/obacter samples were tested for the MIC of three antimicrobials, 
ciprofloxacin, erythromycin and nalidixic acid. These three antimicrobials selected are drugs 
of choice in the treatment of campylobacteriosis. 
Media and inoculum preparation 
As recommended by NCClS, Mueller-Hinton broth was used for the preparation of 
equivalent inoculum (Oxoid: CM 0337;1 litre of this medium contained 300g dehydrated beef 
infusion, 17.5g casein hydrolysate and 1.5g starch at pH 7.32:0.2). Two groups of 
antimicrobials were used in this study: i) macrolide (erythromycin) and ii) (fluoro)quinolone 
(ciprofloxacin and nalidixic acid). Twofold serial dilutions of these antimicrobials were added 
into a molten Mueller-Hinton agar. Stock solution and twofold agar plate are described in 
appendix 1-4. 
Procedures 
The minimal inhibitory concentration (MIC) of each antimicrobial agent was determined by 
the agar dilution method as described by the National Committee for Clinical laboratory 
Standards (NCClS, 2001). Following identification, five purified isolates grown on an 
mCCDA from each positive sample (meat and skin, cavity and tail) underwent susceptibility 
tests with three antimicrobial agents, ciprofloxacin (Bayer Ltd. Co., Newbury, Berkshire,UK), 
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erythromycin (Sigma Ltd . Co ., Poole , Dorset, UK) and nalidixic acid (Sigma Ltd . Co., Poo le, 
Dorset, UK). 
Each isolate was inoculated into Mueller-Hinton broth and incubated micro-aerobically at 
37°C overnight. The bacterial suspension was adjusted to ca . 0.5 McFarland turbid ity 
standard , with the aim of producing broth culture that would yield sim ilar viable counts of 
approximately 108 CFU/ml (0.5 McFarland standard preparat ion is described in Append ix 1-
5). It was diluted 1:10. An aliquot (10 Ill) of the final diluted inoculum was appl ied onto 
twofold antimicrobial Mueller-Hinton agar (ciprofloxacin at a range from 0.125-8 mg/l or 
erythromycin at a ranged from 8.0- 512 mg/l or nal idixic acid at range from 8.0-5 12 mg/l ) 
supplemented with 5% defibrinated horse blood . The agar plates were incubated under 
micro-aerobic condition produced by using gas-generating kits (BBl™ GasPack TM) and kept 
in an airtight container at 42 °C for 48 h (Figure 6.3) . 
The standard strains for control for antimicrobial action are G.jejuni (NCTC 11322) 
Eacherichia coli (NCTC 10418), Pseudomonas aeruginosa (NCTC 10662) and 
Staphylococcus aureus (NCTC 6571 ). The reference strains were obtained from the 
National Collection of Type Cultures (NCTC) , Health Protection Agency (UK). All strains 
were tested in parallel with the samples. Agar without antimicrobial was used as a positive 
control for growth. 
5 pure isolates 
Mul ler-H inton broth 
micro-aerobica lly incubated overnight 
MIC 
Muller-H inton agar 
(doubling concentrat ion) 
Micro-aerobically incubate 42°C, 48h 
Figure 6.3 Antimicrobial susceptib ility testing : an agar dilution method 
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The MIC determination 
After 48-hour incubation , the MIC endpoint was determined at th e concentration where a 
marked reduction took place in the appearance of growth on the test plate , which was 
compared with the growth on the blank control plate (without antimicrobials) . Examples of 
how to interpret the MIC are shown in Figure 6.4 . 
Concentration A B C o E 
Control 
• • • • • 
2mg/l 
• 0 0 0 0 
4mg/l 0 0 0 
Bmg/l 0 
16mg/l 
Figure 6.4 Examples of MIC determination : Lane A as MIC= 16mg/L, Lane Bas MIC= 4mg/L, 
Lane C as MIC= Smg/L, Lane 0 as MIC= Smg/L and Lane E as MIC= 4mg/L. 
Interpretative breakpoint 
The MIC is defined as the lowest concentration of antim icrobial agent that inhibits visible 
growth of organisms . The MICso is equivalent to the concentration of antimicrob ial agent that 
inhibits growth of 50% of Campytobacter samples . 
Breakpoint concentrations published by the British Society for Antimicrobial Chemotherapy 
(BSAC) and NCClS (Thwaites and Frost, 1999; Sarah , 2002 ; Tollefson and Flynn, 2002; 
Luber et at., 2003 and Randall et at. , 2003) were used for the definition and determination of 
the resistance of Campytobacter isolates . The following cut-off concentrations were used : for 
ciprofloxacin MIC ~ 4 mg/l , for erythromycin MIC ~ 8 mg/l and for nalidixic acid MIC 
~16mg/l. Each chicken carcass was considered positive for res istance if it was found to 
harbour one or more resistant isolates . In add ition , the resistance rate of isolates was also 
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considered by assuming that each isolate in each sample is independent and selected 
randomly. 
6.3 Data analysis 
MIC data analysis: Analysis of difference of MICs for the three chicken sources (PIC, POC, 
BIC) was undertaken by ANOVA (Ryan and Joiner, 2003). Additionally, analysis of the 
difference between the three chicken parts (body, cavity and tail) within each group was 
carried out in the same way. 
Resistant rates data analysis: The chi-square test was used to test for association of 
resistance rates with the three groups of chickens and for association of resistance rates 
with the different chicken parts (body, cavity and tail). 
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6.4 Results 
6.4.1 MIC determination 
The results of MICs of three antimicrobial agents, ciprofloxacin, erythromycin and nalidixic 
acid for Campy/obacter isolated from three groups of chicken are summarised in Table 6.1. 
These results show significant difference (p=0.009) for the MICs of nalidixic acid for the 
three groups of chickens. No significant difference of MICs of ciprofloxacin and of 
erythromycin was found for the same groups. The MICso of ciprofloxacin and erythromycin 
for Campy/obacter isolated from pre-packaged organic chicken (POC), pre-packaged 
intensive chicken (PIC) and butcher-intensive chicken (BIC) were the same (1 mg/L for 
ciprofloxacin 128 mg/L for erythromycin). However, the highest values of MIC of each 
antimicrobial agent for isolates from intensive chickens were found to be higher than those 
found in isolates from organic chickens, with the highest values found in isolates from 
butcher's unpackaged samples (ciprofloxacin: 4-8 mg/L for intensive and 2 mg/L for organic, 
erythromycin: 512 mg/L for intensive and 256 mg/L for organic, and nalidixic acid: 256-512 
mg/L for intensive and 128 mg/L for organic). MICso of nalidixic acid for samples from the 
PIC and BIC groups showed the same level (64 mg/L), and were higher than that found in 
isolates from the POC group (32 mg/L). 
Analysis of the difference in the MICs was carried out for the three parts of the chicken 
carcasses (body [meat and skin], cavity and whole tail). These analyses showed a 
Significant difference (p = 0.026) for resistance to erythromycin in Campy/obacter isolated 
from the POC group, with the lowest MIC found in the cavity samples, compared to the other 
two parts. No significant differences could be demonstrated for the two other antimicrobial 
agents. 
Table 6.1 The MIC value of three antimicrobial agents for Campy/abacter isolates obtained 
from three types of chickens 
Antimicrobial 
Ciprofloxacin 
Erythromycin 
Nalidixic acid 
Retail source of chicken 
PIC 
POC 
BIC 
PIC 
POC 
BIC 
PIC 
POC 
BIC 
Range 
0.125-4 
0.125-2 
0.25-8. 
32-512 
16-256 
8-512 
16-512 
8-128 
8-512 
MIC (mg/L) 
MICsoa MIC90b 
1 2 
1 2 
1 4 
128 256 
128 256 
128 256 
64 128 
32 64 
64 256 
a MICso is equivalent to the concentration of antimicrobial agent that inhibits growth of 50% of 
Campy/abaeter samples 
b MICoo is equivalent to the concentration of antimicrobial agent that inhibits growth of 90% of 
Campy/abaeter samples 
119 
6.4.2 Resistance rates 
Using the pre-set breakpoint, 100% of chickens in all three groups were found to harbour 
Campylobacter isolates resistant to erythromycin and nalidixic acid. Chickens from the BIC 
group exhibited the highest resistance rate to ciprofloxacin (26.7% of chickens with resistant 
isolates and 11.6% of all isolates) followed by a lower rate for PIC group (8.7% chicken with 
resistant isolates and 2.9% of all isolates) whereas no isolates from the POC group were 
resistant to ciprofloxacin (Table 6.2). 
Resistance rates were calculated for samples from different parts of the chicken carcasses 
(body [meat and skin], cavity and tail). These show that rates of resistance to ciprofloxacin in 
isolates from meat and skin of the PIC group were higher than those found on the cavity and 
tail samples. In contrast, isolates from the cavity fluid obtained from the BIC group showed 
the highest resistance rate to ciprofloxacin. The resistance rates to erythromycin and 
nalidixic acid found among the different carcass parts in the POC, PIC and BIC groups were 
all in the high range of 82-100% (Table 6.2). 
The distributions of percentage of samples determined for the median MIC of three 
antimicrobial agents from the POC, PIC and BIC groups are illustrated in Figures 6.5 to 6.7. 
Table 6.2 resistance rates of three antimicrobial agents for Campylobacter isolates obtained 
from three types of chickens 
Retail Chickens with Resistant Chicken parts with resistant 
isolatesb Antibiotic source of resistant isolate (%) 
chicken isolatesa (%) (%) Bod~ Cavit~ Tail 
Ciprofloxacinc,f PIC 8.7 2.9 5.6 0 0 
POC 0 0 0 0 0 
BIC 26.7 11.6 10.7 20.8 9.0 
Erythromycind,g PIC 100 100 100 100 100 
POC 100 100 100 100 100 
BIC 100 100 100 100 100 
Nalidixic aCide,h PIC 100 100 100 100 100 
POC 100 95 93.8 94 100 
BIC 100 81.4 82.1 83.3 90.9 
a percentage of chicken carcases harbouring one or more resistant isolates 
b percentage of isolates found to be resistant to a specific antimicrobial agent. 
c,d no significant difference for the MICs of ciprofloxacin and erythromycin amongst POC, PIC and BIC 
e significant at p= 0.009 for the MICs of nalidixic acid amongst POC, PIC and BIC 
f significant at p=0.012 for the percentage of chickens harbouring ciprofloxacin-resistant isolates 
amongst POC, PIC and BIC 
g,h no significant difference for the percentage of chickens harbouring erythromycin-resistant and 
nalidixic acid-resistant isolates among POC, PIC and BIC 
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Figure 6.6 Comparison of median MIC of erythromycin in Campylobacter isolated from PIC, 
POC and BIC 
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POC and BIC 
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6.5 Discussion 
The results in the study show a significant difference of MICs of nalidixic acid for 
Campy/obacter isolated from the three groups of chicken tested. The MICs of ciprofloxacin 
and of erythromycin did not demonstrate a significant difference between these three groups. 
However, the highest MIC values of all three antimicrobial agents for isolates from 
intensively farmed chicken were higher than those found in organically reared chicken. This 
is further highlighted in Figures 6.5-6.7, showing the distribution of percentage of samples 
with median MIC values. This is particularly prominent in Figure 6.7 with relation to nalidixic 
acid MICs in chickens from butcher's shops. Rates of resistance to ciprofloxacin (as 
determined by the application of the pre-set break point) also demonstrate the highest rate 
of resistance in the BIC group (26.7%) compared with the PIC and POC groups (at 8.7% 
and 0% respectively). These findings indicate a potentially worrying trend in chickens from 
unlabelled and therefore presumed less controlled sources. 
The resistance rates to erythromycin and nalidixic acid per carcass were found to be the 
same among the POC, PIC and BIC groups, being 100% in each. Other studies (Loovern, et 
a/., 2001; Ge, et a/.,2003 and Luber et a/., 2003) found varying rates of resistance to the 
three antimicrobial agents tested. These found comparatively higher levels of resistance to 
ciprofolaxacin (30-40%) and lower levels of resistance to erythromycin (30-60%) and 
nalidixic acid (40%). Although reported results vary, the rates of antimicrobial resistance are 
high and are a cause of concern as is the continuing reporting of increasing rates of 
resistance to antimicrobial agents in general and to fluoroquinolones in particular, following 
their use in poultry rearing (Piddock, 1995; Lucey, et a/., 2000b; McDemott, et a/., 2002; Ge 
et a/., 2003 and Humphrey, et a/., 2005). 
Interesting findings of resistance rates in the different parts of the chickens have emerged. 
Ciprofloxacin-resistance rates in the PIC group were highest in the meat and skin. Although 
no statistical significance could be demonstrated, this result would be consistent with a post-
slaughtering contamination of these chickens, indicating that this process may playa role in 
the spread of resistant strains. 
The equivalent data for ciprofloxacin-resistance rates from the BIC samples indicated higher 
levels in the cavity compared with the other parts, suggesting that treatment on the farm may 
be play a role in the development of resistance in these chickens. Since these chickens 
were purchased from sources that do not provide information on their origin, the findings 
suggest that the chickens in the BIC group may have been subjected to less stringent 
regulatory controls than those in the other groups. 
The possibility that the development of antimicrobial resistance in Campy/obaeter may be 
associated with the use of antimicrobial agents on the farm makes it imperative to have 
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more reliable information about the level of their use. A recent study (Humphrey, et a/., 2005) 
has shown that ciprofloxacin-resistant Campy/obaeter strains emerge during fluoroquinolone 
treatment in commercially reared chickens. Following the increased reporting of 
antimicrobial resistance in general, and fluoroquinolone resistance in particular, in 
Campy/obaeter worldwide, attempts have been made to better control their use in animal 
husbandry (Sanchez et a/., 1994; Piddock et a/., 2000; Tollefson et a/., 2002 and Ge et a/., 
2003). The continued presence of very high rates of resistance to erythromycin and nalidixic 
acid in Campy/obaeter from both intensive and organic chickens found in this study (with 
particularly high levels of multi-resistance in the BIC group), indicate that these antimicrobial 
agents may have been used on the farm. 
Several reports have indicated that antimicrobial agents used as growth promoters may 
have a critical role in influencing the development of antimicrobial resistance in bacteria 
including Campy/obaeter (Sanchez et a/., 1994; WHO, 1997; McDermott et a/., 2002; 
Tollefson and Flynn, 2002; Luber et a/., 2003 and Randall et a/., 2003). Despite the 
complete ban on this type of use in chicken husbandry, Campy/obaeter still shows 
resistance to some antimicrobial agents. These findings indicate that substituting 
antimicrobial agents used as growth promoters for therapeutic purposes may contribute to 
the maintenance of antimicrobial resistant strains. Evidence from Denmark shows an 
increase in their use for therapeutic purposes following the banning of the use of 
antimicrobial agents as growth promoters (Arnold et a/., 2004). In addition, the slaughtering 
process, as well as pre and post slaughtering processes (e.g. thinning, transportation and 
packaging), may playa further role in the spreading of resistant strains. 
Currently, there are no studies that demonstrate a direct correlation between the use of 
antimicrobial agents in animal husbandry and the rate of antimicrobial resistance in humans. 
However, three studies have shown an association between strain types of Campy/abaeter 
in human infection and those found in retail chickens (Smith et a/., 1999; Kramer et a/., 2000 
and FSA, 2003) and other studies have proposed that the use of antimicrobial agents in 
poultry husbandry could be one of the factors influencing the development of resistance in 
Campy/abaeter with the risk that this resistance may pass to humans via food (Endtz et a/., 
1991; Loovern et a/., 2001; Sarah, 2002; Luber et a/., 2003; Randall et a/., 2003 and Wagner 
et a/., 2003). 
This study has found that all Campy/abaeter strains isolated from both intensively and 
organically reared chicken have a high resistance rate to erythromycin and nalidixic acid. 
This indicates that the antimicrobial agents currently administered to patients for the 
treatment of Campy/abaeter infection may not be the most effective. This is further 
emphasised by the occurrence of some co-resistance to ciprofloxacin and erythromycin in 
intensively reared chickens. 
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The lack of internationally accepted breakpoints for Campy/obacter makes it difficult to 
clearly interpret and compare the results from different studies (Salazar-Lindo et a/., 1986; 
Loovern et a/., 2001; Sarah 2002 and Luber et a/., 2003). There is therefore an urgent need 
to harmonise and standardise, both the methods for antimicrobial susceptibility testing and 
the use of breakpoint values for resistance determination for Campy/obacter. This will make 
surveillance programmes more effective in monitoring the development of antimicrobial 
resistance in Campy/obacter worldwide. 
6.6 Summarry 
Resistance to the three antimicrobials in Campy/obacter isolated from the PIC, POC and BIC 
groups were determined using an agar dilution method. 
1. The MIC50 values of ciprofloxacin and erythromycin for Campy/obacter isolated from 
these three types of chickens were the same (1 mg/L for ciprofloxacin and 128 mg/L 
for erythromycin). The MIC50 of nalidixic acid for samples from the PIC (64 mg/L) 
and BIC (64 mg/L) groups were higher than that found in isolates from the POC 
group (32 mg/L). 
2. Significant differences in the MICs of nalidixic acid were found (p=O.009), whereas 
no significant differences in the MICs of ciprofloxacin and erythromycin were found 
for the same groups (p>O.01). 
3. Using pre-set breakpoints, 100% of chickens in these three types were found to 
harbour isolates identified as resistant to erythromycin and nalidixic acid. All isolates 
from the POCs were susceptible to ciprofloxacin. The BICs exhibited the highest 
resistance rate to ciprofloxacin (26.7% of chicken with resistant isolates and 11.6% 
of all isolates resistant) followed by a lower rate for the PICs (8.7% of chicken with 
resistant isolates and 2.9% of all isolates resistant). 
4. The rates of resistance to ciprofloxacin in isolates from meat and skin of the PICs 
were higher than those found on the cavity and tails samples. In contrast, the 
isolates from the cavity fluid obtained fron the BICs showed the highest resistance to 
ciprofloxacin (Table 6.2). The resistance rates to erythromycin and nalidixic acid 
found amongst the different carcass's parts in these three types were all in high 
range (82-100%). 
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CHAPTER 7 
Assessment of consumer exposure to Campylobacter 
Background 
This study has three phases (section 1.4). This chapter is one part of the work of phase 2 
which deals with the estimation of health risk from Campy/obacter following the consumption 
of three groups of chickens. This chapter is about the estimation of the exposure (dose) to 
Campy/abacter af a persan cansuming chicken meals or salad. It also compares the 
additional risks from antimicrobial resistance associated with three different sources of 
chicken (PIC, POC and BIC group). 
Estimation of exposure to Campy/abacter was carried out using the results from Chapter 5 
(the numbers and prevalence of Campy/abacter isolated from three groups of chickens) and 
Chapter 6 (levels of antimicrobial resistance to three antimicrobials, ciprofloxacin, 
erythromycin and nalidixic acid). Secondary data and relevant information obtained from the 
literature were also selected and then incorporated with the primary data to estimate the 
doses. 
The exposure to Campy/abaeter was calculated using two different criteria based on: 1) all 
Campy/abacter including antimicrobial susceptible and antimicrobial resistant isolates and 2) 
antimicrobial resistant Campy/abaeter isolates. 
The work in this chapter is in three parts (Figure?1). The first part (part A) describes the 
complete risk exposure model for Campy/abacter from production (farm level) to 
consumption (consumer level). Although this study focuses on exposure to Campy/abaeter 
at the consumer level, it is necessary to consider the whole process from farm to 
consumption. This shows how consumers can be exposed to Campy/abacter through the 
food chain. This helps when considering risk management options (see Chapter 9). It also 
presents what, and how, many data input required for the calculations from farm to 
consumption. This is an explanation of why this study considered the exposure dose at the 
consumer end only. The selected models are also described and presented. The second 
part (part B) identifies the origins of the data input to the selected models at a consumer 
level. The results from part B are presented and discussed in part C. The limitations arising 
from the exposure assessment modelling are also described. 
A fully quantitative microbial risk assessment (QMRA) model involves a high level of 
complexity of data, which is almost impossible without considerably more data than is 
currently available. The main deficiencies are the availability of data related to the farm-to-
table pathway of the pathogen. The approache used in this chapter is to estimate exposure 
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to Campy/abaete, fallawing the consumption of chicken. This provides an assessment of the 
comparative doses resulting from the consumption of chicken raised by different rearing 
practices from the consumer perspective. 
The calculations of exposure following the consumption of chicken harbouring 
Campy/abacte, are carried out as a comparative estimation between three groups of chicken. 
The exact numeric result(s) is/are not as important as the relative effects on management 
options. 
The modelling approaches take into account the growth and inactivation of Campy/abaete, 
following cross-contamination, heat treatment and refrigeratian in private kitchens. Human 
exposure to Campy/abaete, from chicken meals and salad is also considered in relation to 
age and gender. The age and gender of consumers are taken into account into the models 
to introduce variable hygiene levels during food preparation and variable sizes of meals. 
Finally, the outputs of the exposure assessment are used for the estimation of health risk 
(see Chapter8).These approaches are: 
Modelling approach 1 covers the transfer of Campy/abaete, (with and without antimicrabial 
resistance) from a positive chicken to salad during food handling in private kitchens, 
including the effect of refrigeration. 
Modelling approach 2 addresses the changes in prevalence and numbers of 
Campy/abacte, (with and without antimicrobial resistance) in chicken carcasses throughout 
the cooking steps, including the effect of refrigeration. 
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Part A Model description 
~ 
Risk model description 
I 
-¥ -¥ -¥ 
Farm level Slaughterhouse level Consumer level 
I 
-¥ ~ All Campylobacter ABR-CampyJobacter 
I 
-1 -1 ~ 1-
Heat treatment Cross-contamination CVM model Modified QMRA model 
------------------------------ ------------------------------------------------
~ ~ 
Part B Data input: 
Modified QMRA model Consumer level 
I 
-¥ -¥ 
All Campylobacter ABR-Campy/obacter ~ 
Storage approach I 
~ ~ I 
,If 
Delayed preparation Immediate preparation 
I I 
~ ~ 
Modelling: Insufficient Modelling: Contact 
Heat treatment (chicken transfer (salad) 
.. 
---------------------------------~------------------------------------------------------
Part C: Results and Discussion 
Figure 7.1 A conceptual framework of Chapter 7 
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PART A: The exposure model description 
7.1 Introduction 
Illness resulting from Campylobacter infection is affected by a complex multi-factorial 
process associated with bacterial virulence, types of foods, size of meal consumed and the 
individual's immune system (Anderson et al., 2001). The magnitude of infection and the 
degree of illness are affected by dose of viable Campylobacter ingested, the dose-response 
relationship, and related factors, i.e., size of meal, age, gender, and consumption pattern 
(Teunis et al., 1996 and Hass et al., 1999). 
Exposure assessment involves the systematic modelling of the transmission of 
Campylobacter through the food chain from production to consumption. These models relate 
to the growth and inactivation, which are performed as a function of probability given 
prevalence, numbers of Campylobacter and the amount of chicken consumed along the 
consecutive processes of food pathways, taking into account both variability and uncertainty 
(Nauta et al., 2000, WHO, 2001 and Nauta et al., 2005a). By the end of the modelling, the 
outcomes show the estimate of the amount of viable campylobacter ingested and surviving 
the immune system of humans and the likely consequences for human health (Nauta, 2000; 
Christensen et al., 2001; WHO, 2001 and Nauta et al., 2005b). 
The predictive growth and inactivation model 
Food products actually show a low viable pathogenic contamination level. However, it has 
been found that the microbial dynamics at low numbers are important. This is because the 
viability of an individual cell has a much more pronounced effect on the probability of 
infection. The consumption of foods harbouring low numbers of organisms can be likely to 
cause illness if these organisms are in good condition or can be resuscitated (Kozak et aI, 
1996; Uyttendaele et aI, 1999; R0rvik, 2000 and 8tandaert et aI, 2005). 
An estimate of microbial risk to human health following the consumption of foods involves 
the prevalence and the numbers of organisms in foods. The changes in both microbial 
prevalence and numbers may occur throughout the food chain. Hence, the risk model for the 
exposure assessment has been developed based on these dynamic changes of micro-
organism from production to consumption, involving growth and inactivation following the 
change in temperature and time. 
Predictive growth models have been developed since the 1980s. They are based on the 
relationship between bacterial growth and the change in the number of micro-organisms 
over time. This is influenced by a set of intrinsic and extrinsic parameters (or conditions), 
governing growth, survival and control of desirable and undesirable micro-organisms in food 
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systems. Three degrees of modelling: primary, secondary and tertiary are available. Whilst 
the primary models describe the growth and inactivation in the simplest way, using first order 
kinetics, the secondary and tertiary models attempt to account for all relevant parameters as 
well as to integrate data for all aspects in response to environmental factors influencing the 
micro-organism. Van Gerwan and Zwietering (1998) summarised and proposed some 
possible functions for use in predictive modelling. These are presented in Table 7.1. 
Table 7.1 Models described the growth curve of microbial cells under stationary conditions 
(taken from van Gerwan and ZWietering, 1998) 
Growth curve 
Exponential1 
Lag-exponential2 
Logistic3 
Reparameterised 
Gompertz4 
Baranyi5 
Equation 
In(no ) = In(no) + f.1t 
In(no) = In(no), t<A 
In(no) = In(no) + f.1(t - X), t?A 
a In(no) = In(no)+-----[I + exp(b - ex)] 
f.1 x exp(l) , In(no) = In(no) + A exp {- exp[ max (), - t) + 1]} 
A 
eXP(f.1max All (t) -1 
In(no) = In(no) + f.1 max All (t) -In[1 + ( 4.) ] 
exp. 
In(n) = In(no -In(2){ exp[ I~d] - exp[-(t;d)] - exp[ -;1 + exp[~]} 
+ In(2)a(l- (l + * + +.(*)2 + t.(t)3 )exp(~)) 
Probabilitl p p(t) = max 
(1 + exp[k(B - t)]) 
lno is the initial number of organisms, Il is specific growth rate, t is time 
2 A is the lag time 
3a,b and c are fit parameters for logistic equation 
41lmax is the maximum specific growth rate W\ A is the maximum level of increase: In (n,/no). 
4,5 An as defined by Barayi, et al. (1994) 
6d is a fit parameter 
7 P(t) , probability of growth at time t; Pmax , maximum probability; k, rate constant; B time to the 
midpoint of the function 
7.2 Exposure modelling 
Estimation of exposure to Campylobacter through the consumption of chicken involves 
complex and inter-related processes, describing the probability and likelihood of the 
129 
exposure from the initial to the final stage in selected food pathways. Given this complexity, 
it is necessary to separate the overall chain into a number of distinct parts, each 
representing a specific stage in the production to consumption line (WHO, 2001). 
The joint FAOIWHO working group (WHO, 2001, Christensen et al. (2001) and Nauta et al. 
(2005a) described the main stages of exposure modelling which include primary production 
(on farm), processing at slaughterhouses, retail outlets and food handling and preparation in 
the household with likely transport and storage between various stages. Figure 7.2 illustrates 
the most likely pathway by which Campylobacter may be transmitted to humans through the 
consumption of chicken. Three levels of risk model for Campylobacter have currently been 
developed due to availability of data which are i) a farm model, ii) a slaughterhouse model 
and iii) a consumer model. 
Farm 
................................. 
Import 
••••••••••••• _ ................ 1 
Slaughterhouse 
~ 
H •••• 
(Processing, partitioning, -.. Export 
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Figure 7.2 An overview of a pathway of chicken products from production to 
consumers (Christensen et al., 2001) 
7.2.1 A farm model 
Risk modelling at the farm level aims to estimate the rate of colonisation, transmission and 
contamination within and between flocks and prevalence of Campylobacter (WHO, 2001 and 
Katsma et aI., 2005). It also aims to quantify the levels of Campylobacter likely to be present 
in the gut of a colonised chicken before entering the slaughterhouse and processing. 
130 
The estimation of exposure to Campylobacter on the farm involves the colonisation in the 
gut and the contamination of the exterior of the birds. Thus, the modelling approach 
considers the probability of a flock being colonised with Campylobacter and contamination 
on farm and during transport. 
The probability of flocks being positive for Campylobacter (Ppb) was described by a joint 
FAOIWHO working group (WHO, 2001) as a function of the flock prevalence and the within-
flock prevalence. This function is expressed by equation 7-1. 
[7 -1] 
Where; 
Pfp is the flock prevalence, which is the proportion of the national flock that is positive. A positive flock 
is defined as a flock that shows at one bird colonised with Campylobacter. 
Pwfp is the within-flock prevalence of a positive flock at the time of slaughter, which is directly related to 
the rate of transmission and is therefore a time dependent event for a positive flock. The transmission 
of Campylobacter within a flock was rapid. A number of studies demonstrated that once one chick in a 
flock is infected with Campylobacter, the whole flock becomes positive within 4-7 days (Shanker et al., 
1990; Shreeve et al., 2000 and Jacobs-Reitsma et al., 2001). 
The estimate for Pwfp is P () = l(t) wfp t 
N 
Where; 
I(t) is the number of colonised birds within a flock at time t 
t is the time since the introduction of the infection 
N is total numbers of bird within a flock (a flock size). 
[7-2] 
Katsma et al. (2005) described and proposed the additional model for the transmission of 
Campylobacter within a flock, I(t) , by fitting to a logistic9 growth curve for population (see 
Table 7.1). The addition model is shown in equation 7-3 
let) _ __ K_N_I--..::.o __ 
10 + (KN - lo)e-rt 
Where, 
N is the flock size 
K is the carrying capacity (the upper limit of population growth) 
I is the number of colonised chickens in the population, 
r is the growth rate of the colonised chicken in the population (in the absence of 
intra-specific competition) 
t represents the time since the introduction of the infection. 
[7-3] 
The calculation of contamination on the farm and during transport is based on: i) 
Campylobacter status of the flock, ii) faeces shedding from chickens, iii) transmission time 
9 A logistic model assumes that a population N (t) of individuals, cells or inanimate objects grows of 
diffuses at an exponential rate a until the approach of a limit or capacity K slows the growth. 
131 
since the introduction of the infection, iv) number of newly colonised birds and v) the 
distance between negative and positive groups in the transport vehicle (WHO, 2001). 
7.2.2 Slaughterhouse model 
The poultry processing at a slaughterhouse is a dynamic process consisting of a series of 
stages, which starts with slaughter and moves through processing to the transport of the 
final sale product. The different technological stages of slaughter processes may decrease 
or increase contamination (Nauta et a/., 2005a). During slaughter and processing, it is 
expected that Campylobacter from positive chickens could be transmitted to the exterior of 
other carcass or the environment. 
In order to calculate the level of cross-contamination of Campylobacter between chicken 
products, it is necessary to understand each stage of processing and the relative 
consequences of one stage to others. A number of models consider the probability that a 
random chicken product will be contaminated with these micro-organisms and the likely 
number of Campylobacter in contaminated products. In addition, the models also assess the 
stages of processing most likely to impact on the levels of contamination (WHO, 2001; 
Christensen et a/., 2001 and Nauta et a/., 2005b). 
Stages of chicken processing in the slaughterhouse 
In general, the processing of chicken consists of seven or eight main stages as illustrated in 
Figure 7.3. These are: 
Hanging area- shackling, killing, bleeding 
On entry, birds are removed from crates, hung upside down, stunned and bled for up to two 
minutes. Although birds are hung in close proximity and come in to contact with each other 
and the machines, the effect of this stage on cross-contamination is assumed to be 
negligible. 
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Figure 7.3 The main stages of poultry processing at a slaughterhouse (adapted 
from WHO, 2001) 
Scalding 
After slaughter, birds are immersed in a scald tank. This loosens the feathers and facilitates 
plucking. At this point, birds may involuntarily defecate, leading to accumulation of faecal 
matter in the tank. If the birds are colonised with organisms, this results in contamination of 
the scald water and may lead to further contamination to the exterior of the carcasses. 
De-feathering 
This process is a mechanical process comprising a series of machines that are the major 
sites of potential cross contamination. Oosterom et al. (1983) and Izat et al. (1988) showed 
that de-feathering increases the prevalence of contaminated carcasses. 
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Evisceration 
Following the removal of head and feet, chickens are eviscerated, removing the internal 
organs. In this process the birds are either mechanically or manually eviscerated and the 
intestines usually remain intact. If the intestines are damaged, this may lead to a risk of 
gross contamination. However, Oosterom et al.(1983) and Izat et al.(1988) demonstrated 
that even if the viscera remain intact, the levels of enteric bacteria on the exterior of the 
carcass can still increase. 
Washing 
In compliance with EU regulation, following the evisceration, the carcass is washed internally 
and externally. Even though the inside-outside wash is capable of removing visible faecal 
contamination, it does not eliminate bacteria attached to the surface. However, attachment is 
a time-dependent process. Washing the carcass at different stages may loosen the 
attachment. Cudjoe et al.(1991) showed that the washing procedure typically reduced the 
numbers of Campylobacter on a carcass by approximately 90%. 
Chilling 
Within the EU, the chilling processes used to maintain the temperature at 4°C or less may 
involve air-chillers, water chillers and spray chillers (cryogenic nitrogen chillers). Technically, 
the choice of chilling procedures is based on whether the carcass is intended to be a fresh 
or frozen product. For example, air-chillers are generally used for a carcass sold as a fresh 
product. The methods of applying water are used for frozen products. Laisney et al.(1991) 
reported that water chilling reduces the levels of contamination of Campylobacter on 
carcasses since they move through a counter-flow current. In addition, addition of chlorine to 
chill water prevents the cross-contamination of organisms washed off into the water. 
Nonetheless, air chilling does not change the levels of Campylobacter due to its ability to 
survive under these conditions (Cudjoe et aI., 1991). Spray chillers cause less cross-
contamination 
Portioning 
Currently the preferred method for the jointing of the carcass is by mechanical or semi-
mechanical methods. These methods allow the fast line speeds and higher throughout 
required by the industry. The contact between carcasses and a machine or operator's hands 
increases, resulting in higher rates of cross-contamination. This results from the re-
distribution of the contamination of the processed load or carries over contamination from 
the previous day. Gill (1999) showed that the automatic portioning equipment is likely to be a 
potential source of contamination. 
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Grading and packaging 
Grading and packaging is governed by the scald and chill procedure. Water chilled 
carcasses are packed in polythene bags with or without giblets. Air chilled products are 
usually packed without giblets on polystyrene trays and wrapped in cling film. Since there is 
no further information to affirm whether there is potential for cross-contamination at this 
stage, it is assumed that no cross-contamination occurs on the carcasses (WHO, 2001). 
Model description 
A risk model describing the poultry processing has been formulated by the joint working 
group of FAO/WHO (WHO, 2001). The model considers the stages of processing which may 
impact upon the level of Campy/obaeter contaminating a carcass. However, recently Nauta 
et a/.(2005b) also developed and simplified the model of poultry processing for the 
Campy/obaeter Risk Management and Assessment (CARMA) project. This model considers 
growth or inactivation and removal as factors changing the level and prevalence of 
Campy/obaeter. As temperatures in the processing plant should never reach the minimum 
growth temperature for these micro-organisms, it is assumed that Campy/obaeter will not 
grow in this environment. Thus, the model considers only inactivation and removal of 
Campy/obaeter during the consecutive processing stages. This modelling process involves a 
number of different factors affecting individual stages at each point of time. Nauta et 
a/.(2005a) generated a slaughterhouse model (Figure 7.4) as a stochastic process and 
developed a scenario of a model based on the principle of an input-output model (West, 
1986). The principle of the model is that the input of stage "S" is the product (output) from 
the previous stage (stage "S-1 "). 
Environment 
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......•......•........•...... j . 
y 
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inactivati on 
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Stage 5 
Figure 7.4 Diagram of the basic poultry processing model (adopted from Nauta et a/.,2005a) 
(Definition of parameters is given in Tables 7.2 and 7.3) 
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Table 7.2 Model parameters of model equations per stage $ and carcass i (adopted from 
Nauta et al,2005a) 
Parameter Description 
aext,S probability per cfu Campy/obaeter on the exterior (skin and feathers) to move from the 
carcasses exterior to the environment. 
benv,S probability per cfu Campy/obaeter in the environment to move from the environment to 
the carcass exterior. 
afec,S probability per cfu Campy/obaeter in the leaking faeces to move to the environment, 
corresponding probability 1- afec,S per cfu to move from the interior to the exterior of the 
carcass directly). 
eenv,S probability of inactivation or removal per cfu Campy/obaeter in the environment, which is 
not transferred to the carcass exterior. 
eext,S probability of inactivation or removal per cfu Campy/obaeter on the carcass exterior, 
which is not transferred to the environment. 
Pfec,S probability of faecal leakage per carcass. 
Panim fraction of the animals in a positive colonised flock. 
Table 7.3 Model variables of model equations per stage $ and carcass i (after Nauta et 
al,2005a) 
Parameter Description 
mS(i) amount of faeces (g) that leaks from carcass i, given faecal leakage; sampled from a 
lognormal distribution with mean j.lm,S and standard deviation am,S. 
Wfec,s(i) 
Cfec,{i) 
Nfec,s(i) 
Next,s(i) 
amount of faeces (g) that leaks from carcass i: with probability Pfec,S Wfec,s(i)=Q, where 
Wfec,s(i) = ms(i) 
Campy/obaeter concentration in the faeces of carcass i, identical per carcass i for all 
stages (cfu/g faeces), taken the value from a lognormal distribution (1 Q"Normal (j.lc.ac) 
numbers of Campy/obaeter in the leakage from carcass i. 
Nfec,s(i) = wfec,s(i) X Cfedi)· 
numbers of Campy/obaeter on the exterior after processing of carcass i. 
Next,input(i) is model input, taken from a lognormal distribution (1 Q"Normal (j.lN,ON) 
Nenv,S numbers of Campy/obaeter in the environment after processing of carcass i. 
The model considers inactivation and removal of Campy/obacter at each stage, given a 
carcass, i, entering the process stage 5. A carcass is contaminated with Next.s-1(i) colony-
forming units (cfu) of Campy/obacter on the exterior. If 5 is the de-feathering stage, the 
previous stage $-1 refers to the product after scalding, etc. At stage 5, Nfec,s(i) (cfu) obtained 
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from the numbers of Campylobacter in faeces dripping out from carcass i, thus, N'ee is the 
product of amount of faeces (Wfec,s(i)) and Campylobacter concentration in faeces (Credi)). 
In this system, Campylobacter from the exterior or faeces occasionally contaminates the 
environment, i.e. faeces or fluid leak from the positive carcass and remains on a machine or 
worker's hands. This contamination may be transferred back to other carcasses through the 
water, equipment, hands, etc. At this stage, the numbers of Campylobacter in the 
environment {(Nenv, s(i)) can be counted. Given the condition at each stage, the model 
equations per stage S and carcass i are; 
Next,S (i) = (1- aex/,s )(1- cext,S )Next,S-1 (i) + benv,SNenv,S (i -1) + (1- a fee.s)N fee,S (i) [7 -4] 
N(!/lI',s (i) = aex/,SNex/,s (i) + (1- bem,.S )(1- Cenv,S )N(!/lI',s (i -1) + a fec,SN fee,S (i) [7 -5] 
Model input 
Nauta et al.(2005a) described and analysed the model equations 7-4 and 7-5 further. It is 
assumed that at any stage S the number of Campylobacter added and removed per passing 
carcass is the same, thus resulting in !1Nenv,s = O. Although this equilibrium state is not 
possible, it is evident that this situation is likely to be approached after the passage of a few 
carcasses. Therefore, the value of !1Nenv,s is equal to zero if; 
a ex;Nex~S-1 + a fell fee 
bell v +Cenv -bell.fenv 
[7-6] 
Where, Nfee is a product of Wfee and C'ee' If log(Next.s-1) and log (C'ee) is a normal distribution 
with means J-lN and J-lc and variances a 2N and a2c , respectively, the expected value of 
E(Nenv,s) is given by; 
aextE(N ext,S-J) + a fec E ( w fee )E( C fee) 
E(Nenv,S) = b 
b env + C env - envC env 
[7-7] 
()2C 
/I + In(! 0) /l c + In(1 0) 2 Gext lOrN + G jecPjecJ-lmPanim lOr 
E(NenvS)=-=~------------~--~------------------
, benv + Cenv - ben\,cenv 
[7-8] Then, 
In addition, the expected of value E(Next,s) can be determined from equations 7-4 to 7-8 as 
follows: 
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E(Nexl,s) 
= (1- aext )(1- Cex1 )£(Nexl,S-I) + b"I1IE (Nenv,s) + (1- a fee )(£( H'fee )£( C fee) 
a
2
N a 2e 
= (1- a )(1 - C )10,11\ +In(10)-2 b £(N ) (1 )P P 10,11 +In(10)2 
ext eXI + env env,S + - a fee feef-l m anim C 
[7-9] 
Based on an input-output model, the numbers of Campylobacter in carcass i at the end of 
each stage S is the output which will be the input to the next consecutive stage, Applying the 
equations 7-8 and 7-9 the expected numbers of Campylobacter in carcass i at each stage S 
can be calculated consecutively (Figure 7.5). 
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1 
No 
if 
Scalding ....... Next 
input of stage 5 
Next, scalding 
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De-feathering ....... Next, 
Next,defeathering 
Evisceration ....... Next, 
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, 
Washing ..... .. Next, 
Next, washingg 
Chilling ..... .. N ext 
Figure 7.5 Algorithm of input-output process used for poultry slaughter and processing 
(based on the model presented by Nauta et a/., 2005a). 
7.2.3 Modelling consumer exposure to Campy/obaeter 
Two criteria considered for health risk related to Campylobacter following the consumption of 
three groups of chickens in this study are: 1) health risk related to all Campylobacter (with 
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and without antimicrobial resistant isolates) and 2) health risk related to antimicrobial 
resistant Campylobaeter only. Therefore, exposure assessment was independently 
performed, firstly for all Campylobaeter and secondly for antimicrobial resistant 
Campylobaeter. 
Exposure assessment for all Campylobaeter is first presented in this section. From this point 
the word "Campylobaeter' means all Campylobaeter including susceptible and resistant 
isolates. Antimicrobial resistant Campylobaeter (ABR- Campylobaeter) refers to the isolates 
found to be resistant to three antimicrobial agents (ciprofloxacin, erythromycin and nalidixic 
acid). 
Campylobaeter is the most common pathogen found in raw fresh chickens brought into the 
home. During meal preparation, these micro-organisms are obviously transferred to hands, 
utensils, preparation surfaces or other food items (Christensen et al., 2001). Thus, 
individuals can be exposed to Campylobaeter from fresh chicken through these pathways. 
These include direct contamination from the chicken to any food stuffs or indirect 
contamination of preparation surfaces through hands and subsequent ingestion. The 
exposure level is therefore associated with the detail of the events during preparation. 
The FAOIWHO risk assessment model assumes that liquid from fresh carcasses containing 
micro-organisms (included Campylobaeter) may drip onto the hands, surfaces, utensils or 
cutting boards. These events would facilitate the organisms' movement throughout the 
whole pathway from preparation to consumption. 
It is possible that the levels of hygiene practice by a person handling foods may have the 
greatest effect on the level of Campylobaeter in any private kitchen. In England and Wales, it 
was estimated that 35% of outbreaks of foodborne illnesses were related to cooking with 
insufficient heat treatment and 28% were related to cross-contamination during preparation 
(Ryan et aI, 1996). Other reports from the USA and Sweden showed similar results 
(Worsford and Griffith, 1997 and Zhao et aI, 1998 ). 
This study estimates the exposure to Campylobaeter following the consumption of three 
groups of chickens using the combination of risk models developed by a jOint FAOIWHO 
committee (WHO, 2001; Christensen et al., 2001 and Nauta et al., 2005b). The risk models 
of how consumers handle and prepare meals in private kitchens were developed according 
two scenarios. These are: 
~ insufficient heat treatment of the chicken resulting in the survival of Campylobaeter 
~ cross contamination of Campylobaeter due to improper handling procedures (personal 
hygiene). 
The pathways of these two scenarios following the blue blocks are demonstrated in Figure 
7.6. 
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Figure 7.6 A stochastic pathway of a consumer model of risk assessment (developed by 
Soonthornchaikul , 2005 .) 
Scenario 1: Insufficient heat treatment 
Campy/obaeter, in general , is sens itive to the effect of thermal process ing . The joint 
FAOIWHO meeting group (WHO , 2001) developed a model of heat treatment specifica lly fo r 
Campy/obaeter. It is evident that Campy/obaeter tends to rema in attached to the su rface of 
carcasses . Sustained high surface tem peratures (> 70DC) w il l generate enough heat to 
eliminate the organ ism. However, under some condit ions some Campy/obaeter may survive 
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l 
l 
to cause infection. Given insufficient intensity of heat treatment, the estimation of the 
exposure dose is based on the survival rate of Campylobacter. 
Due to the scarcity of data, the modelling of insufficient heat treatment is performed using an 
exponential growth model (see Table 7.1, section 7.1). The model provides a mechanistic 
explanation based on whole cell inactivation kinetics (including cell injury) associated with 
cooking. Also described are the alternative explanations of the means by which 
Campylobacter in the thermally protected areas (such as cracks, air pockets or deep within 
the carcass mass) might survive an otherwise thorough heat treatment. 
The joint of FAOIWHO working group proposes three approaches to the modelling of heat 
treatment, which depend on the assumptions described below (WHO, 2001). These 
approaches are: 1) Internal temperature approach, 2) Protected area approach and 3) The 
heat transfer approach. 
1) Internal temperature approach 
The assumption of this approach is that a representative point in the chicken mass (e.g. a 
drumstick portion) can be expected to receive the mildest heat treatment. The selection 
of this point is partially based on the existence of a cooking temperature survey which 
measured the internal temperature of heat treatment in chicken portions (e.g.drumsticks). 
The reduction in cell numbers at this point is therefore calculated by using a step-wise time-
temperature profile and applying a primary kinetic function at each time-step, (Van Gerwen 
and Zwietering, 1998; and van Gerwen et al., 2000). This also includes the possibility of an 
increase in cell numbers in the period where the chicken is being heated through the range 
of temperatures. The variability of consumer practices is taken into account in this approach 
by varying the stopping point of the final temperature of cooking in the simulated time-
temperature profile. The variation in the stopping point is based on survey data measuring 
the final temperature (Doyle & Roman, 1981 and Gill & Harris 1982). 
2) Protected area approach 
This approach makes four assumptions: i) that only a fraction of the carcasses will 
experience some type of undercooking; ii) that the only cells which have any possibility of 
survival are within an area which is relatively protected (or insulated) from the heat of the 
oven; iii) that some fraction of the cells will be located in the protected areas and iv) that a 
reduction is calculated based on the internal temperature at this protected area and the time 
for which this maximum temperature is applied. 
141 
3) Heat transfer treatment 
This approach is for calculating the internal time-temperature profile at a number of different 
depths in the meat of the carcass. This requires transient heat transfer models and 
parameters of thermal properties applied on the chickens which are generally available in 
food engineering texts. The approach is based on; i) the proportion of bacterial load found at 
the surface and at various depths into the carcass, ii) a simplified characterisation of the 
roasting of a carcass regarding specific heat transfer assumptions and iii) the oven 
temperature and the time at which the chicken is removed from the oven. Therefore, the 
reduction in cell numbers can be characterised at each depth into the chicken meat by 
considering the reduction in each simulated time-step. 
Scenario 2: Cross-contamination 
Recently, several studies investigated the pathways of cross-contamination of bacteria 
during food preparation in either a private kitchen or other catering establishments 
(Worsefold and Griffith, 1997). These noted that either personal hygiene practices or unsafe 
food handling in a private kitchen is associated with a large number of factors. Thus, 
estimating the risk of infection through cross-contamination requires extensive data. Since, 
to date, the availability of essential data is limited, risk assessment of cross-contamination 
involves a large degree of uncertainty. 
To assess the potential of cross-contamination in spreading organisms during meal 
preparation, the prevalence and numbers of Campylobacter transferred to meals during 
preparation should be taken into account. This study focuses on cross-contamination by 
hands and contacted surfaces and cutting boards, due to data availability. 
1) Cross contamination as a result of hygiene practices by a food preparer (by 
hands) 
Several studies have investigated consumers' habits regarding hand washing. Washing 
hands after handling raw food animals is thought to be a crucial factor in minimising cross-
contamination. Brown et al. (1988) found that washing hands could totally eliminate 
Campylobacter remaining on hands, whereas, handling raw chicken without hand washing 
results in other food items becaming contaminated with Campylobacter. This is supported by 
the study of De Boer and Hanne (1990) which investigated the contamination with 
Campylobacter during handling of Campylobacter-positive chickens. 73% of trials showed 
positive findings for detection of Campylobacter on hands. After 3 minutes Campylobacter 
spp. could still be detected in 55% of trials. In addition, Coates et al. (1987) showed that 
Campylobacter from the liquid of raw meat stained on fingers could survive up to an hour. It 
also supported the assertion that hand washing (with water or water with soap) combined 
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with drying can effectively eliminate Campylobacter. However, washing without drying 
cannot remove the organisms from fingers. 
Christensen et al.(2005) indicated that hygiene levels during food preparation vary 
significantly with age and gender of food preparers. There may be an association between 
the hygiene practices of food preparers and likelihood of Campylobacter infection within 
different age and gender groups. The results of most studies related to unsafe food handling 
are summarised in Tables 7.4 
Table 7.4 Consumer behaviours related to hand-washing after handling raw meat and 
poultry (adopted from the WHO, 2001). 
Statement & Observation 
Respondent 
agreeing with the 
statement (%) 
Washing hands not performed 34 
after handling 55.8 
Washing hands not important 
in relation food hygiene 
Personal hygiene not 
important for prevention of 
foodborne disease 
Drying of hands performed 
after hand wash 
36 
58 
18.4 
62 
70 
2) Cross contamination by contacted surfaces 
Reference 
Altekruse et al., 1999 (USA) 
Jay et al., 1999 (Australia) 
Worsford & Griffith, 1997 (UK) 
Jay et al., 1999 (Australia) 
Christensen et al., 2005 
Christensen et al., 2005 
The information from the outcomes of interviews and observations showed the likelihood of 
cross-contamination during food preparation in a private kitchen (Tables 7.5 and 7.6). 
Christensen et al.(2001) reported that the prevalence of Campylobacter spp. on cutting 
boards was 50%. It was found on 9% of vegetable samples handled on a cutting board 
previously used for a raw chicken. Although a chicken was already cooked (heat treatment), 
Campylobacter was detected on the cooked chicken handled on a cutting board previously 
used for a raw chicken (De Boer and Hahne, 1990). Martin et al.(1999) stated that it is 
possible to isolate Campylobacter spp from contaminated domestic kitchen surfaces 50 
minutes after the area was observably dry. Furthermore, Campylobacter spp were isolated 
from the outer layer of packaging of chicken and offal products sold at retail points (Bolton et 
al., 1999b and Burgess et al. ,2005). 
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Table 7.5 Food handling procedures related to age and gender (adopted from WHO, 2001). 
Statement & Observation 
Washing hands not performed 
after handling raw meat and 
poultry 
Cutting board not changed or 
washed after handling raw 
meat and poultry 
Cutting board not sufficiently 
washed 
Utensil not sufficiently washed 
Clean utensils and change of 
cutting boards are not 
important issues in preventing 
food borne disease 
Sufficient heat treatment not 
recognised as a preventive 
option to food borne disease 
Respondent 
agreeing with the 
statement (%) 
Male Female 
47 25 
47 28 
51 46 
51 57 
Related to age 
group (%) 
18-29: 42 
30-64: 32 
>65:29 
18-29:47 
30-64: 29 
>65:24 
17-35:45 
36-45: 38 
>46: 33 
17-35: 32 
36-45: 28 
>46:27 
<24:63 
25-34: 47 
35-54: 41 
<24: 55 
25-34: 52 
35-54: 50 
Reference 
Altekruse et al., 1995 
Altekruse et al., 1995 
Jay et al., 1999 
Jay et al., 1999 
Christensen et al., 2001 
Christensen et al., 2001 
Table 7.6 Consumer behaviours related to cross-contamination by contacted surfaces 
(adopted from WHO, 2001). 
Statement & Observation 
Knives and cutting boards not 
cleaned in warm water + soap after 
handling raw meat and poultry and 
before cutting vegetables and 
salads 
Cutting board not washed after 
handling raw meat and poultry 
The kitchen facilities not sufficiently 
cleaned to avoid cross-
contamination 
Food items handled on not 
sufficiently cleaned cutting boards 
Meat and poultry packaging 
materials stored in the food 
handling area 
Food items handled in a way that 
could lead to cross-contamination 
Respondents agreeing 
with the statement (%) 
46 
33 
19.5 
11.6 
25 
18 
76 
Reference 
Williamson et al., 1992 
(USA) 
Altekruse et al., 1995 (USA) 
Jay et al., 1999 (Australia) 
Worsford & Griffith, 1997 
(UK) 
Worsford & Griffith, 1997 
(UK) 
Daniels, 1998 (USA & 
Canada) 
7.2.4 The development of consumer model as applied to be used 
in this study for Campy/obaeter 
Based on "insufficient heat treatment approach" (WHO, 2001 and Christensen et a/., 2001) 
and "cross-contamination approach (Nauta et a/., 2005) (sections 7.2.3), the models of heat 
treatment and cross-contamination were selected for use in the estimation of the number of 
Campylobacter on a carcass which may be transferred to person consuming that meal. 
Additionally, the effect of refrigeration (storage) on the number of Campylobacter was also 
considered for delayed preparation. 
1) Modelling heat treatment 
The modelling was developed using those three options of insufficient heat treatment 
(section 7.2.3) to estimate numbers of Campylobacter in a chicken after thermal processing. 
As stated previously, under heat treatment, the number of Campylobacter may increase 
through growth, or decrease by inactivation. Modelling is then carried out by using a 
predictive growth model associated with temperature and time during cooking. The 
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exponential models selected for the representation of both growth and inactivation are as 
follows: 
Table 51. r Given a population of bacteria where growth is unrestricted, the rate of 
increase in the population is proportional to the size of the population itself, 
dN 
- = j.iN 
dt 
Where N = number of bacteria, t= time, ~= growth rate at which the population changes over 
time, t 
In N = In No + ut ,when Tstop <Te [7 -10] 
2) The reduction of bacteria at given time and temperature follows first order kinetics 
(described by the The Arrhenius equation 10), and therefore is; 
Thus; 
Where: 
N loglo (-) = -kt 
No 
log N = log No - kt , where k = 2.303/D 
t In N = In No - (-), when Tstop >Te 
D 
No is the population size at the beginning (to), prior to heat treatment for time t 
f.1 is the specific growth rate constant 
[7 -11] 
o is the D-value which is the time required for a 1 log reduction 11 in the size of the bacterial 
population at a given temperature. 
Tstop is the internal temperature of cooking reaching the protected area 
t is a period of time that the protected area exposes to T stop 
Te is the temperature above which growth of Campylobacter does not occur and a number of 
organisms begin declining, assuming Te is 46°C (Doyle and Roman,1981). 
The value of J.1, D, Tstop and t 
The growth rate constant and the D-value can be determined as a function of temperature. 
The FAOIWHO report (WHO, 2001) quantifies the relationship between the value of ~ and D 
for Campy/obaeter with least squares regression models against temperature. The 
regression models are; 
10 The Arrhenius equation is a simple, but remarkably accurate. formula for the temperature 
dependence of a chemical reaction rate. 
11 Each log reduction is a reduction of 90%. So, a 1 log reduction is a 90% reduction, a 2 log reduction 
is 99%, and a 5 log reduction is 99.999%. 
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)l = 1.4943In(Tstop )-5.0885 
o = 1426eo.169r 
[7 -12] 
[7 -13] 
During cooking the protected areas were thought to be exposed to 60° to 65°C for a period 
of time (t) (WHO, 2001). The final temperature (Tstop) at the internal part of a chicken 
(thermally protected area) can be estimated by the mean value of the temperature between 
60°C and 65°C. This mean value of Tstop is estimated from the probability distribution. 
However, due to a scarcity of data, a triangular distribution was selected for calculating the 
mean value of Tstop. The triangular distribution is a function of the minimum, most likely and 
maximum values. These values are 60,64 and 65, respectively. The distribution equation is 
then calculated by; 
Tstop = RiskPERT (60,64,65) (using @Risk*, standard release 4.5 software) 
(*@ Risk is the risk analysis and simulation software produced by Palisade corporation.) 
Similarly, a period of time (t) over which the protected area is exposed to the final 
temperature was taken from the literature (Bryan and Doyle, 1995). The values ranged from 
0.5 to 1.5 minutes and the mean value is calculated by a triangular distribution. The 
equation is; 
t = RiskPERT (0.5,1.0,1.5) (using @Risk, standard v 4.5*) 
2) Modelling cross contamination: A contact transfer model 
Due to the scarcity of data, the estimation of health risk from cross contamination must take 
into account a large degree of uncertainty and variability associated with food handling 
procedures in private kitchens (WHO, 2001; Christensen et a/., 2001 and Nauta et a/., 
2005b). A contact transfer model assumes that some organisms are transferred from a raw 
chicken to preparation surfaces (cutting board, utensil, etc.) or hands. These organisms are 
then transferred from the preparation surfaces to prepared meals and may be directly 
ingested. The transfer of cross-contamination during food preparation is considered as a 
single event in which Campy/obaeter is transferred from the chicken to utensils or cutting 
board, hands or other preparation surfaces and then to prepared food (e.g. a cooked 
chicken, salad) (Figure 7.7). 
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Raw fresh 
chicken (fluid) 
Utensil 
Cutting 
board 
Other 
preparation 
surfaces 
Chicken 
meal/other 
foods 
Cooking 
Consumption 
Figure 7.7 The pathway of cross-contamination as a single event (adopted from WHO,2001) 
Zhao et al.(1998); a joint FAOIWHO working group (WHO, 2001) and Christensen (2001) 
developed mathematical functions describing the transfer of Campylobacter from a raw 
chicken to contacted surfaces. The function consists of: i) the fraction of cells transferred 
from chicken to preparation surfaces and hands (Fchicyrep); and ii) the fraction of cells from 
preparation surfaces and hands to meals (Fprepyrep). 
Ftransfer = Fchic---.prep • Fprep---'prep 
The transfer model is illustrated in Figure 7.8. 
Number of cells 
on chicken 
Total number of 
cells on preparation 
surfaces and hands 
[7 -14] 
Number of 
cells in meals 
Figure 7.8 Steps in the contact transfer model (adopted from WHO, 2001). 
Using the assumptions stated above, Nauta et al (2005b) developed a new model for 
contact transfer, which expresses the probability that each colony forming unit (cfu) of 
Campylobacter in chicken meat is transferred to hands, cutting board and eventually salad. 
The transfer coefficients convey the probability of Campylobacter that can survive during 
meal preparation, and contaminated salad, which is subsequently ingested. Given this 
assumption, the final number of Campylobacter transferred from chicken I to the salad is; 
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[7 -15] 
Where: 
Nsalad (i) = numbers of Campy/obaeter in salad which are transferred from chicken (i)-
tcH = a coefficient for the transfer of Campy/obaeter from chicken to hands. 
tHH = a coefficient for the transfer of Campy/obaeter from hands with or without washing 
tHS = a coefficient for the transfer of Campy/obaeterfrom hands to salad. 
tCB = a coefficient for the transfer of Campy/obaeter from chicken to cutting boards. 
tBB = a coefficient for the transfer of Campy/obaeter from cutting boards with/ without washing 
3) Modelling storage (Refrigeration) 
It is likely that a chicken purchased from a retail outlet may not be cooked immediately, 
being kept in somewhere between 1-7oC (Nauta et al., 2005b). The storage time may vary, 
especially due to the variability of consumer behaviour. The variety of time-temperature 
profiles encountered is presumably large and unknown. In addition, the survival dynamics of 
Campylobacter during storage are not well established. 
Nauta et al.(2005b) developed a modelling approach for the effect of storage on the number 
of Campylobacter. The model is based on the data of the Campylobacter Risk Management 
and Assessment (CARMA) project. By using Maximum Likelihood Estimation (MLE), the 
mean and variance of the numbers of Campylobacter in chicken products stored in plastic 
bags for a week at 4°C were estimated by using the LogNormal distribution. According to 
this, there is a decrease of the numbers between 0.1 and 1.9 logs, with a mean value of 0.9. 
Finally, the risk model applied to a primary inactivation model is; 
log Nstorage = log No - rstorage [7 -16] 
Where: 
Nstorage is the numbers of Campy/obaeter after storage 
rstorage is the variable of which is associated with the survival dynamics of Campy/obaeter during 
storage. This variable is incorporated with a BetaPert Distribution with the minimum, most 
likely and maximum values, that is; rstorage -BetaPert (0.1,0.9,2.1) 
LogNormal distribution is defined with reference to the normal distribution. A random variable X is 
lognormal if its natural logarithm, y= /og(x), is normal. 
Note: Nauta et al. (2005b) explained that the value of 0.1 and 0.9 are obtained from the MLE 
stated above. The maximum value is otherwise taken to be larger than that obtained from 
MLE regarding the small sample size. 
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7.2.5 The consumer model as applied to antimicrobial resistant 
Campylobacter 
Cox and Popken (2004) summarised two different approaches for risk assessment of 
antimicrobial resistant bacteria. 
1) The first method tracks the antimicrobial resistant microbial load from multi-sources 
, 
including chicken, through people. Finally, it estimates the number of patients infected and 
treatment failures, which will occur with and without a ban on antimicrobial use. This 
approach is close to the OMRA currently used for "farm-to-fork" modelling. It also requires 
extensive data to satisfy the model. 
2) The Second method takes the opposite starting point. It starts from patients infected with 
antimicrobial resistant bacteria and determines the maximum proportion of cases that could 
have been caused by antimicrobial use in chicken. This approach therefore requires data on 
cases, trends and genotypes of cases. This approach was developed by the FDA-Center for 
Veterinary Medicine (Bartholomew et al., 2005), which will be referred to the CVM model. 
Currently, only the second of these, the CVM model developed by the U.S. Food and Drug 
Administration Centre for Veterinary Medicine, was available to be used for estimation of the 
exposure to antimicrobial resistant Campylobacter (Bartholomew et al., 2005). However, the 
model does not possess all the features seen in a current quantitative microbial risk 
assessment (OMRA) for Campylobacter. The outcome of the CVM model, then, does not 
show the level of exposure. It expresses the proportion of illness related to antimicrobial 
resistant isolates. Therefore, in this study a new modified model was developed to quantify 
the exposure level. This modified model is based on the principles of exposure assessment 
of a OMRA (see section 7.2.3). Thus, there are two models used for antimicrobial resistant 
Campylobacter in this study. They are: i) the CVM-model and ii) a modified OMRA model 
(from this point "a modified model" refers to a modified OMRA model for antimicrobial 
resistant Campylobacter). 
The CVM model 
The U.S. Food and Drug Administration-Centre for Veterinary Medicine (FDA-CVM) 
developed a relative risk model to estimate the health impact of luoroquinolonese-resistant 
Campylobacter (Bartholomew et al., 2005). Due to some limitations in the model, 
Bartholomew et al.(2005) re-described and also extended the implication of the CVM risk 
model to a current OMRA model. The CVM model assumed that susceptible and resistant 
Campylobacter are equally likely to survive and to cause illness. Given this assumption, this 
model is based on a linear relationship between the weight (in pounds) of chicken consumed 
containing luoroquinolonese-resistant Campylobacter and the annual number of cases of 
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fluoroquinolonese-resistant campylobacteriosis in the U.S. The relationship is expressed in 
Figure 7.9. 
Amount of chicken harbouring 
fluoroquinolones resistant 
Campy/abaeter which is 
consumed 
Number (cases) offluoroquinolones 
resistant campylobacteriosis 
following consumption of chicken 
harbouring FQ-R Campy/abaeter 
(I-.;) 
Figure 7.9 The CVM risk model (adopted from Bartholomew et a/,2005). 
Herein, the model equation can be written as 
[7 -17] 
Where: 
VI is the exposure in year i which is estimated by the product between the annual weight of chicken 
consumed (pounds per capita), the population size, the proportion of carcasses contaminated with 
Campy/obaeter and the proportion of antimicrobial resistant Campy/obaeter (ABR-Campy/obaeter). 
A.I is the proportion of human campylobacteriosis with antimicrobial resistance associated with the 
consumption of chicken. 
Kres is the population-based dose-response parameter associated with Vi and A.i 
That is; A. K
res 
=_1 
~ 
[7 -18] 
Given the linear relationship between A and V (Bartholomew et al., 2005), the value of Kres is 
therefore a constant. 
As seen in the model equation, the model describes the risk related to a proportion of 
chicken harbouring antimicrobial-resistance which is consumed. It does not consider the 
numbers of all Campylobacter carried in the chickens consumed. This implies that the risk is 
associated only with the amount of raw chicken harbouring antimicrobial resistant 
Campylobacter which is consumed. The CVM model does not speculate on the exposure to 
antimicrobial-resistant Campylobacter (ABR-Campylobacter) following the consumption of 
cooked chicken. 
The modified QMRA model 
An estimation of the exposure to ABR-Campylobacter is determined using two scenarios of 
the current QMRA models for all Campylobacter (see section 7.2.3). However, the number 
of ABR-Campylobacter (NO,ABR) input to the models is obtained from the multiplication of the 
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initial numbers of Campy/obacter , No, (see section 5.4.3, Chapter 5) and the fraction of 
antimicrobial resistant isolates (see section 6.4.2, Chapter 6). It is assumed that the 
distribution of antimicrobial resistant Campy/obacter (ABR-Campy/obacter) in chicken is 
random and fits a Poisson distribution. Each ABR-Campy/obacter is independent and can 
survive the immune system and initiate the infection. 
First, given the resistance rate of isolates populated in a chicken carcass, the number of 
ABR- Campy/obacter in chickens is determined by; 
N O,ABR = No x PABR(i) [7 -19] 
Where: 
NO.ABR is the number of ABR-Campy/obaeter (MPN/g) 
No is the initial number of Campy/obaeter (MPN/g) 
PABR(i) is the rate of resistance to three antimicrobials of Campy/obaeter, where i names to 
ciprofloxacin or erythromycin or nalidixic acid. 
Next, the value NO,ABR is processed by the similar methods as described in section 7.2.4. 
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PART B: Data input for the consumer model 
Following the model development, estimations of the exposure to Campylobacter were 
considered for: 1) exposure to all Campy/obacter and 2) ABR- Campylobacter. 
1) The first section (7.3) is for all Campylobacter. The raw data of the MPN values of 
Campy/obacter (section 5.4.3) and other model parameters (secondary data) were inputted 
to three models dealing with heat treatment, cross-contamination and storage. 
2) The second section deals with antimicrobial resistant Campylobacter. The approach 
requires both the numbers of Campy/obacter and the rate of resistance to three antimicrobial 
agents (section 6.4.2). The data were input to the modified QMRA model. As the CVM is not 
for estimating exposure dose, data input for the CVM model and results are presented and 
discussed in Chapter 8 dealing with health risk characterisation. 
7.3 All Campylobacter isolates 
7.3.1 The number of in the chicken meal or salad at the time 
consumption 
In this section, the exposure to Campylobacter associated with the consumption of three 
groups of chickens was calculated following two scenarios. These are: 1) immediate 
preparation and 2) delayed preparation. Two modelling approaches (heat treatment and 
cross-contamination) were applied in each scenario. 
The three scenarios are illustrated in Figure 7.10 
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(Storage) 
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treatment (Nins ) 
Cross-contam ination (Utensi l, 
cutting board , hands) 
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co ntaminated meals 
.. 
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Campylobacter associated with 
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(explained in Chapter8) 
Infective dose I 
Figure 7.10 Scenarios and data inputted of a consumer modelling approaches 
(deve loped by Soo nthorncha ikul , 2005) 
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Scenario 1: Immediate preparation (heat treatment) 
1) Modelling approach: Insufficient heat treat meant 
1. It is assumed that the fresh whole Campylobacter-positive chicken purchased from the 
retail point is immediately prepared and cooked via heat treatment (e.g. roast, grill). During 
preparation the liquid containing these organisms touches and stains a cutting board, 
utensils and hands of a preparer. The numbers of Campylobacter remaining in the carcass 
after transfering to the contacted surfaces and hands can be calculated from equation 7-20 
(Christensen et al., 2001). 
N -N-R-R O/transfer - 0 CCB CBS [7 -20] 
Where: 
No = initial numbers of Campylobacter in chicken 
NOfTransfer = final numbers of Campylobacter in chicken after being transferred to preparation surfaces 
RccB = Log-reduction of Campylobacter from raw chicken to cutting board 
RCBs = Log-reduction of Campylobacter from cutting board to other foods 
2. If the chicken is well cooked, these organisms on the outer layer are likely to be 
inactivated. Bryan and Doyle (1995) stated that during roasting, frying and grilling, surfaces 
of chicken usually reach temperature of 74°C. However, Daniels (1998) reported 
approximately 24% of individuals did not cook properly and did not ensure that the heat 
reaching protected areas is sufficient to inactivate Campylobacter. Some cells (ca. 10-20%) 
in these protected areas may thus survive. 
The numbers of Campylobacter in the chicken insufficiently cooked (Nins ) can be determined 
following two conditions: i) Growth when T<Tc and ii) Inactivation when T>Tc. The 
calculations are based on the equations described below 
• Given T <T c, 
• Given T> T c, 
In N ins = In NO/transfer + ut 
t 
In N ins = In NO/transfer - (D) 
The model parameters are described in Table 7.7. 
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Table 7.7 The model parameters 
Parameter 
2 
RCCB 
RCBS 
Description 
numbers of Campylobacter in 
chicken at the beginning 
Log-reduction of Campylobacter 
from raw chicken to cutting board 
Log-reduction of Campylobacter 
from raw cutting board to other 
foods 
Function 
Taken from section 
5.4.3 , Chapter 5 
RiskPert (1,2,6) 
RiskPert (1,2,6) 
3t-exposure A time that a protected area is Risk Pert (0.5,1.0,1.5) 
exposed to the maximum heat 
Unit 
minute 
Tc A temperature at which the growth Taken from Roman and 0c 
of Campylobacter does not occur Doyle( 1984) 
T stop,prot;> T c 
O-value 
Note: 
(46°C) 
The maximum internal temperature 
in protected area, but lower than T c 
4Risk Pert (37,42,46) 
The maximum internal temperature 5Risk Pert (60,64,65) 
in protected area and higher than T c 
A specific growth rate constant 6 J..l = 1.4943In(T stop)-5.0885 
A time for 1 log reduction of the size 7 D = 14926eo.169TsloP 
population 
minute 
1. All raw data of No were input to the model equations for the calculation of exposure dose 
using @Risk software. 
2. RccB and RCBs following Christensen et al.(2001) 
3. time of exposure adopted from a joint FAOIWHO report (WHO, 2001) 
4. T min and T most likely of T stop,prot;< T c were considered from the optimal temperature (37°C or 42°C) 
and T max was equal to T c (T C = 46°C). 
5. Parameters for Tstop.prot;> Tc were taken from a joint FAO/WHO report (WHO, 2001). 
6 and 7 Parameter for J..l and D were taken from a joint FAOIWHO report (WHO, 2001). 
2) Modelling approach: Cross-contamination 
In relation to food handling in a private kitchen, it is more likely that the liquid from or direct 
contact with the Campylobacter-positive chicken may contaminate other foods, contacted 
surfaces or persons preparing a meal. Due to availability of secondary data, this study 
focuses on salad contaminated with Campylobacter through cross-contamination. The 
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numbers of Campy/obacter in salad are dependent on the transfer fraction from chicken to a 
cutting board and then to salad. It is important to note that the probability of illness from the 
consumption of salad is associated with the number of viable Campy/obaeter at the time 
of consumption. 
Given these assumptions, the final number of Campy/obacter in salad can be obtained from 
the modelling approach described by Nauta et a/.(2005b). The model equation is; 
Based on the data collected from the literature, Nauta et a/. (2005a) applied probability 
distributions to calculate the mean values of the transfer coefficients. These values are 
expressed in Table 7.B. 
Table 7.8 The transfer coefficients per cfu of Campy/obacter associated with food handling 
procedures (adopted from Nauta et a/., 2005b). 
Mean value of 
Probability distribution Reference Source of transfer 
coefficient 
Chicken to hand (tc.H) 0.0415 Beta (1.78,41.1) Montville et al., 2001 
Chicken to cutting board (tC.9) 0.0125 1 0"Normal(0.098,0.61)% Kusumaningrum et aI, 
2004 
Hand to salad (tH.S) 0.207 Beta (0.6,2.3) Montville et al., 2001 
Cutting board to salad (t9.S) 0.343 10"Normal(1.535,0.32)% Kusumaningrum et aI, 
2004 
Hand washing (tH.H) 0.0347 Beta (0.24,6.67) Chen et al., 2001 
Cutting board washing (t9.9) 0.0000464 BetaPert (0,004,1 )Iog Smith et al.,2003 
reduction 
Scenario 2: Delayed preparation 
Table 51. r If the chicken is not cooked immediately, it must be stored at a temperature 
between 1-7oC for a period of time. It is then taken out, raised to room 
temperature and cooked following the scenario 1. The modelling approach 
is performed by applying the model parameters from the CARMA project 
(Nauta et ai, 2005b). The model is; 
log NSlorage = log No - rSlorage 
The parameters are shown in Table 7.9. 
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Table 7.9 The model parameters for the storage model 
Parameter 
No 
NO/s 
*rs/orage 
Description Function/Expression 
The numbers of Campylobaeter Taken from chapter 5 
in chicken at the beginning 
(before storage) 
The numbers of Campylobaeter logNo-- rstorage 
after storage 
the decrease of Campylobaeter BetaPert (0.1,0.9,2.1) 
after storage 
* adopted from the study of Nauta et al., 2005b 
Unit 
log1OMPN/g 
log1OMPN/g 
log1OMPN/g 
2. Following the storage modelling, the new value, No.s, is fed into the models presented in 
scenario 1, insufficient heat treatment (a chicken meal) and cross-contamination (salad) (see 
section 7.3.1 : scenario 1). 
7.3.2 The dose of Campy/obaeter ingested per serving by age and 
gender 
The risk associated with the consumption of Campy/obaeter-positive chickens depends on 
the number of organisms ingested and this is related to the size of the meal. The exposure 
dose to Campy/obaeter ingested is the number of organisms per gram of food (e.g. chicken 
meal) multiplied by the amount of food consumed. It is possible that the size of the meal 
consumed may depend on the age and gender of the consumer. 
Although national dietary surveys carried out in most countries provide food consumption, 
the data on foods consumed are usually in terms of food groups (e.g. red meat, poultry, daily 
product) rather than specific food items (e.g. chicken). Specific dietary surveys for the 
consumption of chicken and related meals in populations are uncommon. One example of 
such a survey is a Danish study (Christensen et a/.,2001) which estimates the size of the 
chicken meal and salad consumed by person given age and gender. These are shown in 
Tables 7.10 and 7.11, respectively. 
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Table 7.10 Distribution of the sizes of chicken meals consumed given age and gender 
(adapted from Christensen et a/., 2001). 
Age and sex group Mean (gram) Standard deviation Distribution 
Female < 18 years 128.8 81.8 LogNormal(a,,B) 
Female 18-29 years 151.1 92.9 LogNormal(a,,B) 
Female 30-65 years 154.1 98.5 LogNormal(a,,B) 
Female >65 years 159.2 1 00.2 LogNormal(a,,B) 
Average (all age group) 148.3 
male < 18 years 128.8 81.8 LogNormal(a,,B) 
male 18-29 years 256.4 197.4 LogNormal(a,,B) 
male 30-65 years 189.0 126.9 LogNormal(a,,B) 
male >65 years 178.4 129.0 LogNormal(a,,B) 
Average (all age group) 188.15 
Table 7.11 Distribution of the sizes of salad portions consumed given age and gender 
(adapted from Christensen et a/., 2001). 
Age and sex group Mean (gram) Standard deviation Distribution 
Female < 18 years 54.6 36.7 LogNormal(a,,B) 
Female 18-29 years 66.5 30.5 LogNormal(a,,B) 
Female 30-65 years 67.6 47.5 LogNormal(a,,B) 
Female >65 years 67.1 46.3 LogNormal(a,,B) 
Average (all age group) 63.95 
male < 18 years 54.6 36.7 LogNormal(a,,B) 
male 18-29 years 106.5 88.4 LogNormal(a,,B) 
male 30-65 years 94.1 65.6 LogNormal(a,,B) 
male >65 years 87.9 51.8 LogNormal(a,,B) 
Average (all age group) 85.78 
As Campy/abaeter in faod items behaves as Poisson distributed, the exposure dose must 
be calculated by the distribution function. Estimation of the exposure to Campy/abaeter per 
serving following the consumption of chicken or salad given gender can be calculated using 
a probabilistic function proposed by Christensen et a/. (2001). These functions are; 
• Number of Campy/abaeter in a chicken meal consumed given age and gender (Nc/AGcs) is: 
N P · (S IONo-RccB-RCBC) [721] CI AGCS = Olsson CI AGCS x -
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• Number of Campylobacter in salad consumed given age and gender (Ns/AGcs) is: 
NSIAGCS = POisson(SSIAGCS x 1 o No-ReeB-ReBs ) [7-22] 
Where: 
No = initial number of Campylobacter in chicken 
Rccs = Campylobacter log reduction from chicken to cutting board 
Rcsc = Campylobacter log reduction from cutting board to chicken 
Rcss = Campylobacter log reduction from cutting board to salad 
SC/AGCS = size of chicken serving given age and gender 
SS/AGCS = size of salad serving given age and gender 
7.4 Antimicrobial-resistant Campylobacter 
The initial number of antimicrobial-resistant Campv/obaeter in chickens 
It is assumed that the number of Campylobacter isolated from chicken includes both 
antimicrobial-susceptible Campylobacter (ABS-Campylobacter) and antimicrobial -resistant 
Campylobacter (ABR-Campylobacter). Given this assumption, the number of ABR-
Campylobacter per carcass is the product of the number of all Campylobacter multiplied by 
the rate of antimicrobial resistance per carcass (see section 6.4.2, Chapter 6). Similarly, the 
number of ABR-Campylobacter per isolate is the product of the number of all Campylobacter 
multiplied by the rate of antibiotic resistance per isolate (see section 6.4.2, Chapter 6). The 
fractions of antimicrobial resistant Campylobacter are presented in Table 7.12. 
Table 7.12 Fraction of antimicrobial resistant Campylobacter isolated from three groups of 
chicken 
Fraction/carcass2 Fraction/isolate3 
Type of chicken 1 Cp4 Eryth5 NA6 Cp Eryth NA 
PIC 0.087 1 1 0.029 1 1 
POC 0 1 1 0 1 0.95 
BIC 0.267 1 1 0.116 1 0.814 
1Type of chicken: pre-packaged intensively reared (PIC), pre-packaged organically reared (POC) and 
unwrapped intensively reared chicken (BIC) 
2 percentage of chicken carcases harbouring one or more resistant isolates 
3 percentage of isolates found to be resistant to a specific antimicrobial agent. 
4 Cp = ciprofloxacin, 5 Eryth = erythromycin, 6 NA = Nalidixic acid 
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Modelling approaches 
The initial numbers of ABR-CampyJobacter were modelled for estimation of exposure to 
ABR-CampyJobacter following the consumption of three groups of chicken harbouring 
antimicrobial resistant isolates. The estimations were performed using similar modelling 
approaches used for all CampyJobacter (immediate preparation and delayed preparation) as 
shown in sections 7.3.1 and 7.3.2. 
7.5 An overview of modelling approaches applied for 
exposure assessment 
All selected probabilistic models used for estimation of the exposure to Campylobacter (with 
and without antimicrobial resistance) in this chapter are described in Tables 7.13 and 7.14. 
Table 7.13 The modelling approaches used for estimation of the exposure doses to all 
Campy/abaeter isolates following the consumption of three groups of chickens 
Modeliling Approach 
1) Heat treatment 
(a chicken meal) 
2)Cross-contamination 
(salad) 
3) Storage 
- Numbers after refrigeration 
- Heat treatment 
- cross-contamination to salad 
Model description and equations 
1N -N-R-R 
. O/transfer - 0 CCB CBS 
2. In N ins = In NO/transfer + ut; when Tstop< Tc 
t 
or l~ns = InN~)/transfe':-(-) ;when T stop> T c 
D 
log Nstorage = log No - rstorage 
see scenario 1 
see scenario 1 
Remark 
see eq. [7-20] 
see eq. [7-10] 
see eq. [7-11] 
see eq. [7-15] 
see eq. [7-16] 
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Table 7.14 The modelling approaches used for estimation of the exposure doses to 
antimicrobial resistant Campylobacter isolates following the consumption of three groups 
of chickens 
Modellling Approach 
Number of ABR-
Campy/obacter 
1) Heat treatment 
(a chicken meal) 
2)Cross-contamination 
(salad) 
3) Storage 
- Numbers after refrigeration 
- Heat treatment 
- cross-contamination to salad 
Modelling description and equations 
N O,ABR = No x PABR(i) 
1. N O,ABR Itransfer = N O,ABR - RCCB - R CBS 
2. ln~ns = InNo,ABHtrans/er+ut; when Tstop< Tc 
t 
or lnN;ns = InNo,ABRtrans/er(d; when T stop> T c 
log Nstorage = log No - rstorage 
see scenario 1 
see scenario 1 
Remark 
see eq. [7-20] 
see eq.[7 -10] 
see eq. [7-11] 
see eq. [7-16] 
Note: All raw data of No were used for the calculation of the exposure doses. The 
calculations were performed using @Risk software, which the values of parameters are 
taken into account as probabilistic distribution (e.g. a lognormal distribution for the mean 
values of MPN, a Poisson distribution for the probability of getting ill given exposure to one 
organism). 
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PART C: Results and Discussion 
The difference in exposure to Campylobacter between two groups of chicken were analysed 
using a Mann-Whitney test. Analysis of Variance (ANOVA) was performed to test the 
difference of the doses between three groups of chickens. 
7.6 Results 
These results consider the exposure to Campylobacter ingested by person consuming 
chicken meals and salad. These meals are assumed to be associated with three types of 
chickens, (PIC, POC and BIC). 
The exposure doses are calculated using the numbers of Campylobacter and amount of 
chicken or salad consumed. Two conditions of meal preparation taken into account were: 1) 
the chicken was cooked immediately and 2) the chicken was kept in the refrigerator for a 
short period of time before being cooked. The results described below were outlined 
following three modelling approaches (heat treatment, cross-contamination and pre-cooking 
storage). 
7.6.1 The effect of heat treatment on the number of Campy/obaeter in 
chicken immediately cooked 
Following the assumptions in each modelling approach, the survival of Campylobacter in any 
chicken meal is dependent on the internal temperature and exposure time (Table 7.7) in the 
protected area during heat treatment. These two parameters were measured as an indicator 
for the prediction of the change of the numbers of Campylobacter in a chicken meal after 
being cooked. 
The numbers of Campylobacter in a cooked chicken meal given the internal temperature 
higher than 46°C (T>T c) are significantly lower than that of T <T c (p<O.001). 2-4 log reduction 
can be achieved when using the model given T <T c compared with 3-6 log reduction using 
the model given T> T c. After heat treatment, the numbers of Campylobacter in meals 
associated with the BIC group still show the highest level significantly (p<O.001). These 
results are presented in Table 7.15 and Figure 7.11. 
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Table 7.15 Comparison of the final numbers of Campylobacter after thermal processing 
between three groups of chicken : Immediate preparation 
Number of Campy/obacter (l og10MPN/g): mean:tSE2 
Type of chicken 1 
N03 Nins4; T<Tc 
p-value 
Nins5 ; T>Tc 
PIC 3.73+0 .59 -1 .08+0 . 06 -2.51.!.-0 .20 <0.001 
POC 4.44:!:.0 .64 -0.44+0 .19 -1.88.!.0.07 <0.001 
BIC 8.10+0 .81 3.31.!.0 .65 1.88.!.0.70 <0.001 
p-va/ue <0.001 <0.001 <0.001 
1 Type of ch icken : Pre-packaged intensively reared (PIC ), Pre-packaged organicall y reared (POC) and 
Butcher intensively rea red chicken (BIC ) 
2 mean and SE are expressed as geometric values 
3 Number of Campylobacter at to (the in itial number after some cells were transferred) 
4 Number of Campylobacter after heat treatment ; when the internal temperature is lower than 46°C. 
5 Number of Campylobacter after heat treatment ; when the internal temperature is higher than 46°C 
10 OPIC 
~ OPOC 
~ 
..... 8 1 r-u OBIC 
"' .Q 6 j 0 
- -::"'0) 
0..-- 4 1 r-E Z .--
",0.. JJ u:iE 2 1 .... c:n HS/TU o .2 ... - I ~ 0 .0 E No 
::l -2 
Z 
-4 Preparation stage 
Figure 7.11 The number of Campylobacter in the immediately cooked chicken associated 
with PIC , POC and BIC given T<Tc or T>Tc 
7.7.2 The number of Campy/obaeter transferred to salad 
The numbers of Campylobacter transferred to a cutting board, utensils and hands are 
dependent on the initial numbers in the carcasses . The lowest level is found in salad 
contaminated with Campylobacterfrom the PIC group (-0.24.!.0.28 IOg lOMPN/g) , whereas the 
highest level (4 .14.!.0.64 log 1OMPN/g) is found in the BIC group , fo r which the initial level of 
Campylobacteris also very high . Table 7.16 and Figu re 7.12 show the details of the findings . 
There is a significant difference for the numbers of Campylobacter transferred to salad from 
those found in PIC , POC and BIC (p<O.001) . 
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Table 7.16 The numbers of Campylobacter transferred from three types of chickens to sa lad 
Number~Campyfubac~r 
Type of chicken (log 10MPN/g): mean:!:SE 
No 1 Nsalad 2 
PIC 3.73~O.59 -O.24~O . 28 
POC 4.44~O.44 O . 39~O.36 
BIC 8 . 10~O . 81 4 . 14~O.64 
p-value <0.001 <0.001 
9 DNo 
~ 
<I> 8 I o Nsalad .... 
(.) 
til 
..Q 7 
0 6 ' 
--::"'0) Q..-- 5 ' E Z tIl~ 4 I U:E [l _ en 3 o .2 ... - 2 <I> .0 1 E 
::J o . 
Z 
-1 PIC POC BIC 
Type of chicken 
Figure 7.12 The number of Campylobactertransferred from PIC , POC and BIC to sa lad 
7.7.3 The number of Campy/obaeter in chicken and salad after storage 
and cooking 
Table 7.17 and Figure 7.13 demonstrate the effect of storage on the numbers of 
Campylobacter. It is evident that after storage the numbers of Campylobacter in chicken 
meals related to these three types of chicken decrease significantly (p<O.001) . In addition , 
the numbers in chicken using the model given T> Te are significantly lower than those given 
T<Tc (p<O.001). Furthermore , the chicken meal associated with the BIC group contained the 
significantly highest numbers of Campylobacter (p<O.001) . 
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Table 7.17 The numbers of Campy /oba eter in a chicken meal and sa lad associated with 
three types of chickens : after storage 
Number of Campy/obaeter (log lOMPN/g) (mean+SE) 
Type of Nins/s 
chicken 
NO/transfer 1 N/ Nsalad T<Tc 
PIC4 3 . 73~0.59 2 . 75~0.53 -1 . 21~0 . 04 -2 . 03~-0.11 
POC::' 4.44~0.44 3.48~0 . 58 -0.48~0.20 - 131 ~0 .07 
BICb 8 . 10~0 . 81 7.13~0 . 78 3 . 17~0 . 58 2 . 34~ 0.53 
p-va/ue <0.001 <0.001 <0.001 <0.001 
1 Number of Campy/obaeter in chicken before storage (at to) 
2 Number of Campy/obaeter in chicken after storage 
3,4 
T>T c 
-3.46+-0.37 
-2 .75+0.33 
0.91 +0.43 
<0.001 
3 Number of Campy/obaeter in chicken after storage and cooking given T <Te and T> T e 
4 significant at p=O. 00005 for the numbers of Campy/obaeter after cooking between T <Te and 
T>Te within a group of PIC or POC or BIC 
'-
10 DPIC 
(l) 
.... 
(.) 8 .--- OP~C 
~ 
.Q 6 0 DBIC 
~Ci 
4 I r7"'7 Q..-E Z ~ "?"<" ~ a.. %} cJJ (,)~ 2 I ~:/. _ OJ ~~~ HJ'7rc oE o I .// .... " .... - ~ (l) -2 I No Ns . s : <Te 
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E 
:::J -4 , 
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-6 
Figure 7.13 The numbers of Campy/oba eter in chicken meal associated with PI C, 
POCand BIC after storage and heat treatment, given T<Tc and T>Tc 
and the numbers in contaminated salad 
7.6.4 The exposure to (all) Campy/obaeter 
Initially, the exposure to Campy /obaeter related to the consumption of three types of 
chickens was calculated following the modelling approaches (Tables 7.13 and 7.14). These 
doses were also considered in respect of the size of the meal at different age and gender 
groups . The results showed no significant difference of exposure doses to Campy/abaeter 
between different serving sizes given age groups . The whole results are presented in 
Appendix 4. 
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Therefore, these following results of the exposure to Campylobacter are calculated using the 
average serving size of a chicken meal or salad for all age groups within the same sex 
(Tables 7.10 and 7.11). The average serving size of chicken meals consumed by female 
groups (age from <18 to > 65 years) was 148.3 g. and by male groups (same range of age 
groups) was 188.5 g. Similarly, the average of the size of salad consumed by females was 
63.9 g. and by males was 85.8 g. 
Immediate preparation: a chicken meal and salad 
Using the average serving size of a chicken meal or salad consumed by female and male 
groups (stated above), the doses of Campylobacter ingested following the consumption of a 
chicken meal given gender and internal temperature reaching the protected area were found 
to be very high in relation to the BIC group (Table 7.18), particularly, when T <T c (about 5 
10gMPN/serving for both sexes). Although when T>T c, the dose is still higher than those 
associated with the PIC and the POC group. After heat treatment, the level of exposure 
associated with the PIC and the POC group was very low (less than 1 10gMPN/serving). The 
exposure dose associated with the consumption of salad exhibited higher values than those 
associated with the chicken meal. The difference is about 1-2 10gMPN/serving. This is 
become clearer when using the model given T> T c. 
Table 7.18 The numbers of Campylobacter ingested per serving of a chicken meal or salad 
immediately prepared, given sex and internal temperature at the protected area 
Dose of Campy/obaeter ingested (MPN/serving): Immediate preparation 
Type of 
chicken Salad Chicken meal: T<Tc Chicken meal: T>Tc 
Female Male Female Male Female Male 
PIC 38 51 12 16 0 1 
POC 157 211 54 68 2 2 
BIC 8.82 x 105 1.18 x 106 3.03 x1 05 3.85 x 105 1.12 x 104 1.41 x 104 
Delayed preparation 
As shown in Table 7.19, the results are in parallel with those found for immediate 
preparation. The consumption of a chicken meal or salad contaminated with Campylobacter-
positive BIC is responsible for the highest level of exposure (3-4 10gMPN/serving for a 
chicken meal and 4-5 10gMPN/serving for salad). This also shows that the levels of exposure 
following the consumption of salad are higher than those from a chicken meal. It is noted 
that after cooking the levels of exposure to Campylobacter associated with the consumption 
of the PIC-meals PIC and the POC-meals were considerably lower « 1 10gMPN/serving). 
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Table 7.19 The numbers of Campylobacter ingested per serving of chicken meal and salad 
associated with three types of chicken after storage, given sex and internal temperature at 
the protected area 
Dose of Campy/obaeter ingested (MPN/serving): Delayed preparation 
Type of 
chicken 
PIC 
POC 
BIC 
Salad 
Female 
4 
21 
9.52 x1 04 
Male 
5 
28 
1.28x105 
Chicken meal: T<Tc 
Female Male 
2 
7 9 
3.27 x104 4.15 x104 
7.6.5 Exposure to ABR- Campylobacter 
Chicken meal: T>Tc 
Female Male 
0 0 
0 0 
1.20 x1 03 1.52x103 
As shown in Table 7.20, the numbers of ciprofloxacin-resistant Campylobacter (CR-
Campylobacter) ingested per serving of a chicken meal or salad associated with the BIC 
group exhibited the highest value, particularly from salad. It is evident that both types of 
meal associated with the POC group were completely free from CR-Campylobacter. In the 
PIC group, the numbers were down to zero when the internal temperature was higher than 
46°C. The exposure to CR-Campylobacter per carcass or per isolate was found to be very 
similar in all groups. 
Table 7.20 The numbers of CR- Campylobacter ingested per serving of a chicken meal and 
salad immediately prepared from three types of chicken, given sex and internal temperature 
at the protected area: a) rate of resistance per carcass and b) rate of resistance per isolate 
Dose of CR-Campylobacter ingested (MPN/serving): Immediate preparation 
Type of 
a: given rate of resistance per carcass b: given rate of resistance per isolate 
chicken Salad Chicken: T<Tc Chicken:T>T c Salad Chicken:T<Tc Chicken:T>Tc 
F* M* F M F M F M F M F M 
PIC 3 4 1 0 0 1 0 0 0 0 
POC 0 0 0 0 0 0 0 0 0 0 0 0 
BIC 105 105 105 105 103 103 105 105 104 104 103 103 
* Sex group: F = female and M = male 
The numbers of erythromycin-resistant Campylobacter (ER- Campylobacter) or nalidixic 
acid-resistant Campylobacter (NAR- Campylobacter) associated with the consumption of 
chicken meals or salads were not greatly different (Tables 7.21 and 7.22). However, the 
findings associated with the BIC group (4-6 10gMPN/serving) were still considerably higher 
than those found in the PIC (1 10gMPN/serving) and POC groups (1-2 10gMPN/serving). The 
exposure dose whether taken into account as per carcass or per isolate was the same. 
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Table 7.21 The numbers of ER- Campylobacter ingested per serving of chicken meal and 
salad immediately prepared from three types of chicken given sex and internal temperature 
at the protected area: a) rate of resistance per carcass and b) rate of resistance per isolate 
Dose of ER-Campylobacter ingested (MPN/serving): Immediate preparation 
Type of 
per carcass per isolate 
chicken Salad Chicken:T<Tc Chicken:T>Tc Salad Chicken:T<Tc Chicken:T>Tc 
F M F M F M F M F M F M 
PIC 36 49 13 16 0 36 49 13 16 0 
POC 102 102 54 68 2 3 102 102 54 68 2 3 
BIC 106 106 105 105 104 104 106 106 105 105 104 104 
Table 7.22 The numbers of NAR- Campylobacter ingested per serving of chicken meal and 
salad immediately prepared from three types of chicken given sex and internal temperature 
at the protected area: a) rate of resistance per carcass and b) rate of resistance per isolate 
Dose of NAR-Campylobacter ingested (MPN/serving): Immediate preparation 
Type of 
per carcass per isolate 
chicken Salad Chicken:T<Tc Chicken:T>Tc Salad Chicken:T<Tc Chicken:T>Tc 
F M F M F M F M F M F M 
PIC 36 49 13 16 0 1 36 49 13 16 0 
POC 102 102 54 68 2 3 102 102 51 65 2 2 
BIC 106 106 105 105 104 104 106 106 105 105 104 10
4 
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7.7 Discussion 
It is clear that cooking parameters, such as temperature, are dependent on the behaviour of 
individual consumers. There were few studies that carried out personal hygiene practice 
during food handling in the household kitchen. (Montville, et aI, 2001; Chen et aI, 2001 and 
Christensen et al., 2005). The estimation of the dose at the time of consumption always 
involves both variability and uncertainty. Hence, probabilistic approaches have been used to 
estimate the dose from the best-case to the worst-case scenarios. On one hand, the best-
case is considered to be where an individual consumes a small chicken portion containing 
few organisms that are inactivated during cooking. On the other hand, the worst-case is 
considered to be where an individual consumes a large portion of highly contaminated and 
improperly cooked chicken. 
7.7.1 The exposure dose after the heat treatment 
Although the internal temperature of cooking can reduce the number of Campylobacter to 
undetectable levels, the numbers in the BIC group after passing the heat treatment even 
given T> T c were found still considerable. Based on the assumption of insufficient heat 
treatment (described in section 7.3.1) and both data collected in this study and secondary 
data, after the heat treatment, the exposure to Campylobacter related to the BIC-chicken 
meal remains very high. This could suggest that: i) there would be significant numbers of 
Campylobacter remaining in the thermally protected areas of the carcass, ii) the models 
used are not sensitive to the model parameters and iii) the values of the parameters (internal 
tempersture and time) used may not be reasonably representing values. The outcomes of a 
sensitivity anaylysis indicate that the models used are sensitive to the changes in the values 
of parameters and thus increasing of either the internal temperature (from 63°C to 72°C) at 
the protected area or the time (from 1 to 5 minutes) can reduce the dose of Campylobacter 
from 108 MPN/g to < 1 MPN/g. The results and further discussion of a sensitivity analysis are 
presented in section 8.4.3. For this reason, highly concentrated chickens should be cooked 
at very high temperatures raising internal temperature at the protected areas. Alternatively, 
cooking time may be increased in parallel. This however, would lead to the question arising 
of whether there can be in practice temperature that is completely sufficient in reducing the 
number of high number of Campylobacter effecting the meal, i.e. taste, appearance, nutritive 
values. As the numbers of Campylobacter in the PICs and the POCs are not very high (~ 5 
log MPN g-1 meat), given T> T c the organisms were almost completely eliminated. Koidis and 
Doyle (1983) recognised that cooking meat at 58-60°C for 2 min or more will inactivate 
106C.jejuni g-1meat. Therefore, this suggests that the dose of Campylobacter from the 
consumption of a chicken meal involves two factors, the initial numbers of Campylobacter 
and cooking procedure parameters, mainly temperature and time. 
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7.7.2 The exposure dose related to the transfer from the positive 
carcass to salad 
The dose of Campylobacter related to the consumption of salad contaminated through 
contact with uncooked chicken was found to be higher than that from the consumption of an 
adequately cooked chicken meal. A sufficient cooking temperature for a whole chicken is 
82°C or is that in practical the centre of meat should not be pink (USDA, 1999). This may be 
a consequence of the direct transfer of Campylobacter from the uncooked chicken to salad 
which is usually consumed without heat treatment. This finding is further emphasised by the 
outcomes found in the BICs. Since the BICs are contaminated with very high concentrations 
of Campylobacter, the numbers transferred to salad are considerably higher than those from 
PICs and POCs. Several factors may influence the number of Campylobacter transferred 
from raw chicken to a cutting board and further to a prepared meal, i.e. the amount of drip 
fluid, the contact area, the time lag between placing the raw chicken and the prepared 
chicken on the cutting board (Rosenquist et al.,2003). Nauta et al.(2005b) considered the 
transfer coefficients for the cross-contamination from a raw chicken to salad which is related 
to the initial numbers of Campylobacter in the carcass (section 7.2.4). Therefore, the initial 
number of the organisms is the significant factor influencing the level of the exposure as well 
as personal hygiene practices in the private kitchen. This supports the notion that proper 
handling of food can decrease the transfer coefficient of the cross-contamination, resulting in 
a reduction in the dose of Campylobacter transferred to salad. Anderson et al.(2001) found 
similar results when estimating the health risk following the consumption of hamburgers. 
7.7.3 The exposure dose to Campy/obaeter after pre-cooking storage 
The exposure doses to Campylobacter per serving of meal following the consumption of a 
chicken meal or salad associated with chicken stored in a refrigerator before being cooked 
were lower than those found in the immediate preparation. This is highlighted by the finding 
from the PIC and POC groups, in particular the dose of Campylobacter after heat treatment 
given T> T c (the dose equals 0). Although typical food storage conditions are not associated 
with the growth of Campylobacter, the length of time at which cells can survive at ambient 
and refrigeration temperatures are significant when considering the health risk, as the 
infective dose is as low as 500 cells (Robinson, 1981; Black et al., 1988 and Solow et al., 
2003). 
7.7.4 The exposure dose to ABR-Campy/obacter 
The dose of ABR-Campylobacter is dependent both on the initial numbers of Campylobacter 
and on the rate of resistance to tested antimicrobials. Similarly, the heat treatment can 
reduce the dose of ABR-Campylobacter if the initial number is not too high. As the initial 
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number of Campylobacter in the PICs was lower than that found in the POCs, the dose of 
CR- Campylobacter isolates associated with the PICs was gradually declined to zero after 
heat treatment. This makes the final outcome similar to that found in the POCs, which were 
free from CR- Campylobacter. The difference of the dose of ER-Campylobacter or NAR-
Campylobacter, in a chicken meal after being cooked, between the PICs, the POCs and the 
BICs emphasises that the initial number of Campylobacter in the carcass is the most 
important factor influencing the level of the exposure to ABR-Campylobacter. The dose of 
antimicrobial resistant Campylobacter could therefore be reduced by lowering the total 
numbers of Campylobacter. This can be achieved by lowering the Campylobacter load at 
various production points and at the kitchen through the good hygiene practices. This is 
supported with the outcomes of a sensitivity analysis. 
Since the serving sizes of meal at different age or gender groups were only slightly different, 
individuals in all age and gender groups have a similar chance of being infected and getting 
ill following the consumption of chicken harbouring Campylobacter. It can therefore be 
assumed that this estimate is for the general population, except for young children or other 
vulnerable group. 
The severity of Campylobacter infection involves health status, immune system, infective 
dose and individual susceptibility to pathogens. Campylobacter infection in vulnerable 
groups such as young children can develop to severe conditions (e.g. high fever, 
septicaemia). These conditions then require intensive treatments including antimicrobial 
administration. Therefore, development of antimicrobial resistance in Campylobacter species 
can cause the failure for antimicrobial treatment in these groups. 
7.7.5 Sensitivity analysis 
It is important to note that the estimation of exposure to Campylobacter was determined 
based on a number of prior assumptions and included the model parameters. The mean 
values of the internal temperature and exposure time were adopted from the literature. 
Given these, the numbers of Campylobacter associated with the BIC as calculated by the 
model as worringly high. It is important to consider whether the risk is truly high or whether 
the model is providing an inaccurate estimate. It is interesting to investigate the sensitivity of 
model parameters used. A sensitivity analysis was therefore performed in order to identify 
the sensitivity of the model to the two main model parameters (internal temperature and 
exposure time). These two parameters are thought to have the greatest impact on the 
numbers of Campylobacter. The results of a sensitivity analysis which are presented and 
discussed in details in sections 8.4.3 and 8.5.3 demonstrate that. 
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7.8 Limitations of a consumer exposure model 
The estimation of the exposure to Campylobacter relies on the information and data (e.g. 
scientific data) and the assumptions taken throughout the entire risk model. The models of 
exposure dose used in this chapter consider two significant factors influencing on the 
numbers of Campylobacter in a chicken meal or salad. These two factors are the cooking 
practice (heat treatment) and kitchen hygiene (cross-contamination). These models require 
considerable data. However, at present, the data available are not complete. Thus, there are 
gaps between the data used, which can be further considered as follows: 
7.8.1 The information on cooking practice 
This study combines two modelling approaches recommended by the joint FAOIWHO 
working group (WHO, 2001) for the estimation of exposure to Campylobacter after heat 
treatment. These models, based on two approaches, are: 1) the internal temperature 
approach and 2) the protected areas approach. The modelling approaches are based on 
observations of the time-temperature profiles in the centre of the drumstick portions of a 
whole roasted chicken as well as the area in the carcass where the least heat treatment is 
achieved (WHO, 2001). Thereby, the expected dose of viable Campylobacter after cooking 
is affected by temperature and time. It is becoming clear that there is currently little 
information on time-temperature profiles for growth and inactivation of Campylobacter during 
the cooking process. The final temperature at the inner part of the carcass (which is 
assumed to be an insulated area for Campylobacter during roasting) is also not reported 
completely. The ranges of time or temperature used in the models had to be taken from 
different studies due to incomplete data. These studies were unfortunately performed with 
different designs and criteria, in particular, the observational definition of undercooking and 
the actual heat treatment applied. Thus, uncertainties can occur alongside the pathways of 
the assumption (On eta/, 1996; Teunis etal.,1997 and Kang etal., 2000). 
In addition, it is assumed that the organisms are evenly distributed not only on the surface 
but also in other locations on the carcass including the inner part of the meat. In fact, there 
has been no evidence to indicate the distribution of Campylobacter inside the meat in a 
chicken carcass. Although some studies implied that a significant habitat of Campylobacter 
may be on the skin of a carcass (Burgess et al., 2005), it has not been demonstrated by 
direct measurements. 
7.8.2 Cross-contamination regarding the kitchen hygiene 
This model assumed that there is transfer of Campylobacter from a contaminated raw 
chicken to preparation surfaces and subsequently from these surfaces to uncooked foods 
such as salad. There are some limitations which need to be considered, when referring to 
this: 
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1) There are little survey data and direct observational data on consumer practices in the 
domestic kitchen (preparation and handling of chicken, for example). The few available 
studies come from the UK and some countries in North America. However, these studies did 
not establish the relationship between consumer practices in the kitchen and the transfer 
coefficient of the organisms, e.g. the numbers of organisms remain on the cutting board 
(whether washed or unwashed). The data fed in to the model in this study were taken from 
different studies and sources. Different pathways of contamination may contribute the 
different quantities of Campy/obaeter to the final meal. There might be a number of plausible 
dose-response models whose fits are consistent with the data. In other word, the dose-
response model depends on the assumptions and data available. Frequently, the 
assumptions of a model are developed from emergent problems, subject to interests and 
data available in parallel with the principle and theory (Cox, 2005). 
2) Except for the report from a joint FAOIWHO (WHO, 2001), there is no data on the 
concentration of Campy/obacter in the fluid attached to the chicken and how many 
organisms there are in the fluid dripping onto the preparation surfaces. 
3) Although the dietary survey in the UK is carried out annually, data on the consumption 
and consumption patterns of chicken or related food items are scarce. There is currently no 
specific data which estimate different types (e.g. intensively reared or organically reared 
chicken) and amounts of a certain chicken consumed. Hence, most data used in this chapter 
were adopted from several studies and different sources, including the consumption data of 
a chicken meal and salad. 
7.9 Summary 
Estimations of the Campy/obacter doses that consumers may expose t, following the 
consumption of chicken meals and salads, were calculated through risk models developed 
from the literature. The risk models include insufficient heat treatment and cross-
contamination. The modelling approaches were performed for two conditions: i) immediate 
preparation and ii) delayed preparation. The results in this chapter indicate that the most 
significant factors affecting the risk from exposure to Campy/obacter following the 
consumption of a Campy/obacter-positive chicken are the numbers of organisms in the raw 
chicken, personal hygiene practices and cooking procedures (mainly temperature and time). 
1. Given the assumptions and data used, the highest dose of Campy/obacter was 
calculated to be associated with the consumption of the BICs (102 -103 MPN/g), 
followed by the POCs and the PICs (less than 10 MPN/g). The exposure to 
Campy/obaeter related to the BIC-chicken meals remains very high, indicating that: i) 
there may be significant numbers of Campy/obaeter remaining in the thermally 
protected areas of the carcass, ii) the models used are not sensitive to the model 
parameters and/or iii) the values of the parameters (internal tempersture and time) 
used may not be resonably sufficient. The outcomes of a sensitivity anaylysis 
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indicate that the models used are sensitive to the changes in the values of the 
parameters and thus increasing of either the internal temperature (from 63°C to 
72°C) at the protected area or the time (from 1 to 5 minutes) can reduce the dose to 
< 1 MPN/g. The results and further discussion of the sensitivity analysis were 
presented in section 8.4.3. This indicates that if elevated internal temperatures 
(63°C-72°C) are achieved for a sufficient length of time (1-5 minutes), the risk can be 
reduced to a very low level. 
2. The above findings indicate that the models are appropriate for use. However, the 
values of model parameters taken from the literature may not be sufficient and lead 
to an inaccurate estimate. As currently the information related to cooking practices in 
kitchens is insufficient, further studies are needed. 
3. The exposure dose to Campylobacter related to salad was found to be higher (1.7 
10gMPN/serving, 2 10gMPN/serving and 6 10gMPN/serving for the PICs, POCs and 
BICs, respectively) than that related to an adequately cooked chicken meal «1 
10gMPN/serving, <1 10gMPN/serving and 4 10gMPN/serving for the PICs, POCs and 
BICs, respectively). It is important to note that this contamination is related to the 
uncooked chicken which directly transmits the organisms to the salad during food 
preparation in the kitchen. Therefore, the reduction of the exposure dose to 
Campylobacter can be achieved by good personal hygiene practices in the kitchen. 
(Table 7.18). 
4. Storage in a refrigerator can reduce the number of Campylobacter to < 10 MPN/g for 
the PICs, to < 20 MPN/g for the POCs and to 103 -105 MPN/g for the BICs. 
5. The exposure dose to antimicrobial resistant Campylobacter depends not only on 
the rate of resistance but also on the initial number of Campylobacter. This is clearly 
supported by the results. The PICs harbour higher numbers of CR-Campylobacter, 
although lower total numbers than that found in the POCs. The BIC group harbour 
both high total numbers and resistance rate to ciprofloxacin (section7.6.5). 
6. As this study aims to compare the relative health risk from Campylobacter with and 
without antimicrobial resistance following the consumption of three types of chicken 
(PICs, POCs and BICs), it assumes that any uncertainty in the exposure dose of the 
host arising from the limitations of the model may affect all these three types equally. 
In addition, as long as the underlying mathematical assumptions are true, good 
estimates on relative changes can be calculated and the model can be used to 
compare the relative exposure to Campylobacter following the consumption of 
different chickens. The results of the sensitivity analysis support this assertion. 
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CHAPTER 8 
Health Risk from Campy/obaeter 
8.1 Introduction 
Infection with Campy/obacter following the consumption of contaminated foods, chickens in 
this context, involves the interaction between host, pathogen and food matrix (Figure 8.1). 
Food matrix 
Disease 
Pathogen Host 
Figure 8.1 Epidemiology triangle for food borne disease (adopted from Coleman and Marks, 1998) 
The infection is not necessarily accompanied by symptoms. Usually symptoms of 
campylobacteriosis in humans are self-limiting and do not require intensive treatments 
(Coker et a/., 2002). During the asymptomatic period, infection status must be confirmed by 
microbiological examination of faecal specimens and in some cases, if necessary, the 
determination of an immune response must be included. 
Health risk in this context is about the probability of infection following ingestion of 
Campy/obaeter and the probability of illness. Estimation of health risk is performed after the 
exposure assessment (Chapter 7), with exposure levels being input to the models used for 
estimating health risk. 
8.2 Background 
This chapter aims to compare the human health risk resulting from Campy/obaeter following 
the consumption of the three different types of chicken. It focuses on risk at the consumer 
level. It links the probability and magnitude of exposure to Campy/obaeter following the 
consumption of a chicken meal or other related food to possible adverse consequences. The 
resulting risk is expressed as the risk per serving of meal consumed. Since there are no data 
available for the consumption of chickens by specific groups (e.g. young children), the risk in 
this study cannot address a specific population. Data on amounts of chicken consumed can 
be incorporated into the model to arrive at estimates for the general population. 
Currently, the models used in other studies are unable to provide a clear estimate of risk due 
to uncertainties in two key components of the model, namely the impact of undercooking 
and the impact of cross-contamination (WHO, 2001; Christensen et a/., 2001; Bartholomew 
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et al., 2005 and Nauta et al., 2005b). Since these processes are the ultimate determinant of 
final exposure of the consumer, the unbounded and irresolvable nature of the uncertainty 
undermines the establishment of a reliable estimate of consumer risk. In addition, the 
models related to the issue of antimicrobial resistance in Campylobacter have not yet been 
applied. However, information from those studies still provides useful information for 
studying potential exposure pathways, and these ways would contribute to the health risk 
posed by Campylobacter associated with the consumption of broiler chickens. 
In this chapter estimation of the health risk is based on the dose-response relationship 
model. The outcomes describe the probability of infection and the probability of illness. In 
addition, the consequence of antimicrobial resistance is also included in the risk for 
additional consideration of health risk. The health risk was independently considered based 
on two criteria: 
1) the risk from Campylobacter itself 
2) the risk from Campylobacter with additional antimicrobial resistance. 
Hence, the methods for estimating the risk were calculated by two separate consecutive 
models. Firstly, the risk from Campylobacter itself (including all Campylobacter isolates with 
and without antimicrobial resistance) was determined using the dose-response relationship 
model based on the studies of the joint FAOIWHO working group (WHO, 2001); Christensen 
et al., (2001) and Nauta et al., (2005b). Secondly, the additional risk from antimicrobial 
resistant Campylobacter was estimated by two separate models, which were a CVM model 
and a modified model adapted from the current quantitative microbial risk assessment 
(QMRA) (section 7.2.5). The framework of this chapter is illustrated in Figure 8.2. 
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with all 
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(from Chapter 7) 
, 
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relationship model 
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Meals contaminated 
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Probability of infection and prob. of 
illness 
CVM-model 
Figure 8.2 A conceptual framework for health risk characterisation performed in this chapter 
8.2.1 The Principle of a dose response-relationship model 
The consumption of foods contaminated with pathogenic organisms may lead to the 
ingestion of a number of these pathogens. Any organisms entering the host have a certain 
probability of survival against the host-defence system and can colonise the digestive 
system and viable organisms may multiply, thereby achieving an infective dose 
(concentration). The infection may be asymptomatic if the host is not ill. However, some 
hosts may become ill and symptoms may vary greatly in severity (Teunis et al., 1996). 
The relationship between the ingestion of a certain number of pathogens, Campylobacter in 
this context, and the possible resulting consequences may be described in a number of 
different ways. The dose is a quantitative measure of the intensity of exposure of a host to 
the pathogen (Teunis, et al., 1996 and Haas et al., 1999). This number of micro-organisms 
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entering the digestive system of a host per exposure event (i.e. consuming a contaminated 
chicken meal or salad) may be expressed in different units of functional particles of 
pathogens (e.g. colony-forming unit). 
In principle, a dose response relationship may be determined experimentally, with healthy 
volunteers using various doses of the pathogen of interest. The results are scored and 
integrated with a mathematical function to predict the probability of infection or disease at 
the doses occurring in real life situations. 
However, these doses are often so low that the probability of infection is then quite small. 
Studies on large numbers of volunteers would be needed in order to fill this knowledge gap. 
This would be impossible to do in the real situation. Therefore, most studies estimate the 
dose using experimental data at high doses for the calibration of the model, resulting in 
extrapolation to low doses under the circumstance similar to that of a real life situation (Black 
et al., 1988 and Teunis et al., 1996). 
A human volunteer trial for Campylobacter jejuni was performed by Black et al. (1988). It 
was performed on 89 adult volunteers who were fed doses of C.jejuni ranging from 8 x 102 to 
2 X 109 organisms. Latter on, Medema et al.(1996) used these outcomes from this trial to 
develop a dose-response relationship for C.jejuni infection using a Beta-Poisson model to fit 
the data. It establishes a relationship between the level of microbial exposure and the 
likelihood of the probability of illness from ingesting a certain amount of pathogenic 
organisms which is bound by zero (no effect) and one (complete conversion to adverse state) 
(Teunis et al., 1996 and Haas et al., 1999). This model assumes that all strains have the 
same potential to cause human illness (Mead, 2004). The model is based on the chain of 
transitional probability of the occurring events displayed in Figure 8.3, which distributes as a 
stochastic process. 12 The susceptibility parameters a. and ~ were used to characterise 
susceptibility and variability of response to the pathogen within a population. As a result, the 
maximum likelihood estimates for the model were: probability of getting ill (a) = 0.145 and 
probability of not getting ill (~) = 7.59 (Medema et al., 1996). 
12 A stochastic process is a random function, which a random variable X is defined on a probability 
space (0, Pr) with values in a space of functions F. 
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Figure 8.3 Subsequently events occurring after the exposure of host to pathogen (modified 
from Teunis et ai, 1996): a) exposure assessment pathway (Chapter 7) and b) 
estimation of health risk (Chapter 8) 
Although these model parameters (a and ~) have been thought to be overestimated, there 
are currently no other studies that can provide a better solution. These parameters have 
been therefore adopted to characterise health risk from Campylobacter in a number of 
reports (WHO, 2001; Christensen et aI., 2001 and Nauta et aI, 2005b). 
It was indicated that the infective dose of C. jejuni which may cause illness in some 
individuals is as low as 500 cells (Black et al., 1988). However, a number of studies suggest 
that host susceptibility is also a key factor influencing infective dose to some degree 
(Kothary and Babu, 2001). The pathogenic mechanisms of Campylobacter are currently still 
not completely understood. Thereby, when an individual is infected with Campylobacter, the 
precise infective dose of Campylobacter is uncertain. It is unknown whether there is a 
required minimum dose or if a single organism is sufficient. 
The basic assumption therefore is that the probability of ingesting precise j organisms from 
an exposure in which the mean dose is d organisms is Pdj/d). The probability of k 
organisms (:::,j) surviving the immune system and being able to initiate the infection is Pz (k/j). 
If the distribution of organisms between doses is random (i.e. Poisson distributed) and each 
organism has an independent and identical probability of surviving the immune defences 
and initiating infection, the overall probability of k organisms surviving to initiate the infection 
is given by 
00 
P(k) = I~(J/d)P2(k/ j) [8-1 ] 
j=i 
If the minimum number of the organisms (denoted as Kmin ) survives and then initiates 
infection, the probability of infection can be determined by 
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/'f., 'l) 
~nf = I I~(j / d)P2(k / j) [8-2] 
k=kmin j=k 
Based on these assumptions (equations 8-1 and 8-2) and dose-response model parameters 
(a and ~), the models for estimating health risk related to Campylobacter were developed by 
a number of studies (Medema et ai, 1996; Teunis et aI., 1996; Haas et al., 1999; Havelaar et 
al., 2000 and Nauta et al., 2005b). The model equations are: 
1. Probability of infection ~nrCd;a,fJ) = 1-[1- p]d 
Where: 
p is the probability of infection from ingestion of one organism 
d is the dose ingested 
a and ~ are dose-response model parameters (Medema et al., 1996) 
2. Probability of illness given infection 
~lIlinf(d;a,fJ) = 1- (1- Beta(a,fJ)d) 
[8-3] 
[8-4] 
Nauta et al. (2005b) quantified the value of probability of illness given infection (Pili/inf) shown 
in equation 8-4 using the trial data from Black et a/.(1988). In the trial, there were 29 of 89 
volunteers that showed symptom of illness. If a person becomes infected, there is a certain 
probability that the person will become ill. Thus, the uncertainty about the true value of this 
probability is described by a beta distribution. The probability of getting ill given infection is 
Beta (a,~), when a = 29+1 and ~ = (89-29)+1 (Nauta et a/., 2005b), therefore; 
~ll/inf = 0.33 [calculated with -RiskBeta* (29+1, (89-29)+1)) [8-5] 
* using @ Risk software release 4.5 
Including the studies of Black et al. (1988); Havelaar et al. (2000) and Nauta et al. (2005b), 
the dose-response model for estimating probability of illness from ingestion of d organisms 
used in this chapter is: 
~ll (d) = ~nf (d) X ~ll linf (d) [8-6] 
Note: Details of the development of a dose-response relationship is shown in Appendix 3-1. 
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8.3 Methodology 
8.3.1 The estimate of the health risk related to Campy/obaeter 
From this point "health risk" includes probability of infection and probability of illness and 
"Campylobacter "refers to all Campylobacter (with and without antimicrobial resistance). 
The health risks following the consumption. of a Campylobacter-positive chicken was 
estimated following the exposure assessment (Chapter 7). The exposure doses were input 
to the model parameters described by Christensen et al., (2001) and Nauta et al., (2005b). 
Health risks are considered following the consumption of chicken meals and salads. 
Calculations of these are: 
1. Probability of infection from a dose of Campylobacter in a chicken meal given gender was 
calculated by: 
~nfC/O,E = 1- (1- ~c )NClG ,N c/o> 0 [8-7] 
Where: 
P1C is probability of infection from exposure to one Campylobacter. 
NC/G is numbers of Campylobacter in chicken meal ingested per serving given gender group. 
2. Probability of illness from a dose of Campylobacter in a chicken meal given gender was 
calculated by: 
~IlC/O,E = ~nfC/O.E x ~1l/infC [8-8] 
Where: 
Pill/infC is probability of getting ill given probability of infection which can cause adverse 
consequences. From literature, PiII/infC = Beta (29+1, 89-29+1)= 0.33, adopted from Nauta et al., 2005b. 
3. Probability of infection from a dose of Campylobacter in salad given gender was 
calculated by: 
[8-9] 
4. Probability of illness from a dose of Campylobacter in salad given gender was calculated 
by: 
~IlS/O,E = ~nfS/O.E X ~1l/infS [8-10] 
Model parameters used for above calculations are presented in Table 8.1 
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Table 8.1 The parameters for the estimation of health risks of host to Campy/obaeter 
following the consumption of chicken meals and salads (adopted from Christensen et a/., 
2001 and Nauta et at, 2005b) 
Parameter 
SC/G 
SS/G 
Description Distribution/Expression 
Average size of chicken serving given Table 8.2 
gender 
Average size of salad serving given Table 8.2 
gender 
NC/G Numbers of Campy/obaeter in chicken Poisson (Sc/G X 2N;ns) for immediate 
meal serving given gender preparation 
or Poisson (Sc/G x 3N;nsls ) for delayed 
preparation 
NS/G 
PinfC/G.E 
PiIIC/G.E 
PillS/gender,E 
Numbers of Campy/obaeter in salad 
serving given gender 
Probability of infection from exposure to 
one Campy/obaeter 
Probability of infection from a dose in 
Poisson (Sc/G x 4Nsalad) 
0.018748 [RiskBeta (0.145,7.59)5] 
chicken serving given gender, given (1 n )NClG N 0 1 - - '1 C 'C / G > 
exposure(E) 
Probability of infection from a dose in 
chicken serving given gender, given 1 (1 D )NS/G N 0 
- -'1C ,S/G> 
exposure(E) 
Probability of illness from a dose in PinfC/G.E X 6Pili/infC 
chicken serving given gender,E 
Probability of illness from a dose in PinfS/gender,E X Pili/infC 
salad serving given gender,E 
1 gender of person ingesting meal 
2,3,4 numbers of Campy/obaeter in chicken meals (immediate and delayed preparation) and salad 
5 RiskBeta (a,p), the value of a and f3 were obtained from Medema et at, 1996 
6 Pili/inf is Beta (29+1, 89-29+1) (from Nauta et a/.,2005) 
Table 8.2 The average serving size of a chicken meal and salad (based on data from 
Christensen et al., 2001 ) 
Consumer group 
Female 
Male 
Serving size (gram) 
Chicken meal (SC/G) 
148.30 
188.15 
Salad (SS/G) 
63.95 
85,78 
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Calculation procedures 
Calculations of the probability of infection and probability of illness associated with the 
consumption of a chicken meal and salad can be carried out using equations from 8-7 to 8-
10. The parameters fed to the models are shown in Tables 8.1 and 8.2. The examples of 
calculations are demonstrated below: 
1. Probability of infection from a dose (PinfC/G,E ) can be calculated following equation [8-7]. 
~nf C / G,E = 1 - (l - ~ c) N C / G , N c / G > 0 
Where: 
1.1 P1C = probability of infection from exposure to one Campylobacter 
~ RiskBeta (a,~), using @Risk release 4.5*, a = 0.145, ~ = 7.59 
~ RiskBeta (0.145, 7.59) 
~ 0.0187 
1.2 NC/G = Numbers of Campylobacter in chicken meal serving given gender 
~ RiskPoisson (serving size given gender x conc. of Campylobacter g-1 
~ RiskPoisson (148.30 x 0.08 MPM/g) [example for person (female) consumes chicken 
meal associated with the PIGs given T <T c) 
~ 12 
1.3 PinfC/G,E = 1-(1-0.0187)12 
~0.78 
Therefore the probability of infection is 78% when the female group consumes the PIC-
chicken meal contaminated with Campylobacter with a dose 0.08 MPN/g which was 
estimated using the model when T <T c. 
2. Probability of illness from a dose in chicken serving given gender (PilIC/gender, E) can be 
consecutively calculated using above result. This is: 
PilIC/G,E = PinfC/G,E X Pili/inf ; where Pililinf is 0.33 
= (0.78 x 0.33)100 = 26.31 % 
Therefore the probability of illness given probability of infection (78%) is 26.31 % 
8.3.2 Risk model for antimicrobial resistant Campy/obaeter 
In this chapter the additional risk from antimicrobial-resistance associated with the 
consumption of a chicken meal or salad was characterised by two different models: i) the 
CVM-risk model and ii) a modified dose-response relationship model based on the OMRA 
model (mOMRA). 
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The CVM-risk model 
The principle of the CVM-risk model (developed by the Food and Drug Administration-
Center of Veterinary Medicine) is explained in section 7.2.5. As described in the CVM-risk 
model, a relative human risk of antimicrobial resistant Campy/obaeter (ABR-Campy/obaeter) 
associated with the consumption of chicken is given by; 
[8-11 ] 
As the aim of this section is to compare a relative health risk of ABR-Campy/obaeter 
following the consumption of the PICs, the POCs and the BICs, the values of APIC, APoc and 
ABIC following the CVM-risk model are as follows; 
[8-12] 
[8-13] 
ABIC = Kres{ ABIC X S x F pos/BIC X P ABR (i)) [8-14] 
Where: 
i denotes three antimicrobial agents (i.e. ciprofloxacin or erythromycin or nalidixic acid). 
The meaning of the parameters in equations 8-12, 8-13 and 8-14 are described in Table 8.3 
Table 8.3 The description of model parameters modified from CVM-risk model 
Parameter Description Unit 
AplC amount of PIC harbouring ABR-Campy/obaeter consumed pounds 
Apoc amount of POC harbouring ABR-Campy/obaeter consumed pounds 
ABIC 
s 
Fpos/PIC 
Fpos/PoC 
Fpos/BIC 
PABR(i) 
amount of BIC harbouring ABR-Campy/obaeter consumed 
population size 
fraction of positive-Campy/obaeter chicken (PIC) 
fraction of positive-Campy/obaeter chicken (POC) 
fraction of positive-Campy/obaeter chicken (BIC) 
proportion of ABR-Campy/obaeter where three 
antimicrobials taken into account are ciprofloxacin, 
erythromycin and nalidixic acid) 
Kres an antimicrobial resistance transfer coefficient 
pounds 
people 
Remark 
0.83 (chapter 5) 
0.80 (chapter 5) 
1.00 (chapter 5) 
chapter 6 
However, there are currently no specific data for: i) the association between health risk from 
Campy/obaeter infection and the consumption of chicken harbouring antimicrobial resistant 
Campy/obaeter and ii) the consumption of chickens reared from different systems. The 
amount of chicken consumed was also taken to be the amount of chicken consumed in 
general. Therefore, the calculations using equations 8-12, 8-13 and 8-14 are carried out by 
assuming that the value of ApIC, Apoc and ABIC are the same. As Kres is assumed as a 
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constant for either type of chicken, the relative health risk of ABR-CampyJobacter is 
therefore determined by; 
j ·PIC - F pos/PIC X P ABR (i) 
ApOC - F pos/POC X P ABR (i) 
ABIC - F pos/BIC X P ABR (i) 
[8-15] 
[8-16] 
[8-17] 
Therefore, health risk (denoted as "I.") involves the fraction of positive-CampyJobacter 
chicken and proportion of ABR- CampyJobacter. These values (Chapters 7 and 8) were 
inputted to the equations 8-15, 8-16 and 8-17. 
The development of the modified QMRA model (mQMRA) 
As shown in equations 8-15 to 8-17, the parameters input to the CVM model do not include 
the numbers of CampyJobacter in chickens. The CVM model is probably less sensitive for 
comparing the relative risk from the consumption of chicken meals or salad assocated with 
three different groups of chickens. It is evident that there is a significant difference of the 
numbers of CampyJobacter (MPN/g) between these three groups, with the highest level 
found in the BIC group. Although the resistance rate to erythromycin and nalidixic acid of 
CampyJobacter in the PIC, pac and BIC groups were found to be similar (100%), the 
resistance rate to ciprofloxacin is slightly different. In particular, the pac group was found to 
be free from ciprofloxacin-resistant CampyJobacter. Therefore, in order to quantify and 
compare the health risk from ABR- CampyJobacter with a specific antimicrobial which is 
related to the types of chicken consumed, the mQMRA used for antimicrobial resistant 
CampyJobacter was customised from the current QMRA model used in Chapter 7 (for details 
see section 7.2.5, Chapter 7). 
Instead of using the initial numbers of CampyJobacter, the mQMRA considers the number of 
ABR- CampyJobacter as a product of the initial number multiplied by the rate of resistance to 
specific antimicrobial, namely, ciprofioxacin, erythromycin and nalidixic acid, that is; 
[8-18] 
Next, the number of ABR- CampyJobacter (No. ABR) was further modelled using equations 
from 8-7 to 8-10. The calculations were performed similarly to those demonstrated in section 
8.3.1. 
8.3.3 Sensitivity analysis 
The models and model parameters used were adopted from the joint FAOIWHO working 
group and international literature. In the model of heat treatment, internal temperature and 
exposure time were based on the data from the literature. Internal temperature varied from 
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60 to 65°C and the exposure time was from 0.5 to 1.5 minutes. Given these data, the heat 
treatment models used may not fit to the BIC group. As a result, the health risk following the 
consumption of cooked chicken meal remains high. Currently, there is no further information 
expressing higher internal temperature or exposure time that those stated above. However, 
to identify the greatest impact from the changes of variable input, a sensitivity analysis was 
performed. Rather than using only values from the literature, a new set of values of internal 
temperature and exposure time were assumed and defined for use, assuming, during heat 
treatment, amount of time and internal temperature may increase to higher levels than those 
previously used in the models. Of these values, the mean values were estimated using the 
probabilistic distribution (using @Risk release 4.5 software). These mean values, presented 
in Table 8. 4, were fed in to the heat treatment model at T>T c (In Nins= In No-(tIO). Results of 
this were presented in section 8.4.3 and discussed in section 8.5.3. 
Table 8.4 Mean values of parameter time (ti) and internal temperature (T) 
Exposure time (min) 
RiskPERT(min,most likely,max) 
0.5,1,1.5* 
1.5,2,2.5 
2,3,4 
3,4,5 
4,5,6 
Mean value of 
time (min) 
2 
3 
4 
5 
Internal temperature (0C) 
RiskPERT(min,most likely, max) 
60,64,65 
60,64,68 
62,65,68 
63,65.5,69.5 
64.5,66.5,70 
65.5,67.5,71 
66,69,72 
67,70,73 
68,71,74 
70,72,74 
Mean value of 
temperature (DC) 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
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8.4 Results 
It is important to note that this finding was carried out following the assumption and data 
available. However, the sensitivity analysis was performed to test the reliability of the heat 
treatment model givenT> T c. 
8.4.1 Health risk of Campy/obaeter 
Determination of the health risk of person consuming a chicken meal 
prepared immediately 
1) Probability of infection 
According to the model and data set, the consumption of chickens purchased from butchers' 
shops (the BIC group) can cause infection with Campylobacter (100%), either cooking with 
internal temperature 13 lower than T c (T c = 46°C) or higher than T c. In the POC group, the 
probabilities of infection when T <T c range from 64-72.4% and they decline gradually to 3.7% 
when T> T c (Table 8.5). The probability of infection from ingesting these micro-organism 
attributable for the PIC group shows the lowest value and significantly different from the 
POCs and the BICs (p<0.001), in particular, if T> T c, the risk was reduced to 0-1.9%. There 
is no difference of the probability of infection occurring between female and male consumers 
for all groups of chicken. 
Table 8.5 The probability of infection (%) caused by the consumption of a chicken meal 
contaminated with Campylobacter transferred from three types of chicken given gender and 
internal temperature at the protected areas 
Probability of infection (%) 
Type of chicken 1 Chicken meal: T<T c2 Chicken meal: T>Tc3 
Female Male p-value Female Male p-value 
PIC 20.32 26.12 NS 0 1.88 NS 
POC 64.01 72.39 NS 3.71 3.71 NS 
BIC 100 100 NS 100 100 NS 
p-value* <0.001 <0.001 <0.001 <0.001 
1 Pre-packed intensively-reared (PIC), pre-packed organically-reared (POC) and butcher intensively-
reared chicken (BIC) group 
2.3 Internal temperature at the protected area lower or higher than 46°C (T c) 
* Using chi-square to analyse the significant difference of probability of infection between three groups 
13 Internal temperature refers to the temperature at the insid~ of chicken meat, which is defined as the 
protected area. Campylobacter in this area is thought to be viable. 
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2) Probability of illness 
The probability of illness is about 7-9 % following the consumption of the PICs, 21-23 % for 
the POCs and 33% for the BICs. However, when T>Tc, it is less than 1% following the 
consumption of the PICs, 1-2% for the POCs and 33% for the BICs. Given T>Tc, a gradual 
decrease is found in the probability of illness associated with the consumption of the PICs 
and the POCs (Table 8.6). The decrease is about 6-8 % in the PICs and 20 % in the POCs. 
However, the rates found to be associated with the consumption of the BICs were consistent 
at 33 % whether either model (given T <T c or given T> T c) was used. So far, the consumption 
of a chicken meal associated with the BIC group was found to have a significantly higher 
potential to cause illness than those from the PICs and the POCs (p <0.001). 
Table 8.6 The probability of illness (%) caused by the consumption of a chicken meal 
contaminated with Campylobacter transferred from three types of chicken given gender and 
internal temperature at the protected areas 
Probability of illness (%) 
Type of chicken Chicken meal: T<T c Chicken meal: T>T c 
Female Male p-value Female Male p-value 
PIC 6.70 8.62 NS 0 0.62 NS 
POC 21.12 23.88 NS 1.22 1.22 NS 
BIC 33 33 NS 33 33 NS 
p-value <0.001 <0.001 <0.001 <0.001 
Determination of the health risk for a person consuming salad 
1. Probability of infection 
The results from the consumption of salad related to the POC and BIC groups demonstrate 
a high probability of infection in both female and male groups (ranged from 95-98% for the 
POCs and 100 % for the BICs). The values found in the PIC group are significantly lower 
than the other two groups (p<O.001). These values are about 61 % for a male group and 51 % 
for a female group. There is no evidence to show a significant difference in probability of 
infection between female and male groups. 
2. Probability of illness 
The probability of illness related to the consumption of salad contaminated with 
Campylobacter from the uncooked PICs is about 18-26% for men and 18-20% for women; 
from the POCs is 31-33% for both sexes; and from the BICs is 33% for all age and sex 
groups. It is evident that in the female group, the difference of the probability of illness 
following the consumption of salad related to three groups of chicken is significant (p=O.02), 
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whereas there is no significant difference found in the male group. However, in the same 
group of chicken, there is no significant difference found in both genders. These results are 
shown in Table 8.7. 
Table 8.7 The health risk caused by the consumption of salad contaminated with 
Campylobacter transferred from three types of chickens 
Type of chicken 
Probability of infection (%) Probability of illness (%) 
Female Male p-value* Female Male p-value 
PIC 51.28 61.91 NS 16.92 20.43 NS 
POC 94.88 98.16 NS 31.31 32.39 NS 
BIC 100 100 NS 33 33 NS 
p-va/ue** <0.001 <0.001 0.02 NS 
* Using Fischer's exact test to analyse the significant difference between two groups 
**Using Chi-square test to analyse the significant difference between three groups 
Determination of the health risk for a person consuming meals prepared from 
pre-refrigerated chicken 
1. A chicken meal 
Table 8.8 presents the health risk related to the consumption of chicken meals cooked after 
the chickens have been stored in a refrigerator. These were found to be highest in the BICs. 
The results are statistically significant at p <0.001. The health risk related to the PIC and 
POC groups when immediately prepared and given T <T c were higher than those found in 
the delayed preparation. If, however, using the model given T> T c, the outcomes from 
immediate and delayed preparation were very similar. This is in contrast to the results found 
in the BIC group, which the phase of preparation (immediate or delayed) and temperature of 
heat treatment did not change the health risk from Campylobacter. 
Table 8.8 The health risk (%) associated with the consumption of a chicken meal prepared 
from three types of chickens after being stored in a refrigerator 
Probability of infection (%) Probability of illness (%) 
Type of T<Tc T>Tc T<Tc T>Tc 
chicken Male Female Male Female Male Female Male Female 
PIC 1.88 3.71 0 0 0.62 1.23 0 0 
POC 12.41 15.66 0 0 4.09 5.17 0 0 
BIC 100 100 100 100 33 33 33 33 
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
• No significant differences of heath risk found between female and male for all groups of chicken 
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2. Salad 
Salads contaminated with the uncooked CampyJobacter-positive BICs stored in a refrigerator 
have the highest values of health risk to consumer, followed by the POC and the PIC groups, 
respectively (Table 8.9). In the PICs and POCs, the values from the immediate post 
preparation consumption group were found to be significantly higher than those from the 
delayed post preparation consumption group (p<O.001). However, in the BIC group, all 
values were found to be the same whether salad is contaminated with the positive carcasses 
before or after the chickens were stored in a refrigerator. 
Table 8.9 The health risk caused by the consumption of salad contaminated with 
CampyJobacter transferred from three types of chickens after being stored in a refrigerator 
Probability of infection (%) Probability of illness (%) 
Type of chicken 
Female Male Female Male 
PIC 7.29 9.03 2.41 2.98 
POC 32.79 41.13 10.82 13.57 
BIC 100 100 33 33 
p-value 0.0001 0.0001 0.0001 0.0001 
No significant differences of health risk found between female and male for all groups of chicken 
8.4.2 Comparison of health risk due to antimicrobial resistant 
Campy/obaeter between the three groups of chicken 
The health risk determined by the CVM model 
The health risk from ABR-CampyJobacter following the consumption of three groups of 
chicken can be determined with two different assumptions. These assumptions are based on: 
i) the rate of resistance to three antimicrobials as a proportion per carcass and ii) the rate of 
resistance to three antimicrobials as a proportion per isolate (section 6.4.2, Chapter 6). 
Note: rate /carcass means percentage of chicken carcases harbouring one/more resistant isolates 
rate /isolate means percentage of isolates found to be resistant to a specific antimicrobial 
As shown in Table 8.10, given a ciprofloxacin resistance rate per isolate, a health risk (Asd 
from the consumption of the BICs is approximately 4.8 times over that related to the PICs 
(Apd, whereas there is no additional health risk from CampyJobacter associated with the 
consumption of the organic chickens. For erythromycin and nalidixic acid, the risks are 
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slightly different between these three groups of chicken. The value of i'BIC-erythromycin 
resistance found in the BICs is higher than those associated with the PIC and poe groups. 
When using the resistance rate per carcass (Table 8.10), the risk of ciprofloxacin-resistant 
Campy/obaeter from the BICs is still higher than those from the PICs. There is no additional 
health risk from ciprofloxacin resistance related to the consumption of organic chickens. 
Although the additional risks related to erythromycin and nalidixic acid resistance in these 
three groups are only slightly different, the highest rate is still found in the BIC group (1.00 
for both ABIC-erythromycin and ABlc-nalidixic acid). 
Table 8.10 The health risk of antimicrobial-resistant Campy/obaeter following the 
consumption of chicken given three types of chickens and antimicrobials using a eVM model 
Health risk (A): isolate 1 Health risk (A): carcass2 
Type of 
chicken 
Ciprofloxacin Erythromycin Nalidixic Ciprofloxacin Erythromycin Nalidixic 
acid acid 
PIC 0.02 0.83 0.83 0.07 0.83 0.83 
POC 0 0.80 0.76 0 0.80 0.80 
BIC 0.12 1.00 0.81 0.27 1.00 1.00 
1 Health risk determined from the proportion of isolates found to be resistant to tested antimicrobials. 
2 Health risk determined from the proportion of carcasses harbouring one/more resistant isolates 
The health risk determined by the modified QMRA 
From this approach the additional health risk refers to the probability of infection and 
probability of illness associated with ABR-Campy/obaeter following the consumption of a 
chicken meal or salad. 
1. A chicken meal 
Tables 8.11 and 8.12 show that according to the model the highest additional risks related to 
Campy/obaeter resistant to three antimicrobials were found in the BIC group (i.e. 100% 
probability of infection and 33% probability of illness) whether the model used is given T <T c 
or given T> T c. 
The results from the PIC group show very low additional risks related to ciprofloxacin-
resistant Campy/obaeter (CR-Campy/obaeter) « 2% probability of infection). For other two 
antimicrobials (erythromycin and nalidixic acid), the additional risks were found to be higher 
than that related to CR-Campy/obaeter. These risks related to ER- and NAR-Campy/obacter 
were found to be less than those from the POCs and the BICs, respectively. This becomes 
clear when using the model given T> T c· 
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There is no additional risk related to CR- Campylobacter from POC-chicken meals. The risks 
related to other antimicrobial resistances were found to be fairly high (64-72 % for ER-
Campylobacter and 62-71 % for NAR-Campylobacter). However, when the internal 
temperature used is higher than T c, the risks were reduced to very low levels. Levels of 
additional health risks related to POC-chicken meals were found to be between the levels 
from the PICs and the BICs (PICs<POCs<BICs), except for that related to ciprofioxacin 
resistance. 
Levels of the additional risks related to ABR- Campylobacter show the same whether the 
levels were taken into account as a proportion of a carcass or of an isolate. 
Table 8.11 Probability of infection of person consuming chicken harbouring ABR-
Campylobacter 
Probability of infection (%) 
Type of Type of 
chicken antimicrobial 
T<Tc T>Tc 
'carcass !isolate 'carcass lisolate 
F M F M F M F M 
Ciprofloxacin 1.9 1.9 0 0 0 0 0 0 
PIC Erythromycin 21.8 26.1 21.8 26.1 0 1.9 0 1.9 
Nalidixic acid 21.8 26.1 21.8 26.1 0 0 1.9 1.9 
Ciprofloxacin 0 0 0 0 0 0 0 0 
POC Erythromycin 64.0 72.4 64.0 72.4 3.7 5.5 3.7 5.5 
Nalidixic acid 64.0 72.4 61.9 70.8 3.7 3.7 5.5 3.7 
Ciprofloxacin 100 100 100 100 100 100 100 100 
BIC Erythromycin 100 100 100 100 100 100 100 100 
Nalidixic acid 100 100 100 100 100 100 100 100 
Table 8.12 Probability of illness of person consuming chicken harbouring ABR-
Campylobacter 
Probability of illness (%) 
T<Tc T>Tc 
Type of Type of 
chicken antimicrobial 'carcass 'isolate 'carcass /isolate 
F M F M F M F M 
Ciprofloxacin 0.6 0.6 0 0 0 0 0 0 
PIC Erythromycin 7.2 8.6 7.2 8.6 0 0.6 0 0.6 
Nalidixic acid 7.2 8.6 7.2 8.6 0 0.6 0 0.6 
Ciprofloxacin 0 0 0 0 0 0 0 0 
POC Erythromycin 21.1 23.9 21.1 23.9 1.2 1.8 1.2 1.8 
Nalidixic acid 21.1 23.9 20.4 23.4 1.2 1.8 1.2 1.2 
Ciprofloxacin 33 33 33 33 33 33 33 33 
BIC Erythromycin 33 33 33 33 33 33 33 33 
Nalidixic acid 33 33 33 33 33 33 33 33 
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2. Salad 
Table 8.13 shows that salad contaminated with ABR-Campylobacter transferred from the 
uncooked BICs exhibited the highest health risk whether the resistance is to ciprofloxacin or 
erythromycin or nalidixic acid (100% probability of infection and 33% probability of illness). 
The results from the PIC groups show lower risks than other two groups, except for the risks 
related to CR- Campylobacter. There is no risk related to CR-Campylobacter following the 
consumption of POC-salad. 
Table 8.13 Health risks of person consuming salad contaminated with ABR-Campylobacter 
Probability of infection Probability of illness 
Type of Type of Icarcass !isolate Icarcass lisolate chicken antimicrobial 
F M F M F M F M 
Ciprofloxacin 5.5 7.2 1.9 1.9 1.8 2.4 0.6 0.6 
PIC 
Erythromycin 49.4 60.4 49.4 60.4 16.3 19.9 16.3 19.9 
Nalidixic acid 49.4 60.4 49.4 60.4 16.3 19.9 16.3 19.9 
J 
Ciprofloxacin 0 0 0 0 0 0 0 0 
POC E ryth romyci n 94.9 98.1 94.9 98.1 31.3 32.4 31.3 32.4 
Nalidixic acid 94.9 98.1 94.0 97.7 31.3 32.3 31.0 32.3 
Ciprofloxacin 100 100 100 100 33 33 33 33 
BIC Erythromycin 100 100 100 100 33 33 33 33 
Nalidixic acid 100 100 100 100 33 33 33 33 
8.4.3 Sensitivity of the model 
The changes of the variables input, time and internal tempaerature, have the great imact on 
the outcomes. When the mean value of time increases, the health risk can be reduced to 
very low. Similarly, increase of the mean value of internal temperature greatly affects the 
health risk. The results are presented in Tables 8.14 - 8.17 and Figures 8.4 and 8.7. 
Table 8.14 The exposure dose and health risk following a change of time (ti) given internal 
temperature at the protected area 63°C 
Parameter function of t, Time (tj) Dose Prob. infection (%) Prob. illness (%) 
[RiskPERT(min,most likely,max)] (min) (MPN/g) Female Male Female Male 
0.5,1,1.5* 1 75.16 100 100 33 33 
1.5,2,2.5 2 4.49 100 100 33 33 
2,3,4 3 0.27 53.09 61.18 17.52 20.19 
3,4,5 4 0.02 3.71 5.5 1.2 1.8 
4,5,6 5 0.001 0 0 0 0 
* The amount of time previously used for the risk modelling presented In chapter 7 
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Table 8.15 The exposure dose and health risk following a change of internal temperature 
(DC) given a time of 1 minute that the protected area exposes to heat 
Parameter function of T (0C) Temperature Dose Prob. infection (%) Prob. illness (%) 
[RiskPERT(min,most likely,max)] (oC) (MPN/g) Female Male Female Male 
60,64,65 63 75.16 100 100 33 33 
60,64,68 64 44.73 100 100 33 33 
62,65,68 65 24.2 100 100 33 33 
63,65.5,69.5 66 11.69 100 100 33 33 
64.5,66.5,70 67 4.94 100 100 33 33 
65.5,67.5,71 68 1.78 99.32 100 32.78 33 
66,69,72 69 0.53 77.57 84.92 25.6 28.02 
67,70,73 70 0.13 30.2 36.5 9.97 12.05 
68,71,74 71 0.02 5.51 7.3 1.82 2.41 
70,72,74 72 0.003 0 1.9 0 0.006 
Table 8.16 The exposure dose and health risk following a change of internal temperature 
(DC) given a time of 2 minutes that the protected area exposes to heat 
Parameter function of T (oC) Temperature Dose Prob. infection (%) Prob. illness (%) 
[RiskPERT(min,most likely,max)] (oC) (MPN/g) Female Male Female Male 
60,64,65 63 4.49 100 100 33 33 
60,64,68 64 1.58 98.85 99.65 32.62 32.88 
62,65,68 65 0.47 72.9 81.09 24.06 26.76 
63,65.5,69.5 66 0.11 26.12 31.51 8.62 10.39 
64.5,66.5,70 67 0.02 5.52 7.3 1.82 2.4 
65.5,67.5,71 68 0.003 0 0 0 0 
Table 8.17 The exposure dose and health risk following a change of internal temperature 
(DC) given a time of 3 minute that the protected area exposes to heat 
Parameter function of T (0C) Temperature Dose Prob. infection (%) Prob. illness (%) 
[RiskPERT(min,most likely,max)] (0C) (MPN/g) Female Male Female Male 
60,64,65 63 0.27 53.09 61.18 17.51 20.19 
60,64,68 64 0.06 14.05 18.75 4.6 6.2 
62,65,68 65 0.009 1.87 3.7 0.006 1.2 
63,65.5,69.5 66 0.001 0 0 0 0 
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A chicken meal: immediate cooking with T>Tc 
1) Increase of amount of time that the protected area is exposed to the heat given an internal temperature of 63°C 
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Figure 8.4 Level of health risk when increasing time of exposure to heat treatment given internal temperature 63°C 
2) Increase of internal temperature given 1 minute that the protected area is exposed to the heat 
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Figure 8.5 Level of health risk when increasing internal temperature given 1 minute of exposure time to heat treatment 
3) Increase of internal temperature given 2 minutes that the protected area is exposed to the heat 
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Figure 8.6 Level of health risk when increasing internal temperature given 2 minutes of exposure time to heat treatment 
4) Increase of internal temperature given 3 minutes that the protected area exposes to the heat 
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8.5 Discussion 
The health risks from Campylobacter are considered in relation to probability of infection and 
illness. These negative consequences can be induced by exposure to potentially hazardous 
organisms at different levels on the health of consumer. Both the probability of infection and 
probability of illness are taken into account. The risk is dependent on the circumstances 
which are influenced to various degrees by the pathogens, host characteristics and food 
matrix including condition of ingestion. It is important that any consideration of risk to human 
health from Campylobacter (with and without antimicrobial resistance) focuses on the 
moment occurring at the time of consumption of the food (chicken or salad). 
8.5.1 The comparison of relative health risk associated with three 
types of ch icken 
The results from the BIC group harbouring very high numbers of Campylobacter with high 
antimicrobial resistant isolates show the association between the probability of infection and 
the exposure dose of potential (viable) Campylobacter. The consumption of a BIC-meal 
therefore may result in high risk of infection. 
It appears that the value of probability of illness related to the BIC consumptions based on 
probability of infection (Pili/inf) use in the model is very high (33%). This may be as attributed 
to a bias due to the insufficiency of the human exposure study (Teunis et al., 1999; Teunis et 
al., 2005 and Vialette et al., 2005) and of other data (i.e. cooking parameters, transfer 
coefficients related to hygiene practices in a private kitchen). 
If elevated internal temperatures (63°C-72°C) are achieved for a sufficient length of time (1-5 
minutes), the probability of illness related the BICs can be reduced from 33% to <1 %. 
Clearly, the use of a risk model and data must be carefully considered. Ineffective risk model 
or insufficient data may lead to an inaccurate outcome. A sensitivity analysis has hightlighted 
the need for careful consideration of the model parameters and data used (i.e. the mean 
values of internal temperature and time). 
As stated before, this study aims to investigate the relative a health risk of Campylobacter 
following the consumption of three groups of chicken, which were supplied from the different 
rearing systems and distributed from a slaughterhouse with different packaging methods. 
Thus, the dose-response relation model is still able to reliably demonstrate the difference of 
health risk induced between these three types. As a result, the consumption of chicken 
meals or salad associated with the BIC group would cause the infection and illness with a 
higher probability than that related to the PIC and the POC groups. It is also to state that the 
consumption of the PIC causes lowest consequences, in particular, after being cooked. The 
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consumption of salad contaminated with the uncooked chicken contributes a higher risk than 
that from a chicken meal properly cooked. 
This suggests that the degree of a health risk at the time of consumption is associated with 
the concentration of Campylobacter in the carcass before and after cooking. However, this 
assumes that the organisms can survive the human immune system and initiate an infection 
(Mead, 2004). Moreover, this is clearly influenced by pathogens and food matrix, with host 
characteristics assumed to be constant. It is important to note that these results provide the 
information for general population (not for a specific at risk groups), suggesting that if it is to 
be used for a vulnerable group, young children, elderly people, immuno-compromised host, 
etc., the current dose response model may not be reliable. Since the immune system of 
these groups may be deficient or lower than that of healthy group, the dose that can initiate 
an infection is likely to be lower than that for the general population. However, it is unlikely to 
that a dose-response model for these individual groups could be developed from current 
epidemiological data because of the sporadic nature of Campylobacter. This concern has 
been recognised in several studies (Anderson et al., 2001; Adak et al., 2002; Adak et al., 
2005). The probabilistic approaches have been applied to the QMRA model in attempt to 
include both uncertainty and variability due to the lack of data or some limitations of the 
approaches (Teunis et al., 1997 and Kang et al., 2000). 
It is interesting to note that the consumption of salad contaminate with uncooked chickens 
may cause a higher risk to human health than eating a chicken meal. The consequence of 
cross-contamination may be a key factor in increasing or decreaSing health risk. Thereby, 
the magnitude of the risk is highly dependent on individual food-handling practices 
(Christensen et ai, 2001; Rosenquist et al., 2003; Bartholomew et al., 2005 and Nauta et al., 
2005b). Individuals vary greatly in the stringency of their kitchen hygiene, so the data on 
personal hygiene in the kitchen should be taken into account. Since there are currently few 
studies on food-preparation practices in private kitchens, it is difficult to quantify precisely 
doses related to cross-contamination, which affect the level of the risk. However, with 
probabilistic approaches applied to the estimations, these findings can support the notion 
that a great deal of health risk following the consumption of a contaminated chicken or other 
food commodity could be eliminated or reduced with good hygiene practice in the private 
kitchen (Bartholomew et aI., 2005 and Nauta et al., 2005b). In addition, a proper cooking of a 
chicken alters the health risk Significantly, in particular, on carcasses harbouring low 
concentrations of Campylobacter. For the carcasses harbouring high concentrations, 
bearing a high risk, it may be necessary to combine several approaches in order to reduce 
the risk. Although, a decrease in the numbers of Campylobacter occurs after refrigeration, 
other consequences which have not been investigated and elucidated may come to light 
following refrigeration. Using the storage under refrigeration to reduce the number of 
organism should not be recommended to consumers. 
199 
8.5.2 The comparison of relative health risk related to antimicrobial-
resistant Campy/obaeter 
Estimation of health risk related to antimicrobial resistant Campylobacter involves numerous 
factors. It requires a large number of data. It is difficult to directly relate contributions from 
antimicrobial resistance in Campylobacter to human health following the consumption of 
chicken. Until now there is no evidence to demonstrate a direct relationship between 
antimicrobial resistance in animals and in humans. Several studies showed that 
antimicrobial resistance in humans comes from a number of sources (i.e. overuse of 
microbials in humans, environment). Currently, there has been one study that performed a 
probabilistic risk assessment for fluoroquinolones resistant Campylobacter (FQ-
Campylobacter) (Bartholomew et al., 2005). However, this recent work, using the CVM-risk 
model quantified the relationship between amount of chicken harbouring ABR-
Campylobacter consumed and a number of cases of human campylobacteriosis with 
fluoroquinolones resistance phenomena. It appears that both prevalence of a positive-
Campylobacter chicken and a proportion of FQ- Campylobacter in the chickens were 
considered at the retail point (at which the carcass is a raw product), even before cooking. 
Herein, the CVM model does not focus on the risk at the time of consumption and thus does 
not reflect to the real situation. Nonetheless, at present, no adequate and appropriate model 
is available for predicting the health risk of antimicrobial-resistance Campylobacter at the 
time of consumption. 
Health risk related to antimicrobial resistant Campylobacter in this context was considered 
as not only the additional risk to human campylobacteriosis, but also the comparative risk 
following the consumption of three different types of chicken. Therefore, two models were 
used in parallel for assessing the health risk. Whilst, the CVM model was selected because 
it is only a quantitative risk model currently used for FQ- Campylobacter, the new modified 
model was developed for quantifying health risk related to the exposure dose at the time of 
consumption. 
Using the CVM model, the health risk from the resistant isolates (to either erythromycin or 
nalidixic acid) of Campylobacter isolated from the BICs is high and is different from the other 
two groups (PICs and POCs) around 20%. There is no difference found between the PICs 
and POCs for these antimicrobials, except for ciprofloxacin resistance. It is become clear 
that as the organic chickens are free from ciprofloxacin-resistant Campylobacter, there is no 
additional health risk related to ciprofloxacin resistance to be concerned about. 
The modified model (mQMRA) considers the health risk at the time of consumption of the 
chicken. The results found are very interesting. The health risks of CR- or ER- and NAR-
Campylobacter following the consumption of the PICs and POCs diminish rapidly with heat 
treatment, in particular, when using the model given T > T c. Notably, after cooking the 
additional health risk of CR- Campylobacter following the consumption of the PICs is zero, 
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being equal to that found to be associated with the organic chicken (completely free from 
CR- Campy/obaeter). In addition, the health risks related to ER- and NAR- Campy/abaeter 
following the consumption of salad contaminated with Campy/abaeter from the PICs are 
lower than those found contaminated with Campy/abaeter from the POCs and BICs. This 
can be explained by the initial lowest number of Campy/abaeter isolated from the PICs 
compared with other two groups. 
The additional health risk of these three antimicrobial resistant Campy/abaeter associated 
with the consumption of a chicken meal or salad associated with the BICs remains high. This 
suggests that the numbers of Campy/abaeter in the raw carcasses playa significant factor 
for the estimate of a health risk to consumers. If the carcass harbours low concentrations of 
the organism and it is treated with the proper cooking or food-handling, the health risk of the 
antimicrobial resistant Campy/abaeter can be diminished to as Iowa level as that found in 
the carcass free from the antimicrobial resistant isolates. In contrast, a carcass harbouring 
high level of this organism remains a high risk associated with antimicrobial resistance to be 
concerned about. However, the dose-response model used for estimating health risk was 
based on one human exposure study. It is possible that the model and availabilities of data 
are thus leading to an inaccurate estimate. The results from a sensitivity analysis support 
this notion. 
Compared with the CVM model, the mQMRA model provides a sounder basis for the 
estimation of the risk at the time of consumption. Interestingly, both models indicated that 
the consumption of the BICs can cause high risk to human health in terms of illness and 
failure of antimicrobial treatment. Whilst the result from the CVM model suggests that the 
consumption of both the PICs and BICs (intensively reared chicken) can cause an infection 
with Campy/obaeter resistant to ciprofloxacin, the mQMRA shows that after heat treatment 
the risk of CR- Campy/abaeter related to the PIC group is completely eliminated. 
Furthermore, the CVM model showed that the consumption of the PICs can cause higher 
additional risk related to CR-, ER- and NAR- Campy/abaeter than those by the POCs. In 
contrast, the mQMRA showed that the consumption of the POCs may lead to more health 
risk regarding ER- and NAR- Campy/abaeter than that by the PICs. 
Whilst the CVM model seems to estimate the health risk at the upper bound (a conservative 
approach for the worst case) (Anderson et a/., 2003 and Cox and Popken, 2004), the 
mQMRA using the probabilistic approach includes both the best case and the worst case. 
Different findings due to use of different models can introduce a conflict for consumers. If 
this is distributed to the public without clearer explanation, consumers would be confused 
with this information. The results from the CVM model could additionally lead to public 
concern on the effectiveness of antimicrobial therapy for campylobacteriosis because 
ciprofloxaein is the drug of choice in treatment of campylobacteriosis and broad-spectrum 
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antimicrobials used for the infection with an additional complication, in particular, in the 
vulnerable group (Helms et al., 2005). 
It is difficult to compare findings here to other studies because most studies have not carried 
out the probabilistic health risk assessment for ABR- Campylobacter following the 
consumption of chickens. In addition, none of those attempted to determine the comparative 
risk between intensively and organically reared chickens. Moreover, whether the carcass is 
sold as a pre-packaged or unwrapped product has not been taken into account. In other 
words, there is no evidence of comparison of cross-contamination occurring at the retail 
point. Thereby, the cross-contamination after the processing at slaughterhouse has not been 
considered clearly. 
Each model has limitations as it is constrained by unresolved uncertainties. It appears that 
no robust evidence has verified the direct transfer of antimicrobial resistant Campylobacter 
from animals to humans via the consumption of foods (Bartholomew et al., 2005). Ideally, in 
doing so, it is necessary to use an effective surveillance system to track both resistant 
organisms and antimicrobial use, providing the information on antimicrobial use which 
should be able to relate back to the information on resistance. In addition, there is a need to 
collect definite consumption data and information of what product is thought to be the major 
sources of Campylobacter and antimicrobial resistance. It is useful to consider the health 
risk from Campylobacter with and without antimicrobial resistance using different models 
and assumptions. One model or assumption can provide supportive data or information for 
the other. For example, Hurd et al.(2004) and Cox (2005) applied the event hazard or fault 
scenario to determine a public health consequences of antimicrobial use in animals. This 
method is a deterministic risk assessment which requires a great number of extensive 
scientific and numeric data. Bartholomew et al., (2005) considered the event obtained from 
reported campylobacteriosis related to the consumption of chickens at consumer level. The 
former provides the overview of the problem. The latter focuses on a specific group. 
8.5.3 The sensitivity of the model parameters 
In spite of scarcity of data, the risk can be further predicted using the modelling approaches. 
However, the result must be interpreted following the assumptions and conitions fed to the 
model. In addition, the sensitivity of a change in parameter to the outcome must be 
considered. This notation can be demonstrated so far with the previous results of health risk 
related to the consumption of the BIC-meals. The very high health risk was found to be 
related to the BIC group harbouring high numbers of Campylobacter. However, the risks 
were characterised using the assumptions and data from the literature. There are two 
parameters involving the heat treatment model: i) time (t,.) that the protected area exposes to 
the internal heat and ii) internal temperature (T) reaching the protected area. The ranges of 
time of exposure to internal heat fed into the model are 0.5-1.5 minutes [Risk Pert (0.5,1,1.5), 
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mean value - 1 minute] The ranges of internal temperature fed into the model are 60 - 65°C 
[ RiskPert (60,64,65), mean value- 63°C]. There are currently no other studies investigating 
the effect of cooking with longer time and higher internal temperature on Campy/obaeter 
carried out in chickens. 
The health risks related to the BIC group can be reduced to as Iowa level as those found in 
the PICs and the POCs when the time or internal temperature was slightly increased 
compared to the values previously used. This suggests that the health risk is sensitive to a 
change of the variable time and temperature. Therefore, the models selected for use are 
sensitive to variation in the inputs. However, this demonstration generated using 
mathematical equations and is not a real situation. More studies related to the association of 
time, internal temperature and Campy/obaeter level in the protected area are required. It is 
questionable whether it is possible to increase the heat treatment or time of cooking 
sufficiently high as to be able to reach the point as demonstrated above without deterioration 
of the meals. It is noted that, changing of time and temperature does not affect the health 
risk related to a chicken meal given T<Tc and salad. 
8.6 Summary 
The health risks (probability of infection and probability of illness) were calculated using 
exposure doses to Campy/obaeter (with and without antimicrobial resistance) calculated in 
Chapter 7. The calculations were performed based on the assumptions from the literature 
related to establishment of probability of infection and probability of illness. Additional data 
(e.g. seving size of a chicken meal) were obtained from other studies. The results in this 
chapter are as follows: 
1. When comparing the three types of chicken using currently available data, the risk of 
Campy/obaeter associated illness related to the consumption of chicken meals from 
the BICs is higher (33% probability) than that related to the POCs (1-24% probability) 
and the PICs (0-7% probability). However, this is the worst case scenario. The best 
case scenario is that the elevated internal temperatures (63°C-72°C) can be 
achieved for a sufficient length of time (1-5 minutes). It results in the reduction of the 
health risk associated with the BICs from 33% to <1 % (section 8.4.3 and Figures 8.4 
to 8.7). It becomes clear that the risk model and data fed to the calculation must be 
carefully selected as they may result in an inaccurate outcome. 
2. The consumption of salad contaminated with Campy/obaeter transferred from a 
Campy/obaeter-positive PIC and POC is more likely to cause illness than that 
related to an adequately cooked chicken meal (16-20% for the POCs, 31-32% for 
the POCs and 33% for the BICs. However, this contamination is related to the 
uncooked chicken, suggesting that the reduction of health risk can be achieved by 
good hygiene practices in the kitchen. 
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3. Using the CVM-model, the additional health risk associated with ABR-
Campylobacter is found to be highest following the consumption of meals prepared 
from the BICs (Table 8.10). However, the CVM model considers the association 
between the prevalence of Campylobacter-positive chicken at retail outlet and the 
numbers of cases of campylobacteriosis with antimicrobial resistance. This does not 
represent real health risk occurring at the time of consumption. It could be therefore 
the worst case scenario of health risk associated with ABR-Campylobacter. 
4. Using the mQMRA, the risk of ABR-Campylobacter associated illness is found very 
high following the consumption of meals related to the BICs (33% probability of 
illness). However, if internal temperature and time of thermal at the protected area 
are increased to higher levels than those stated in the assumptions, the health risk 
related to the BIC can also be reduced. 
5. There is no apparent additional health risk related to ciprofloxacin resistance 
following the consumption of chicken meals prepared from organic chickens. The 
consumption of the PICs- and the BICs-chicken meals may lead to Campylobacter 
infection with antimicrobial resistance. The risk related to ciprofloxacin resistance 
related to the PIC was lower than that related to the BICs when using current data 
«1 % for the PIC and 33% for the BICs). The health risk related to antimicrobial 
resistance following the consumption of chicken meals can be reduced to a very low 
probability if elevated internal temperatures (63°C-72°C) are achieved for a sufficient 
length of time (1-5 minutes). 
The results suggest that the risk model and data used must be carefully selected as they 
may result in an inaccurate outcome. It may be misleading and lead to an inappropriate 
interventions for the mitigation of the health risk. The banning animal antimicrobials to 
reduce selection pressure for resistance in bacteria may cause an increase numbers and 
consequently in the incidence of illness. However, if antimicrobials were allowed to be freely 
used on the farm, over time Campylobacter may develop high resistance genes and 
resulting in Campylobacter load in chicken can referring to high numbers. This could 
potentially lead to a considerably higher risk to human health. The effectiveness of an 
intervention for the management of risk related to Campylobacter with and without 
antimicrobial resistance may involve several factors. It cannot be resolved by a single 
intervention, for example banning antimicrobial use in animal or controlling farm practices, 
without also regulating at the point of sale. Finally, it is important to understand the effect of 
any intervention on other foodborne infections such as Salmonella and E. coli in order to 
achieve an intregrated approach. 
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CHAPTER 9 
Potential Interventions for the Management of Health 
Risk related to Campy/obaeter and Antimicrobial 
Resistance in Poultry Production 
9.1 Background 
9.1.1 General 
Although Campy/obacter infection does not cause severe illnesses (except for the vulnerable 
groups) unlike those caused by E.coli 0157:H7 or Sa/monella, it has been recognised as the 
most common pathogen amongst these food borne pathogens found to be associated with 
enteritis. This is also found similar in the UK, where Campy/obacter is currently the highest 
identified causes of bacterial infectious intestinal disease (I I D)(Campy/obacter jejuni 77.3%, 
Sa/monella 20.9%, Escherichia coli 0157:H7 1.4%). A high prevalence of positive 
Campy/obacter has been found in poultry. The economic burden (i.e. medical costs and 
productivity losses) due to Campy/obacter infection is large (Bean and Griffin, 1990; Bryan 
and Doyle, 1995; Buzby and Roberts, 1997; Adak et a/., 2002; Bull et a/., 2003; ACMSF, 
2004 and Burgess, et a/., 2005). This confluence of human health and Campy/obacter 
(zoonotic bacteria) associated with the consumption of poultry has been a growing public 
health issue. In addition, the emergence of antimicrobial resistance resulting in failure of 
antimicrobial therapy for this organism has introduced an additional potential risk to human 
health (Engberg et a/., 2004). It has been proposed that antimicrobial use in poultry 
husbandry may induce the development of resistance to antimicrobials in Campy/obacter 
species with the risk that this resistance may pass to humans via the food chain (Endtz et a/., 
1991; Loovern et a/. J 2001; Sarah, 2002; Luber et a/. J 2003; Randall et a/., 2003 and Wagner 
et a/., 2003). However, contribution of Campy/obacterwith antimicrobial resistance to human 
health from the consumption of poultry, mainly chicken, is not yet elucidated. 
Several sources of Campy/obacter infection and antimicrobial resistance in humans have 
been considered following the evidence identified by epidemiological data and case control 
studies (Endtz et aI., 1991; Evans et aI., 1998 and Helms et a/., 2005). Evidently, chickens 
may constitute one of the major sources of human campylobacteriosis. In addition, the 
association between the consumption of Campy/obacter-positive chicken and the causation 
of illness in humans has been indicated by several studies (Bryan and Doyle, 1995; Corry 
and Atabay, 2001 and Coker et a/., 2002). Other studies have demonstrated an association 
between the strains of Campy/obacter in human infection and those found in retail chickens 
(Smith et a/., 1999; Kramer et al., 2000 and FSA, 2003b). Chicken meals contaminated with 
Campy/obacter usually look, smell and taste normal due to the odourless characteristic of 
this organism. Thus, the Campy/obacter-positive chicken cannot be detected by visual 
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inspection (Koidis and Doyle, 1983). At the consumer level, the ingestion of undercooked 
chicken and improper handling of raw chicken have been described as important factors in 
Campylobacter infection (Worsefold and Griffith, 1997 and Christensen et al., 2005). 
Heat, particularly through cooking, has long been the principal method of eliminating 
pathogens in food (James and Corry 2000; and Solow et al., 2003). Various heat treatment 
procedures have been suggested for decontamination of raw meat, e.g. hot water treatment 
(dipping or spraying), steam at atmospheric, high or reduced pressure, high intensity dry 
heat or microwave heating. Clearly, hot water treatment can significantly reduce the 
numbers of bacteria only after relatively long contact times and high temperatures (Corry 
and Atabay, 2001). However, some of these thermal approaches may have residual effects 
on appearance and taste. Both steam and microwave heating cannot treat the surface of 
poultry meat without causing some surface deterioration (Goksoy et al., 2000 and Corry and 
Atabay, 2001). 
The application of irradiation, i.e. gamma rays, electron beams, is an effective method for 
eliminating Campylobacter in poultry products after processing. It can also be applied to 
warm, chilled or frozen carcasses. However, this method is relatively expensive and is 
unattractive to consumers (Corry and Atabay, 2001). Although post processing, storage 
under refrigeration or freezing conditions will reduce the numbers of micro-organism in 
chicken products (Anderson et al., 2003), this method is not recommended due to other 
concerns, e.g. quality, taste, nutrient losses. 
During meal preparation at home, individuals can be exposed to Campylobacter from a fresh 
chicken through a number of pathways. Different studies have demonstrated that during 
meal preparation, cross-contamination through hands and work surfaces (e.g. cutting boards, 
utensils, etc.) is the key to widespread dissemination of Campylobacter (Christensen et al., 
2005). 
Currently, a numbers of countries, including, Denmark, Canada, the Netherlands, New 
Zealand, Norway, the U.K. and the USA, have implemented control measures to reduce the 
prevalence of Campylobacter in poultry throughout the food chain from farm to consumer 
and subsequently the incidence and burden of illness in humans (Anderson et aI, 2001; 
Anderson et aI, 2003; ACMSF, 2004; Batz et aI, 2004; Christensen et al., 2005 and Nauta et 
aI, 2005b). In some countries, risk management interventions were undertaken following 
formal risk assessment, whilst in others risk management has been performed without 
assessing the risk. However, in other countries (e.g. New Zealand) the risk profile of 
Campylobacter led to no further intervention (Lake et aI, 2003). Most studies focused mainly 
on health risk from Campylobacter infection related to the consumption of chicken. There 
were only few studies that considered the risk of Campylobacter infection in conjunction with 
the antimicrobial resistance phenomenon. Furthermore, almost all management options 
were developed for intensively produced poultry rather than for extensive poultry (free-range 
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or organic flocks). This may have limited the choice of interventions to be implemented 
according to the criteria of rearing procedures (UK-DEFRA, 2005). 
Some intervention options currently proposed for the control of foodborne pathogens in 
general were considered in this chapter. It is important to note that this study does not intend 
to provide a risk management strategy. 
9.1.2 Current risk intervention options for the control of Campy/obaeter 
and other enteric pathogens in poultry production 
Proposed risk intervention options for the control of foodborne pathogens including 
Campy/obaeter in poultry production include standards (e.g. good agricultural practices), 
guidelines and other control measures aimed at reduction of human illness resulting from 
infection with foodborne pathogens, e.g.Campy/obaeter, Sa/monella, through the food chain 
A range of interventions for the control of Campy/obaeter in poultry have been developed 
and recommended by a number of organisations (FSAI, 2001; CAC, 2002a and FSA, 2003a). 
Preventative intervention can take place at any stage from farm to slaughterhouse, including 
transportation. The various options for preventative intervention ideally require using the 
best available data on the probability and distribution of risk and how risk can be reduced 
most effectively and efficiently. 
Ideally, there should also be specific options for the control of Campy/obaeter that are 
appropriate to a particular rearing method, i.e. intensive or extensive (free range/ organic) 
rearing (WHO, 2004). These control measures would be more practical if designed for 
particular rearing practices. With the current state of poultry rearing practices, it is not 
possible to establish a precise option for intensive or extensive systems. Most interventions 
are formed as general guidelines for poultry production and thus can be applied to any 
foodborne pathogens at any stage of production. For example, hygiene measures can be 
generally applied to control Campy/obaeter or Sa/monella or Eeo/i colonisation in birds on 
the farm or to control cross-contamination at the slaughterhouse (ACMSF, 2004). Bio-
securiti 4 practices have been introduced to both intensive and extensive farm in order to 
reduce the flock prevalence of food borne pathogens. However, for extensive farms, allowing 
birds to be outside during daytime, some practices, such as human traffic control
15 
and 
access restriction, need to be adjusted before implementation. In addition, to date, there is 
no specific control measure or intervention available at the consumer level. 
The Codex Committee on Food Hygiene (CAC, 2002a) recommended control measures for 
the control of Campy/obaeter in poultry and management options for implementation in the 
14 Bio-security means keeping farm units secure from the introduction of new diseases, and minimising 
the spread of disease within herd. 
15 Human traffic control is to restrict visitors entering the range or building. 
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various stages of production from farm to table. Table 9.1 summaries assumptions and 
statements of interventions based on the current information and knowledge (CAC, 2002a 
and CAC, 2002b). It may be noted that: i) there are the differences and limitations in these 
approaches and ii) these interventions are general practices that can be applied for any 
foodborne pathogens. 
Table 9.1 The control measures for food borne pathogens as applied for the control of 
Campylobacter in poultry (adapted from CAC ,2002a) 
Staging of process 
Farm 
Transport 
Slaughter 
Retail 
Domestic kitchen and 
catering 
*Note: 
Intervention 
Extensive (free range/organic) 
+Promotion and application of good agricultural practice' (GAP) for 
structural and general measures 16, operational measures 17 
+Control of antimicrobial and chemical usage 
+ Vacci nation 
+ Phage treatment (experimentation) 
Intensive rearing 
+Siosecurity and hygiene measures 
house construction and ventilation 
environmental hygiene surrounding poultry houses 
cleaning and disinfection 
water 
visitors/vehicles 
physical barriers 
rodent and pet control, wild birds 
thinning/crate hygiene 
number flock per farm 
single species farms 
pre-Slaughter testing 
+Control of the breach of biosecurity and hygiene addressing 
catching hygiene and crates 
trucks/drivers 
stress-time/distance 
segregation of flock 
+ Testing on entry 
+ Reduction of cross-contamination 
scheduling (end of day)/ channelling; in combination with 
decontamination 
Good manufacturer practice (GMP)/Good hygiene practice (GHP), 
carcass treatment (decontamination) 
Packaging 
+ End product testing 
+ Application of HACCP (Hazard AnalYSis Critical Control Point) 
+ Hygiene measures for processing at retail 
+ Packaging control (packaged/unpackaged) 
+ Promotion of GHP particularly focusing on 
- cross-contamination between food commodity 
- personal hygiene during food preparation and cooking. 
Good agricultural practice (GAP) is the methods of land use which can best achieve the 
objectives of agronomic and environmental sustainability. GAPs are described in several 
different Codes of Practice designed by producers organizations (e. g COLEACP), importers 
and retailers consortia (e.g. BRC, FPC, CIMO, EUREP) and Government bodies 
16 Structural and general measures, e.g. poultry house, visitors 
17 Operational measures, e.g. cleaning, disinfection, insecticide control 
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representing consumers (e.g. UK Food Standards Agency). Many UK supermarkets have in 
addition their own codes of practice which their suppliers must satisfy. American retailers 
use a different standard called SQF 2000, which is based on HACCP (NRI, 2003). 
Good Manufacturing Practice (GMP) is the minimum sanitary and processing 
requirements for food companies. GMPs are the part of quality assurance that ensures 
products are consistently produced and controlled to the quality standard appropriate to their 
intended use and as required by the marketing authorisation (WHO, 1997}.GMPs are not 
designed to control specific hazard, but are intended to provide guidelines to help 
processors' produce safe and wholesome product (FDA, 1999) 
Good hygiene practice (GHP) is a set of practices, essential to support HACCP 
programme. It includes all control measures of food safety during the manufacture, storage 
and distribution that ensure the minimisation or prevention of contamination of the food from 
excessive micro-organisms, physical and chemical contamination (CIEH, 2004). 
9.2 Current risk intervention practices and questions 
Potential interventions as applied for the control of Campylobacter from production to 
consumption have been proposed by several organisations. The main objectives of these 
options are the reduction of Campylobacter prevalence and cross-contamination in poultry. 
However, most interventions have not considered other additional consequences, for 
example, antimicrobial resistance (CAC, 2002a; WHO, 2002c; ACMSF, 2004; WHO, 2004 
and Batz et ai, 2004). 
The mitigation for antimicrobial- resistant Campylobacter is however approached separately 
by different organisations. Since most studies suggested that the rates of resistance to 
certain antimicrobials have been increasing following the introduction of antimicrobials to 
animal husbandry, the precautionary principle has been introduced to mitigate health risk 
related to antimicrobial resistant Campylobacter. The principle is that banning or prudent 
antimicrobial use may achieve a reduction of human risk from antimicrobial resistant 
Campylobacter (Endtz et al., 1991; Evans et al., 1998; Teuber, 2001; Bartholomew et al., 
2005 and Helms et al., 2005). 
Contrary to this assumption, Phillips et al. (2004) and Cox (2005) demonstrated potential 
human health benefits of antimicrobial use in food-producing animals as well as postulating 
that withdrawing antimicrobials may increase the incidence of campylobacteriosis. It is 
important to note that this controversy may result from the different predictive models used, 
assumptions or data and information available, but it could also result from a failure to 
consider the risk tradeoffs that occurs in this circumstance (Graham and Wiener, 1995). 
209 
The risk model for fluoroquinollone-resistant Campylobacter (FQ-Campylobacter) proposed 
by the center of veterinary medicine (Bartholomew et al., 2005) considered the health risk 
related to FQ-Campylobacter following the consumption of chicken harbouring resistant 
isolates. The impact was calculated by using the numbers of cases of human 
campylobacteriosis per year and the rate of FQ-resistance in raw chicken carcasses. 
Actually, the chicken is consumed as a cooked meal. Thus, it is possible that the outcome is 
overestimated because cooking (heat treatment) is able to reduce the numbers of 
Campylobacter whether it is susceptible or resistant to antimicrobials, resulting in reduction 
of health risk. 
Cox (2005) estimated health risk associated with antimicrobial resistance by using the basic 
logic of multiplicative approach. The approach was based on the association between the 
expected incremental numbers of adverse human health consequences per year caused by 
an antimicrobial resistance and those prevented by an antimicrobial use in chicken. The 
result demonstrated that continued use of virginiamycin in chickens would prevent at least 
thousands of times more illness days. The application of the precautionary principle 
(withdrawing antimicrobial use) is thought to be a non-specific approach and would rather 
contribute other unexpected consequences, for example, increase of the incidence of illness 
in consumers. 
Risk intervention options for the control of Campylobacter, whether it is susceptible or 
resistant to antimicrobials should be based on knowledge of relevant factors, i.e. principles, 
assumptions, data available, socio-economic impact, cost-benefit consideration, 
acceptability, culture, attitude, environment impact and risk transfer phenomena. A number 
of questions arise from current risk management options (Table 9.1) and a number of recent 
reports of how the risk mitigation options were implemented in some countries (Denmark, 
Netherlands, and the United Kingdom) (Christensen et al., 2001; ACMSF, 2004; Batz et al., 
2004 and Nauta et al., 2005b). From these the following issues emerge: 
1) Maintenance and consistency 
The recommendations or suggestions or regulations proposed require high responsibility 
and incorporation among regulators, stakeholders and workers to carry on the practices 
following the guidelines. It is difficult to maintain the persistence of workers in continuing the 
good practice. Therefore, long term maintenance would be difficult. For example, following 
on-farm biosecurity practice, changing footwear believed to be important for preventing the 
entry of Campylobacter into broiler flocks is required for every person who accesses to the 
farm. This recommendation would be strictly carried out at the begining; however, it would 
probably be relaxed as time goes by. 
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2) Difference in practice between countries 
The systems of production in one country are usually different to some degree from those in 
others, e.g. size of industry, climate. Changing footwear, for instance, may not be effective 
on an extensive farm since birds in this farm are allowed to be outside in daytime (UK-
DEFRA, 2005). Again, single species farms may be possible for an extensive farm. However, 
this would not be able to protect the extensive birds from other animals from outside, in 
particular, wild animals. 
3) Inter-relationship between the control measures 
The options have been set up for an individual part of the pathway of poultry production from 
farm to consumption (e.g. on farm, slaughterhouse, transport). However, the control of 
pathogenic contamination in poultry (chicken) meat leading to infection in humans involves 
many factors. Some factors are interconnected and may be either synergistic or antagonistic. 
If each risk management option is constructed without reference to the previous or following 
step, some evidence may be missing and this might impair effectiveness. For example, 
during the transport of birds from farm to slaughterhouse, the control measures are not 
clearly documented. It is possible that a flock negative at the exit of a farm becomes a 
positive flock at the entrance of a slaughterhouse from cross-contamination (Slader et al., 
2002). 
Correctly followed biosecurity practice specifies that transport crates must be washed in a 
soak tank water (ACMSF, 2004). However, there is no guidance on how to discard the wash 
water after use. It can be therefore assumed that if the water is discarded into the 
environment without decontamination, cross-contamination could occur. Figure 9.1 shows 
the cycle of Campylobacter in the human-chicken-environment pathway. 
Faeces 
l __ _ 
Feed 
Environment 
(soil, water) 
Humans 
Figure 9.1 Human-chicken-environment pathway of Campylobacter 
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4) A vai/ability of up to date current scientific data 
Recommendations or regulations may not rely on current scientific data. In general, testing 
and channelling 18 of positive birds is recommended for slaughter and processing in 
slaughterhouses. Usually, extensive (organic and free range) birds are processed before 
intensive birds on the same day. EI-Shibiny et al., (2005) as well as other studies (including 
this study) showed that the organic chicken harbours higher numbers of Campylobacter than 
that found in intensively reared chicken. Channelling by processing the extensively reared 
bird before the intensive may increase cross-contamination of Campylobacter rather than 
reducing it. It is therefore necessary to review and update data consistently. 
Additionally, at present there are no practical and specific control measures for antimicrobial 
resistant Campylobacter in poultry. Most recommendations only involve the development 
and establishment of a surveillance programme on general non-human usage of 
antimicrobial agents and a surveillance programme on antimicrobial resistance in bacteria 
from animals to humans (EMEA, 1999; FAO, 1997; FSAI, 2001 and WHO, 2004). 
The outcome of this study (probability of infection and probability of illness from ABR-
Campylobacter presented in Chapter 8) indicate that the most important factor causing the 
health risk to humans is the number of organisms found in chicken carcasses. A chicken 
carcass harbouring ABR-Campylobacter, but with low numbers, would be less of health risk 
than a carcass harbouring high numbers of Campylobacter susceptible to antimicrobial 
agents. The withdrawal of antimicrobial use in food-producing animal would not therefore be 
an appropriate solution. In the light of this, it is necessary to re-consider mitigation options 
for antimicrobial resistant Campylobacter, in particular, for organically reared chickens which 
tend to be exposed to higher environmental levels of Campylobacter (EI-Shibiny et al., 2005 
and Chapters 7 and 8). 
5) Enforcement law and practice 
Currently, most countries in the European Economic Area and North America issue 
guidance or Regulations or Acts for food hygiene and safety at the retail point or other 
equivalent premises, to enforce and ensure that food products are safe for consumers 
(Montforts et al., 2004). However, in reality, effective enforced control relies on authorised 
officers in terms of inspection, enforcement and managerial responsibility. The findings from 
the BIC group (unwrapped intensively reared chickens purchased from butcher's shops) 
(Chapters 5 to 8) suggest a need to ensure that control measures are undertaken 
competently. The qualifications of food inspection officers are important. The food inspection 
officers should comprehend their task. For example, sampling in accordance with 
18 Channelling use for holding and uploading food animal during slaughtering process in order to prevent cross-
contamination. 
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microbiological examination must be undertaken by the officer who is properly trained in the 
appropriate techniques. 
6) Consumer guidance 
A number of studies from several countries have reported programmes for mitigation of 
poultry consumption related to health risk from Campylobacter and other foodborne 
pathogens (Christensen et al., 2001; ACMSF, 2004; Batze et al., 2004 and Nauta et al., 
2005b). Few interventions have been developed and implemented on the farms, at 
slaughterhouses or, even, at retail premises. None of these have addressed consumer 
perception. The subject of health risk is yet to be directly and meaningfully communicated to 
consumers. For example, some countries campaign on personal hygiene of food handling in 
the household. However, there are no monitoring measures in place to ensure that the risk is 
perceived transparently by public (Frewer, 2004 and Renn, 2004). 
As such, it would not improve personal hygiene practices during food preparation, becuase 
most suggestions or recommendations are too abstract and unclear for consumers. For 
example, it has been stated that Campylobacter infection is related to the consumption of 
undercooked chicken (Adak, et al., 2005). It is then suggested that chicken must be cooked 
properly. This suggestion is ambiguous and leaves the public without clearer explanation of 
which is the correct level of cooking for chickens. 
In addition, the mitigations do not focus on a specific group, i.e. young children or 
immunocompromised host. It is well recognised that members of these groups are 
vulnerable, and tend to develop complications after infection. In particular, the current risk 
assessment models are developed from feeding trials on healthy volunteers, who may have 
better immune function. It is therefore necessary to consider special risk management 
options for these particular groups. 
7) Cost benefit analysis 
Cost benefit analysis has not been taken into account meaningfully. The implementation of 
potential control systems always implies financed investment. Any additional costs resulting 
from interventions must be put onto the cost of final products and consumers eventually. In 
addition, since broiler chicken production is extremely price competitive, this would inevitably 
encourage illegal products (from illegal slaughterhouse or unknown sources of chicken), 
which may be cheaper in price, to be introduced to the markets. It is evident that the 
consumption of chickens from unknown sources may carry an increased risk to humans 
compared with pre-packaged properly labelled and identified chickens. This consideration is 
supported by the results of the BIC group expressed in Chapters 5-8. 
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9.3 Factors which should influence interventions 
Intervention options in this study are considered in parallel with the current options 
presented in Table 9.1 and the rationales generated from the findings of this study. It is 
important to note that the risk assessment in this study is calculated for the general 
population. Special needs groups such as young children, elderly people, pregnant women 
or immuno-compromised hosts require better stringent regimes. However, more information 
is required in order to generate risk models for these specific groups. 
This study focuses on the comparison of the relative risks from Campylobacter (with and 
without antimicrobial resistance) to human health from the consumption of different groups 
of chicken (PIC, POC or BIC). The implications for risk management are considered based 
on: i) the results from Chapters 7 and 8 related to Campylobacter with and without 
antimicrobial resistance at a consumer phase and ii) literature 
On the basis of the findings of this study (Chapters 7 and 8), the relevant results include the 
following: 
1. The most significant factors influencing health risk associated with Campylobacter 
are the number of organisms, personal hygiene practices and cooking procedures. 
Cooking procedures and personal hygiene in food preparation in a private kitchen 
can significantly alter the health risk from the consumption of Campylobacter-
positive chicken. 
2. The consumption of salad contaminated with Campylobacter transferred from a 
positive uncooked carcass can cause higher risk than that related to a chicken meal 
properly cooked. 
3. The health risk associated with antimicrobial-resistant Campylobacter (ciprofloxacin, 
erythromycin and nalidixic acid) is found to be highest following the consumption of 
meals prepared from the BIC group harbouring the high numbers of Campylobacter 
with high resistance rate to antimicrobials. 
4. The consumption of meals prepared from organic chickens is free from health risk 
related to ciprofloxacin resistance. However, the risks related to the other two 
antimicrobials (erythromycin and nalidixic acid) are still high, being equal to that 
following the consumption of intensively reared chicken whether the carcass is 
wrapped or not. 
5. The health risk related to antimicrobial resistance following the consumption of 
meals prepared from PIC can be reduced to very low probability if the meal is 
cooked with the sufficient heat, which must be reach the area protected from heat of 
the carcass, such as, drumsticks. 
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6. The health risk in the general population associated with the consumption of 
positive- Campylobacter chickens is not influenced by the age and sex of the 
consumer. 
As a result of above assumptions and findings from previous chapters, the primary factors 
influencing risk intervention options for Campylobacter at the consumer level can be 
summarised as follows: 
1. The number of Campylobacter in the carcass is the most important factor causing 
the risk to human health. Therefore, the reduction of the number of Campylobacter 
in chicken is the critical control point of the health risk associated with the 
consumption of chicken in this context. 
2. Antimicrobial resistance would cause additional risk to human health if the chicken 
carcass harbours Campylobacter with a high resistance rate as well as a high 
number of organisms. 
3. Cross-contamination rather than undercooking is the main source of Campylobacter 
for a person consuming a meal prepared from chicken. Proper meal preparation 
can effectively reduce the risk. In particular, if the carcass harbours low numbers of 
organisms, the numbers can be reduced to level below the infective dose. 
The evidence suggests that the health risk caused by Campylobacter is related to not only 
the prevalence of positive chickens but also the number of bacteria in each carcass and 
ultimately the dose ingested. Reduction of prevalence of Campylobacter contamination of 
carcasses and of the concentration of contamination has broadly equal importance in terms 
of risk reduction. However, the objective of achieving Campylobacter-free chickens is 
improbable without very vigorous and expensive control measures. 
The intervention component in this study is concerned with reducing health risk caused by 
Campylobacter to as low as reasonably achievable (ALARA) taking into account economic 
considerations. Using the rationales stated above, mitigation options can be constructed 
following two scenarios: i) Reduction of the prevalence and number of Campylobacter, and ii) 
Reduction of the rate of resistance to antimicrobial agents. The first scenario can be carried 
out throughout the whole pathway from farm to consumption. As antimicrobial use on farms 
is recognised as the predominant factor for antimicrobial resistance in Campylobacter, the 
potential intervention for reducing the rate of resistance to antimicrobials must mainly focus 
on implementation on the farm. 
9.4 Intervention scenario 
Following the results of the risk assessment (Chapters 7 and 8), this study further explored 
the mitigation options recommended for foodborne pathogen. These options are selected 
and therefore applied for the control of poultry production in relation to reduction of health 
risk from Campylobacter. However, the limitations in data available prevent the application of 
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a full process of risk management including economics and public perception. Following the 
risk decision-making process presented in Figure 9.2, the potential intervention options 
(Slock "S") were considered against two scenarios, which are: i) scenario 1: reduction of 
health risk related to all Campylobacter isolates and ii) scenario 2: reduction of health risk 
related to antimicrobial resistance in Campylobacter. 
Cost-benefit analysis 
Countermeasures 
Political/culture 
limitations 
......................................................... 
A 
B 
'I 
Risk assessment 
- prob. of infection 
- prob. of illness 
(Chapters 7&8) 
, 
Drivers of risk 
management 
Risk management 
options 
: 
.................................... 
........... ~ i . ............................. . 
..(. 
Acceptability 
............................... y 
Risk management-
decision making 
process 
Risk prioritisation 
........................ , ................................. . 
. r Law/regulations 1 
'«.. ............... ; ; 
t ....................................................... J 
Figure 9.2 A framework of the risk decision-making process 
9.4.1 Scenario 1: Reduction of health risk related to all Campy/obaeter 
isolates 
As explained in section 9.3, the mitigation for health risk of Campylobacter associated with 
the consumption of chicken can be performed by reducing either the prevalence or the 
number of organisms, or both. Shanker et al. (1990) found that after the first bird was 
infected with Campylobacter, widespread dissemination of this organism can take place 
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throughout the whole flock within 4-7 days. Thus, the reduction in numbers is easier to be 
achieved than the reduction in prevalence (in particular, the achievement of free-
Campy/obacter chicken). Under this scenario, the risk management options focus on the 
reduction of Campy/obaeter load on the carcass. The reduction of Campy/obaeter load can 
be considered from farm to consumption as shown in Figure 9.3. 
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Figure 9.3 A scheme of scenarios in reducing the Campy/obacter load and antimicrobial 
resistance in the chicken. 
The recommendations presented in the following issues were constructed based on the 
interventions generally recommended for the control of foodborne pathogens (e.g. 
Sa/monella) in poultry production. The aim of reduction the microbial load, Campy/obaeter in 
this context, in chicken from production to consumption is now considered at each 
production stage. 
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Rearing practices on farm 
a) On farm- Extensive rearing 
Recommendations are: 
1. Under the condition regarding the regulations for broiler chickens designated as 
organic products, biosecurity and GAP are essential measure for the control of 
Campy/obacter on farm. 
2. Vaccination is not practical and would add more economic burdens for producers. 
More studies are required to ascertain whether: i) vaccination is able to positively 
prevent the colonisation of Campy/obacter in broiler chickens; ii) vaccination can 
have negative effect(s); and iii) if the benefit of vaccination can surpass the 
additional cost. 
3. If possible, the environment of the farm (water, soil, feed and litter) must be 
inspected and monitored periodically. However, it is necessary to re-evaluate the 
need for monitoring. If the results are somewhat constant, inspection can become 
occasional. 
4. Low-cost husbandry and veterinary support is a necessity for poultry production, in 
particular, small scale farms. Farmers must be instructed regarding proper 
husbandry procedures in order to improve skills and understanding of the current 
situation. 
5. The study of the potential for transmission of infection between animal husbandry 
and wildlife, thought to be one of significant sources of Campy/obaeter, is urgently 
needed. This is particularly pertinent for extensive rearing systems in order to clarify 
how such relationships influence the microbial load. This would help in the 
development of practical risk management for an extensive farm. 
6. The use of dietary modification has been proposed for reducing Eeoli 0157:H7 
population in cattle (Russell and Rychlik, 2001). Probiotics, e.g.fructo-
oligosaccharides, can promote growth of the native microflora which can eliminate 
pathogenic bacteria from the intestine (Zopf and Roth, 1996). This may be an 
alternative procedure to promote intestinal health of birds (Callaway et a/., 2003). 
However, it needs more studies to identify the mechanism which affects the 
organisms in the gut. 
b) On farm- Intensive rearing 
Recommendations: 
1. The biosecurity or GAP or GHP is very effective for the control of cross-
contamination (Mead, 2004). The control must extent to what will occur following 
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these practices, in particular, residual waste discarded into environment. 
Decontamination strategies must be included. However, further studies are required 
to understand the need and establishment of the treatment system for the 
environmental pollution on the farm. It is clear that it will cost more money to 
implement this treatment system. This also requires cooperation from several 
sectors, e.g. veterinary, scientist, ecologist, stakeholder, etc, which may not be easy 
to achieve. The attitude of people who have to follow the instruction may determine 
the degree of success of the intervention. 
2. Although, intensively reared broilers are reared for commercial purposes, they are 
living and sensitive. To safeguard welfare20 and avoiding suffering, a wide range of 
needs must be taken into account. Maintaining a good indoor environment in the 
building is essential for broiler welfare. Examples of important factors in the building 
are stocking density, live-weight of birds, ventilation rate, indoor temperature and 
type and management of drinkers. Fresh air and sunlight are beneficial for the 
health of birds. It necessary to apply stringent control to rearing conditions, for 
example, low stocking density of birds in a house in order to prevent overcrowded 
causing breast blisters and leg problems and eventually infection. 
3. Dietary modification (similar to recommendation 6 of on-farm extensive rearing) 
Slaughtering and processing 
The cross-contamination by Campy/obaeter from skin, hides or the alimentary tract cannot 
be completely eliminated during slaughtering procedures as currently practiced. However, 
implementation of the appropriate measures would help to minimise such contamination. In 
the United Kingdom, either domestic21 or export-approved slaughterhouses22 are governed 
by the Meat Hygiene and Inspection Regulations. The regulations provide guidelines for the 
processes of slaughter and cutting of carcasses. These are supervised by authorised 
officers of the local authority, who are trained for the purpose. The legislation controlling the 
production of meat is largely directed towards the reduction of the risk to humans from 
pathogenic organisms carried by animals. They tend to concentrate on the reduction of 
pathogenic organisms in meat and meat products, and therefore attempt to anticipate the 
routes by which meat could potentially be contaminated by this specific group of organisms. 
Although, in practice, many slaughterhouses find it difficult to comply with the requirements, 
in order to gain legal recognition they have to adopt the recommended interventions. These 
are described in Table 9.1. As these interventions are essential measures for micro-
organisms, in such a way the control of Campy/obaeter must follow the standards of the 
20 The welfare of animal is defined as regards its attempts to cope with its environment, which may 
lead to disease and injury. 
21 Domestic slaughterhouse producing meat is not for export 
22 Export-approved slaughterhouse producing meat is for export 
219 
regulations. The efficiency of implementation of the approved control measures as standard 
operating procedures must be consistently high at all stages and all times. This needs to be 
governed by legislation via food authorised officers as well as the control measures being 
communicated to all personnel throughout the entire production. 
It is more likely that the regulations will be stringently followed by medium or large premises, 
which are usually licensed. For small scale premises, it is difficult to complete the standard 
operating procedures without involving monetary investment as well as understanding the 
control measures. Most operate with old machines or old systems. It is vital to reinforce 
small scale premises to strictly adopt at least a basic quality assurance to the process. 
Although the current control measures for Campylobacter have been recommended by a 
number of organisations, this study reinforces the need for recommendations by focusing on 
key factors arising from the findings in Chapters 7 and 8. These factors are: 
1) Channelling procedure 
Usually, most slaughterhouses operate the processing of both intensively and extensively 
reared chicken by applying channelling procedures, in which the extensive birds will be 
processed before the intensive ones. It appears that the extensively reared chickens highly 
expose to micro-organism, resulting in harbouring higher numbers of micro-organism. 
Therefore, if the objective of the channelling is for the control of cross-contamination of 
micro-organism, the intensively reared birds should be processed before the extensive ones. 
For example, as the extensively reared chickens harbour higher numbers of Campylobacter, 
this type of channelling and its objective must be carefully re-considered. 
2) Hygiene measures 
For premises that cannot afford to change equipment, proper cleaning and sanitary 
treatment of equipment can decrease cross-contamination. Basic hygiene practices can be 
applied to achieve this goal with less cost. The intervention measure for hygiene practices 
requires that some stages of the entire process are identified as critical point for 
transmission of micro-organisms. From the literature reviews shown in Chapter 7, the stages 
of slaughter and processing considered as critical points of cross-contamination include 
incoming birds at the entrance of slaughter facility, scalding, de-feathering, evisceration and 
packaging and chill. The suggestions are as follows: 
Incoming birds 
Usually birds entering plant are coated with excreta. It is therefore necessary to remove all 
foreign materials, including faeces. The contamination at this early stage of the process can 
block the passage of the equipment or contaminate the equipment at the following stages, 
e.g. scalding. Therefore, incoming birds must be cleaned by chlorinated rinse. 
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Scald- tank 
The scalder23 is the most important area of processing in wh ich cross-contamination with 
micro-organism sheds from the gut of birds (Humphrey and Lann ing , 1987) freq uently 
occurs . A scald tank (Figure 9.4) always accumulates excreta . If the water does not flow 
properly (Figure 9.5), this can become a source of micro-organ ism includ ing Campylobacter 
transferred to success ive birds (Cason and Shackelford , 1999; and Russe ll , 2002 ). 
Recommendations: 
1. It is essential to control the flow of scald water and ensure a rapidly moving flow as 
counter-current direction (Figure 9.6) . 
2. The temperature of the scald water must be as high as possible (should be over 
60°C) without causing breast striping. 
3. Fresh water must be re-added into the sca ld-tank frequently. 
4. A Multi-tank scalder is more effective in reducing microbial concentration remain ing 
on the carcasses . 
5. Cleaning and sanitation of the sca ld tank must be carried out regular ly and 
frequently to eliminate the organic material in the scalder. 
6. Further research is necessary into the development of the system of scald-tank , 
which can mix the scald water properly, reduc ing bacteria suspended in the scalder. 
Figure 9.4 Scald water containing a high concentration of excreta . 
(taken from http://pubs.caes .uga.edu/caespubs/pubcd/B1222.htm 19 December 2005) 
23 Scalder is a tank containing hot water in which the birds are submerged to soften feather follicles for 
feather removal 
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Figure 9.5 Scald water that is not f lowing and acts as a bath . 
(taken from http://pubs .caes .uga .edu/caespubs/pubcd/B 1222.htm. 19 December 2005) 
Figure 9.6 A counter-current water fl ow 
De-feathering 
The level of cross-contamination in the carcass entering the defeathering stage is 
associated with the previous stage of the process , scalding . If the water in a scald tank is 
dirty from organic materials , accumulating high numbers of micro-organ isms , It may increase 
cross-contamination to the carcasses . If high levels of contaminants are presented on the 
carcasses , these contaminants can be driven into the feather foll icle du ri ng picking. 
Recommendations: 
1. Pre-de-feathering processes (e.g. at the entrance of incom ing bird , scalding) must 
be strictly controlled . 
2. Regular cleaning of working areas or equipment is very important . Feathers 
removed from the carcasses must be discarded properly and the surrounding must 
be cleaned up regularly. Although the presence of fea thers and feather follicles does 
not make a sign ificant difference in carcass bacteri al contam inat ion Immediately 
after defeathering or in spoilage bacte ri a after 1 week of refrigeration (Cason et 
al., 2004) , poor cleaning in the de-feathering stage (Figure 9.7) could be a source of 
micro-organ isms over time and it may increase the cross-contamination 
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Figure 9.7 De-feathering system after scalding 
(taken from http://pubs.caes.uga .edu/caespubs/pubcd/B1222.htm 19 December 2005) 
Evisceration 
After being killed , scalded and defeathered , the carcass head , shanks and viscera are 
removed . Inedible viscera or guts 24 are removed by loosening the crop 25 In sma ll fa rm s 
these viscera are manually eviscerated (Figure 9.8) . If the gut is torn , the exterior of the 
carcass can be contaminated with faeces (Figu re 9.9). A torn crop or a crop removal 
machine can be a source of contamination (Figures 9.10 and 9.11 ). One gram of gut con ten t 
can carry 109 bacteria (Mead , 2004). In some countries , at th is stage washing of the ca rcass 
is permitted in order to clean off faecal content. 
Recommendations: 
1. Proper feed withdrawal 26 before processing will help reduce tears and faeces in the 
gut and a crop . 
2 . Washing carcasses with chlorinated water after gut removal may be necessary. 
3. Unwanted viscera must be removed from the working area us ing a hygienic process , 
for instance, using water to continually wash the viscera away. 
4 . Proper training for individuals who works at th is point in order to ensure correct 
evisceration , avoiding gut tears . 
5. This stage must be inspected carefully and frequen tly . Ca rcasses found to be 
contaminated with gut content must be condemned immediately . 
24 Viscera include intestines , oesophagus , sp leen , reproductive organs and lungs 
25 A crop (ing luvies) is an enlargement or out pouching of the oesophagus proximal to the 
proventriculus , or glandular stomach and functions primarily in a food storage role for aVian species 
~6 Feed withdrawal refers to the tota l leng th of time the bird IS Without feed before processing Th is 
includes the time the birds are in the house without feed , as well as the time the birds are In trans it and 
in the live hold area at the plant. 
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Figure 9.8 Eviscerat ion in a smal l scale plan t 
(taken from http ://attra .ncat.org/attra-pub/poultryprocess .html#Feather: 22 Decembe r 2005) 
Figure 9.9 Intestinal cuts and torn intestines and nicked ven t due to improperly funct ion ing 
venting machine (taken from http ://pubs .caes .uga .edu/caespubs/pubcd/B1222. htm . 19 December 
2005) 
Figure 9.10 Faeca l material in crop of chicken 
(taken from http ://pubs .caes.uga .edu/caespubs/pubcd/B1222 .htm. 19 December 2005) 
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Figure 9.11 Crop remova l mach ine 
(taken from http://pubs .caes .uga .edu/caespubs/pubcd/8 1222 .htm. 19 December 2005) 
Packaging 
The findings from this study have identified differences between th e pre-packaged and 
unwrapped carcasses indicating that packag ing may influence the process of cross-
contamination. 
Recommendations: 
1. Carcasses should be packed as soon as they are washed and then properly ch illed . 
2. The pre-packaged product must be stored at a strictly controlled temperature (4°C or 
below) . 
3. The pre-packaged product must be labelled in a manner that accurate ly describes 
the product and does not mislead the consumer. Labelling shou ld be regu lated and 
the unwrapped unlabelled carcasses must not be distributed to the market. 
Retail outlets 27 
Poultry products at a retail point are displayed in several different ways. Whole carcasses 
are often displayed without refrigerat ion at open market sta lls, part icu larly, in the deve loping 
world . Refrigerated products are disp layed in shops and other retail un its unpackaged or 
over-wrapped on plastic trays . Meat and pou ltry are sometimes sold from mobile refrigerated 
shops. In developing countries sma ll sca le producers may se ll by barteri ng for other 
consumable items (Silverside and Jones, 1992). 
The BIC group were found to harbour not only the highest numbers of Campylobacter bu 
also highest rate of antimicrobial res istance. Th is is consisten t wi th the open presenta Ion 0 
27 Retail outlet is where a consumer directly purchases a dressed or eViscerated ch icken ca rcass 
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the unwrapped carcass causing high cross-contamination. If no labelling is provided, it 
should be assumed that the carcass is supplied by unlicensed or illegal premises. 
Recommendations: 
1. Premises which sell or offer raw meat or poultry must register with the local food 
authority as licensed premises. 
2. At least one person working in the shop or outlet must be trained in food hygiene. 
3. Poultry product must be pre-packed with labelled before being distributed from the 
slaughterhouse. Unwrapped carcasses should not be displayed or packaged at a 
retail point. 
4. In mix businesses, raw meat products must be handled or displayed in accordance 
with hygienic requirements. Individual meat products must be separately put on the 
certain area of the shelf. This is for prevention of cross-contamination among these 
products. 
5. Individual meat products, if possible, must be situated in an individual tray to prevent 
the leakage of liquid from the carcasses or other meat. This is in particular 
necessary for the unwrapped poultry products. 
6. Jeremiah and Gibson (1997) found that the light used for displaying meat products 
can raise the surface temperature of exposed products, resulting in increasing 
growth of pathogen. It is therefore Intensity and duration of display illumination must 
be monitored and control. 
7. Authorised food officers must regularly inspect and, if possible, check the premises 
that do not comply with the regulations. 
Consumers 
Medeiros et al. (2001) described that far essential food handling behaviours consumers 
must be educated, including personal hygiene, proper cooking and prevention of cross-
contamination. The evidence indicates that food handling and cooking in a kitchen at home 
can dramatically reduce the probability of infection and probability of illness related to 
foodborne pathogen including Campylobaeter in carcasses. As presented in Chapters 7 and 
8. After cooking, the health risk from Campylobaeter can be reduced to be very low levels. 
Currently, these issues have been introduced to the public by focusing on good hygiene 
practices (FSA, 2005). For example: 
1. Personal hygiene guidelines (washing hands, covering hairs during food preparation, eet.) 
2. Cleaning work surfaces and equipmen, for example: 
• Cutting boards should be used separately among raw meat. fish poultry and vegetables. It 
must be cleaned and dried up immediately after each use. A wooden cutting board should 
be visually checked to assure that food is not getting imbedded in cracks or crevices. 
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• Kitchen dishcloths, sponges and aprons must be washed daily. Hand-washed dishes 
should be air-dried as repeated using towels to dry them will spread germs. 
• Cutlery and utensils previously used for raw meat should be washed before the next use. 
· If meat, poultry or seafood was in a marinade, bring marinade to a boil for at least 3 
minutes before using as a sauce. 
3. Special care should be taken when cooking for a special groups (children, elderly people 
or immuno-compromised person), ensuring a proper temperature and time for cooking. 
4. Refrigerator rules should be implemented. This should include: i) checking temperature 
since correct temperature can preserve food commodity and reduce the risk of food 
poisoning and ii) putting poultry on the bottom shelf of the refrigerator and separate from 
cooked food. 
Although a number of recommendations have been made available to public, it is evident 
that the public does not comprehend the messages thoroughly. This may be because of: i) 
lack of clear evidence to illustrate the consequences resulting from improper food handling 
or preparation, ii) non-specific instruction (e.g. proper temperature, washing cutting board 
regularly), iii) demanding requirements (e.g. keeping raw meat separately from cooked food 
and vegetables is merely impossible for some families), iv) insufficient information related to 
the real situation in a private kitchen regarding the food handler or preparer and persons 
consuming meal and v) public perception on health risk from Campylobacter with and 
without antimicrobial resistance following the consumption of chicken. 
Recommendations: 
1. Since public perception, which may depend greatly on the way in which information 
is presented, influences food selection, the information from risk assessment must 
be transparently conveyed to the public. Information from credible sources is more 
likely to influence public perception of a risk than is information from sources that 
lack this attribute. Based on what consumers perceive, they would be able to decide 
what their preferences are. 
2. The recommendations advised to public must provide meaningful, relevant and 
accurate information. Their relevance to kitchen hygiene must be clear and practical 
so that consumers will want to apply them in kitchens, for example, what would be 
the sufficient temperature for a proper cooking, how often the cutting board needs to 
be cleaned. 
3. More research is needed on personal behaviours during food preparer in a kitchen 
at home in order to construct the meaningful and precise recommendations which 
consumers can be clearly understood. This includes experiments which reflect the 
real situation during cooking, e.g. temperature, time, etc. 
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4. Consumers' participation may be necessary for the development of risk 
communication messenges, strengthening the link and comprehension improving 
the perception. 
9.4.2 Scenario 2: Reduction of health risk related to antimicrobial 
resistance in Campy/obaeter 
Since the emergence of antimicrobial resistance in foodborne pathogens, the use of 
antimicrobial agents in food-producing animal husbandry has been strictly controlled. Some 
countries adopted the precautionary principle, banning antimicrobial use, to mitigate the risk. 
To date there have not been any interventions that can effectively mitigate the risk related to 
antimicrobial resistance in food borne pathogens. More importantly, both studies related to 
antimicrobial resistance in food borne pathogens and mitigation for Campylobacter are not 
harmonised and continuous, varying from working group to working group or countries to 
countries. 
The findings from Chapters 7 and 8 indicate that the health risk from antimicrobial resistant 
Campylobacter depends on the numbers of organisms rather than the rate of resistance. 
Banning antimicrobial use in food animal husbandry may not be effective for risk 
management without causing other risks. However, it remains necessary to control the use 
of antimicrobial agents in animal husbandry. This is because increasing resistance to 
antimicrobial of pathogens threatens the potential action of antimicrobial agents and may 
cause the failure of treatment for infection in patients, especially vulnerable groups. 
Risk management options for scenario 2 considered alongside the findings in Chapters 7 
and 8 can be constructed with reference to the numbers of organism and the rate of 
resistance to antimicrobials. Firstly, reduction in the number of Campylobacter can be 
achieved by following the steps in scenario 1. Secondly, the mitigation for the reduction of 
the rate of antimicrobial resistance in Campylobacter can be achieved by concentrating on 
the use of antimicrobial agents on the farm. This is because the use of antimicrobials on the 
farm is thought to be a major contributing factor in antimicrobial resistant-Campylobacter (Ge 
et al., 2003 and Hurd et al., 2004). 
The precautionary principle may not be appropriate for the health risk related to antimicrobial 
resistant Campylobacter following the consumption of chicken. Cox (2002) compared the 
economic costs of the different risk management interventions for Campylobacter by using 
the four scenarios of management options (Table 9.2) in order to calculate the costs for the 
implementation and illness reduction. It is evident that banning antimicrobial agent 
(enrofloxacin) is not an economic option, whereas adding chlorinated water or using 
antimicrobial spray on the farm (reducing the numbers of organisms) can significantly 
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decrease the cost. Ball and Goats (1996) suggested that 'It 'IS . necessary to conSider where 
the overall risk benefit is and what is achievable. 
Table 9.2 Comparison of cost and benefit of the intervention cost for reducing microbial 
health risk (adopted from Cox, 2005) 
Scenario Implementation cost (m) Illness cost Net cost (m) 
(m) 
Ban enrofloxacin 11.7 9.8 21.5 
additional chlorinated water 120.1 -253.7 -133.6 
antimicrobial spray 105.3 -296.8 -191.5 
Irradiation 810.9 -305 505.9 
Recommendations: 
1. If banning antimicrobial use in animal husbandry is to be enforced through 
legislation, further studies are required in order to identify whether it can significantly 
reduce the risk from antimicrobial resistant bacteria to humans. This would provide a 
relatively simple framework for consideration of the tradeoffs between the reduction 
of campylobacteriosis (with and without antimicrobial resistance) and the reduction 
of antimicrobial resistant campylobacteriosis. 
2. It has been recognised that sources of antimicrobial resistant pathogens poses risks 
to human health via a number of routes including overuse or misuse in humans. The 
control measure of prudent antimicrobial use should include the use in humans in 
the community, hospitals and the use in animals. 
3. The control measure for antimicrobial use presents a dilemma. On the one hand, 
due to an impact of antimicrobial resistance associated with antimicrobial use in 
veterinary practice on human health, withdrawal of antimicrobial use is required. On 
the other hand, withdrawal of antimicrobial use on the farm may increase infection 
with pathogens in poultry and subsequent health risk to humans following the 
consumption of poultry. 
In this context the control measure of antimicrobial use in animal on the farm should be 
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considered in two separate ways, which are: 
1. A short-term mitigation in relation to the reduction of the numbers of foodborne 
pathogens is that certain antimicrobial agents may be permitted in use on the farm in 
order to reduce the infection with pathogens in broilers. This requires: i) clarification of 
classes and types of antimicrobial agents permitted, ii) record of the use, i.e. names of 
agent and of flock administrated with the certain antimicrobial and duration of the use 
and iii) review and monitor at least annually regarding the appropriate use of 
antimicrobial agents and the prevalence of a positive flock with and without 
antimicrobial resistance. 
2. A long-term mitigation aims at prevention of the increase of antimicrobial resistance 
rate in foodborne pathogens. Although antimicrobial agents used in poultry may 
reduce the numbers of pathogens, over time these organisms may develop the 
resistance to antimicrobials frequently used. This could result in diminishing the 
potential action of the antimicrobial and then it may not be able to reduce the numbers 
of micro-organisms. Thus, the health risk from pathogens including Campy/obaeter 
may increase, whereas, the efficiency of antimicrobials for the treatment of infections 
may decrease. Therefore long-term mitigation must consider: i) antimicrobial agents 
permitted to be used in animals must not be the same or equivalent type as those 
used in humans, ii) further researches on alternative agents able to reduce the 
numbers of micro-organisms without inducing the development of the resistance in 
micro-organisms are required in order to minimise antimicrobial use in animal 
husbandry, iii) other control measures to reduce the numbers of micro-organisms 
must be enforced and be applied from production to consumption and iv) an effective 
surveillance system is necessary. 
3. The information on antimicrobial use and its impact must be efficiently disseminated to 
all interested parties. It is important that farmers must be included as members of the 
working groups. In this context, farmers should be informed and educated about 
antimicrobial use and relative risk to humans and the environment. An effective 
exchange of information would enhance the understanding of this situation between 
scientists, veterinary, regulators and farmers. Clear understanding will lead the parties 
to the right issue of concern, for example: 
• Scientist or veterinary presents the association between antimicrobial use on the farm 
and the development of antimicrobial resistance. 
• Regulator explains the strategies of the control measures. 
• Farmer demonstrates real situation of what occurs on the farm. 
• Economist compares cost and benefit of the implementations. 
More importantly, cooperative relationships provide a larger number of data and relevant 
information which are essential to develop robust interventions. Thus, an efficient and 
effective risk management option would have likely achieved. 
4. More studies are needed in order to; 
• identify the sources of antimicrobial-resistant Campy/abaeter in humans. 
• elucidate the association between antimicrobial-resistant Campy/abaeter in humans 
and antimicrobial-resistant Campy/obaeter in animals. 
• develop a robust and responsive infrastructure for the surveillance of animal and 
human health associated with Campy/abaeterwith and without antimicrobial resistance. 
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• estimate the costs and benefits of interventions. 
9.5 Conclusion 
The effectiveness of the various interventions may be measured in terms of the achievement 
of targets/goals and the benefits. Whilst the achievement can be analysed using cost-
effectiveness technique, the estimation of the benefits involves monetary values which could 
then be incorporated into cost-benefit analysis (Bennett, et al., 2003). 
Since multiple entry points exist for foodborne pathogens from production to consumption, 
multifaceted intervention approaches are required to successfully control contamination of 
poultry during the various phases in the food chain. The control measures used for 
preventing colonisation on farms include hygiene practices, biosecurity, immunisation, 
dietary management and antimicrobial use, and biological control procedures. Cross-
contamination in the processing plant can be reduced through good manufactural practices, 
temperature controls, chemical interventions, water replacements and counter-flow 
technology in the scalder and chiller, and equipment maintenance. Food handling at retail 
outlets and by consumers (i.e., storage at the proper temperature and adequate cooking) 
are the final critical control points from farm to consumer (Callaway, et al., 2003). 
Although these measures can be generally applied for the control of all food borne pathogens, 
the characteristics of each pathogen must be taken into consideration and an understanding 
that contamination can be introduced into foods at numerous points along the food chain is 
requires (Callaway, et al., 2003). For example, i) cross-contamination with Salmonella does 
not affected by chilling in the same manner as Campylobaeter, chilling practices cannot 
effectively reduced cross-contamination of Salmonella; but can reduce the numbers of 
Campy/obaeter, ii) Campylobaeter cannot mutiply during processing unlike E. coli and 
Salmonella and therefore preventing faecal contamination at the beginning of processing 
may be the most effective practices in controlling cross-contamination of Campylobaeter. 
Good agricultural practices (GAPs), good manufactural practices (GMPs) and good hygiene 
practices (GHPs) (Note of Table 9.1) are the most successful intervention in controlling 
cross-contamination and can be implemented for the control of all food borne pathogens at 
any stage of the food chain with less monetary involvement (Bennett et al., 2003). Other 
interventions such as immunisation, dietary management, competitive exclusion, use of 
bacteriophage have been contemplated and are currently under investigation (Hovde et al., 
1999; Huff et al., 2001 and Callaway et al., 2003). 
In conclusion, potential intervention options in this study were constructed based on the 
results of the risk assessment (Chapters 7 and 8) and the control measures for the control of 
foodborne pathogens from production to consumption recommended by other studies. 
These relate to the reduction in health risk associated with Campylobaeter by reducing the 
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numbers of Campy/obacter in the chickens. The interventions in scenario 1 (section 9.4.1) 
aim at the reduction of the Campy/obacter load in chickens. The mitigations can efficiently 
decrease the numbers of organisms through the full process from farm to consumption. 
Options are therefore discussed at each stage. The interventions of scenario 2 (section 9.4.2) 
focus on the practices on the farm. However, the interventions of the scenario 1 are still 
useful for the reduction of the health risk of antimicrobial resistant Campy/obacter. The 
options were recommended as short term and long term interventions. 
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CHAPTER 10 
Conclusion 
Insufficient information related to Campy/obacter infection has generated the uncertainties in 
the development of the control measures. Risk tradeoffs stimulate fluctuations between 
permission and prohibition of antimicrobial use in animal husbandry. This induces ambiguity 
in the shared understanding amongst scientists, regulators, producers and consumers. 
This study evaluates the relative risk of Campy/obacter (with and without antimicrobial 
resistance) associated with the consumption of intensively and organically reared chickens 
using quantitative microbial risk assessment (QMRA). It attempts to identify and 
demonstrate the key factors in the consideration of the potential interventions for the 
management of health risk. These are discussed below. 
10.1 Isolation and enumeration methods 
Consideration of risk related to Campy/obacter focuses on health impact on humans at the 
time of consumption. As only viable Campy/obacter can cause infection, conventional 
culture methods for isolation and enumeration used in this study are therefore appropriate 
for determining prevalence of Campy/obacter-positive chicken. Although molecular methods 
thought to have reliability, they are sensitive to not only viable but also the dead cells. 
Therefore, they are likely to overestimate for the prevalence of infection. 
Clearly, conventional culture methods are imperfect measurements, generating the errors. 
However, these errors can be minimised with the appropriate application of mathematical 
and statistical methods as demonstrated in Chapter 5. This will be useful for a large scale 
works or routine work where molecular methods are not available or are too expensive to 
perform. The application of mathematics and statistics can also be used for the adjustment, 
without extra cost, of isolation rates thought to be underestimated. Nonetheless, sufficient 
primary data is still required. This highlights the need for the establishment of internationally 
accepted standard methods and data bank for Campy/obacter. The MPN method has been 
found to be the most sensitive culture method but at the same time it needs to be revised as 
it is time and material consuming. The large volume of samples containing micro-organisms 
used in the MPN method needs to be treated before disposal. This is costly and will be long 
term problem. The modified MPN method developed in this study overcomes some of the 
undesirable problems above and addresses the principle of waste minimisation. However, it 
needs to be further evaluated for the reliability and an accurate approach for its 
interpretation should be established. Estimation of the accurate values of MPN can be 
resolved using the maximum likelihood estimation. 
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In addition, the different results of isolation rates for Campylobacter found in the different 
parts of the chicken (meat & skin, cavity and tail) indicate that sampling procedures may 
greatly influence the error of measurement. 
10.2 Perspective on antimicrobial resistance in Campy/obaeter 
Two patterns of the minimum inhibitory concentration (MIC) distribution were found between 
three antimicrobials. Theses were: i) very low MIC and ii) very high MIC. The very low MICs 
were found to be associated with ciprofloxacin, whose equivalent antimicrobials have been 
prohibited to be used in animal husbandry. The high MICs were associated with the other 
two antimicrobials (erythromycin and nalidixic acid), whose equivalent forms have been used 
for treatment of sick birds and as growth promoters. This evidence may indicate that if no 
effective control measures in antimicrobial use on the farms, Campylobacter may develop 
resistance to ciprofloxacin in the future similar to what is found for erythromycin and nalidixic 
acid. The evidence found in the organic group which is free from ciprofloxacin resistance 
highlights this notion. In other word, the current low-MIC found against ciprofloxacin may 
represent a point in time similar to that found in the past for erythromycin and nalidixic acid. 
However, consideration for the control measures must take into account evidence obtained 
from different sources and should address complex issues. Conflicts arise from 
implementation of the interventions currently used for the reduction of Campylobacter level 
on one hand and for the reduction of antimicrobial resistance in Campylobacter on the other. 
These originated from: i) lack of co-operation amongst working groups, ii) lack of availability 
of data due to partial information and iii) lack of internationally accepted standard methods 
and surveillance programmes. Although conflicts resulting from these tradeoffs are inevitable, 
they can be minimised by reducing gaps in the availability of data and information in terms of 
scientific findings, socio-economic issues, policy demography and politic. Health risk 
associated with this pathogen cannot be completely eliminated without causing other 
consequences. Hence, if necessary, the mitigation approaches must be flexible to some 
degree and address both short term and long-term planning. 
10.3 The usefulness of risk analysis on food safety management 
for Campy/obaeter 
This study considers the relative health risk associated with the consumption of three types 
of chicken which are raised in two different rearing systems. It also considers whether the 
stringent controls are able to reduce exposure and therefore health risk. In this context, the 
estimate of the exposure dose to Campylobacter (with and without antimicrobial resistance 
was considered in relation to the effect of the heat treatment (cooking) and the 
Campylobacter number transfer coefficients for the number of Campylobacter in chicken 
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meals and salads. The exposure dose establishes the likelihood of a population being 
harmed by Campy/obaeter. Reduction in the numbers of Campy/obaeter in chicken using 
simple and low cost interventions is likely to greatly mitigate that risk 
In this context, quantitative microbial risk assessment is very useful for the evaluation of the 
risk from foodborne pathogens (including Campy/abaeter) and the additional eansequences 
related to antimicrobial resistance. It can identify main factors and where the interventions 
can be most effective. It has the potential to provide evidence for risk managers to set 
priorities for risk identification and risk management options. However, the scarcity of current 
data generates significant uncertainty and often results in controversy amongst stakeholders. 
The main differences originate from the different predictive models used and assumptions or 
data and information available. They could also result from a failure to consider risk tradeoffs. 
Thus, the risk models adopted for use need to be clearly described and limitations and gaps 
in the data taken into account. 
Some considerations arising from this study suggest unexpected conclusions related to 
antimicrobial resistant Campy/abaeter. The results were interpreted and discussed based on 
the assumptions applied to the each of the models used. It is clear that some factors are not 
included due to lack of data. Despite the lack of data and the uncertainties, this study can 
demonstrate how risk assessment can be applied to microbial food safety management. It 
can then be incorporated into risk management and the decision making process for the 
selection of the best course of action and the implementation of appropriate control 
measures. 
Food risk management is a plausible strategy to be implemented for the control of 
Campy/abaeter (with and without antimicrobial resistance). It is a useful process that 
balances conflicts arising between interests groups. The outcome of food risk assessment 
and food risk management can lead to the development of standards, guidelines and other 
recommendations for food safety. This may change the way nations approach food safety 
and public health decisions. 
Risk decision making is a conditional process which requires the dissemination of 
information. The interaction between relevant factors must be transparent. This process 
would benefit from the sharing of local knowledge and expertise. Cooperation amongst 
organisations is extremely important. 
In theory, the information gathered in recent studies is sufficient to initiate the process of 
construct international strategies which can be implemented in different types of husbandry 
(i.e. small-scale or large scale farming). However, in practice, it is difficult to implement these 
strategies due to conflicts of interests amongst scientists, regulators and stakeholders as 
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well as members of the public. The different perceptions of risk do not facilitate 
understanding amongst these groups. Nevertheless, the risk management options currently 
used can be the core of further development of specific mitigation options and these may be 
revised in future. 
10.4 Conclusion and recommendations 
1. Current methods for Isolation, enumeration and antimicrobial susceptibility testing 
used worldwide should be harmonised and it is necessary to establish internationally 
accepted standard methods. These standard methods should be implemented 
appropriately depending on the type and study objective. 
2. Appropriate mathematical and statistical methods should be included in all studies 
and as some limitations can be addressed using the appropriate approaches and 
complex, expensive lab methods may not be necessary. 
3. QMRA for estimating heath risk related to antimicrobial resistant Campylobacter 
should be re-considered. A revised model is necessary for the assessment and it will 
contribute to an effective risk management. 
4. Further studies on several aspects as addressed in previous chapters are required 
to reduce the gaps in the availability of data. 
10.5 Further prospects 
I would consider this work as the preliminary for my future work in Thailand. A number of 
issues arising from this study ignited my interest and enthusiasm for the application of risk 
analysis and related subjects (e.g. Bayesian statistics). In this light I would keen to: 
1. apply risk assessment to other aspects of food safety management in Thailand 
where control systems may be different from the system in the UK. These 
differences involving demography, tradition, culture, climate and other related issues 
greatly influence risk assessment and risk management; 
2. explore the usefulness of the potential of mathematical and statistical methods for 
the application of microbial risk assessment where, due to the characteristics of 
micro-organisms, uncertainties playa bigger role than in chemical risk assessment; 
3. introduce risk communication to in future evaluation of food safety management. 
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Appendix 1 
Media composition 
Appendix 1-1: Formular composition of Bolton broth 
Formula 
Meat peptone 
Lactalbumin hydrolysate 
Yeast Extract 
Sodium chloride 
Alpha-ketoglutaric acid 
Sodium pyruvate 
Sodium metabisulphite 
Sodium carbonate 
Haemin 
pH 7.4 + 0.2 
gm/litre 
10 
5.0 
5.0 
5.0 
1.0 
0.5 
0.5 
0.6 
0.01 
Appendix 1-2: Composition of the selective supplement 
Type of antibiotic mg/vial Action 
Cephalosporin (cefoperazone) 10 inhibits Enterobacter spp., 
Serratia spp., Pseudomonas 
aeruginosa, some Proteus spp., 
Yersinia enterocolitica 
T ri methopri m 10 inhibits Proteus spp. and gram 
positive cocci 
Vancomycin 
Cycloheximide 
10 
25 
inhibits gram positive cocci 
inhibits yeasts and moulds. 
Appendix 1-3: A com osition of 
Formula 
Nutrient Broth No.2 
Bacteriological charcoal 
Casein hydrolysate 
Sodium desoxycholate 
Ferrous sulphate 
Sodium pyruvate 
Agar 
H 7.4 + 0.2 
mllitre 
25.0 
4.0 
3.0 
1.0 
0.25 
0.25 
12.0 
lement 
Cefoperazone 
Amphotericin B 
m Ivial 
16 
5 
Appendix 1-4: Preparation of two-fold of concentration of antimicrobial 
Final plate conc.{mg/L) Stock used{mg/L) Vol. per 100ml 
1024 10000 10.24 ml in 90 ml 
512 5.12mlin95ml 
256 2.56 ml in 97.5 ml 
128 1280 IJI in 99 ml 
64 640 IJI 
32 320 IJI 
16 160 IJI 
8 
4 
2 
Final plate conc.(mg/L) 
1 
0.5 
0.25 
0.125 
1000 
Stock used(mg/L) 
100 
10 
800 IJI 
400 IJI 
200 IJI 
Vol. per 100ml 
1 ml 
500 IJI 
250 IJI 
1.25 ml 
Vol. per 20ml{lJl) 
2048 IJI in 18 ml* 
10241J1 in 19 ml* 
512 IJI 
256 IJI 
128 IJI 
64 IJI 
32 IJI 
160 IJI 
80 IJI 
40 IJI 
Vol. per 20m 1 
200 IJI 
100 IJI 
50 IJI 
250 IJI 
Appendix 1-5: The 0.5 McFarland standard is prepared by added O.5ml of O.048M BaCI~ 
(1.17%w/v BaCI2. 2H20) to 99.5ml of O.18M H2S04(1 %w/v) with constant stirring. It was 
distributed into a screw cap bottle of the same size and with the same volume as those used 
in growing the broth cultures. 
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Type of chicken 
PIC 
POC 
BIC 
Appendix 2 
Number of purchasing days 
Shop's Name 
M&S 
Morrison 
Sainsbury 
Tesco 
Waitrose 
M&S 
Morrison 
Sainsbury 
Tesco 
Waitrose 
Butchers'shop 
Branch 
Bounds Green 
Camden Town 
East Barnett 
Endfield Town 
Finchley 
Holaway 
Ponders End 
Wood Green 
Bounds Green 
Camden Town 
East Barnett 
Endfield Town 
Finchley 
Holoway 
Ponders End 
Wood Green 
Finchley 
Hackney 
Holaway 
Palmmers Green 
Ponders End 
Seven Sisters 
Wood green 
No. of purchasing day 
25 
15 
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Appendix 3 
Model Equations 
Appendix3- 1: A dose -response- relationship model 
A dose response model estimates a relationship between the level of microbial exposure 
and the likelihood of occurrence of adverse consequence. The basic assumption is that the 
probability of ingesting precisely j organisms from an exposure in which the mean dose is d 
organisms is Ptfj/d). The probability of k organisms (~j) surviving the immune system and 
able to initiate the infection is Plk/j). If the distribution of organisms between doses is 
random and hence it is Poisson distributed and that each organism has an independent and 
identical probability of surviving the immune defences and initiating infection. The overall 
probability of k organisms surviving to initiate the infection is given by 
00 
P(k) = I~(J/d)P2(k/j) 
j=1 
If infection occurs when the minimum number of the organisms (denoted as Kmm) survives 
and then initiating infection, the probability of infection may be given by 
Y: 00 
~nf = I I~(j / d)P2 (k / j) 
k=kmin j=k 
It is noted that Kmin may not be a single number but may in fact be a probability distribution 
(Haas ef a/., 1999). By using the exponential dose-response model, the model for estimating 
the dose can be simulated in which assumes that the distribution of organisms between 
doses is random (Poisson distribution). It is as well the organism has the independent and 
identical probability of survival, defined as r, and the single hit theory is applied, Kmm equals 
1. In addition, the survival is the binomial distribution. Therefore, the probability of infection 
can be re-written as 
00 00 d j ., ~ ~ -d][ J. (1 .)J-k k ~nf = ~ ~[-., e k!( '!-k) -/ r 
k=kmin J=k J. J 
This can be written in terms of d and r; 
Y: . i 
h· h' ~ [d(l-r)J1- e-d(l-r) this has As considering the second summation of equation, w IC IS ~ (j-k)! ' 
the form of a Poisson distribution, where 
-)1 n 
Pen) = _e _f.1_ 
n! 
j=k 
Of:; -11 /I 
. . th t' ~ e f.1 As such the summation It is therefore the summation of a POisson series, a IS ~ " ' 
n=O n. 
is equal to unity. Hence, as a function of the dose, d, is given by 
00 ( dr) k e -dr 
~nf(d; r) = I k' 
k =k'nin . 
Given that the summation of a poisson series is equal to unity. This can be re-written as 
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As the single-hit theory applied, kmin =1, this simplifies to give the equaton above. This is 
referred to the exponential dose response relationship. 
Finf (d; r) = 1 - e -rd 
The model assumes a constant survival probability; however, there may be variation in the 
probability of infection given host responses and pathogenicity of organisms. Therefore, the 
probability of the organisms surviving immune defences and initiating infection, that is r, is 
assumed to follow a beta-Poisson, then; 
Finf (d; a, 13) = 1 - [1 + ~ r a 
13 
Finf (d; a, 13) = 1 - [1 _ p] d 
Here p is the probability of infection from ingestion of one organism, d is the dose ingested. 
Given p - beta (a,~) where the parameter a,~ are the maximum likelihood estimates 
obtained from Medema et at. (a = O.145,~ = 7.589) the probability of illness given infection is 
obtained as; 
~11 linf (d; a, 13) = 1- (1- Beta(a, f3)d) 
Appendix3- 2: The Gibbs sampler (taken from Joseph et aI, 1995) 
For two diagnostic tests, the full conditional distribution are as follows: 
S1 / Y1, Y2, Y3'y4 a s\ ,13 s\ - Beta(Y1 + Y2 + a s\ ,Y3 + Y4f31i1) 
C /u v wx Y11 Y2 Y3Y4a ,13 -Beta(w+x-(Y3+ Y4)+a c\u+ v -(Yl +Y2)+f3q ) 1 " " , " q q 
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Appendix 4 
Exposure assessment 
Appendix 4-1 The probability of.infectio.n (%) following the consumption of a chicken meal 
prepared from three types of chicken given age, gender and internal temperatures at the protected areas. 
Age T~~e of chicken PIC POC BIC T<Tc T>Tc T<Tc T>Tc T<Tc T>Tc M F M F M F M F M F M F <18 18.8 18.8 0 0 58.9 58.9 3.7 3.7 100 100 100 100 18-29 34.1 21.8 1.9 0 82.8 64.7 5.5 3.7 100 100 100 100 30-65 26.1 21.8 1.9 0 72.9 65.4 5.5 3.7 100 100 100 100 >65 24.7 23.3 1.9 1.9 70.8 66.6 3.7 3.7 100 100 100 100 
Appendix 4-2 The probability of illness (%) following the consumption of a chicken meal 
prepared from three groups of chicken given age, gender and internal temperatures at the 
protected areas. 
T~~e of chicken Age PIC POC BIC T<Tc T>Tc T<Tc T>Tc T<Tc T>Tc M F M F M F M F M F M F <18 6.2 6.2 0 0 19.4 19.4 1.2 1.2 33.0 33.0 33.0 33.0 18-29 11.2 7.2 0.6 0 27.3 21.4 1.8 1.2 33.0 33.0 33.0 33.0 30-65 8.6 7.2 0.6 0 24.1 21.6 1.8 1.2 33.0 33.0 33.0 33.0 >65 8.2 7.7 0.6 0.6 23.4 22.0 1.2 1.2 33.0 33.0 33.0 33.0 
Appendix 4-3 The probability of infection and illness following the consumption of salad 
contaminated Campylobacter transferred from Three types chicken. 
Probability of infection (%) Probability of infection (%) Source PIC POC BIC PIC POC BIC 
Age M F M F M F M F M F M F 
<18 45.4 45.4 92.1 92.1 100 100 18.4 18.4 30.4 30.4 33.0 33.0 
18-29 69.6 52.2 99.3 95.4 100 100 26.4 20.7 32.8 31.5 33.0 33.0 
30-65 64.0 53.1 98.6 96.7 100 100 24.2 20.9 32.5 31.6 33.0 33.0 
>65 62.6 53.1 98.3 95.5 100 100 23.7 21.1 32.4 31.6 33.0 33.0 
Appendix 4-4 The probability of infection (%) fol.lowing the consu~ption of a chicken meal 
and salad contaminated with Campylobacter given group of chicken, age, gender and 
temperature 
Source of contamination 
PIC POC BIC 
Age T<Tc T>Tc T<Tc T>Tc T<Tc T>Tc 
M F M F M F M F M F M F 
<18 55.7 55.7 45.4 45.4 96.8 96.8 92.4 92.4 100 100 100 100 
18-29 80.0 62.6 70.2 52.2 99.9 98.4 99.3 95.6 100 100 100 100 
30-65 73.4 63.3 64.6 53.1 99.6 98.5 98.6 95.8 100 100 100 100 
>65 71.9 64.0 63.3 54.0 99.5 98.5 98.4 95.7 100 100 100 100 
Appendix 4- 5The probability of illness (%) following the consumption of a chicken meal and 
salad contaminated with Campylobacter given group of chicken, age, gender and 
temperature 
Source of contamination 
PIC POC BIC T<Tc T>Tc T<Tc T>Tc T<Tc T>Tc Age M F M F M F M F M F M F <18 18.4 18.4 15.0 15.0 31.9 31.9 30.1 30.5 33.0 33.0 33.0 33.0 18-29 26.4 20.7 23.2 17.2 33.0 33.0 32.8 31.6 33.0 33.0 33.0 33.0 30-65 24.2 21.0 21.4 17.5 32.9 32.5 32.5 31.6 33.0 33.0 33.0 33.0 >65 23.7 21.1 21.0 18.0 32.9 32.5 32.5 31.6 33.0 33.0 33.0 33.0 
Appendix 4- 6 The probability of illness (%) following the consumption of an immediately 
cooked and delayed cooked chicken (PIC) meal given age, gender and internal temperature 
Immediate preparation Delayed preparation Age T<Tc T>Tc T<Tc T>Tc M F M F M F M F 
<18 6.2 6.2 0 0 0.06 0.06 0 0 18-29 11.2 7.2 0.06 0 1.2 0.06 0 0 30-65 8.6 7.2 0.06 0 1.2 0.06 0 0 
>65 8.2 7.7 0.06 0.06 1.2 1.2 0 0 
Appendix 4-7 The probability of illness (%) following the consumption of salad contaminated 
with Campylobacter isolated from PIC given age and gender. 
Age 
<18 
18-29 
30-65 
>65 
Immediate preparation 
M F 
15.0 15.0 
17.2 23.0 
17.5 21.1 
17.5 20.7 
Delayed preparation 
M F 
1.8 1.8 
2.4 4.1 
2.4 3.5 
2.4 3.5 
Appendix 4-8 The probability of illness (%) following th~ consumption of an imm~diately 
cooked and delayed cooked chicken (POC) meal given age, gender and Internal 
temperature 
Immediate preparation Delayed preparation 
Age T<Tc T>Tc T<Tc T>Tc 
M F M F M F M F 
<18 19.4 19.4 1.2 1.2 3.5 3.5 0 0 
18-29 27.3 21.4 1.8 1.2 6.7 4.1 0 0 
30-65 24.1 21.2 1.8 1.2 5.2 4.6 0 0 
>65 23.4 22.0 1.2 1.2 5.2 4.6 0 0 
A endix 4-9 The probability of illness (%) associate~ with the consumption c:~aminated with Campylobacter contributable for POC given age and gender. 
Age 
<18 
18-29 
30-65 
>65 
Immediate preparation Delayed preparation 
Male Female Male Female 
30.4 30.4 9.5 9.5 
32.8 31.5 16.0 11.2 
32.5 31.6 14.3 11.2 
32.4 31.5 14.0 11.2 
of salad 
27-1 
Appendix 4·10 The probabilit~ of illness (%) following the consumption of an immediately 
cooked and delayed cooked chicken (BIC) meal given age, gender and internal temperature 
Immediate ereearation Dela~ed ereearation Age T<Tc T>Tc T<Tc T>Tc M F M F M F M F 
<18 33.0 33.0 33.0 33.0 33.0 33.0 33.0 33.0 18-29 33.0 33.0 33.0 33.0 33.0 33.0 33.0 33.0 30-65 33.0 33.0 33.0 33.0 33.0 33.0 33.0 33.0 
>65 33.0 33.0 33.0 33.0 33.0 33.0 33.0 33.0 
Appendix 4·11 Probability of illness of person consumed chicken harbouring ciprofloxacin-
resistant Campylobacter after heat treatment given age, gender and group of chicken. 
Internal temperature of cooking (T): T<Tc 
Age (year) ~~P~ro~b~ab~i~lit~y~(O~~~):~M~ __ ~P~r~ob~a~b~ili~ty~(~%~)~:F~ __ =P~r~o~ba~b~il~itY~(~~o)~:M~ __ ~Pr~o=b~ab~iI~it~y~(~~o)~:~F~ 
PIC POC BIC PIC POC BIC PIC POC BIC PIC POC BIC 
Internal temperature of cooking (T): T>Tc 
<18 
18-29 
30-65 
>65 
Average 
6.2 0 33 6.2 0 33 0 0 33 0 0 33 
11.2 0 33 7.2 0 33 0 0 33 0 0 33 
8.6 0 33 7.2 0 33 0 0 33 0 0 33 
8.2 0 33 7.7 0 33 0 0 33 0 0 33 
8.55 0 33 7.08 0 33 0 0 33 0 0 33 
Appendix 4·12 Probability of illness of person consumed chicken harbouring erythromycin-
resistant Campylobacter after heat treatment given age and gender. 
Age 
<18 
18-29 
30-65 
>65 
Internal temperature of cooking (T1 ): T <T c 
Probability (%): M Probability (%): F 
PIC POC BIC PIC POC BIC 
6.2 19.4 33 6.2 19.4 33 
11.2 27.3 33 7.2 21.4 33 
8.6 24.1 33 7.2 21.6 33 
8.2 23.4 33 7.7 22.0 33 
Internal temperature of cooking (T): T>Tc 
Probability (%): M Probability (%): F 
PIC POC BIC PIC POC BIC 
o 1.2 33 0 1.2 33 
0.6 1.8 33 0 1.2 33 
0.6 1.8 33 0 1.2 33 
0.6 1.2 33 0.6 1.2 33 
Appendix 4·13 Probability of illness of person consumed chicken harbouring nalidixic acid-
resistant Campylobacter after heat treatment given age and gender. 
Age 
<18 
18-29 
30-65 
>65 
Internal temperature of cooking (T1): T<Tc 
Probability (%): M Probability (%): F 
PIC POC BIC PIC POC BIC 
6.2 18.7 33 6.2 18.7 33 
11.2 26.8 33 7.2 20.7 33 
8.6 23.4 33 7.2 20.9 33 
8.2 22.8 33 7.7 21.4 33 
Internal temperature of cooking (T): T>Tc 
Probability (%): M Probability (%): F 
PIC POC BIC PIC POC BIC 
o 1.2 33 0 1.2 33 
0.06 1.8 33 0 1.2 33 
0.06 1.2 33 0 1.2 33 
0.06 1.2 33 0.06 1.2 33 
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